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Chapter 1 
Introduction and Aims of the Thesis 
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With aging all tissues are subjected to degenerative processes. For the vascular bed this process 
is called atherosclerosis and involves thickening and induration of one or more layers of the 
vessel wall, of mainly the arteries. Atherosclerosis of the coronary arteries starts at a young age, 
but remains symptomless for many years. During this period atherosclerotic lesions mature from 
fatty streaks to fibrous lesions and lipid laden plaques with calcifications and ulceration ofthe 
endothelial surface. This maturing process is accompanied by a narrowing or stenosis of the 
diseased coronary atieries. Eventually, the stenosis may become severe and restrict blood flow 
to the distribution territory of the diseased coronary artery. 
The heart is an aerobic organ and relies on oxygen to maintain its contractile function and 
viability. Under nom,.l conditions oxygen is already nearly maximally extracted from the blood 
atld an increase in oxygen dematld will primarily be met by an increase in coronary blood flow. 
Even under conditions of strenuous exercise healthy coronary arteries can meet the increased 
energy demand ofthe myocardium. However, in the presence of a coronary artery stenosis, the 
energy demand may not be met and an imbalance develops between demand and supply, leading 
to regional myocardial ischemia. The latter is characterized by anaerobicmetabolism (e.g. lactate 
extraction changes to lactate production), loss of regional contractile function and potentially 
lethal arrhytlmlias. 
TIle ultimate fate of ischemic myocardium depends on the duration and the severity of the 
coronary artery occlusion, and the ability to supply the ischemic myocardium via coronary 
collaterals. Complete coronary occlusions lasting less than 2 minutes have no persisting effects 
on the myocardium, as upon reperfusion there is an almost immediate recovery of contractile 
function. I On the other hand when severe myocardial ischemia persists longer than 20 minutes 
myocardial cells start to die and contractile function will never fully recover after institution of 
reperfusion.2 With ischemic episodes lasting between 2 and 20 min myocardial cells remain 
viable, but when perfusion of the ischemic myocardium is restored there will be no immediate 
recovery of contractile function as tIus may remain depressed for hours to days. TIns 
phenomenon of prolonged contractile dysfunction of reperfused viable myocardiwn has first been 
described by Heyndrickx et al' and is called myocardial stunning. 
When a region of the myocardium is stunned, there is no need for treatment when the 
remainder of the myocardium is functioning nonnally and global left ventricular function is not 
compromised. However, when stumnng is so severe that global left ventricular fimction becomes 
impaired, stunning may require treatment. Chapter 2 presents an overview of the different 
pharmacological modalities that have been used to prevent and treat myocardial stunning. 
Stunning is usually examined in the left ventricle. Little is known about the development 
of stunning in the right ventricle and its response to phannacological interventions. Because 
filling of the left ventricle is dependent on the cardiac output of the right ventricle, loss of right 
ventricular contractile function may also compronuse global left ventricular filllction.4 Thus, the 
response of the stunned right ventricle to inotropic stimulation could play an important role in 
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the restoration of global left ventricular function. In chapter 3 the effect of a brief occlusion of 
the left anterior descending coronary artery on both left and right myocardial contractile function 
has been examined and the responses of stunned left and right myocardium to chronotropic and 
inotropic stimulation were studied. 
The mechanisms behind the sustained contractile dysfunction of stunned myocardium are 
still not very well understood. Bolli reviewed many of the proposed hypotheses and concluded 
that an action of oxygen-derived free radicals and a disturbance of the intracellular calcium 
handling are the most likely mechanisms leading to stunning.' The intracellular location of this 
disturbance, however, has been a major point of discussion (Figure I). Krause et al proposed that 
a decreased calcium uptake by the sarcoplasmic reticulum and subsequent decrease in calcium 
transient underlies the prolonged contractile dysfunction of post-ischemic myocardium.6 This 
hypothesis has been challenged by Lamers et al who found that the maximal calcium uptake by 
the sarcoplasmic reticulum isolated from stunned myocardhffil had not decreased.' Kusuoka and 
Marban, who had found that in stunned myocardium calcium transients were increased,s also 
challenged the hypothesis of Krause et ai' and advocated a decrease in the sensitivity of the 
myofilaments to calcium as a major factor l.U1derlying myocardial stUlUling.8 Current view holds 
that the fonnation of free radicals during ischemia and early reperfusion and the subsequent 
decrease in the sensitivity of the myofilaments to calcium are likely mechanisms underlying 
myocardium stunning.5,9 Thus, a rational therapy for stunned myocardium should be either to 
inhibit the foonation oxygen-derived free radicals or to restore the calcium sensitivity of the 
myofilaments. The role of oxygen-derived free radicals in the genesis of myocardial stunning 
and its prevention by free radical scavengers has been studied and reviewed extensively (see ref 
5) and the role of free radical scavengers in ameliorating stunning has therefore not been 
reviewed in chapter 2. 
Until recently in vivo evidence for a decreased calcium sensitivity of the myofihrils as a 
cause of stunning could not be obtained, because all available calcium sensitizing agents also 
possessed phosphodiesterase inhibitory properties, and could therefore enhance myocardial 
contractile function by a mechanism different from calcium sensitization of the myofibrils. In 
this thesis the effects of a novel calcium sensitizer EMD 60263, which is devoid of 
phosphodiesterase inhibiting properties, on contractile function of nomlal and stunned 
myocardium have been investigated (Chapter 4). TIlere is some scepticism about the therapeutic 
use of calcimn sensitizers to restore myocardial contractility.l0 In stUlU1ed myocardium levels of 
intracellular calcium are increased and enhancing the calcium sensitivity of the myofilaments 
may impair diastolic relaxation and myocardial filling. \Ve have addressed this issue in chapter 
5 by studying the effect ofEMD 60263 on diastolic function of normal and stunned myocardium. 
To investigate whether EMD 60263 indeed increased myocardial contractile function by 
enhancing the myofibrillar calcium sensitivity, we have also tested the effect of this agent on 
isolated purified sarcoplasmic reticulum vesicles and myofibrils (chapter 6). In figure I is shown 
how these two cell organelles are involved in nonnal intracellular handling of calcium during the 
Introduction and aims of the thesis 11 
SARCOLEMMA MVOFILAMENTS 
Fig 1. Schematic presentation of the Intracellular calcium handling of the myocardium. The numbers 1. 2 and 3 
depict possible locatiQns of a disturbance In the calcium handling. A decrease in available aclivator calcium (1) 
caused by a decreased calcium uptake by the sarcoplasmic relfculum (3) has been proposed as underlying the 
prolonged post-ischemIc myocardial dysfunction. However, current view holds that foonatlon of oxygen-derived free 
radicals causes a decrease in the myofibrillar sensitivity to calcium (2). Ca2+=calcium ion; SR=sarcoplasmic 
reticulum, TnC=lroponin C. 
excitation-contraction coupling. From a homogenate of stunned and not-stunned porcine 
myocardium sarcoplasmic reticular vesicles and myofibrils are purified and subsequently 
biochemically characterized before their response to EMD 60263 was tested. 
In the second part of this thesis the modulation of atherosclerosis in the vena-arterial bypass 
grafts was studied. Atherosclerosis in the coronary vasculature can become so severe that the 
viability of the myocardium becomes at risk because of impaired blood supply and therefore the 
need for coronary revascularization develops. Coronary bypass grafting and percutaneous 
transluminal angioplasty with or without stenting are the most often used approaches to restore 
normal myocardial perfusion. The ultimate success of these interventions, however, is hampered 
by an ensuing accelerated development of atherosclerosis. 
Bang et al have reported, that in the Inuit population (Eskimos on the west coast of 
Greenland) the mortality from cardiovascular disease was lower than in a comparable population 
of Danes. 1I This observation has been correlated with a high intake of fish oil. These 
epidemiological findings were followed by a large number of experimental studies showing that 
n-3 fatty acid component of fish oil has potential beneficial effects on the risk factors of 
atherosclerosis such as plasma lipoprotein levels, thrombosis, hypertension, endothelial 
dysfunction and inflammatory response. These aspects are reviewed in chapter 7. The 
experimental studies primarily concent arterial atherosclerosis, however, as knowledge on the 
effects of fish oil in vena-arterial bypass grafts is limited. In the subsequent chapters it was 
therefore investigated whether fish oil call modulate not only the progression (chapter 8), but also 
the regression of atherosclerosis (chapter 9) in vein grafts. 
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In saphenous vein grafts the benefits of fish oil may stretch from reduction in platelet 
aggregation to inhibition of fibrointimal' hyperplasia. Fish oil, administered prior to coronary 
bypass surgery, may in the early post-operative phase decrease the incidence of thrombosis. This 
will not only decrease early failure, but, as thrombosis is also implicated in the development of 
fibrointimal hyperplasia (due to release of growth factors from the activated platelets), improve 
the long-tenn patency rates of vein grafts. The prevention of intimal hyperplasia in both vein 
grafts and aorta by fish oil is discussed in chapter 8. Once intimal hyperplasia has developed in 
the vein graft fish oil may still exert a favorable effect as it may alter the chemical composition 
of the lipids present in the lesion. The latter can facilitate the removal of the lipids from the 
vessel wall. Furthenuore, the action of several cellular components in the intima is modified by 
fish oil, and thus fish oil may reduce the release of growth factors. Therefore, in chapter 9 not 
the preventive effect, but the regressive effect of fish oil on intimal hyperplasia in saphenous vein 
grafts is the focus of attention. 
Aims of the thesis 
In chapters 2 to 6 the focus of attention is the prolonged post-ischemic myocardial contractile 
dysfunction, myocardial stunning and the various phannaceutical modalities of treating this 
phenomenon. A decrease in myofibrillar calciwn sensitivity is likely to Wlderlie this phenomenon 
and current inotropic drugs overcome this decrease in myofibrillar calcium sensitivity by 
increasing the calcium transients. A more rational therapy is to restore the myofibrillar calcium 
sensitivity with calcium sensitizers. We have therefore investigated the effects of myofibrillar 
calcium sensitization with EMD 60263 on systolic and diastolic function. 
Chapters 7 to 9 focus on the problems conceming revascularisation of the myocardium with 
venous coronary artery bypass grafting. In vein grafts atherosclerosis occurs in an accelerated 
fashion and is responsible for late graft failures. Although fish oil has been shown to inhibit 
intimal thickening of the graft, the role of lipoproteins is still unclear. We have therefore 
investigated the role of modulation of plasma lipoproteins by fish oil on progression and 
regression of vein graft atherosclerosis. 
E.\perimenlal madel 
Studies have been perfonned in pigs, not only because of the extensive experience that exists 
with this species in the laboratory of Experimental Cardiology, but also because the pig is 
particularly suited for cardiovascular studies. The latter has been doubted for a long time 
although Leonardo da Vinci already used pigs to demonstrate the motion of the heart nearly five 
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centuries ago. Among those who questioned the usefulness of pigs in biomedical research was 
the Russian physiologist Pavlov, who after he brought a pig into his laboratory found its 
shrieking so disruptive that he banned pigs from his laboratory with the declaration that all swine 
are hysterical. 12.13 
In the last 20 years the pig has gained an increasing popularity in biomedical research. Tllis 
has not only been the consequence of scientific considerations as many laboratories replaced 
dogs as their animal model by pigs, but also because of factors such as costs and adverse pressure 
on the use of dogs in biomedical research. A number of considerations which makes the porcine 
model so useful for the studies described in this thesis are listed below. 
Compared to the dog the pig has a coronary arterial anatomy more similar to that of man.(14} 
Post mortem studies of the porcine heart also revealed similarities between man and pigs in 
intramural branching patterns, supply to papillary muscles and nodal conduction tissue. Rather 
striking differences exist between the presence and function of coronary collateral vessels in 
normal hearts of dogs and pi~s. Dog hearts usually have many subepicardial and intraseptal 
anastomoses, the number of which may vary, whereas in pig hearts only few subendocardial 
anastomoses are found. 14 Because ofthe wide range in the number of coronary collaterals that 
can be fo~nd in dogs a coronary artery occlusion in this species may result in different degrees 
of myocardial ischemia and mortality rates whereas in pigs an acute coronary artery occlusion 
invariably results in severe ischemia. Furthemlore, complete coronary artery occlusion in pigs 
has a higher mortality from ventricular fibrillation than in dogs." In the pig the innate collateral 
circulation in the distribution territory of left anterior descending and left circumflex coronary 
arteryis approximately 1.0 and 5.5 ml/nlinIlOOg, respectively ofa total blood flow of 100-130 
mVminil OOg.16 Pigs can develop coronary collaterals, however. Twelve weeks after implantation 
of an ameroid constrictor around the left circumflex coronary artery, collateral blood flow to the 
myocardium supplied by the left circumflex coronary artery can be as lligh as 80% ofleft anterior 
descending coronary artery blood flow at rest and approximately 50% during exercise. Because 
of the potential contribution ofthe collateral blood flow to myocardial perfusion in normal dogs, 
myocardial perfusion must be determined (e.g. with radioactive microspheres) after a native 
coronary artery has been occluded in order to determine the perfusion deficit. In normal pigs 
there is usually no need for such additional measurements as collateral perfusion will invariably 
be less than 5% of baseline. 
Domestic swine develop atherosclerosis spontaneously as they grow older and early lesions 
and their location closely resemble those in man. 17,18 But just as in man atherosclerosis is a slow 
process. However, the development of atherosclerotic lesions can be accelerated by either 
hypercholesterolemia or endothelial denudation or a combination of both interventions. '9 In 
contrast, dogs rarely develop atherosclerosis and are more resilient to hypercholesterolemia than 
pigs. The atherosclerosis process in dogs also has a higher media involvement than in humans, 
monkeys or pigs.20.21 Furthermore, the response to injury in the coronary arteries are different for 
pigs and dogs. Schwartz et al damaged coronary arteries in pigs and dogs using tantalum stents 
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on oversized balloons and observed that, despite similar injury scores, dogs have significantly 
less neointimal thickening and area stenoses than pigs.22 Their results also suggested that there 
was no relation between injury and neointimal thickness in dogs and therefore the authors 
proposed the pig as a morc appropriate model to study the development of neointima. Other 
characteristics which lllay promote pigs as a better model to study the development and 
regression of atherosclerosis than dogs are the lipoprotein metabolism and the fibrinolytic 
system,23,24 In contrast to humans dogs have very low levels oftriglycerides, VLDL and LDL. 
Lipoproteins may therefore have a d~fferent role in the pathogenesis of atherosclerosis.(23) In 
contrast synun lipoprotein profile in pigs and humans is quite similar, and from previous studies 
from our laboratory it appears that in pigs the plasma lipoproteins respond to modulation with 
dietary n-3 fatty acids.25-21 1brombosis is often implicated in the development of atherosclerosis. 
TIle higher activity of the fibrinolytic system in dogs warrants caution in the interpretation of 
intervention studies that may produce thrombosis.28 
In the atherosclerosis studies ofthis thesis we have used Gottingen miniature swine, instead 
of the usual fann pigs (Yorkshire x Landrace), which have been used in the myocardial sturming 
experiments. Farm pigs grow rapidly and will reach an adult weight approaching or exceeding 
300 kg if fed ad libitlllll." This weight gain limits the use of these farm pigs in long lasting 
experiments. The problem of size can be overcome by using breeds of miniature swine. The 
Gottingen miniature swine is not a naturally occurring breed of miniature swine, such as the 
Yucatan, Kangaroo Island, Lee Sung and Assam Pigmy Hog, but is the result of a breeding 
program with 4 strains of breeding stock at the University ofG5ttingen in G5ttingen, Germany." 
Miniature swine with their smaller stature and lower rate of growth pose less demands and thus 
are more economical in care and feeding. An advantage of Gottingen miniature swine is that they 
respond better to high cholesterol feeding than Yorkshire x Landrace pigs. In a pilot study we 
have found in G5Uingen miniature swine that with a 2% cholesterol diet their plasma cholesterol 
level increased from 3 mM to 15 mM, prior and after 2 weeks of diet, respectively. In a previous 
study from our laboratory we had to add bile acids to the diet of farm pigs to increase their 
plasma cholesterol level from 2 mM to to mM.JO Moreover, Kobari et al have shown that high 
fat and high cholesterol feeding induced fatty streaks and fibrous lesions in the aorta of G5ttingen 
miniature swine.J1 The same group of investigators also reported that the a cholesterol lowering 
diet induces regression of fatty streaks in the aorta of Gottingen miniature swine.(31) 
In spite of the similarity ofthe atherosclerotic process in the pig compared to that of man, 
the cost and duration of the studies, often exceeding a period of one year, limit its general 
acceptance and has led to the development of other experimental pig-models, which produce 
results in a shorter period of time. Considerable attention has therefore been paid to the 
development of lesions in saphenous vein grafts implanted as an end-to-end anastomosis in the 
carotid artery. The advantage of this model is that the lesions in the grafts, which show a large 
degree of similarity with lesions in human vein grafts, already develop without a specific dietary 
intake and within a much shorter period oftime (1-2 montllS). Angelini and Newby proposed that 
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tltis model is ideal to test anti-atherosclerotic therapies, because of the analogy between graft mld 
arterial atherosclerosis mld because atherosclerosis arises more rapidly and predictably in grafts 
than in native coronary arteries.32 
16 
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Pharmacological Modulation of Myocardial Stunning 
Dirk J. DUllcker, MD, PhD, Loe Kie Soei, MD, Pieter D. Verdouw, PhD. 
When regional myocardial stunning leads to impairment of global left ventricular 
function pharmacotherapy may become important. In this chapter we review rational 
modalities of treatment, based on our current understanding of the mechanisms and 
pathogenesis of stunning. After stunning has been established, only administration of 
positive inotropic agents (Il-adrenoceptor agonists, calciun\, calcium promotors and 
calcium-sensitizers) results in complete recruitment of contractile function. In view of 
the role of oxygen-derived free radicals in the pathogenesis of stunning, it is not 
surprising that only those agents that exhibit at least some free radical scavenging 
properties (e.g. prostacyclinmimetics, ACE inhibitors, calcium antagonists and 
ubiquinone) attenuate myocardial stunning. The observations that the degree of 
stunning is determined by the severity of the preceding period of ischemia implies that 
recovery of post-ischemic function can also be enhanced by pretreatment (or treatment 
at the onset of ischemia) with agents that reduce the severity of ischemia or the 
associated calcium overload (e.g. Il-adrenoceptor antagonists, calcium antagonists, 
adenosine, K'ATP channel openers and NIt!l-f exchange inhibitors). A wide variety of 
phannacological interventions are presently available for prevention or treatment of myocardial 
stunning, but the choice and hence the efficacy of specific treatment depends critically on the 
timing of the intervention. 
(In Vainer SF, Heyndrickx G, Wijns W (eds) : Inlrinsic adaplive mechanisms during 
Ischemia and reperfusion, Fulura Publishing) 
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Although contractile function of regionally stunned myocardium ultimately recovers 
completely, 1,2 it may temporarily produce critical impairment of global left ventricular function. 
This is especially true for patients who already have a compromised left ventricular function. 
Therefore, the development of pharmacological strategies for treatment and prevention of 
myocardial stunning is important. 
The fIrst approach to improve post-ischemic dysfunction of stunned myocardium involved 
the use of positive inotropic agents.3 A rational therapy should, however, be based on an 
understanding of the pathogenesis of myocardial stunning. A number of mechanisms have been 
fonvarded to explain stunning, including loss of- and reduced ability to synthesize high-energy 
phosphates, impairment of microvascular perfusion, impairment of sympathetic neural 
responsiveness, generation of oxygen-derived free radicals, activation of leukocytes, reduction 
in the activity of creatine kinase, and disturbances in calcium homeostasis.4.7 At the present time, 
the release of oxygen-derived free radicals together with calcium overload during the early phase 
of reperfusion are cOllSidered to be key events in the pathogenesis of stunning,4,5 which may 
cause a decreased sensitivity of the myoflbrils to calcium.6.7 
Understanding of the limitations of the parameters that are used to describe contractile 
function and the modulation of the severity of myocardial stunning by the experimental 
conditions are pivotal for proper assessment of pharmacological interventions aimed at 
amelioration of stunning. III vitro studies usually employ models of global myocardial ischemia 
and therefore use global cardiac function parameters such as left ventricular developed pressure 
(isovolumically beating hearts) and cardiac output (working hearts) to assess the degree of 
stunning. In ill vivo experiments stunning is produced regionally by temporary occlusion of a 
coromiry artery, requiring measurement of local contractile function parameters such as regional 
segment shortening or wall thickening. However, all of these parameters are preload- and 
afterload-dependent and are therefore not a true measure of intrinsic myocardial contractility. 
Furthermore, afterload-dependency may be further increased in stunned compared to normal 
myocardium.s Consequently. measurements of left ventricular developed pressure, cardiac output 
and systolic wall thickening and segment shortening should ideally be made under identical 
loading conditions. Alternatively, changes in left ventricular pressure should be included in the 
assessment of contractile performance by using parameters derived from the left ventricular 
pressure-volume or left ventricular pressure-segment length (or wall thickness) relations such 
as external work and maximal elastance.s.lI 
The degree of stunning is determined in part by the ischemic burden (flow defIcit and 
duration),12 which suggests that either formation of the amount of oxygen-derived free radicals 
or the myocardial susceptibility to the damage by oxygen-derived free radicals increases with 
the severity of the ischemic insult. Consequently, in studies of pharmacological modulation of 
stuiming measurement of residual myocardial perfusion during ischemia is a necessity. This is 
particularly true for animals which possess an extensive coronary collateral circulation such as 
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the dog. Labeled microspheres are the fIrst choice of measurement as this technique allows 
measurement of residual myocardial blood flow and its transmural distribution. Animals such 
as the pig have negligible collateral blood flow, so that in acute experiments measurement of 
residual myocardial perfusion during total coronary artery occlusion is less mandatory. 
Studies of myocardial stunning have been performed in a large variety of ill vitro (often 
non-blood perfused) and ill vivo models and stunning has thus been produced under very 
different experimental conditions. III vitro heart preparations not only suffer from limited 
hemodynamic stability but also from progressive edema formation, allowing only a short period 
in which recovery afpost-ischemic function can be studied. Furthermore, durations of ischemia 
that do not result in myocardial necrosis under ill vivo conditions, may already produce 
irreversible damage in isolated perfused hearts. Thus Borgers et al 13 observed that even a 15-
minute period of global ischemia in isolated rabbit hearts irreversibly damaged 8% of the 
myocytes. In in vivo studies the importance of the experimental conditions is illustrated by 
observations that post-ischemic contractile dysfunction is more pronounced in pentobarbital-
anesthetized open-chest than in awake dogs." An explanation might be that pentobarbital 
. anesthesia, in part via altering hemodynamic conditions, results in higher oxygen demand at the 
onset of ischemia.14 The effect of anesthesia on myocardial oxygen demand and its importance 
for the degree of stunning is also suggested by other studies. Thus, halothane1S or isofluranel6 
anesthesia, which were associated with significantly lower levels of myocardial work than 
fentanyl15 or morphinelet-chloralose/urethane anesthesia, 16 resulted in better recovery of 
contractile function following a IS-minute coronary artery occlusion in dogs. Unfortunately, in 
these studies post-ischemic recovery was not detennined at similar afterloads which precludes 
a defInite conclusion regarding the role of anesthesia as a determinant of the degree of 
myocardial stunning. Another variable that can influence functional recovery of stunned 
myocardium is temperature. Open-chest animal preparations are more susceptible to temperature 
variations than awake animals. Triana et al showed that a decrease in body core temperature by 
as much as 2°C markedly improved function of the stunned region with minimal effect on 
function of remote nomlal myocardium.14 Consequently, a rigorous control of body temperature 
is required in open-chest studies of myocardial stunning. Finally, recovery of post-ischemic 
contractile function has been examined in models which employed periods of ischemia that may 
have produced a mixture of both reversible and irreversible myocardial injury. In these studies 
recovery of regional function wiII in part depend on the amount of irreversibly damaged 
myocardium. Only those studies that have employed periods of ischemia which exclusively 
produce reversible injury will be discussed. 
In this chapter we will fIrst address studies in which pharmacological agents were 
administered after myocardial stunning had been produced. Subsequently we will review studies 
of agents that act primarily by decreasing the severity of myocardial ischemia and/or prevent the 
development of stunning by interfering with formation of oxygen-derived free radicals or 
calcium overload during early reperfusion. For an extensive discussion of the therapeutic 
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potential of scavengers of oxygen-derived free radicals, such as super oxide dismutase and 
catalase, the reader is referred to reference 5 in which the role of oxygen-derived free radicals 
in the pathogenesis of stunning has been discussed in great detaiL 
Positive inotropic dl'ugs 
Adrenergic receptor agollists 
Little was known about the origin of its functional abnonnalities when the ftrst studies were 
undertaken to stimulate contractile function of stunned myocardium. Initially. it was believed 
that the deterioration of contractile function after its initial recovery following a brief coronary 
artery occlusion was due to reperfusion damage. To investigate the nahlre of this reperfusion 
damage, Smithl1 subjected anesthetized dogs to a lO-minute left anterior descending (LAD) 
coronary artery occlusion followed by IS minutes ofreperfusion resulting in an 85% decrease 
of velocity of early systolic shortening. The post-ischemic dysfunction was associated with a 
depressed blood flow and oxygen consumption. However, oxygen extraction was not altered and 
lactate production remained positive, indicating that stunned myocardium was distinctly different 
from ischemic myocardium. An intracoronary infusion of isoprenaline (0.1 ?lg/min for 10 
minutes) restored velocity of shortening and increased regional myocardial oxygen consumption 
but did not result in a change in lactate extraction, which would have been expected if stunned 
myocardium contained residually ischemic myocardium. An intracoronary bolus injection of 
isoprenaline (0.1 ~g) also improved early systolic shortening of stunned myocardium, reaching 
a maximum 30 seconds after injection. The effect disappeared within 10 minutes after the bolus 
injection, suggesting that isoprenaline increased contractility without modifying the mechanism 
that underlies myocardial stunning. Similarly, Bolli et al18 reported that after 3 hours of 
reperfusion following a IS-minute LAD coronary artery occlusion systolic wall thickening of 
the akinetic segment could be restored to pre-ischemia levels with isoprenaline (0.1 ",g/kg/min, 
iv) for up to 30 minutes, but that function returned to pre-infusion levels after the infusion was 
stopped. Becker et a1'9 demonstrated that the inotropic response to intravenous infusions of 
epinephrine could be sustained for I hour when myocardium stunned by 12 sequences of 5-
minute LAD coronary artery occlusion and 10 minutes of reflow, was stimulated after I-hour 
ofreperfusion. After termination of the infusion contractile function declined to similar values 
as observed after Ule I hour reperfusion period. These early studies indicated that p-agonists are 
capable of recruiting contractile reserve of stunned myocardium without deleterious effects. 
Nonetheless, in stunned myocardium oxygen consumption was reported to be abnormally high 
with respect to the work performed, implying a reduced mechanical efficiency.20,21 Therefore, 
we studied the effect of inotropic stimulation on mechanical efficiency of stunned porcine 
myocardiumy,22 Two sequences of lO-lllinute coronary artery occlusion and 30 minutes of 
reperfusion decreased systolic segment shortening from 18±2% to 7±2%, while external work 
(represented by the area enclosed by the left ventricular pressure- segment length relation) 
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decreased to 50% of baseline. Since myocardial oxygen and lactate consumption decreased to 
70% and 15% of baseline, respectively, a significant decrease in mechanical efficiency (defined 
as the ratio of external work and oxygen consumption) occurrecl.22 Intravenous infusion of low-
dose dobutamine (2 {lglkglmin) increased segment shortening, external work and oxygen 
consumption to baseline levels, so that mechanical efficiency was restored. In a subsequent 
study, using the left ventricular end-systolic pressure-segment relation, we showed that stunning 
not only decreased maximal elastance (Enta,) and external work, but also increased the potential 
energy,lI suggesting that the impaired mechanical efficiency was the result of a reduction in 
efficiency of energy transfer from total work to external work. The effect of dobutamine on 
mechanical efficiency could be explained by the increased efficiency of energy transfer, which 
resulted from the increase in maximal elastance. Importantly, dohutamine restored mechanical 
efficiency without evidence of anaerobic metabolism, reflected by the dobutamine-induced 
increases in oxygen and lactate consumption.22 Our findings are supported by Kida et al who 
reported that in porcine myocardium subjected to a I5-minute coronary artery occlusion, ATP 
loss was not aggravated when swine received a high dose of dobutamine (10 {lglkglmin) 
throughout the 120-lIlinute reperfusion period.v These studies suggest that inotropic stimulation 
does not aggravate post-ischemic contractile and metabolic abnormalities. 
To investigate whether the contractile reserve of stunned myocardium is impaired, Becker 
et al titrated an intravenous dose of epinephrine to produce a maximal increase in systolic 
segment shortening. Twelve cycles of a 5-minute coronary occlusion followed by 10 minutes 
of reperfusion decreased segment shortening from 21.8% to 7.9% at 60 minutes of recovery. 
Due to occurrence of arrhythmias in response to the same dose of epinephrine during the post-
ischemic period, slightly lower doses had to be infused in 4 of the 1 I animals, so that the average 
dose of epinephrine was 24.5 {lglmin at baseline and 20.6 {lglmin following stunning. 
Consequently, the post-ischemic maximal response (24.9% shortening) remained somewhat 
below the maximal response to epinephrine given before ischemia (30.5%), but a similar trend 
was found in the remote control segment (l7.0% vs 22.1%), suggesting that contractile reserve 
of the stunned region was not different from that of normal myocardium. To minimize the 
influence of loading conditions we used end-systolic pressure-segment relations to study the 
effect of a low dose of dobutamine (2 {lglkglmin, iv) on maximal elastance (E=,) of stunned and 
nonnal myocardium.2{ A lO-minute coronary artery occlusion and 30 minutes of reperfusion in 
open-chest swine decreased segment shortening and Ema-,: to 55% and 40% of baseline, 
respectively. Dobutamine increased segment shortening and Ema-,: to 95% and 170% of baseline 
in the snmned left ventricular region, respectively. In the normal region dobutamine had no 
effect on segment shortening but increased EmA-'I: to 165% of baseline. These studies suggest that 
stunned myocardium is more sensitive to inotropic stimulation, but that it does not exhibit a 
decreased contractile reserve compared to normal myocardium. 
In conclusion, there is ample evidence that beta-adrenergic receptor agonists are effective 
in recruiting function of stunned myocardium. Stimulation by these agents does not appear to 
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produce deleterious effects, and several of these agents are therefore currently used clinically to 
detect viable but dysfunctional myocardium in patients." 
Calcium cmd calcium promo/ars 
Ito et al infused calcium into the coronary artery of 10 open-chest swine before and 30 
minutes after a IS-minute coronary artery occ1usion.26 Under normal conditions, calcium 
increased segment shortening from 26±2% to 37±2%, whereas calcium increased shortening 
from 12±3% following stunning to 35±3%, indicating the presence of normal contractile reserve 
in stunned myocardium. In view of the greater increase in segment shortening produced by 
calcium in stunned than normal myocardium, the authors concluded that reduced availability of 
calcium most likely contributed to myocardial stunning. 
Smith administered the calcium ionophore A 23187 (2 mg) into the coronary artery of four 
dogs that had been subjected to a IO-minute coronary artery occlusion followed by 15 minutes 
of reperfusion. l1 Velocity of early systolic shortening increased, reaching a maximum after 30 
seconds, but deteriorated below pre-drug levels 10 minutes after administration. The author 
concluded that increased calcium influx during established reperfusion aggravated myocardial 
stunning. However, without data of the effects on A 23187 on systolic wall thickening or 
hemodynamics, interpretation of this study is difficult. In contrast, Ito et al did not observe 
deterioration of segment shortening below preMcalcium levels upon withdrawal of calcium 
infusions. 26 
Continuous infusion of the calcium entry promotor BAY 5959 starting before a IO-minute 
coronary artery occlusion in anesthetized dogs and continued until 3 hours of reperfusion 
resulted in complete recovery of systolic wall thickening against approximately 60% in vehicle-
treated animals.27 Diastolic arterial blood pressure was not affected therefore excluding a major 
contribution of changes in loading conditions. The authors did not allow washout of the drug and 
could therefore not determine whether stimulation of the myocardium during ischemia and eady 
reperfusion exerted deleterious effects on post-ischemic function. 
In conclusion, increases in intracellular levels of calcium can effectively recruit contractile 
reserve. The weight of evidence suggests that the calcium-mediated inotropic stimulation is 
without deleterious effects on stunned myocardium. 
Calcium sensitizers 
Disturbances in calcium homeostasis have been proposed to play an important role in 
myocardial stunning.4.7 Abnormalities in calcium transients were initially thought to be 
responsible,26.28 however, more recent work has shown that in stunned myocardium the 
sensitivity of the myofibrils to calcium is decreased,29,30 while calcium transients may actually 
be increased.6.7,31 Consequently, pharmacological restoration of myofibrillar calcium sensitivity 
appears a rational therapeutic approach. 
Heusch et al studied the inotropic response to the proposed calcium-sensitizing agent AR-L 
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57, and reported that the increase in velocity of systolic thickening produced by this agent did 
not differ for stunned and nonnal myocardium in an ill vivo canine model of stunning produced 
by a 15-minute coronary occlusion.32 Korbmacher et aI investigated the effects of the 
thiadiazinone derivative EMD 57033 on stunned myocardium in au isolated rabbit heart model 
and found that the function of both normal and stunned myocardium was improved. 33 
Interpretation of these studies is difficult as these agents (particularly AR-L 57) also increase 
contractility by phosphodiesterase inhibition?4,35 
We investigated the effects of the thiadiazinone derivative EMD 60263 (a calcium 
sensitizer devoid of phosphodiesterase-inhibiting properties3S,36) in anesthetized pigs in which 
regional myocardial stunning was produced by two sequences of lO-minute coronary artery 
occlusion and 30 minutes ofreperfusion-" EMD 60263 (0.75-1.5 mg/kg, iv) restored systolic 
segment shortening and mechanical efficiency of the stunned myocardium with minimal effect 
on segment shortening and mechanical efficiency in normal myocardium (Fig. 1), 
Phosphodiesterase inhibition and increased calcium sensitivity via uradrenergic receptor 
activation were excluded as mechanisms of inotropy, as the actions of E:MD 60263 were 
unmitigated in the presence of combined alpha and beta-adrenoceptor blockade. We also 
demonstrated that the effects ofEMD 60264, the enantiomer of EMD 60263 which is devoid of 
calcium sensitizing properties but shares its rectifier current II;r-mediated bradycardic action, did 
not enhance post-ischemic segment shortening (Fig. I). 
Increases in calcium sensitivity not only improve systolic performance but may at the same 
time affect diastolic/bnction adversely." We therefore studied the effect ofEMD 60263 on the 
pattern of regional diastolic segment lengthening in the same porcine model of myocardial 
stunning." EMD 60263 in a dose of 1.5 mg/kg had no adverse effect on regional diastolic 
function yet restored regional systolic function. However, when the dose of E:MD 60263 was 
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Fig 1. Graphs showing the effect of the calcium sensitizer EMD 60263 and its enantiomer EMD 60264 on both 
stunned (left panel) and not stunned (right panel) myocardium. LADCA:::left anterioar descending coronary 
artery; LCXCA:::[eft circumflex coronary artery; SS:::systoJic segment shortening; BL:::baseline; ST=stunning; 
.:::EMO 60263, i..:::EMD 60264, for both 01:::1.5 mg/kg, O2=3.0 mg/kg.O=saHne-treated group, 0 1=3 ml, O2=6 
ml; *p<.05 vs baseline and +p<.05 vs stunning. 
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increased to 3.0 mg/kg relaxation abnormalities emerged, illustrated by a delay in the onset of 
segment lengthening in both stunned and normal regions. In contrast, the enantiomer EtvID 
60264 had no effect on either systolic or diastolic functioIl. The effects of EMD 60263 on 
diastolic functioIl have been compared to those of EMD 57033 in an isolated rabbit heart 
mode!." In that study EMD 57033 inlproved systolic and diastolic function dose-dependently, 
whereas EMD 60263 had a deleterious effect on diastolic function but only at higher 
concentrations. The doses used in that study (3 and 10 flM) appear to be rather high, however, 
as in our ill vivo experiments plasma concentrations remained below 2 J1M after administration 
ofEMD 60263 in a dose of 1.5 mg/kg, iv (unpublished data). 
The available data suggest that calcium-sensitizers can effectively recruit function of 
stunned myocardium. Although at high doses a negative lusitropic effect may become apparent, 
low doses can fully restore systolic function without an adverse effect on diastolic function. 
Calcium-sensitizers which display some phosphodiesterase inhibiting activity, particularly at 
higher doses, may be less likely to cause relaxation abnormalities. 
Beta-adrenergic receptor antagonists 
The negative chronotropic and inotropic actions of beta-adrenergic receptor antagonists can 
alleviate regional ischemia by lowering the energy requirements and by improving transmural 
distribution of myocardial perfusion. AlUlOugh the anti-ischemic actions of beta-blockers would 
be expected to enhance recovery of post-ischemic function, results of studies are equivocal. 
Discrepancies in results could be explained by timing and route of administration and half life 
of the beta-blocker used. Since bradycardia during reperfusion does not improve function of 
stunned myocardium,37 beta-adrenoceptor blockers administered during reperfusion are likely 
to aggravate post-ischemic dysfunction due to their negative inotropic action. Thus, in order to 
be most effective beta-blockers should be present before and during ischemia in order to obtain 
a maximal anti-ischemic effect, but absent during reperfusion in order to avoid further 
depression of contractile function of stunned myocardium. The most favorable effects can thus 
be expected from pretreatment with agents such as esmolol which have a short half life. Several 
studies support this hypothesis. For instance, an intravenous infusion of esmolol (0.10-0.15 
mg/kg/rnin, resulting in 18% reductions in heart rate and LVdP/dtmax) which was started before 
and continued throughout a I5-minute coronary artery occlusion in anesthetized dogs, resulted 
in enhanced recovery of function of stunned myocardium.·n In contrast, an intracoronary 
infusion of propranolol (0.30 mg/kg + 0.01 mg/kg/hr), which had no effect on heart rate or 
systolic arterial blood pressure, failed to improve recovery of function in the same canine model 
of myocardial stunning. 42 Infusion was started prior to occlusion and continued during the ftrst 
two hours of the 3-hour reperfusion period, but it is unlikely that washout of propranolol (total 
dose 1.5 rug/kg) was complete within one hour after stopping the infusion. The failure of 
propranolol to ameliorate stunning is best explained by the persisting negative inotropic actions 
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of propranol during reperfusion which outweighed the anti-ischemic effects during coronary 
artery occlusionY In addition, the absence of bradycardia may have attenuated the anti-ischemic 
effect, which is supported by observations that pretreatment with specific bradycardic agents 
enhances recovery of function of stunned ill yocardium. 4J 
Przyklenk and Kloner" infused esmolol (0.10-0.15 mg/kg/min, iv) for two hours starting 
after 30 minutes of reperfusion following a IS-minute coronary occlusion to test the hypothesis 
that stunning is a protective phenomenon which prevents viable tissue to become irreversibly 
damaged. After 24 hours recovery of wall thickening in the animals treated with esmolol was 
not different from that of control animals, or animals which underwent the same protocol but 
received the afterload-reducing agent hydralazine. 
The available data indicate that beta-adrenergic receptor antagonists can improve recovery 
of post-ischemic function by anti-ischemic actions, and should therefore be present during 
ischemia. To obtain maximum benefit these drugs should he absent during reperfusion. 
Calcium antagonists 
Calcium antagonists could attenuate myocardial stunning, because of an anti-ischemic 
action secondary to their effects on the coronary circulation (coronary vasodilation) and systemic 
hemodynamics (peripheral vasodilation and negative inotropy). The anti-ischemic actions of 
agents such as verapamil and diltiazem is further enhanced by their bradycardic action, whereas 
the anti-ischemic effect of the dihydrophyridines may be mitigated by a reflex mediated 
tachycardia. Another argument in favor of a role for calcium antagonists in myocardial stunning 
is derived from the two stage model for the role of calcium in the development of stunning 
proposed by Opie.46 According to this hypothesis cytosolic calcium increases during ischemia, 
while at the same time the oscillations in calcium decrease suggesting a reduced ability of the 
cell to maintain calcium homeostasis. Immediately upon restoration of blood flow, calcium 
oscillations increase and contractile function transiently increases (fIrst stage). The newly formed 
oxygen-derived free radicals may increase cytosolic calcium during eady reperfusion by a 
number of actions including release of calcium from the sarcoplasmic reticulum,41 stimulation 
of the sodium-calcium exchanger and increased entry of extracellular calcium via voltage-
operated calcium channels.48 The ability of calcium antagonists to prevent calcium overload and 
their reported oxygen-free radical scavenging properties49.s1 may thus enhance their potential in 
preventing stunning. After the events during the very early reperfusion period a second stage 
follows during which contractile function is still decreased, most likely secondary to a decreased 
sensitivity of the myofilaments to calcium.6,1 During this second stage an inteIVention with 
calcium antagonists does not appear opportune in view of their potential negative inotropic 
actions. 
In spite of its negative inotropic properties, przyklenk and Kloner" reported that verapamil 
attenuated stunning produced by a IS-minute coronary occlusion in open-chest dogs when 
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SWT DURING OCCLUSION AND REPERFUSION 
occlusion reperfusion 
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Fig 2. Effect of nifedipine on recovery of systolic wall thickening in anesthetized pigs in which left anterior 
descending coronary artery blood flow was reduced to 25% of baseline for 30 minutes. Infusion of nifedipine (1 
J.lg/kg per min) started 10 minutes before the stenosis was released and lasted 15 minutes. The dose of 
nifedlpine redistributed transmural blood flow during ischemia In favor of the endocardium. Data (mean ± SO) 
are expressed as percent of baseline values. *p<.05 vs untreated group. Wrth permission from EUr Heart J (56) 
administered after 30 minutes of reperfusion. However, in this study the fall in arterial blood 
pressure could have contributed to the increase in segment shortening. To avoid systemic 
hemodynamic effects, the same group of investigators53 studied nifedipine during intracoronary 
infusion in the same model of stunning. Nifedipine administration was started after 30 minutes 
of reperfusion, and was reported to result in improved contractile function. The dose of 
nifedipine was so low that it had no effect on myocardial blood flow, yet the authors proposed 
a direct effect of nifedipine on the myocardium, possibly involving an oxygen-derived free 
radical scavenging action of the calcium antagonist. 49·51 This appears highly unlikely as 
antioxidant tllerapy is only effective when started at the onset of reperfusion. ',S In keeping with 
these latter observations Ehring et at observed no effect on recovery of systolic wall thickening 
when nisoldipine was administered 4 minutes into reperfusion following a I5-minute coronary 
artery occlusion." The adequacy of the dose of nisoldipine was illustrated by the drug's 
protection when it was administered prior to ischemia. This study confirmed earlier observations 
by Van der Giessen et al in a porcine model of coronary thrombosis that addition of nifedipine 
to porcine plasmin did not enhance recovery of function after reperfusion had been established. 55 
The benefit of administration of calcium antagonists during established reperfusion is also 
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questioned by the observations that contractile function of stunned myocardium can be recmited 
with substances that increase rather than decrease trans-sarcolemmal calcium fluxes. 26,27,Sl 
The effectiveness of treatment with calcium-antagonists during ischemia may depend on 
the timing of administration. When administered just prior to reperfusion calcium-antagonists 
may protect via prevention of oxygen-derived-free-radical induced calcium overload during 
early reperfusion.45-51 When given early after the onset of ischemia calcium antagonists may in 
addition exert a beneficial effect through an anti-ischemic action.56-60 In our laboratory an 
intravenous infusion of nifedipine was started 20 minutes after blood flow in the left anterior 
descending coronary artery of pigs was reduced to 25% of baseline for 30 minutes and continued 
until 5 minutes into reperfusion. 56 During the partial coronary artery occlusion there was 
complete loss of systolic wall thickening which recovered to 75% of baseline in the nifedipine 
group, but only to 50% of baseline in the vehicle treated group (Fig. 2). The dose of nifedipine 
(I ~glkg/min) was sufficient to produce an 8 mmHg decrease in mean aortic pressure, normalize 
the slightly elevated left ventricular end diastolic blood pressure, modestly increase transmural 
blood flow of the ischemic myocardium with a redistribution of flow in favor of the 
subendocardium. In spite of the apparent anti-ischemic effects there was no improvement in 
function during the ischemic episode, most likely because the improvement in blood flow was 
insufficient to lead to systolic contraction. The data, however, demonstrate that nifedipine 
reached the ischemic territory and may have prevented excessive cytosolic calcium 
concentrations. This may have resulted in a better preservation of the calcium sensitivity during 
the second stage of recovery. However, it cannot be determined from our study whether the 
enhanced post-ischemic contractile recovery was due to an anti-ischemic effect or due to 
modulation of the reperfusion conditions. Administration of verapamil (0.2 Jig/kg + 0.6 
J.lglkglmin, iv) at the onset of reperfusion following a 15 minute coronary occlusion resulted in 
improved recovery of contractile function, but the drug-induced hypotension could have 
contributed to this action. In our study nifedipine was discontinued at 5 minutes of reperfusion 
so that after 60 minutes of reperfusion aortic blood pressure was no longer different from that 
in the control group, while the improvement in wall thickening persisted. Ehring et al 
administered nisoldipine (5 Jig/kg, iv) 10 minutes after the onset of a 15-minute coronary artery 
occlusion and found that post-ischemic recovery of stunning was not improved.54 However, 
nisoldipine had no effect on collateral blood flow, while the calcium antagonist-induced-
hypotension was prevented by inflation of an intraaortic balloon. Therefore, an anti-ischemic 
effect could only have occurred via a direct myocardial effect. Because pretreatment with 
nisoldipine did result in a better functional outcome the authors concluded that the beneficial 
effect of the calcium antagonist was related to an attenuation of calcium overload during the first 
few minutes of ischemia, rather than during early reperfusion. It cannot be excluded, however, 
that due to intravenous administration just 5 minutes prior to reperfusion, levels of nisoldipine 
in the ischemic myocardium may have been too low to prevent calcium overload during early 
reperfusion. 
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In ill vitro studies pretreatment with calcium antagonists has consistently resulted in 
improved post-ischemic function) but in these studies the drugs were usually present in doses 
sufficiently high to significantly depress function. 61-63 III vil'o studies have been performed in 
anesthetized dogsS4,6O,6M$ and have been consistently positive when the calcium antagonists were 
already present before ischemia was produced (see also ref 69). In most of these studies a 
decrease in aortic blood pressure may have contributed to the positive outcome. either by 
decreasing energy demand during ischemia and by decreasing afterload during reperfusion. One 
study avoided this pitfall as the authors controlled arterial blood pressure with an intra-aortic 
balloon. 54 Under these controlled conditions nisoldipine improved recovery of contractile 
function, indicating that calcium antagonists can exert a protective effect independent of an 
effect on the loading conditions. 
AnoOler mechanism of protection by calcium antagonists could be an increase in blood flow 
to the ischemic myocardiulll, but in most studies calcium antagonists failed to increase collateral 
blood flow,54,59,6O,63,66,69 suggesting that an increase in flow cannot be the only mechanism of 
protection, Improvement in myocardial blood flow can result in an increase in contractile 
function (Gregg phenomenon) and several studies have suggested that this might be a 
mechanism by which calcium antagonists improve post-ischemic fUllction,S2,60,64,69,70 However, 
calcium antagonists also result in an improvement in recovery of function in the absence of an 
increase in myocardial blood flOW. 6S,66 
Magnesium is an endogenous calcium antagonist and could ameliorate stunning similar to 
pharmacological calcium antagonists. This has indeed been shown in isolated perfused rat 
hearts63 and in anesthetized open-chest pigs?' In the latter study magnesium improved post-
ischemic function not only when administered before but also when administered during 
coronary artery occlusion and the fIrst minutes of reperfusion. Pigs lack a significant coronary 
collateral circulation and an anti-ischemic effect because of its presence during ischemia can thus 
be excluded, suggesting that magnesium exerted its protection during reperfusion, possibly by 
decreasing the oxidative stress. 
In summary calcium antagonists can improve recovery of post-ischemic function when 
administered prior to ischemia. The protection cannot be entirely explained by increases in 
myocardial blood flow and favorable hemodynamic actions during ischemia. Finally, it also 
appears that the degree of protection afforded by pretreatment are similar for the different classes 
of calcium antagonists. 4S.~6,69 
Eicosanoids 
Prostacyclinmimetics 
Cyc10xygenase converts arachidonic acid into cyclic em!operoxide intermediates PGG2 and 
PGH" which then form prostaglandins and thromboxane J/.. . Prostacylin (Pql ) is the main 
cyc100xygenase product in the vascular endothelium and a potent vasodilator of various vascular 
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Fig 3. Recovery of systolic wall thickening after 20 minutes of left anterior descending coronary artery 
occlusion (solid bar) in (e) lloprost (100 nglkg per min) and (0) solvent-treated pigs. Data are expressed as 
ll% from baseline (40 ± 2% for the lIoprost and 35 ± 3% for the solvent group). Each point represents the 
mean, and vertical lines S.B.mean, of the number of animals In parentheses. *p<.01. With permission from Sf J 
Pharmacal (74). 
beds including the coronary circulation. In addition, this eicosanoid inhibits platelet aggregation, 
stabilizes lysosomal membranes and prevents formation of oxygen-derived free radicals by 
inhibition of neutrophil function, all of which may exert a beneficial effect on myocardial 
stunning.'),73 Since prostacyelin has a half life in the order of only a few minutes, stable 
analogues of prostacyclin (ilaprost) or compounds which enhance its endogenous production 
(defibrotide) have been developed to prolong the duration of action. 
In anesthetized pigs, a continuous intravenous infusion of iloprost (100 ng/kg/min) that was 
started 10 minutes before a 20-minute coronary artery occlusion improved recovery of post-
ischemic wall thickening without attenuating the severity of myocardial ischemia, as indicated 
by the breakdown of A TP.14 Although contribution of a reduction in afterload to the improved 
wall thickenIng could not be exeluded, the 8 mmHg decrease in arterial blood pressure was 
likely too small to entirely explain the improved recovery of function (Fig 3). Farber et al" 
started administration of iloprost to anesthetized dogs either before the coronary artery occlusion 
or at the onset of reperfusion. Iloprost enhanced recovery of post-ischemic function in both 
groups of animals, but was most effective when present already prior to and during ischemia. 
The beneficial effect of iloprost could again not be explained by an effect on systemic 
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hemodynamics, collateral blood flow or better preservation of higher energy phosphate levels. 
A decrease in formation of oxygeuMderived free radicals by activated neutrophils may have 
contributed, which would also explain the modest protection when the drug was administered 
at the oruet of reperfusion." Farber et al also showed that prostaglandin E, improved systolic 
wall function in anesthetized dogs after stunning myocardium by a IS-minute coronary 
occlusion, but the marked hypotension produced by the prostaglandin contributed, at least in 
part, to the enhanced recovery of post-ischemic functiou. 76 
Hohlfeld et aln reported that defibrotide enhanced recovery of systolic wall thickening that 
followed a 5-minute coronary artery occlusion in anesthetized pigs. The authors ascribed their 
findings to both a reduction in ischemia-reperfusion induced platelet aggregation and a free 
radical scavenging action. Taken together these studies indicate that prostacyclinmimetics 
attenuate myocardial stunning, which is most effective when these agents are present during the 
ischemic period, but their mechanism of action is not fully understood. Thus, whereas 
scavenging of oxygen-derived free radicals may contribute to their salutary effects, it is 
questionable whether platelet aggregation contributes significantly to contractile abnormalities 
that follow very brief coronary occlusions. 
1111"01nboxane inhibitors 
Thromboxane A, (DCA,) is the main arachidonate metabolite in platelets and may be 
released from ischemic myocardium. TXA2 releases catecholamines from terminal nerve 
endings, mediates vasoconstriction and enhances platelet aggregation, actions that may 
exacerbate myocardial stunning. The actions of TXA2 can be antagonized by inhibiting TXA2 
synthesis or blocking TXA, receptors. The effects of the TXA, receptor antagonist SQ 29,548 
on recovery of post-ischemic contractile function were studied in open-chest dogs that 
underwent a 15-minute coronary artery occlusion followed by 5 hours of reperfusion. 78 Post-
ischemic segment shortening was markedly improved irrespective whether drug administration 
was started prior to occlusion or 1 minute prior to reperfusion. In contrast, pretreatment with BM 
13.505, another TXA, receptor blocker, failed to ameliorate myocardial stunning produced by 
15-minute coronary artery occlusion followed by 3 hours ofreperfusion in open-chest dogs.79 
An explanation for these different findings is not readily found, as both compounds were shown 
to provide adequate TXA2 receptor blockade and to exert no effect on pre-occlusion 
hemodynamics or regional myocardial perfusion. It cannot be excluded that the different 
reperfusion conditions may have played a role, as in the study of Farber and Gross coronary 
arterial inflow was restricted to match pre-occlusion blood flow values. Interestingly, Farber and 
Gross, using the same restricted reperfusion model observed that pretreatment with the TXA2 
synthetase inhibitor dazmegrel enhanced post-ischemic segment shortening, and decreased 
coronary venous TXB, levels while increasing 6-keto PGII. levels (breakdown products of 
TXA, and prostacyclin, respectively) in the coronary venous blood." These findings suggest that 
dazmegrel produced its beneficial actions via an increase in prostacyclin as a result of 
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"endoperoxide steal"'O In support of this hypothesis the authors observed that pretreatment with 
indomethacin (which itself had no effect on stunning, while decreasing both prostacycHn and 
TXA, production) attenuated the enhanced release of prostacyclin and prevented the beneficial 
effects of dazmegrel on post-ischemic function. These findings suggested that TXA, did not 
contribute to stunning and that improvement of post-ischemic contractile function by TXA2 
synthetase inhibitors acted via an endoperoxide steal mediated increase in prostacyclin 
production.80 The available data do not allow a definitive conclusion regarding the potential 
usefulness of TXA, receptor antagonists in the treatment of myocardial stunning. On the other 
hand, TXA2 synthetase inhibitors appear to be protective via an increased prostacyclin 
production. 
ACE-inhibitors 
Activity of angiotensin I converting enzyme (ACE) is increased during acute coronary 
artery occlusion,81 which results in increased production of angiotensin II and increased 
breakdown ofbradykinin.82 Since angiotensin IT is a potent vasoconstrictor and positive inotropic 
agent,7S and bradykinin stimulates prostacyclin production, increased ACE activity during 
coronary artery occlusion could aggravate myocardial stunning. Consequently ACE inhibitors 
may attenuate stunning.83,84 In isolated perfused rat hearts captopril improved recovery of left 
ventricular developed pressure and L VdP/dtm« following a 15-minute period of global ischemia 
when this ACE inhibitor was present in the perfusate at the time of ischemia. 85,86 Interpretation 
of these data is complicated by observations that 15-minute of global ischemia in isolated buffer 
perfused hearts can already result in irreversible damage. 13 
Przyklenk and Kloner infused enalapril for 2.5 hours starting after 45 minutes of 
reperfusion following a IS-minute coronary artery occlusion in anesthetized dogs.87 Enalapril 
(2 mg/kg iv bolus followed by 2 mg/kg per hour) resulted in enhanced recovery of systolic 
segment shortening to 50% of baseline versus 20% in the control group, but caused a 20 rnmHg 
reduction in arterial pressure which contributed, at least in part, to the improved post-ischemic 
segment shortening. Westlin and Mullane studied the effects of captopril (5 mg/kg iv) on 
recovery of function following a IS-minute coronary artery occlusion in open-chest dogs.88 
Administration of captopril prior to ischemia or just before reperfusion resulted in similar 
improvement of recovery of segment shortening to 50-60% of baseline compared to 0-10% in 
the control dogs. The mechanism of protection appeared to be the result of scavenging of oxygen 
derived free radicals as SQ 14,534 (5 mg/kg iv) (a captopril stereoisomer with minimal ACE 
inhibiting properties but similar scavenging properties) given at the onset of reperfusion 
produced a degree of protection similar to that by captopril. Furthermore, an equihypotensive 
dose of enalapril (1.6±O.1 mglkg iv) (which lacks the free radical scavenging sulfhydril moiety) 
administered prior to the occlusion had no significant effect on post-ischemic function, which 
also excludes systemic hemodynamics as a cause for the captopril-induced protection.88 In 
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contrast, Przyklenk and Kloner found that administration of enalapril at the end of a IS-minute 
coronary artery occlusion improved recovery of function to 70-80% of baseline values versus 
0-20% in control animals." The differences in the results of the two studies could be due to 
differences in tinling of administration. The fInding that in the study by Westlin and Mullane 
recovery of the enalapril-treated animals was worse than in the control group may point towards 
more severe ischemia after treatment with enalapril. Collateral blood flow was not measured in 
that study, but despite the 20 mmHg reduction in mean aortic blood pressure produced by 
enalapril, the rate pressure product was ahnost 30% higher during the coronary artery occlusion 
in the enalapril- treated dogs. On the other hand, in the study by Przyklenk and Kloner", 
collateral blood flow tended to be higher in the enalapril group (- 0.20 ml/minlg) than in the 
control group (- 0.09 mJImin/g) although the small number of animals in each group (n~6) did 
not yield statistical significance. Interestingly, whereas the doses of enalapril were nearly 
identical (1.5 fig/kg, iv versus 1.6±0.1 rug/kg, iv) a 20 mmHg decrease was reported in one 
study but no effect on blood pressure was reported in the other. In accordance with the study by 
Westlin and Mullane," Przyklenk and Kloner observed that zafenopril (IS mg/kg, iv), another 
ACE inhibitor with a sulfhydril group, and SQ 14,534 resulted in similar improvement recovery 
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of post-ischemic function when administered at the onset of reperfusion. These findings could 
not be explained by differences in systemic hemodynamics Of myocardial blood flow. 89 
Ehring et al90 studied the role of bradykinin in the beneficial effects of non-sulfhydril ACE 
inhibitors. For this purpose rantiprilat (20 fl-g/kg, iv) was administered in the absence and in the 
presence of the bradykinin B, receptor antagonist HOEI40 on regional myocardial perfusion and 
wall thickening, while mean arterial blood pressure was kept constant with an intra-aortic 
balloon (Fig. 4). This study established that the effect of ramiprilat on recovery of post-ischemic 
wall thickening was bradykinin mediated. Since bradykinin promotes synthesis of both 
prostacyclin, which can ameleriorate stunning,14,15 and nitric oxide, the authors further 
investigated which of these two pathways was involved in the attenuation of stunning, For this 
purpose anesthetized dogs received either the cycloMoxygenase inhibitor indomethacin or a 
combination of indomethacin and ramiprilat, the synthase inhibitor N"-nitro-L-arginine methyl 
ester (L-NAME) or a combination ofL-NAME and ramiprilat before they were subjected to a 
IS-minute coronary artery occlusion and 4 hours of reperfusion. Regional blood flows in the 
four groups were not different but wall thickening of the stunned myocardium recovered to 47% 
of baseline during reperfusion in the animals which received L-NAME in combination with 
ramiprilat. The authors therefore concluded that attenuation of stunning by ramiprilat involves 
a cascade of bradykinin and prostaglandins but not nitric oxide. The design of the study did not 
allow to determine when ramipralat exerted its beneficial effect as the drug was only 
administered prior to ischemia. 
Data from the literature indicate that ACE inhibitors, administered prior to ischemia or just 
before the onset of reperfusion, enhance early recovery of post-ischemic function. The 
mechanism of protection likely involves scavenging of oxygen-derived free radicals (sulfuydril 
compounds) or bradykinin-mediated release of prostacyclin. 
Adenosine 
Adenosine exerts a number of favorable actions during myocardial ischemia and 
reperfusion, including coronary vasodilation, replenishment of depressed ATP stores, stimulation 
of glycolysis, inhibition of calcium transport, and inhibition of leukocyte function, lipolysis and 
free radical generation.91,92 Since these actions can attenuate stunning,4 several investigators have 
examined if increased levels of endogenous adenosine have a salutary effect on stunning. 
Kitakaze et al42 reported that ctcadrenoceptor stimulation had a beneficial effect on stunning 
and following their earlier report that release of adenosine was regulated by ct,-adrenoceptor 
activity,93 they suggested that attenuation of stunning by ct1-adrenoceptor agonists could be 
mediated by adenosine. The findings, that the adenosine receptor antagonist 8-
phenyltheophylline blocked the beneficial effect of methoxamine and that exogenous adenosine 
administered before a coronary occlusion ameliorated stunning in the presence of prazosin 
supported this hypothesis. 42 Attenuation of stunning by ct1-adrenoceptor stimulation had also 
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been ascribed to an increase in the sensitivity of the myofilaments to calcium, however.9.f,95 
Zughaib et al" circumvented the potential pitfalls of adrenoceptor stimulation and 
investigated whether combined inhibition of adenosine deaminase and nucleoside transport 
improved post-ischemic dysfunction produced by a I5-minute coronary artery occlusion in 
anesthetized dogs. Intracoronary infusions, which were used to ensure that the effects were 
independent of changes in systemic hemodynamics, had no effect on loss of systolic wall 
thickening during ischemia, but improved recovery of function during reperfusion compared 
with the control group. That enhanced recovery could be secondary to differences in perfusion 
during occlusion (collateral blood flow) and reperfusion, systemic hemodynamic variables, or 
myocardial ATP levels was excluded." Compared with control dogs, the levels in adenosine 
were six times higher in the treated dogs, while the levels in inosine were six times higher in the 
control animals, suggesting that the increased endogenous adenosine levels attenuated stunning. 
The results by Zughaib et al" are consistent with those reported for acadesine, an other agent 
that increases endogenous levels of adenosine. 98 
The same group of investigators99 also examined in the same canine model whether 
exogenous adenosine alleviated stunning. Anesthetized dogs were therefore again subjected to 
a I5-minute coronary artery occlusion and 4 hours of reperfusion but received either 
intracoronary infusions of adenosine or saline starting either 30 minutes before occlusion until 
I hour after onset of reperfusion or 2 minutes before reperfusion until I hour after onset of 
reperfusion.99 Exogenous adenosine improved recovery of post-ischemic function when present 
during ischemia, but failed to improve function when infusion started just prior to reperfusion.99 
The beneficial effect of exogenous adenosine could, similar to the study by Zughaib et ai," not 
be explained by an augmented collateral blood flow or more favorable hemodynamic conditions 
during ischemia. That adenosine had to be present during ischemia in order to be effective 
suggests that it acted by attenuating ischemic injury. Studies in anesthetized dogs suggest that 
the responsible adenosine receptor subtype is the Al subtype. 100 The latter authors also showed 
that pretreatment with glibenclamide, in a dose which had no effect on recovery of stunned 
myocardium itself, abolished the protection by the selective adenosine Al agonist 
cyclopentyladenosine, which suggests that the protection by stimulating adenosine Al receptors 
is, at least in part, mediated by activation ofK+AlP channels. 
K+ ATP channels openers 
K+ channels that are sensitive to intracellular levels of ATP (K ATP channels) have been 
identified in a number of tissues, including vascular smooth muscle cells and cardiornyocytes. 
When ischemia occurs and levels of ATP near the sarcolemma decrease, these K+ channels are 
thought to become activated resulting in an outward flux of K+. K+ AlP channel opening is 
potentially protective during myocardial ischemia. lOi Thus, coronary vasodilation could promote 
collateral blood flow white shortening of the cardiomyocyte action potential duration would 
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result in a decrease of activator calcium influx during phase 2 of the action potential, and reduce 
calcium overload of the cardiomyocyte,I02,103 The consequent attenuation of ischemia injury 
would then result in a better recovery of post-ischemic function. 
Early studies demonstrated a protective effect of the mixed nitrate-K+All' channel activator 
drug nicorandil on myocardial stunning. Thus, Gross et al observed that a IS-minute total 
coronary artery occlusion produced a sustained depression of systolic segment shortening to 
approximately 20% of baseline which lasted throughout the 4 hour reperfusion period; 
pretreatment with intravenous nicorandil resulted in recovery of segment shortening to 70% of 
baseline.10-t Nicorandil is not a pure K + All' channel activator as it also exhibits nitrate-like 
properties, but its effects can be blocked by glibenclamide indicating that its K+All' channel 
activator properties are likely responsible for the observed protection,lOS Further~ore, studies 
with selective K+ATP channel openers such as cromakalin106,I01 and bimakalim108 also improve 
contractile recovery following 15 minutes of regional ischemia in the dog heart, while pure 
nitrates offer only a slight degree of protection. lOt The observation that intracoronary 
administration106 or intravenous administration of non-hypotensive doses lOS ofK+ AlP openers 
enhanced post-ischemic recovery of function indicates that the decrease in afterload is not 
required for protection. This is further supported by the finding that pretreatment with 
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Fig 5. The effect of the K'AlP channel activator aprikatim on stunned myocardium. Data are from a saline-
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glibenclamide had no effect on the hypotension by the K+ AlP channel openers but abolished the 
protective effect on function. 109 Increased collateral blood flow or increased perfusion during 
reperfusion can also not explain the protection by K+ ATP channel openers,105,10& suggesting that 
these agents reduce ischemic injury at the level of the cardiomyocyte. 
The timing of administration of a K+ATP channel opener appears to be critical for its 
beneficial effect on myocardial stunning. In all of the above cited studies administration of the 
compounds was started at least 10 minutes prior to the onset of ischemia and continued 
throughout the ischemia and, at least part of, the reperfusion period. Protection was absent when 
aprikalim was administered intravenously to dogs immediately prior to the 180-minute period 
of reperfusion that followed the IS-minute coronary artery occlusion (Fig. 5).10' 
In conclusion, there is ample evidence that locally or systemically administered K+ATP 
channel openers improve the recovery of post-ischemic contractile recovery of regionally 
stunned canine myocardium, but only when administered prior to the onset of ischemia. In 
contrast, protection appears absent when the drugs are administered at the onset of reperfusion. 
The mechanism by which K+AIP channel openers attenuate myocardial stunning is not entirely 
clear. Shortening of the action potential appears currently the most likely explanation for the 
protective action as the protective effects occurs independent of an increase in collateral blood 
flow or a reduction in afterload. 
Sodium-hydl'ogen exchange inhibitors 
Excessive activation of the plasma membrane sodium-hydrogen (Na + -H+) exchanger during 
ischemia and early reperfusion causes intracellular sodium overload. 109•110 Increased levels of 
sodium will, because of their linkage with the sodium-calcium (Nat _Ca2+) exchange, raise 
intracellular calcium levels, and thereby contribute to the development of calcium overload. I09 
Furthermore, activation of the Na+-H+ exchanger decreases intracellular acidosis; the latter 
attenuates the harmful effects of calcium overload by an effect on the Ca'+ regulated ATPase. 
Because an increased Na+-H+ exchange activity plays an important role in events leading to 
cardiac dysfunction during myocardial ischemia and reperfusion it is conceivable that inhibition 
of the Na+ -H+ exchange ameliorates cardiac dysfunction during stunning. III 
Hata et al,1I2 applying the time varying elastance concept and the oxygen consumption-
pressure volume area relation in the excised cross-circulated canine-heart model, found that rapid 
correction of acidosis after global myocardial ischemia caused a transient overshoot of 
contractility followed by a post-acidotic stunning, which was not caused by a decreased 
contractile efficiency. Restoration of contractile function by calcium resulted in a V02 intercept 
of the linear Vorpressure volume area relation that exceeded control levels, while total oxygen 
cost was higher in post-acidotic than normal hearts. Inhibition of the Na+-H+ exchange system 
by selective inhibition with dimithylamiloride almost completely prevented the contractile and 
energetic abnormalities of the post-acidotic stunned myocardium in this model, implying that 
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rapid recovery of pH resulted in stunning through activation of the Na+-W exchange system. The 
important conclusion of thls study must be that rapid recovery of pH after ischemia and the 
subsequent Ca2+ overload may underlie myocardial stunning, in a similar manner as post-acidotic 
stunned myocardium. 
Fuhlre studies in ill vivo models of pure regional stunning must examine whether inhibition 
of the Na+-H+ exchange system indeed contributes to attenuation of regional stunning and 
whether administration must occur prior to the onset of ischemia or reperfusion or can still have 
salutary effects when administrated after stunning has been established. 
Ubiquinone and HMG-CoA reductase inhibitors 
Ubiquinone (Coenzyme QIO, COQlO) is under normal conditions present in most cells in 
which it functions as an essential cofactor, being an electron-carrier in oxydative 
phosphorylation. In high doses CoQro promotes stabilization of cell membranes and has been 
shown to possess antioxydative effects by acting as a free radical scavenger. 1I3 In order to 
investigate whether the antioxydative effect had a beneficial effect on myocardial stunning, Atar 
et aI''' red CoQ" to pigs for 20 days before the left anterior descending coronary artery was 
occluded for 8 minutes and reperfused for 2 hours, while the animals were under anesthesia. 
Compared to a control group, the stunning time (defined as the time interval in which systolic 
wall thickening returned to baseline) was reduced in the CoQ" treated animals from 33 minutes 
to 14 minutes. The protective mechanism remained unknown but the authors speculated that the 
favorable action was caused by protection from free radical mediated reperfusion injury. 
HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase is a key enzyme in the 
biosynthesis of cholesterol and HMG-CoA reductase inhibitors are therefore useful in the 
treatment of hypercholesterolemia. Pravastatin and simvastatin are competitive inhibitors of 
HMO-eoA reductase and prevent formation of mevalonic acid, 115 which is a precursor in the 
biosynthesis of both cholesterol and ubiquinone. A decreased synthesis of ubiquinone impairs 
the energy generating system, and may lead to further deterioration of cardiac function under 
pathophysiological conditions. 116 Thls could be especially true for simvastatin which inhlbits 
synthesis of sterol equally in hepatic and non-hepatic celis, whereas pravastatin enters only 
hepatocytes. Ichihara et aim red pravastatin and simvastatin (2 mg/kg po) for 3 weeks to dogs 
which, while under anesthesia, were subjected to a IS-minute coronary artery occlusion of the 
left anterior descending. After 2 hours of reperfusion systolic segment shortening of the post-
ischemic myocardium was absent in the simvastatin group while it had recovered to SO% of 
baseline in the control and pravastatin groups. Levels of ATP, but not of any other metabolite, 
were about 20% lower in the simvastatin group compared to the control and pravastatin groups, 
suggesting that ischemia may have been more severe in the simvastatin group. However, without 
measurement of the effects of treatment modalities 011 collateral blood flow the significance of 
these findings remains unclear. 
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Pl'opionyl-L-cm'nitine 
Post-ischemic myocardium is characterized by glycogen depletion and an impairment of 
free fatty acid oxidation due to depletion of camitine and citric acid cycle intermediates and fatty 
acylCoA-induced inhibition of adenine nucleotide translocase. In addition, glucose oxidation 
may be decreased due to fatty acylCoA induced inhibition of pyruvate dehydrogenase. In view 
of the importance of preservation of glucose oxidation for Ca++ homeostasis during early 
reperfusion, the carnitine deficiency and fatty acyl-CoA accumulation have been suggested to 
be causally related to the contractile dysfunction during reperfusionY' Administration of 
carnitine or L-propionyl carnitine might improve the capacity of the myocardium to use p-
oxidation of fatty acids for energy production and for extraction of the harmful excess of fatty 
acid intermediates,119,120 thereby enhancing glucose oxidation.121 
Two periods of IO-minute total coronary artery occlusion each followed by 30 minutes of 
repetfusion resulted in 20% loss of myocardial tissue levels of carnitine in open-chest swine,l20 
Three days of oral pretreatment with L-propionylcarnitine (100 mglkg per day) increased 
camitine tissue levels by 30% compared to non-treated animals both at baseline and at the end 
of the second 30-minute reperfusion period. This increase in carnitine tissue levels was 
associated with a borderline statistically significant improvement of post-ischemic regional 
myocardial segment shortening. In view of the concomitant reduction in mean aortic blood 
pressure it would appear that L-propionylcarnitine, despite maintaining adequate postischemia 
tissue levels of carnitine, failed to exert a beneficial effect on myocardial stunning. 
Factors exacerbating myocardial stunning 
If anti-ischemic actions of pharmacological agents and timely treatment with oxygen-
derived free radical scavengers attenuates stunning, it may he assumed that conditions or agents 
that enhance ischemia or free radical production aggravate myocardial stunning. In man some 
of these conditions may be the consequence of life style or medication taken to treat clinical 
conditions. For instance, the HMG CoA reductase inhibitor simvastatin has been shown to 
exacerbate stunning in anesthetized dogS. 117 
lllilibitioll 0/ elldotllelial derived relaxillg/actor 
Hasebe et al investigated the effect of inhibition of nitric oxide (NO) on the severity of 
stunning in awake dogs. For this purpose the NO synthesis inhibitor N'-nitro-L-arginine (L-NA, 
30 f.'glkglmin) was administered into the coronary artery starting 11 minutes before the onset 
of the IO-minute coronary artery occlusion while a maintenance dose (6 f.'glkglmin) was started 
at the onset of reperfusioll. 123 Compared to control (saline infusions) wall thickening was 
significantly less at 30 minutes reperfusion in both the subendocardium and sub epicardium. The 
results could not he ascribed to differences in hemodynamics or myocardial perfusion in the 
presence of absence of L-NA during reperfusion. There was a slight increase in oxygen demand 
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in the L-NA-treated animals during coronary artery occlusion in the face of similar coronary 
blood flows. It is highly unlikely that considered the amount of loss of function the enhanced 
stunning could be caused by more intense ischemia. 12 Consequently NO synthesis inhibition 
exacerbated stunning which could not be related to more severe ischemia during occlusion. The 
mechanism by which NO synthesis inhibition aggravated stunning remained unknown but the 
authors postulated that other actions of NO (such as on oxygen-derived free radical formation, 
platelet aggravation or neutrophil activation) could be involved. 
Smoking 
Przyklenk'" investigated whether nicotine, infused in a dose mimicking the levels reached 
by humans after smoking a single cigarette, had a detrimental effect on contractile function of 
normal and stunned myocardium. Infusion of nicotine (80 ltg/kg over a 1 O-minute period) at 30 
minutes before a I5-minute coronary artery occlusion in anesthetized dogs did not affect 
regional segment shortening before and during ischemia (Fig. 6). In these animals, recovery of 
segment shortening of post-ischemic myocardium was 29% and 22% at 1 and 3 hours of 
reperfusion, respectively, while in the control animals segment shortening of the stunned 
myocardium recovered to 54% and 50%, respectively (both p<0.05 vs the nicotine-treated 
animals). When given at 1 hour ofreperfusion, nicotine caused an almost complete loss of the 
partially recovered fUllction. The deterioration in function was not the consequence of 
unfavorable changes in systemic hemodynamics or coronary blood flow, but additional 
experiments suggested that it was most likely mediated by oxygen derived free radicals acting 
on reversibly injured myocardium as infusion of the free radical scavenging agent N-2-
mercaptopropionylglycine (50 mg/kg/hr) starting at 45 minutes of reperfusion prevented the 
deterioration in segment shortening by the nicotine infusion at 1 hour of reperfusion. From her 
data Przyklenk suggests that future studies should also investigate whether these observations 
can be confrrmed during either active or passive smoking. 
Magnesium deficie/lcy 
Herzog et aFl reported a delayed recovery of function in magnesium deficient pigs 
subjected to a brief coronary artery occlusion compared to a group of control animals. The 
authors ascribed their finding to impaired free radical defense systems as levels of glutathione 
were 43% lower in the hypomagnesemia than in the control group. 
Conclusion 
Recovery of reversible post-ischemic myocardium can be enhanced by a variety of 
pharmacological interventions, that either recruit function after myocardial stunning has been 
established or which prevent tile development of myocardial stunning by either an anti-ischemic 
action or inWbition of calcium-overload or formation of oxygen derived free radicals, in 
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particular during the early reperfusion phase. It is noteworthy, however, that only in the studies 
using beta-adrenergic receptor agonists and calcium sensitizing agents regional function could 
be restored to nomlal. All other preventive interventions only partially enhanced recovery. This 
may have been a consequence of the doses used, but it is likely that these interventions targeted 
only one aspect of stunning (severity of ischemia, calcium-overload Of oxygen-derived free 
radicals). 
We have restricted ourselves to describing the results of studies with a limited number of 
phannacological agents, most of which are currently used in clinical practice. The list can easily 
be expanded with agents such as N-acetylcysteine, 126 vitamin E127,128 or its hydrophilic analogue 
MDL 74,405,129 which have all been shown to improve post-ischemic function similar to other 
antioxydants such as superoxyde dismutase + catalase,13o.l32 mercaptopropionyl glycine!3] and 
desferrioxamine. 134 
At the present time a wide variety of phaflnacologieal interventions are thus available for 
prevention attenuation or treatment of myocardial stunning, but the choice and hence the efficacy 
of specific treatment depends on the timing of administration. 
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Objectives and Results. Regional end-systolic pressure-segment length relationships (ESPSLR) were 
used to compare the degree of right and left ventricular stunning, induced by a 10 minute occlusion of the 
left anterior descending coronary artery (LADCA) and the response to subsequent atrial pacing (50 beats 
per minuteabove intrinsic heart rate) without and with dobutamine (2 1-191k9 per min in 9 anesthetized open-
chest pigs. From the ESPSLR, the slope Ees (at 100 mmHg for the left and 25 mmHg for the right ventricle) 
and the total area of the pressure-length relationship, the PLA were determined. From the latter, the 
distribution into external work (EW) and potential energy (PE) as well as the efficiency of energy transfer 
(EET = EWIPLA) were calculated. In both the stunned left and right ventricular myocardium Eu and EW 
were reduced, according to the same finear regression equations (./lEes = 0.7 Ees.oose~r.a - 11.4, r2 = 0.86 and 
flEW = 0.4 EW~.a + 2.3, f = 0.67). EET of the stunned left and right ventricular segments decreased as 
PLA remained unchanged, due to an increase In PE. EET decreased from 0.84 ± 0.02 to 0.71 ± 0.03 
(P<.OS) in the stunned right ventricular segment and from 0.71 ± 0.02 to 0.44 ± 0.03 (P<.OS) in the stunned 
left ventricular segment. Atrial pacing did not affect EET with respect to stunning levels, while the additional 
infusion of dobutamlne restored Ew EWand PE and consequently EET to baseline values. 
Conclusionsln conclusion, the right ventricle is susceptible to stunning. During atrial pacing the EET 
was lower than expected from the Ees> which could, in agreement with the time varying elastance concept, 
be explained by an Increase in afterload (a consequence of the decrease in SV). Dobutamine not only 
increased E"S! EWand EET, but also restored the relationship between ~s and EET in both ventricular 
stunned segments. (Am J Phys/o/.1993;265 (Heart Clre PhysioI34): H2099-H2109.) 
Keywords _ myocardial stunning _ regional contractility (E..J _ external work • efficiency 
of energy transfer _ right ventricle _ left ventricle _ dobutamlne _ atrial pacing _ pig 
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The consequences of brief periods of ischemia for parameters of regional myocardial fUllction, 
such as systolic segment length shortening and systolic wall thickening, have been studied far 
less extensively for the right than for the left ventricle.2,3,'",,',14 Since both systolic segment 
length shortening and systolic wall thickening are load dependent, their application in a 
comparative study involving both the right and left ventricles may be subjected to serious 
discussion,1,9 In analogy to the time varying elastance concept,3) Aversano er all have studied the 
end-systolic left ventricular pressure-segment length relationship and shown that the slope of the 
line, connecting the end-systolic pressure-segment length points (E,,) produced by varying the 
loading conditions of the heart, provides a load independent index of regional myocardial 
contractility. Furthermore, the area enclosed by the ventricular pressure-segment length loop 
represents an index for the external work performed by the examined myocardial segment. 5,26,35 
Recently, we20 have extended the analogy of the former groupsi,S,25,3S and used the entire area 
enclosed by the end-diastolic and end-systolic pressure segment length relationships, the pressure 
length area (PLA), as an index for total mechanical work, which is the sum of the external work 
and potential energy." With this approach, it was shown that during left ventricular stunning 
contractility (E,,) and external work decreased, but also that total mechanical work remained 
unchanged. The latter was caused by an increase in potential energy, which negated the decrease 
in external work and implied a decrease in the efficiency of energy transfer.20 In the same study, 
we also showed that stimulation of stunned left ventricular myocardium with dobutamine 
increased Ees and external work, while PLA remained unchanged, resulting in a full recovery of 
the efficiency of energy transfer, thereby preventing an excessive increase in oxygen 
consumption,20 
It has been shown that the time varying elastance concept both globally and regionally·!"'2,30 
is applicable to both ventricles and we therefore extended our analysis to the right ventricle in 
order to compare the degree of right and left ventricular stunning and the recruitability of E", 
external work and efficiency of energy transfer during chronotropic and inotropic stinlUlation. 
Right and left ventricular stunning was induced by a 10 min occlusion of the left anterior 
descending coronary artery, which is short enough to prevent the development of subendocardial 
necrosis of the left ventricle?8 
Methods 
Gelleral 
All experiments were performed in accordance with the Guiding Principles in the Care and 
Use of Animals as approved by the Council ofthe American Physiological Society and under the 
regulations of the Committee on Animal Experimentation of the Erasmus University Rotterdam. 
After an overnight fast, cross-bred Landrace x Yorkshire pigs (HYC, Hedel, the 
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Fig 1. illustration Indicating the location of the ultrasound crystals In the left and right ventricular myocardium 
perfused by the left anterior descending coronary artery (LAOCA, shaded area) and in the control regions, perfused 
by the left circumflex coronary artery (LCXCA) and right coronary artery (RCA). SL = segment length 
Netherlands) of either sex (23-30 kg) were sedated with 20 mg/kg ketamine Lm. (AUV, Cuijk, 
The Netherlands), anesthetized with 5 mg/kg metomidate i.v. (Janssen Pharmaceutica, Beerse, 
Belgium), intubated and connected to a ventilator for intermittent positive pressure ventilation 
with a mixture of 0, and N, (I :2, v/v). Respiratory rate and tidal volume were set and adjusted, 
when necessary, to keep arterial blood gases within the normal range." Catheters (7F) were 
placed in the superior caval vein for (i) continuous infusion of 10-15 mglkg/h sodium 
pentobarbitone (Sanofi, Paris, France), (ii) the administration of 4 mg of the muscle relaxant 
pancuronium bromide (Organon Teknika B.V., Boxtel, The Netherlands) prior to thoracotomy 
and for the infusion of dobutamine. Catheters were also positioned in the descending aorta for 
withdrawal of blood samples and measurement of central aortic blood pressure. A 7F Sensodyn 
micromanometer-tipped catheter (B. Braun Medical B.Y., Uden, The Netherlands), inserted via 
the left carotid artery, was used to measure left ventricular pressure, while another microtipped 
catheter was advanced into the right ventricle via the right subclavian vein to monitor right 
ventricular pressure. After a midline sternotomy, the left mammary vessels were ligated and the 
second left rib was removed for ease of further instrumentation, and the heart suspended in a 
pericardial cradle. The adventitia surrounding the aorta was dissected free and an electromagnetic 
flow probe (Skalar, Delft, The Netherlands) placed around the vessel for measurement of 
ascending aortic blood flow. On the proximal tllird afthe left anterior descending coronary artery 
(LADCA), a small segment was dissected free of its adventitia for subsequent positioning of an 
atraumatic arterial clamp. Pacing leads were attached to the left atrial appendage and connected 
to a pacing stimulator. Rectal temperature was monitored throughout the experiment and 
maintained between 37" C and 38° C using external heating pads. 
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PLA = PE + EW 
EET = EW/PLA 
Ea, = tan ex 
10 
Segment Length (mm) 
20 
Fig 2. Scheme illustrating the calculation of indices for total mechanIcal work (PLA), potential energy (PE), external 
work (EW), efficiency of energy transfer (EET) and Eu from the left and right ventricular pressure segment length 
relationships. In this figure E~s for the left and right ventricle were determined at 100 mmHg and 25 mmHg, 
respectively. lVP = left ventricular pressure, RVP ::: rightvenlricular pressure, Lo = segment length at zero pressure. 
Regional myocardial segment length shortening was measured by sonomicrometry (Triton 
Technology Inc., San Diego, CA, USA) using four pairs of ultrasonic crystals (Sonotek 
Corporation, Del Mar, CA, USA, Fig I, diameter 2 mm). Two pairs were placed in the 
subendocardial regions of the left ventricle and the midmyocardium of the right ventricle 
supplied by the LAD CA. The LADCA perfused area was identified by a short « 5 sec) 
occlusion, causing a sharp demarcation between the oxygenated myocardium and the bulging 
blue myocardium deprived of oxygenated hemoglobin. The other two pairs were placed in 
regions of each ventricle remote from the distribution area of the LADCA (Fig 1). 
Er:perimel1tal protocol 
After completing the surgical procedures, a 30-45 min stabilization period was allowed 
before baseline recordings were made of pressures in the descending aorta (AP), left and right 
ventricles (L VP and RVP, respectively) and their respective first derivatives (LVdP/dt and 
RVdP/dt), ascending aortic blood flow (cardiac output, CO) and segment length changes in the 
four regions. With the respirator switched off, the aorta was then gradually clamped to create a 
series of 10-20 beats with variable afterIoads (duration 5-10 s) for the construction of the left 
ventricular end-systolic pressure-segment length relationships. The right ventricular end-systolic 
pressure-segment length relationships (ESPSLR's) were subsequently obtained by gradually 
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clamping the pulmonary artery over a similar period of 5-1 0 s, also with the respirator switched 
off. The ventricular pressures and segment length signals were digitized (sample rate 250 Hz) 
with an 8 bit AD-converter (Tiepie Engineering, Leeuwarden, The Netherlands) and stored on 
disk for further off-line analysis. 
After all baseline data were recorded, the LADCA was occluded for 10 min. After recording 
oftlle systemic hemodynamic parameters and segment length changes, the coronary artery was 
reperfused for 30 min. At that time, the heart rate was raised by 50 beats per minuteand 5 min 
later an intravenous infusion of dobutamine (2 I1g/kg per min was started for 10 min, while atrial 
pacing was continued. In earlier studies we have shown that 2 Ilglkg per min dobutamine 
increases the pig's own heart rate by less than 50 beats per minute. 11 Collection of all data was 
repeated after 30 min of reperfusion, after 5 min of atrial pacing and at the conclusion of the 
dobutamine infusion. 
Data ([nalysis mId statistics 
Left and right ventricular systolic segment length shortening were calculated as the 
difference between lengths at end-diastole and end-systole and expressed as a percentage of end-
diastolic length. Baseline end-diastolic segment length measurements were normalized to 10 nun. 
End-diastole was determined at the peak positive dP/dt while end-systole was determined at 
peak-negative dP/dt, which corresponds closely to the zero crossing point of the flowmeter 
tracing and thus the closure of the aortic and pulmonary valve of the left and right ventricle, 
respectively,13 
The end systolic pressure-segment length relationships (ESPSLR's) of both ventricles were 
determined by fitting the end systolic pressure-segment length data points (Fig 2), which were 
calculated by an iterative algorithm, to a second order polynoma, similar to the method described 
extensively by Mirsky 24 and Van der Velden er al." Briefly, since the length at zero pressure 
(Lo) is unknown, Lo was taken equal to zero and the end systolic pressure-segment length point 
for each individual beat was calculated on basis of the maximal elastance for that beat. 
Subsequently, linear regression was applied to the calculated end-systolic pressure-segment 
length point and a first estimate ofL, was obtained. Using this new L,-estimate and the maximal 
elastance for each beat, end-systolic pressure segment-length points were again calculated, 
applying linear regression, which resulted in a second estimate of Lo. This sequence of steps was 
continued until the change in Lo was less than 0.25 mm. This usually took 3-4 iterations. With 
this procedure end-systole not necessarily coincides with end-systole based on the definition of 
peak positive and peak negative dP/dt. Since a second order polynoma described the ESPSLR 
more accurately than the linear regression, the slope of the ESPSLR became dependent on 
segment length. We, therefore, characterized the ESPSLR of the left ventricle by the slope (E~) 
at 100 mmHg and the length at the zero pressure intercept (Lo; see also reference 20). For the 
right ventricle, we used the slope at 25 lllll1Hg (Fig 2). In addition we determined the average of 
the area of 10 consecutive pressure-segment length loops as the index of the external work (EW, 
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TABLE 1. Hemodynamics at baseline, during 10 min occlusion and 30 min reperfuslon of the left anterior 
descending coronary artery (LAOCA), and subsequent chronotropic and Inotropic stimulation In 9 
anesthetized swine 
Baseline 
MAP, mm Hg 95+3 
HR, bpm 109±5 
CO, Urnin 2.48£0.16 
LVSP, mm Hg 112±3 
LVdP/dl"." mm Hgls 2320±220 
Occlusion 
84+2· 
107±6° 
2.03±0.16* 
103±3* 
1830±120* 
Reperfusion 
85±3* 
99±6'" 
2.15±0.20* 
Atrial pacing' 
87±3* 
148±6** 
1.98±0.22* 
Atrial pacing + 
Dobutamineb 
87±3* 
149±6*-
2.41±O.21f(l 
104±3* 100±4* 111±3'o 
1790±150* 1690±130* 3210~ 
LVEDP, mm Hg 11±1 14±1* 12±1 12±1 9±1 
SVR, mm Hg/(Umin} 40±3 43±4 44±7 42±5 39±5 
RVSP, mm Hg 36±2 31±1* 32±2 36±2 39±2*0 
RVdP/dt.ra.. mm Hgls 730±130 580±140* 590±140* 590±180* 1100±41()"'> 
RVEDP, mm Hg 7±1 8±1 8±1* 7±1 6±1*o 
a Heart rate was Increased by 50 beats per mlnuteover the heart rate measured aher 30 mm of repeffuslon; g 
Oobutamlne was infused at 211g1kglmin for 10 mIn. MAP::: mean arterial blood pressure; HR::: heart rate; CO::: 
cardIac output; LVSP ::: left ventricular systolic pressure; LVdP/dt.r,... ::: maximal rate of rise of left ventricular 
pressure; LVEOp::: left ventricular end-dIastolic pressure; RVSP::: right ventricular systolic pressure; RVdP/d!.r.... 
::: maximal rate of rise of right ventricular pressure; RVEDP ::: right ventricular end-diastolic pressure. All data have 
been presented as mean±SEM. 
* P<.05 vs Baseline 
* P<.05 vs Reperfusion 
o P<.05 vs Atrial pacing. 
Fig 2). Potential energy (PE, Fig 2) was determined by integrating the second order polynoma 
from L, to the end-systolic segment length (L,,) as described earlier." The sum of potential 
energy and external work equals the total mechanical work performed by the myocardium 
pressure length area (PLA, Fig 2). The efficiency of energy transfer EET was deftned as 
EWIPLA." 
All data have been presented as mean and standard error of the mean (SEM). Statistical 
analysis was perfomled for each variable by repeated measures of ANOV A. When significance 
was reached (P<.05), paired t-tests were applied with a Bonferroni correction for multiple 
measurements. The statistical difference between the regression equations were evaluated by 
analysis of covariance (ANCOV A), using a standard package (Statgraphics, Rockville, Maryland, 
USA). 
RESULTS 
Systemic hemodynamics 
Occlusion oftlle LADCA caused all ± 2% decrease (P<.05, Table I) in mean arterial blood 
pressure, because ofa fall in cardiac output (14 ± 4%, P<.05). Both LVdP/dt~, and RVdP/dt=, 
decreased by approximately 20% (P<.05). L VEDP increased by 3 ± 1 mmHg (P<.05) over its 
baseline value of II ± 1 rnrnHg, while R VEDP did not change. During reperfusion L VEDP 
decreased by 2 ± 1 nlIllHg, while none of the other parameters was signiftcantly affected. Atrial 
pacing did not lead to significant changes apart from the increase in heart rate. During the 
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Fig 3. Original tracing showing hemodynamics and regional segment length changes for the control and stunned 
left and right ventricular myocardium. ECG ::: electrocardiogram; AoP, LVP and RVP are aortic, [eft ventricular and 
right ventricular pressure, respectively; LVdP/dt::: first derivative of left ventricular pressure; AoF ::: aortic floW; SL 
::: segment length; LADCA ::: left artery descending coronary artery; LCXCA ::: circumflex artery; RCA::: right 
coronary artery; ES and ED are end-systole and end·diastole, respectively; End-diastole was determined at peak 
positive. LVdP/dt and RVdP/dt (not shown) for the left and right ventricle, respectively. End-systole was determined 
at peak negative peak dP/dt. 
additional infusion of dobutarnine, there were increases in both LVdP/dt~, (by 108 ± 17%, 
P<.OS) and RVdP/dt~, (by 94 ± 20%, P<.OS) and in left (to its baseline value) and right (to 
10%over its baseline value) ventricular systolic pressures. Cardiac output also returned to 
baseline values (Table I). 
Regional segment length shortening 
Occlusion of the LADCA resulted in bulging of the ischemic segment of the left ventricle 
as systolic segment length shortening (%SS) decreased to -4 ± 1%, and to an almost complete 
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TABLE 2. Systolic segment length shortening at baseline, during 10 min occlusion and 30 min reperfuslon 
of the lett anterior descending coronary artery (LADCA), and subsequent chronotropic and Inotropic 
stimulation In 9 anesthetized swine 
Left ventricle 
non-stunned area 
EDL, mm 
ESL, mm 
SS, % 
stunned-area 
EDL (mm) 
ESL(mm) 
88(%) 
RIght ventricle 
non-stunned area 
EDL(mm) 
ESL(mm) 
88(%) 
stunned-area 
Baseline 
10.0 
B.7±O.1 
14±1 
10.0 
8.2±0.1 
18±1 
10.0 
8.3±0.1 
17±1 
Occlusion 
10,5±O.1" 
9.3±0.2* 
12±1 
11.2±0.3* 
11.8±0.5* 
~4±1* 
9.5±0.3 
7.9±0.4 
17±3 
Reperfusion 
9.6±0.4 
8.4±0.4 
13±1 
10.4±0.2* 
9.5±0.2* 
10±1* 
9.6±0.2 
8.3±0.2 
14±1* 
Atrial paclng~ 
9.1±O.4H 
8.3±0.4 
9±1'" 
9.9±0.2' 
9.2±0.2* 
8±1*' 
9.7±0.2 
BA±0.2 
14±2* 
Atrial pacing + 
Dobutamineb 
9.5±O.2* 
8.4±0.3 
12±1° 
9,8±0.1' 
7.8±0.4'O 
17±2'0 
9.3±0.2* 
7.9±0.2 
1S±2 
EDL (mm) 10.0 10A±OA 9.5±O.5 9.7±OA 9.3±OA 
ESL (mm) 7.3±D.4 10.1±O.5* 8.1±0.3 B.3±DA 7.0±OA+o 
SS (%) 27±4 3+2* 14+3* 14+3* 24+4'0 
k Heart rate was increased by 50 beats per mlnuteover the heart rate measured after 30 min of reperfusion; b 
Dobutamine was infused at 211gfkglmin for 10 min. EDL = end-diastolic segment length (normalized to 10 mm at 
baseline); ESL = end-systolic segment length; SS = segment length shortening; All data have been presented as 
mean±SEM. 
* P<.DS vs Baseline 
• P<.OS vs Reperfus!on 
o P<.OS vs Atrial pacing. 
loss of function of that of the right ventricle as %SS decreased to 3 ± 2% (Fig 3 and Table 2). 
Segment length shortening of the post-ischemic myocardium of both ventricles recovered only 
partially during reperfusion (to 61 ± 9% and 54 ± 7% of baseline for the left and right ventricles, 
respectively). Increasing heart rate by atrial pacing decreased segment length shortening by 
approximately 30% versus baseline in both stunned and non-stunned left ventricular 
myocardium, wltile segment length shortening of the stunned and of the non-stunned right 
ventricular segments were not affected. With the addition of dobutamine, segment length 
shortening of the stunned segments and the non-stunned segment of the left myocardium returned 
to baseline, while that of Ute non-stunned myocardium of the right ventricle remained unchanged 
(Fig 3 and Table 2). 
Regional cOlltractility 
An example of the changes in Ees of the left and right ventricular segments during the course 
ofthe experimental protocol is shown in Fig 4. As shown, regional end-systolic pressure-segment 
length relationships decreased during stunning for both the right and left ventricular intervention 
areas, while they remained approximately constant for the control regions. Eeg of the non-stunned 
myocardium of both ventricles was unchanged after 30 minutes of reperfusion following the 10 
minute occlusion period (Table 3). Atrial pacing had only a minimal effect on E~, but the 
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Fig 4. Examples showing end-systolic pressure-segment length relationships as well as pressure-segment loops 
obtained from afterload changes for both right and left ventricular segments. 
TABLE 3. Regional Mechanics and Energetics at Baseline, After 10-ml" Occlusion and 3D-min of 
Reperfusion of the LAOCA and Subsequent Chronotropic and Inotropic Stimulation of Nine Anesthetized 
Swine 
Baseline Reperfusion Atrial pacing Atrial pacing + 
dobutamine 
Left ventricle 
Non-stunned area 
Ees. mm Hglmm SS±6 76±8 79±9 147±19··Q 
La, mm 7±0.6 7.3±0.8 l.1±D.S S.4±0.7 
EET O.71±O.O2 0.60±0.02 0.54±O,07* O.77±O.OS'Q 
stunned area 
Ets • mm Hglmm 77±10 30±5~ S3±12 131±3S*'o 
Lo,mm 7.8±0.S 8.1±0.S 7.7±0.S 7.9±0.6 
EET 0.70±0.02 0.44±0.03~ 0.40±0.04* 0.68±0.OS'0 
Right ventricle 
Non·stunned area 
Eu. mmHglmm 30±? 43±10 43±10 64±13HO 
Lo, mm 6.4±0.6 6.7±0.6 7.4±0.4 7.2±0.4 
EET 0.82±0.03 0.76±0.02 0.67±0.03* 0.81±0.03° 
Stunned area 
Eu , mm Hg/mm 33±6 23±4* 26±6 64±9HO 
LQ,mm 4.9±0.6 S.6±0.9 S.8±0.9 S.2±0.9 
EET 0.84+0.03 0.70+0.04* 0.61+0.07* 0.81±O.O4" 
Values are means ± SE. Heart rate was increased by 50 beats per minute over the heart rate measured after 
30 mIn of reperfusion. Dobutamine was infused at 2 JJglkg per mIn or 10 min. E .. , slope of end-systolic pressure 
segment-length relationship; Lo. optimal length; EET, efficiency of energy transfer. 
* P<.05 vs Baseline 
, P<.05 vs Reperfusion 
o P<.OS vs Atrial pacing 
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Fig 5. Total mechanical work (PLA), external work (EW) 
and potential energy (PE) before (Baseline) and after 30 
min reperfusion (Rep) following a 10 min occlusion of the 
left anterior descending coronary artery and subsequent 
atrial pacing (PacIng) and the additional Infusion of 
dobutamine (Pacing + Dobutamine) of non-stunned and 
stunned right ventricular myocardium. Data have been 
presented as meantSEM (n = 9). * P<.05 vs Baseline; 
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additional infusion of dobutamine caused a doubling of the E" of both the left (184 ± 29%, 
P<.05) and right ventricle (214 ± 31%, P<.05) compared to baseline. After 30 min of 
reperfusion, Eo. of the stunned myocardium had decreased in both the left (to 42 ± 6% of 
baseline, P<.05) and right ventricle (to 80 ± 8% of baseline, P<.05; Table 3). Eo. of the two 
stunned myocardial segments was also not affected by atrial pacing, but increased both by a 
similar amount as in the non-stunned myocardium during the additional infusion of dobutamine. 
The intercepts at zero left ventricular pressure (Lo) for the non-stunned and stunned myocardium 
were unchanged for both ventricles after 30 min of reperfusion and were also not modified by 
atrial pacing and the additional infusion of dobutamine (Table 3). 
Regional pressure-segment length area's 
The total mechanical work (PLA) of the left ventricular myocardium inside and outside the 
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distribution area of the LADCA was unchanged at the end of the reperfusion period and not 
affected by atrial pacing and the additional dobutamine infusion (Fig 5). There were, however 
some striking differences in the pattern of the external work (EW) and potential energy (PE), the 
two components which determine PLA. While there were no marked changes in these two 
components in the non-stunned myocardium during the different experimental conditions, there 
were considerable changes in the stunned left ventricular myocardium. After 30 min of 
reperfusion, PE had doubled, while EW had decreased to 60% of baseline. Atrial pacing did not 
affect EW and PE, but both indices returned to baseline values during the additional infusion of 
dobutamine (Fig 5). From these data it follows that the efficiency of energy transfer (EET) of 
the non-stunned myocardium during baseline (0.71 ± 0.02, Table 3) did not change during the 
experiment, except after atrial pacing (P<.05 vs baseline). It decreased to 0.44 ± 0.03 (P<'05) 
after 30 min of reperfusion ill the stunned myocardium. Atrial pacing did not further lower EET 
in the stunned region (0.40 ± 0.04), but the additional infusion of dobutamine restored EET to 
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baseline values (0.68 ± 0.05). 
PLA of the non-stunned and stunned right ventricular myocardium also did not change 
during the experiment, except after atrial pacing (1'<.05 vs baseline) (Fig 6). Since in the stunned 
region EW decreased and PLA did not change after reperfusion, EET decreased from 0.84 ± 0.03 
to 0.70 ± 0.04 (P<.05). In the non-stunned myocardium, EET remained unchanged (0.82 ± 0.03 
at baseline and 0.76 ± 0.02 after reperfusion (NS)). Atrial pacing had no further affect on the 
EET of the stunned region, but lowered the EET in the control region from 0.76 ± 0.02 to 0.67 
± 0.03 (P<.05 vs baseline) due to a decrease in EW. Dobutamine restored EW, PE (Fig 6) and 
EET (Table 3) to baseline values in the stunned as well as in the non-stunned segments. 
Relationships between Ew EW and EET 
In Fig 7 we have related the decreases in E~ of the individual animals during stunning to 
their respective baseline values and observed that for both ventricles the decreases were linearly 
related (r' = 0.86) to the values determined at baseline. We could also demonstrate such a linear 
relationship for EW (r = 0.67, Fig 8). 
In Fig 9 the relation between E~ and EET (EWIPLA) has been depicted for the myocardial 
segments inside the distribution area of the LADCA for both ventricles. It proved that the data 
points obtained under baseline conditions and after stunning could be described by hyperbolic 
relationships: EET = 1/(1 + 3l/E~)(r' = 0.61) and EET = I/(I + 6.6/E~)(r' = 0.44) for the left 
and right ventricle, respectively. The figure also shows that EET was considerably lower than 
expected from these relationships during atrial pacing, but the relationship was restored during 
the additional infusion of dobutamine. 
DISCUSSION 
It has recently been appreciated that right ventricular dysfunction might contribute to the 
hypotension and thereby, indirectly the degree of left ventricular dysfunction, during and after 
myocardial infarction. 8,29,32 This study shows, that even after brief periods of ischemia, induced 
by occlusion of the LADCA, the right ventricle also becomes stunned and thereby might, 
indirectly, contribute to the left ventricular dysf?nction observed during left ventricular stunning. 
Segment/ength jilOJ"tening and Ee$ 
In assessing the severity of right and left ventricular stunning, we used both systolic segment 
length shortening (%S8) and the slope of the end-systolic pressure segment-length relationship 
(E.), the reason being that %S8 may be mainly determined by (regional) end-diastolic and end-
systolic volume changes and does therefore not necessarily reflect myocardial contractility. Some 
striking differences were indeed observed in the pattern of changes in %SS and E~s. Firstly, at 
baseline %SS of the right ventricular myocardium was slightly larger than that of the left 
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ventricular myocardium and showed, in agreement with earlier studies6.7,13,14,26 fairly large 
regional differences (Table 2). On the other hand, Eo. (and also the maximuIll rate of rise in 
ventricular pressure) was higher for the left than for the right ventricle, which is also in 
agreement with earlier studies.2I·3~33 Secondly, both %SS and Eo. were reduced significantly after 
30 min of reperfusion following the coronary artery occlusion, but both parameters responded 
differently when the heart was stressed by atrial pacing. Systolic segment length shortening 
decreased, in both the stunned and non-stunned left ventricle, but was not affected in the right 
ventricular segments. Ees, on the other hand, tended to increase in the stunned left and right 
ventricular segments and remained unchanged in the non-stunned segments, which is compatible 
with the small effect of atrial pacing on EO' An interesting obselVation is that end-diastolic length 
of both (stunned and non-stunned) left ventricular segments decreased during pacing, while it did 
not change for the right 'ventricular segments. This decrease in end-diastolic segment length of 
the stunned left ventricle strongly suggests that in this segment the decrease in %SS was not due 
to a loss of contractile ftmction but was caused by the decrease in stroke volume. The ftnding that 
Ees of the stunned segments tended to increase supports this hypothesis. Finally, %SS was 
restored during infusion of dobutamine, which is in agreement with earlier investigations using 
inotropic stimulation.2.3,1l,12,20 E~, on the other hand, increased to almost twice the baseline 
values. Hence, it appears to be preferable to use indexes such as E~, when one wants to compare 
the effects of inotropic and chronotropic stimulation on contractility of stunned myocardium, 
which is working against different afterloads. 
Ees ill stunned left and right ventricular segments 
Right ventricular stunning was accompanied by a decrease of contractility, although the 
absolute change was less than for the left ventricle. This might be due to a lower oxygen demand 
of the right ventricle before the ischemic period, resulting in a smaller oxygen debt during the 
300 
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occlusion period. Indeed, PLA and Ee>J two indexes of oxygen demand, were much lower for the 
right than for the left ventricle (Table 3), in accordance with the lower oxygen consumption per 
gram of right ventricular myocardium. 21 In addition, the observation that baseline contractility 
is a main factor determining the decrease of contractility during stunning for both the right and 
left ventricular myocardium, might be explained by the same working hypothesis since a higher 
contractility leads to a higher external work30,33 and both factors are known to be related to a 
higher oxygen demand.33 A similar observation has been reported by Kass er al,16,17 who showed 
that in canine and human hearts, the regional ischemia-induced decrease in global Ees depended 
on its pre-ischemia values. These authors interpreted their results on basis of a two compartment 
model, describing the ischemic region with a smaller slope of the (passive) pressure-volume 
relationship (i.e. higher compliance) as the remote area. 16,17 The model calculations and the 
measurements indicated that the greater the active stiffness of the myocardial wall initially, the 
larger the effect of replacing a region of the myocardium by more compliant tissue. 16,17 
Therefore, these authors interpreted their ftndings, solely on a mechanical basis. However, a 
recent study showed that purine efflux induced by a short period of ischemia is related to pre-
ischemic myocardial function, indicating that a higher contractile function before the ischemic 
period leads to a higher ATP-catabolism during similar ischemic periods. 1O 
In view ofthe non-linearity of the ESPSLR curves of both ventricles it might be argued that 
an index based on a linear relationship such as the preload-recmitable stroke work relationship 
would be preferable. ls,27 The advantage of the regional ESPSLR curves is, however, that, in 
addition to an estimation of Ecs they also allow the calculation of indexes for external work, 
potential energy, total mechanical energy output and efficiency of energy transfer of the 
examined segments. I,4,18,20,33 A further advantage of the time varying elastance concept is that it 
has established a relationship between Ees and efftciency of energy transfer. 4,18 
Efficiency of energy transfer ill stunned left and right ventricular segments 
Using the time varying elastance concept, Burkhoff er al 4 have shown that EET and Ees are 
related by EET ~ 1/(1 + 0.5 EjE«) in which E. equals the ratio of mean arterial blood pressure 
and stroke volume. Myocardial stunning decreased mean arterial blood pressure and stroke 
volume to the same extent, which implies that I) the EET of the non-stunned left ventricular 
segment remained unchanged as E~ did not change, while 2) the EET of the stunned left 
ventricular segment decreased due to a decrease in Ees. Atrial pacing decreased stroke volume 
but had no effect on mean arterial blood pressure, which resulted in a decrease in EET despite 
a virtually unchanged E!s (Fig 9). During the dobutamine infusion, the ratio of mean arterial 
blood pressure and stroke volume increased but did not return completely to baseline values. 
Nevertheless, the EET values obtained after dobutamine coincided with the relationship 
determined during baseline and stunning, suggesting a less pronounced roll of Ea during high 
contractile states, which is in agreement with data from Nozawa er al 21 and Morris er al 26 
The response of EET and the relationship between EET and Ecs in the right ventricular 
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segments due to the 10 min occlusion, followed a similar pattern as the left ventricle, since the 
end-systolic right ventricular pressure decreased in a similar amount as stroke volume and 
probably Ea for the right ventricle also remained constant after coronary occlusion and 
subsequent reperfusion. The observed decrease of EET, therefore, mainly resulted from the 
decrease of Ees 
of the right ventricular stunned region. Again the response of atrial pacing appeared unbeneficial, 
while the EET values after dobutamine coincided with the EET-E" relationship. 
In addition, by comparing the EET-E" relationship for both ventricles, it can be shown that 
despite lower Ees values for the right ventricle as for the left ventricle during baseline conditions, 
EET values are ahnost similar because oftlle lower afterload or E. for the right ventricle (Fig 9). 
Due to the steepness of the resulting hyperbolic relationship between EET and E" for the right 
ventricle, BET is more sensitive to absolute changes in Ecs. However, the small absolute decrease 
of Ees for the right ventricular stunned segment as compared to the left ventricular stunned 
segment, explains why EET was only modestly reduced (by 15%), while EET was reduced by 
38% in the left ventricle. 
Limitations of the study 
Regional myocardial contractile function is often characterized by systolic segment length 
shortening or systolic wall thickening. Analogous to the time varying elastance concept (end-
systolic pressure-volume relationships), Aversano er al have used the end-systolic pressure-
segment length relationship to obtain an index of regional myocardial contractility, I which is 
more load-independent than segment length shortening. The time varying elastance concept also 
enables the calculation of the total mecharucal work performed by the myocardium. The area 
inside the pressure-volume loop (mmHg.mm3) represents external work, while the difference 
between total mechanical work (the area enclosed by the end-systolic and end-diastolic pressure-
volume relationships and the systolic pressure-volume trajectory) and external work represents 
potential energy.3O,33 Several investigators have shown that, in analogy to the approach taken by 
Aversano er aI, for both ventricles the area enclosed by the pressure-segment length loop, in spite 
of its difference in dimensions (mmHg.mm), is also a reliable index of external work and relates 
to regional oxygen consumption. 5,19,23.,26,35 We have extended tIus analogy by considering the area 
(PLA) enclosed by the end-systolic and end-diastolic pressure segment length relationships and 
the systolic-pressure segment length trajectory (PLA).20 The consequence of this assumption is 
that the dimensionless variable EET can be calculated from the ratio of EW and PLA. The close 
agreement between the present values of EET and the values obtained from pressure-volume 
relationships, obtained during baseline conditions and during infusion of dobutamine27 are in 
accordance with this argument. 
In constructing the ESPSLR, we only used gradual increases in afterload, which leaves the 
determination of potential energy open to criticism. We have, however, shown that ESPSLR's 
(and consequently also E., PE and PLA) constructed from changes in afterload alone are almost 
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identical to the ESPSLR's constructed by varying both pre- and afterload.20 Similar to earlier 
investigators,4,3{l,33,34we found that the ESPSLR were described more accurately with a non-linear 
than with a linear relationship. This finding makes the slope of the ESPSLR (E,,) segment-length 
dependent. To characterize contractility we used the E" at 1 00 InmHg for the left ventricle and 
the E~ at 25 mmHg for the right ventricle. To examine the possibility that our conclusions were 
determined by the choice of these pressure values, we also determined Ees and BET at end-
systolic pressures of 125 and 75 InmHg for the left ventricle and at 50 mmHg for the right 
ventricle. Ees calculated at different end-systolic pressures changed similarly for both the right 
and left ventricular stunned segments during reperfusion, atrial pacing and the additional infusion 
of dohutamine, indicating that the relative response of the E~ values is similar in the range of 
end-systolic pressures normally encountered during our experiments. 
A distinct difference was found between the hyperbolic relationships ofEET and E" for both 
stunned segments, when analyzed for the different end-systolic pressures (Fig 10). We therefore 
also analyzed the relationships between EET and E" at the end-systolic pressures found during 
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each steady state before the changes in afterload were applied ("working point"). Although these 
working points were different between and during experiments, the resulting hyperbolic 
relationship was close to the 100 mmHg curve for the left ventricle (compare Fig 9 with Fig 10). 
However, the choice of 25 mmHg used for the analysis of the right ventricular data, resulted in 
quantitatively different conclusions at the working point for the right ventricle (Fig 10). Since 
it is theoretically better to estimate these relationships at a constant cnd-systolic pressure18 and 
25 mmHg was in the working range found in our studies, this approach was followed in the 
present study. 
In conclusion, this study confIrms that after a brief occlusion of the LADCA, not only the 
left ventricle, but also the right ventricle became regionally stunned and therefore might 
contribute to left ventricular dysfunction. The decreases in Ees and EW depended on their 
baseline values and were considerably less for the right than for the left ventricle, but for both 
ventricles, the decreases in Ees and EW could be described by the same linear relationship. 
Because for both stunned ventricular area's EW decreased and the PLA was less affected, the 
efficiency of energy (EET ~ EWIPLA) was decreased. During baseline conditions and stunning 
E~ and EET of both ventricular stunned segments were related by a hyperbolic relationship. 
During atrial pacing the relationships were uncoupled as EET was lower than expected from 
the Eo;, which could. in agreement with the time varying elastance concept. be explained by an 
increase in Ea (a consequence oftlle decrease in SV). Dobutamine not only increased Eeos, EWand 
EET, but also restored the relationship between E" and EET in both ventricular stunned 
segments. 
Right and left ventricular stunning 73 
References 
I, Aversano T, Maughan WL, Hunter WC, Kass DA, Becker LC: End-systolic measures of 
regional ventricular performance: Circulalion 1986;73:938-950, 
2, Becker LC, LevinellI, Di Paula AF, Guarnieri T, Aversano T: Reversal of dysfunction in 
postischemlc stunned myocardium by epinephrine and post-extrasystolic potentiation. JAm 
Coli Cardiol 1986;71:580-589, 
3, BolliR, Zhu wx, Myers ML, Hartley CJ, Roberts R: Beta-adrenergic stimulation reverses 
postischemic myocardial dysfunction without producing subsequent functional 
deterioration, Alii J Cardiol 1985;56:964-968, 
4, Burkhoff D, Sagawa K: Ventricular efficiency predicted by an analytical model. Am J 
Physiol 1986;250 (ReguialDlY Inlegralive Comp 1'hysiol 19):RI021-RI027, 
5. Calvin IE Jr.: Pressure segment length analysis of right ventricular function: influence of 
loading conditions, Am J Physiol 1991 ;260 (Hearl Cire Physiol 29):HI087-H1 097, 
6. Chow E, Foppiano L, Farrar DJ: Regional contractile performance during acute ischemia 
in porcine right ventricle, Am J 1'hysiol 1992;263 (Hearl Cire 1'hysiol 32):H135-HI40, 
7, Chuong CJ, Sacks MS, Templeton G, Schwiep F, Johnson RL Jr.: Regional deformation 
and contractile function in canine right ventricular free wall. Am J Physiol 1991;260 (Hearl 
Circ Pysiol 29):HI224-Hl235, 
8, Cohn IN, Guiha NH, Broder MI, Limas CJ: Right ventricular infarction, Clinical and 
hemodynamic features, Am J Cardiol 1974;33 :209-214, 
9, Crottogini AJ, Willshaw P, Barra JG, Lascano EC, Pichel RH: Differential effects of left 
ventricular anterior descending coronary occlusion on left and right ventricular anterior 
wall thickening in the conscious pig, Cardiovasc Res 1992;26:221-225, 
10, De Jong JW, Huizer T, Janssen M, Krams R, Tavenier M, Verdouw PD: High energy 
phosphates and catabolites, In: Ischaemia-repe/fusion in Cardiac S/lrge/y. Eds: H.M, Piper 
and C,J. Preusse, KlOwer Academic Publishers, Dordrecht, 1993,120-138, 
11. Duncker DJ, McFalls EO, Keams R, Verdouw PD: Pressure-maximal coronary flow 
relationship in regionally stunned porcine myocardium, Am J PhY8ioi 1992;262 (Hearl Cire 
1'hysiol31):Hl744-Hl751. 
12, Ellis SG, Wynne J, Braunwald E, Henschke CI, Tamas Sandor DP, Kloner RA: Response 
of reperfusion-salvaged, stunned myocardium to inotropic stimulation. Am Heart J 
1984;107:13-19, 
13. Guth BD, Schulz R, Heusch G: Evaluation of parameters for the assessment of regional 
myocardial contractile function during asynchronous left ventricular contraction. Basic Res 
CardiolI990;85:550-562, 
14. Johnston WE, Vinten-lohansen J, Shugart HE, Santamore WP: Positive end-expiratory 
pressure potentiates the severity of canine right ventricular ischemia-reperfusion injury_ Am 
J Ph),siol 1992;262 (Hearl Cire Ph),siol 31 ):H 168-Hl76, 
74 
15. Karunanithl MK, Michniewicz J, Copeland SE, Fene1ey MP: Right ventricular preload 
recruitable stroke work, end-systolic pressure-volume, and dP/dt",.,,-end-diastolic volume 
relations compared as indexes of right ventricular contractile performance in conscious 
dogs. Circ Res 1992;70:1169-1179. 
16. Kass DA, Marino P, Maughan WL, Sagawa K: Determinants of end-systolic pressure-
volume relations during acute regional ischemia in situ. Circulatioll 1989;80: 1783-1794. 
17. Kass DA, Midei M, Brinker J, Maughan WL: Influence of coronary occlusion during 
PTCA on end~systoHc and end-diastolic pressure-volume relations in humans. Circulatioll 
1990;81 :447-460. 
18. Kass DA, Kelly RP: Ventriculo-Arterial Coupling: Concepts, Assumptions, and 
Applications. Ailil Biollled Eng 1992;20:41-62. 
19. Kedem J, Sonn J, Scheinowitz M, Weiss HR.: Relationship between local oxygen 
consumption and local and external cardiac work: effect of tachycardia. Cal'diovasc Res 
1989;23: 1043-1052. 
20. Krams R, Duncker DJ, McFalls EO, Hogendoorn A, Verdouw PD: Dobutamine restores 
the reduced efficiency of energy transfer from total mechanical work to external 
mechanical work in stunned porcine myocardium. Cardiovasc Res 1993;27:740-747. 
21. Kusachi S, Nishiyama 0, Yasuhara K, Saito D, Haraokas S, Nagashima H: Righ! and left 
ventricular oxygen metabolism in open-chest dogs. Alii J Phy,ioI1982;243 (Heart Circ 
PhysioI12):H761-H766. 
22. Maughan WL, Shoukas AA, Sagawa K, Weisfeld! ML: Instantaneous pressure-volume 
relationships of the canine right ventricle. Circ Res 1979;44:309-315. 
23. McFalls EO, Duncker DJ, Krams R, Sassen LMA, Hogendoorn A, Verdouw PD: The 
recruitment of myocardial work and metabolism in regionally stunned porcine 
myocardium. Alii J Physio11992;263 (Heart Circ PhysioI32):HI724-H1731. 
24. Mirsky I: The concept of systolic myocardial stiffness with applications to the assessment 
of myocardial contractility in health and disease. In: Cardiac Mechanics and Functioll ill 
the Normal and Diseased Heart. Eds: M. Hori, H. Suga, J. Baan, E.L. Yellin. Springer-
Verlag Tokyo, 1989,91-101. 
25. Morris JJ, Pellom GL, Murphy CE, Salter DR, Goldstein JP, Wechsler AS: Quantification 
of the contractile response to injury: assessment of the work-length relationship in the intact 
heart. Circulation 1987;76:717-727. 
26. Morris SJ, Szwarc RS, Braun E, Roth B, Ball HA: Mechanism of increased ejection 
fraction following dobutamine in the anaesthetized mini-pig: application of the ventriculo-
arterial elastance coupling equation. J Mol Cell CardioI1992;24:S43. 
27. Nozawa T, Yasumura Y, Futaki S, Tanaka N, Uenishi M, Suga H: Efficiency of energy 
transfer from pressure-volume area to external mechanical work increases with contractile 
state and decreases with afterload in the left ventricle of the anesthetized closed-chest dog. 
Circulation 1988;77: 1116-1124. 
Right and left ventricular stunning 75 
28, Reimer KA, Jennings RB: Myocardial ischemia, hypoxia and infarction, In: T7le Hem't alld 
Cm'dio\>asculm' System, Second Edition, Eds: H.A Fozzard, E. Haber, R,B. Jennings, A.M, 
Katz, RE. Morgan, Raven Press, Ltd" New York, 1991, 1875-1973, 
29. Rigo P, Murray M, Taylor DR, Weisfeldt ML, Kelly DT, Strauss HW, Pitt B: Right 
ventricular dysfimction detected by gated scintiphotography in patients with acute inferior 
myocardial infarction, Circulatioll 1975;52:268-274, 
30. Sagawa K, Maughan WL, Suga H, Sunagawa, K: Cardiac contraction and the pressure-
volume relationshlp. Oxford University Press, Oxford, New York, 1988. 
31. Sassen LMA, Bezstarosti K, Van def Giessen WJ, Lamers JMJ, Verdouw PD: 
L-propionylcarnltlne increases post-ischemic blood flow but does not affect recovery of 
the energy charge, Am J Physiol1991 ;261 (Heart Circ PhysioI30):HI72-HI80. 
32. Setaro JF, Cabin HS: Right ventricnlar infarction, In: Cardiology Clillics, 1/le right 
velltric/e, Eds: M.S, Remetz and H.S, Cabin, W.B. Saunders Company, Harcourt Brace 
Jovanovich, Inc" 1992, 69-90. 
33. Suga H: Ventricular energetics. Physiol Reviews 1990;70:247-277, 
34. Van der Velde ET, BurkhoffD, Steendijk P, Karsdon J, Sagawa K, Baan J: Nonlinearity 
and load sensitivity of end-systolic pressure-volume relation of canine left ventricle. 
Circulatioll 199i;83:315-327, 
35. Vinten-Johansen J, GayheartPA, Johnston WE, Julian JS, Cordell AR: Regional function, 
blood flow, and oxygen utilization relations in repetitively occluded-reperfused canine 
myocardium. Am J Physio11991;261 (Heart Circ PhysioI30):H538-H547, 

Chapter 4 
MyofibrillaI' Ca2+ Sensitization Predominantly Enhances Function 
and Mechanical Efficiency of Stunned Myocardium 
RUJlning title: Cci+ sensitization (nld myocardial stunning 
Lae Kle Soei, MD; Loes M.A. Sassen, 1vID; Dong Sheng Fan, .MD; 
Tineke van Veen, MD; Rob Krams, MD; and Pieter D. Verdouw, PhD 
Experimental Cardiology, Thoraxcenter 
Erasmus University Rotterdam (the Netherlands) 
Myofibrillar Ca2+ Sensitization Predominantly Enhances Function 
and Mechanical Efficiency of Stunned Myocardium 
Lae Kie Soei, MD; Laes M,A. Sassen, MD; Dong Sheng Fan, MD; 
Tineke van Veen, MD; Rob Keams, MD; and Pieter D. Verdouw, PhD 
Background. Myocardial stunning Is not only characterized by a decreased regional postischemic 
function, but also by a relatively high oxygen consumption ~e. decreased mechanical efficiency). Several 
lines of evidence suggest that the underlying mechanism may involve a decreased sensitivity of the 
myofibrils to calcium, but in vivo evidence is lacking. We therefore evaluated this hypothesis In vivo using 
EMD 60263, a calcium-sensitizing agent, which Is devoid of any phosphodiesterase-inhibiting properties. 
Methods and Results. We first established the effect of two consecutive doses ofEMD 60263 (0.75 
and 1.5 mJlk9; Lv.; n = 7), admnistered at 15 min Intervals, on segment length shortening (SLS), external 
work index EW (the area inside the left ventricular pressure-segment length loop), myocardial oxygen 
consumption {!oIfIIO~ and mechanical efficiency (EWfMVOJ in anesthetized pigs with normal myocardium. 
After the highest dose of EMD 60263, SLS In the distribution area of left anterior descending coronary 
artery (LADCA) had increased from 13 ± 1% at baseline to 17 ± 1% (P<.05). EW, myocardial oxygen 
consumption (MVOJ and mechanical efficiency (EWfWlV0 2 per beat) were, however, not significantly 
affected (123 ± 10%, 98 ± 9% and 85 ± 13% of baseline, respectively). In 14 other anesthetized pigs 
myocardial stunning Was induced by two sequences of 10 min LADCA occlusion and 30 min of myocardial 
repertusion. After induction of stunning the two doses of EMD 60263 (n = 7) or saline (3 mL and 6 mL; n 
= 7) were Infused. In the distribution area of the LADCA the stunning protocol caused decreases In SLS 
from 16 ± 1% to 8 ± 1% (P<.05) and in EWto 49 ± 5% of baseline (P<.05), while MV02 was only minimally 
affected (P>.05). Consequently, mechanical efficiency had decreased to 59 ± 8% of baseline (P<.05). 
Infusion of saline did not affect any of these regional myocardial variables, but after administration of EMD 
60263 SLS recovered dose-dependent/y to 15 ± 2% after the highest dose of the drug. EW and mechanical 
efficiency also recovered dose-dependently to a9 ± 4% (P<.OS vs stunning) and to aa ± 7% (NS vs 
baseline) of baseline, respectively. In the not-stunned segment SLS increased from 15 ± 2% (at baseline) 
to 18 ± 2% (after the highest dose), while EW per beat was not changed significantly. An adrenergic mode 
of action ofEMD 60263 was excluded by blocking the alpha- and beta-adrenoceptors with phentolamine 
and propranolol, respectively, 15 min before administration of EMD 60263 Qe, 15 min into the second 
reperfusion period) In 5 additional experiments. In these experiments the EMD 60263-induced increases 
In SLS and EW were not attenuated. Because EMD 60263 decreased heart rate from 106 ± 4 to 76 ± 3 
beats per minute (P<.05) in the animals with stunned myocardium we performed 5 experiments with the 
specific negative chronotropic compound zatebradine (UL~FS 49; 0.1 - 0.5 mglkg) to rule out bradycardia 
as a contributing factor to the effects of EMD 60263. These doses of zatebradine lowered heart rate from 
116 ± 5 to 55 ± 1 beats per minute (P<.05), but had no effect on SLS of stunned and not-stunned 
myocardium. 
ConclusIons. Calcium sensitization affects function and mechanical efficiency of the stunned 
myocardium more profoundly than of not-stunned myocardium, lending support to the hypothesis that Ca2+ 
desensitization of the myofibrils is involved in myocardial stunning. (Circulation. 1994j90:959~969) 
Key Words • EMD 60263 • systemic hemodynamics • regional myocardial function • 
myocardial oxygen consumption 
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The mechanism underlying the prolonged contractile dysfunction after a short period of 
myocardial ischemia ("myocardial stunning") is still unknown. Proposed hypotheses include a 
reduced ability to synthesize high energy phosphates, impairment of regional perfusion, 
impainnent of the sympathetic neural responsiveness, generation of free radicals, activation of 
leukocytes, reduction in the activity of creatine kinase and disturbances in the calcium 
homeostasis, but most of these mechanisms have been refuted (for review see References 1 and 
2). The current view holds that generation of free radicals and disturbances in the calcium 
handling of the myocardial cell, mechanisms that are not mutually exclusive, are the two most 
likely mechanisms that cause this reversible postischemic dysfunction. 1 
Transient calcium overload as found during the early reperfusion phase may lead to 
disturbances in the calcium homeostasis and/or decreased sensitivity of the myofilaments to 
calciuIll.3,4 Several groups of investigators have shown that the capacity of cardiac sarcoplasmic 
reticulum to transport Ca2+ decreases time-dependently during ischemia5-7, which suggests that 
a reduced function of the Ca" pump might playa role in the mechanism leading to stunning. In 
a recent study, however, we have shown that in stunned myocardium of intact open-chest pigs 
the phosphorylation state of phospholamban was unchanged, and the Ca'+ uptake by the 
sarcoplasmatic reticulum was even slightly increased8, while regional myocardial contractile 
function was still severely depressed.' These data suggest that a change in the active l':a 
transport of the sarcoplasmic reticulum may not be the principal cause of the contractile 
dysfunction of stunned myocardium. Nlarban and co-workers found no differences in 
intracellular Ca2+ transients in isolated ferret hearts before and after stunning and therefore 
concluded that the cmciallesion in stunning occurs at a later stage of the excitation-contraction 
process ie, the responsiveness of the myofilaments to calcium.4,10 Up till now, ill vivo evidence 
of this hypothesis has been difficult to obtain because agents which possess Ca2+ sensitizing 
properties, such as AR-L 5711,12, sulmazole 13,14 and pimobendan 15,16 increase myocardial 
contractility predominantly via inhibition of phosphodiesterase and thus by increasing the Ca2+ 
transient. 
In the present study we report on the cardiovascular effects of the thiadiazinone derivative 
EMD 60263 (Figure I) in pigs with stunned myocardium. In ill vitro experiments this compound 
has been shown to be a potent Ca2+ sensitizer devoid of any phosphodiesterase-inhibiting 
properties (I. Lues and M. Klockow, personal communication November 1993). The same 
investigators also demonstrated that in voltage-clamped myocytes the presence of EMD 60263 
affected the delayed rectifier current IKr in a way which is characteristic for class III antiarrhyth-
mic action. Potassium channel blockade might potentially increase myocardial contractility by 
increasing the action potential duration and therefore Ca2+ influx. This mechanism does not 
contribute to a positive inotropic effect ofEMD 60263, however, as its enantiomer EMD 60264, 
which only differs from EMD 60263 because it lacks Ca2+ sensitizing properties, exerts a 
negative inotropic action (U. Ravens, personal communications, November 1993). 
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Fig 1. Diagram shows the chemical structure of EMD 60263. 
In the present study myocardial stunning was induced by two cycles of to min coronary 
artery occlusion, separated by 30 min of reperfusion. This protocol causes a prolonged 
depression of regional myocardial function without myocardial necrosis11,18, while ea 2+ uptake 
by the sarcoplasmic reticulum and phosphorylation of phospholamban is not depressed.8 The 
effect ofEMD 60263 on regional myocardial function was assessed by studying both the systolic 
segment length shortening (SLS) and tile external work (EW) performed by the stunned and not-
stunned myocardial segments. External work was estimated from the area enclosed by the left 
ventricular pressure-segment length loop, which has been validated as a reliable index by several 
groups of investigators. 19.20 Because a major characteristic of stunned myocardium is also a 
relatively high oxygen consumption for the amount of work perfonned21,22, a phenomenon which 
may also point towards a decrease in the calcium sensitivity2J, we also evaluated the effect of 
EMD 60263 on mechanical efficiency, which is the amount of external work performed by the 
myocardium per unit consumed O2, 
Methods 
Animal care 
All experiments were performed in accordance with the guiding principles in the care and 
use of animals as approved by the Council of the American Physiological Society and under the 
regulations of the animal care cOlllmittee of the Erasmus University Rotterdalll) Rotterdam, the 
Netherlands. 
Surgical Preparation 
After an overnight fast cross-bred Landrace x Yorkshire pigs of either sex (23-30 kg, n ~ 
31) were sedated with ketamine Lm.(20-30 mglkg, Apharmo, Huizen, The Netherlands) and 
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anesthetized with sodium pentobarbital i.v. (20 mg/kg, Sanofi, Paris, France). The ani.mals were 
intubated and connected to a respirator for intermittent positive pressure ventilation with a 
mixture of oxygen and nitrogen. Respiratory rate and tidal volume were set to keep arterial blood 
gases witllin the nonnal range: pH between 7.35 and 7.45; pCO, between 35 mm Hg and 45 mm 
Hg; pO, between 120 mm Hg and 180 mm Hg. Catheters were inserted into the superior caval 
vein for continuous administration of sodium pentobarbital (5 mg/kg/h) and haemaccel 
(Behri.ngwerke A.G., Marburg, FRG) for replaci.ng blood withdrawn duri.ng sampling. Fluid-
filled catlleters were positioned in the descendi.ng aorta for withdrawal of blood samples and to 
monitor the central aortic blood pressure. Through the left carotid artery a 
micromanometertipped catheter (B. Braun Medical B.V., Uden, The Netherlands) was i.nserted 
into the left ventricle for measuring left ventricular blood pressure and, by electrical 
differentiation, its first derivative (LVdP/dt. After administration ofpancuronium bromide (4 
mg, Organon Teknika, Oss, The Netherlands) a midsternal thoracotomy was perfonned and the 
heart was suspended in a pericardial cradle. An electromagnetic flow probe (Skalar, Delft, The 
Netherlands) was placed around the ascendi.ng aorta for measurement of aortic blood flow 
(cardiac output). A proximal segment of the left anterior descendi.ng coronary artery (LADCA) 
was then dissected free for placement of an atraumatic clamp for occluding the coronary artery 
(n ~ 24) or a Doppler flow probe (n ~ 7), while the accompanying vein was cannulated for 
collection of local coronary venous blood. 
Regional myocardial segment length shortening was measured by sonomicrometry (Triton 
Technology Inc., San Diego, CA, USA). One pair of the ultrasonic crystals was implanted i.nside 
the distribution area of the LADCA and another pair inside the distribution area of the left 
circumflex coronary artery (LCXCA). The crystals of each pair were positioned i.n the 
midmyocardiallayer approximately 10-15 mm apart. 
In order to determi.ne regional blood flows the left atrial appendage was cannulated for 
i.njection of a batch of 1-2xlO' carbonized plastic microspheres (15 ± I ~m (SD) in diameter) 
labelled with either "Sc, "Nb, I03Ru, Ji3Sn or 14lCe (NEN Company; Dreieich, FRG). Starti.ng 
15 s before the injection of microspheres, blood was withdrawn from a femoral artery at a rate 
of 10 mLimin until 60-65 s after completion of the i.njection of the microspheres. At the end of 
each experiment the area perfused by the LADCA was identified by ligation of the coronary 
artery at the site of occlusion and injection of patent blue violet (Sigma, St. Louis, MO, USA) 
via the left atrial catheter. The heart and a number of other organs were excised and handled as 
described previously to determine regional blood flOWS. 24 
Erperimelltal protocols 
After the preparation had remained stable for at least 30 min following completion of the 
instrumentation, baseline values were obtained for systemic hemodynamic variables, regional 
myocardial function and arterial and coronary venous blood gases. Samples were collected for 
the measurement of hemoglobin concentration, oxygen saturation, pH, pC02 and p02. 
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We first evaluated the effect two doses of EMD 60263 (0.75 mg/kg and 1.5 mg/kg, 
dissolved in 3 mL and 6 mL saline, respectively) on global systemic hemodynamics, regional 
systolic segment length shortening, external work, myocardial oxygen consumption and 
mechanical efficiency in seven animals with a normal intact coronary circulation. Each dose was 
infused over a 3 min period and infusions were separated by a 15 min interval. In these animals 
LADCA blood flow was measured with the Doppler flow probe. 
In 14 animals a batch of radioactive microspheres was injected for the measurements of 
regional myocardial blood flow. The LADCA was then occluded for 10 min and subsequently 
the myocardium reperfused for 30 min. This sequence of 10 min occlusion and 30 min of 
reperfusion was then repeated. At the end of the second reperfusion period in 7 animals 0.75 
mglkg EMD 60263, dissolved in 3 mL saline, was infused over a period of3 min. Fifteen min 
later, this was followed by a second dose of 1.5 mglkg EMD 60263 dissolved in 6 mL saline and 
again infused over a period of 3 min. In 7 other animals, the same volumes of saline were 
infused at similar time intervals. Systemic hemodynamics variables, segment length changes and 
regional myocardial blood flows were determined at baseline, at the end of the second 30 min 
reperfusion period (stunning) and 15 min after infusion of each dose ofEMD 60263 or saline. 
In five additional animals, the alpha- and beta-adrenoceptors were blocked 15 min before 
administration of the first dose ofEMD 60263 (ie, after 15 min reperfusion following the second 
10 min occlusion). Alpha- and beta-adrenoceptor blockade was achieved with I mg/kg 
phentolamine and 0.5 mglkg propranolol followed by an infusion of 0.5 mg/kg/h, respectively." 
During the course of the experiments it was found that EMD 60263 did not only affect regional 
myocardial function, but also exerted a pronounced bradycardic effect. In order to assess 
whether the bradycardia contributed to the changes in regional myocardial function, we 
performed another five experiments in which stunning was induced as described above and 0.1 
mglkg of the specific negative chronotropic agent zatehradine (UL-FS 49)26,27 was administered 
intravenously at the end of the second 30 min reperfusion period. At 15 min intervals this was 
followed by doses of 0.2 mg/kg and 0.5 mg/kg. In these experiments no radioactive 
microspheres were injected, 
Data analysis (Old presentation 
Systolic segment length shortening (SLS) was calculated from the tracings as 100% x (EDL 
- ESL)!EDL, in which EDL and ESL are the segment length at end-diastole and end-systole, 
respectively. These time points were deftned as the opening and closure of the aortic valves, 
respectively. Left ventricular pressure and myocardial segment length were digitized (sample 
rate 250 Hz) on a personal computer using an 8 bit AD converter. The area inside the left 
ventricular pressure-segment length loop was calculated and multiplied by 10 mm1EDLBMdine to 
arrive at a normalized index for external work (EW). 
Oxygen consumption of the myocardium perfused by the LADCA (MVO,) was calculated 
as the product of the local transmural myocardial blood flow (using the radioactive microsphere 
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data in the animals with stunning and the Doppler flow measurements in the animals without 
stunning) and the difference in the oxygen contents of the art~rial and local coronary venous 
blood." Mechanical efficiency was defined as the ratio of external work and myocardial oxygen 
consumption (EWIMV02 per beat). Because the index EW reflects external work, but has not 
its dimensions, we have expressed the changes in EWIMVO, per beat as percentage change of 
baseline. 
The 14 animals were arbitrarily assigned to treatment with saline or EMD 60263 at the end 
of the second 30 min period C'stunningll) and because no differences existed between the groups, 
the values oftllOse groups obtained at baseline as well as those obtained at the end of the second 
30 min reperfusion period ("stunning ll ) were pooled. Statistical significance of the changes 
induced by the stunning protocol were evaluated by the Student's paired t-test. The effects of 
EMD 60263 and saline during stunning were assessed by twoMways analysis of variance with 
repeated measures and Bonferroni adjustment (BMDP Statistical Software Inc., Los Angeles, 
CA, USA). Statistical significance was accepted for P<.OS (two-tailed). All data have been 
presented as arithmetic mean ± SEM. 
Dl'IIgs 
EMP 60263 (supplied by Prof. Dr. P. Schelliug, E. Merck, Darmstadt, Germany) was 
dissolved in saline to obtain infusion rates of 1 and 2 mUmin for the doses of 0.2S mg/kglmin 
and O.S mg/kglmin, respectively. Zatebradine (UL-FS 49) was a gift from Dr. J. Diimrngen (Dr. 
Karl Thomae GmbH, Biberach an der Riss, Germany) and also dissolved in saline. Propranolol 
hydrochloride (ICI-Pharma, Rotterdam, The Netherlands) and phentolamine-methanosulfonide 
(Ciba-Geigy, Basel, Switzerland) were also dissolved in saline. 
Results 
Effect of EMD 60263 in anesthetized pigs 
Systemic hemodYllfflnics 
Infusion ofEMD 60263 caused a slight decrease in mean arterial blood pressure (from 8S 
± I mrn Hg to 78 ± 3 mm Hg, P<.OS), owing to a fall in diastolic arterial blood pressure (13 ± 
3%, P<.OS) as systolic arterial blood pressure remained unchanged (Table 1). The decrease in 
diastolic arterial blood pressure appeared to be secondary to a prolongation of the duration of 
diastole as heart rate decreased dose-dependently by as much as 37 ± 3% from its baseline value 
of 118 ± S bpm (P<.OS). Cardiac output decreased as the increase in stroke volume (34 ± 7%, 
P<.OS) was not sufficient to compensate for the decrease in heart rate. LVdP/dtmax, left 
ventricular endMdiastolic pressure and systemic vascular resistance (calculated as the ratio of 
mean arterial blood pressure and cardiac output) were not affected. 
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TABLE 1. Effect of the Ca2+ sensitizer EMD 60263 on systemic hemodynamics of seven 
anesthetized open~chest pigs 
Baseline EMD 60263 (~g/kg) 
0.75 1.5 
HR, bpm 118±S 94±s' 74±S' 
SAP, mmHg 103±1 102±1 101±3 
MAP,mmHg 8s±1 81±1 78t3' 
DAP, mmHg 76±1 72±2' 67±3' 
CO,Umin 2.2±0.1 2.0±0.2' 1.8±0.1' 
SV,mL 19±1 21±2 2s±3' 
LVdP/dtmax, mm Hg/s 2300±160 2410±180 2420±130 
LVEDP, mmHg 7.1±1.1 7.1±1.0 7.3±1.1 
SVR, mm Hg/(Umin) 39±2 42±4 44±3 
HR indicates heart rate; SAP, MAP, and DAP, systolic, mean, and diastolic arterial pressure, 
respectively; CO, cardiac output; SV, stroke volume; LvdP/dt, maximal rare of rise in left ventricular 
pressure; LVEDP, left ventricular end-diastolic pressure; and SVR, systemic vascular resistance. The two 
doses of EMD 60263 were administered over 3 minutes at 15-mlnute intervals; data were obtained 15 
minutes after administration of each dose. Vaues are mean±SEM. 
·P<.05 vs baseline. 
Regional myocardial peljormance 
EMD 60263 caused slight and similar increases (P<'05) in the systolic segment length 
shortening in the distribution areas of both the LADCA (from 13 ± 1% to 17 ± 1%) and the 
LCXCA (from 13 ± 1% to 17 ± 2%) (Table 2). In the same table is also shown that external 
work (EW per beat) also increased to the same extent in both areas (23 ± 13% and 28 ± II % in 
the distribution areas of the LADCA and LCXCA, respectively). Taking into account the EMD 
60263-induced decrease in heart rate it can be calculated that EW per min did not change. 
EMD 60263 had no effect on oxygen extraction in the distribution area of the LADCA and, 
because LADCA blood flow did also not change, also no effect on myocardial oxygen 
consumption (MVO,). Mechanical efficiency (EW/MVO, per beat) was not affected after the 
lowest dose, but tended to decrease after the highest dose ofEMD 60263. 
Effect of EMD 60263 in anesthetized pigs with stunned myocardium 
Systemic hemodynamics 
The two cycles of 10 min coronary artery occlusion and 30 min of reperfusion caused a 
slight decrease in mean arterial blood pressure (from 91 ± 2 mID Hg to 86 ± 2 mm Hg, P<.05), 
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TABLE 2. Effect of the Ca2+ Sensitizer EMD 60263 on Regional Myocardial Function and Myocardial 
Oxygen Consumption in Seven Anesthetized Open-Chest Pigs 
Baseline EMD 60263 (~glkg) 
0.75 1.5 
LADCA 
SLS,% 13±1 14±1 17±1' 
EWlbeat, mm Hg. mm 129±9 147±8 158±17 
CV02_.31t % 30±2 30±2 30±3 
CBF,mUmin 27±4 25±4 25±4 
MV02, tJmoVmin 79±11 72±10 76±12 
EWIMV02 , % baseline 100 99±5 85±13 
LCXCA 
SLS,% 13±1 15±1' 17±2' 
EWlbeat, mm Hg.mm 114±7 130±14 137±13' 
LADCA' indicates left anterior descending coronary artery; SLS, segment length shortening; EW, 
external work; CV02_S3t' coronary venous oxygen saturation; CBF, coronary blood flow; MV02 , myocardial 
oxygen consumption; and LCXCA, left circumflex coronary artery. The two doses of EMD 60263 were 
administered over 3 minutes at 15·minute intervals; data were obtained 15 minutes after administration of 
each dose. Values are mean±SEM . 
• P<.05 vs baseline 
which was primarily caused by the fall in cardiac output from 2.64 ± O.IS Llmin to 2.30 ± 0.06 
Llmin (P<.OS) as systemic vascular resistance was only slightly increased (Table 3). Because 
heart rate was not affected, stroke volume fell in parallel with cardiac output. L VdP/dtmax was 
decreased by 19 ± 3%, while left ventricular end-diastolic pressure was unchanged (Table 3). 
Infusion of saline after 30 min of reperfusion following the second 10 min occlusion had 
no effect on any of the systemic hemodynamic variables. On the other hand, administration of 
EMD 60263 resulted in dose-dependent decreases in mean arterial blood pressure, owing to a 
decrease in diastolic arterial blood pressure (by as much as 14 ± S%, P<.OS), while systolic 
arterial blood pressure was unaffected (Table 3). The decrease in diastolic arterial blood pressure 
appeared to be again secondary to a prolongation of the duration of diastole, as heart rate 
decreased dose-dependently by as much as 28 ± 3% (P<.OS) after administration of the higher 
dose of EMD 60263. Stroke volume increased (2S ± 7%, P<.OS), which was not enough to 
compensate for the decrease in heart rate, as cardiac output still rell by II ± 4% after the higher 
dose. Systemic vascular resistance, LVdP/dtmax and left ventricular end-diastolic pressure were 
also not affected by EMD 60263 in this series of experiments. 
TABLE 3. Effect of the C';" Sensitizer EMD 60263 on Systemic Hemodynamics of Anesthetized Open..chest Pigs After Myocardial Stunning 
Change From Stunning 
Saline (n=7) EMD 60263 (n=7) 
Baseline Stunning 1.0 2.0 0.75 1.5 
(n=14) (n=14) mUmin mUmin mg/kg mg/kg 
HR, bpm 10S.1±1.6 10S.6±3.6 -O.4±2.S -1.9±3.S -14.1±1.6t -30.3±3.2t 
SAP, mm Hg 113.9±2.1 106.9±2.S" -O.9±2.9 4.0±2.6 -3.4±3.2 -2.1±4.9 
MAP, mm Hg 91.1±1.7 S6.4±2.4· -O.6±3.2 2.4±2.S -S.6±3.4 -S.4±4.3 
DAP, mm Hg SO.4±1.6 77.S±2.5 -1.6±2.6 O.4±2.S -6.0±3.S -11.3±4.0t 
CO,Umin 2.64±0.1S 2.30±O.O6· O.O4±O.1 O.06±O.OS -O.09±O.OS -O.23±O.OS 
SV,mL 24.S±1.3 22.0±O.S· O.2±O.S 1.0±1.1 2.2±O.St S.3±1.3t 
LVdP/dtmax, mm Hgis 2240±10S 1S10±10S' 43±74 39±67 37±28 97±9S 
LVEDP, mm Hg 9.4±O.7 10.3±O.9 -O.6±O.4 O.6±O.7 -O.14±1.62 1.0±1.38 
SVR, mm Hg/(Umin) 36.0±2.3 38.0±1.S O.O±1.0 1.0±1.0 1.0±2.0 2.0±3.0 
Definitions are as in Table 1. Pigs undewent two periods of 10 minutes occlusion of the left anterior descending coronary artery (LADCA) each followed by 
30 minutes ofreperfusion. stunning values were obtained after 30 minutes of reperfusion following the second LADCA occlusion. Saline and EMD 60263 were 
administered over 3 minutes at 15-minute intervals; data were obtained 15 minutes after administration of each dose. Values are mean±SEM . 
.., P<.05 vs Baseline (only for values obtained during stunning) 
t EMD 60263-induced change from stunning is significantly different (P<.05) from the saline-induced change from stunning at comparable time point. 
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Regional myocardia! segment length shortening 
During each of the two occlusions there was a complete loss of systolic segment length 
shortening in the distribution area of the LADCA, while there was only a partial recovery during 
the subsequent reperfusion periods (from 16 ± 1% at baseline to 8 ± 1% of the end of the second 
reperfusion period). Figure 2 shows that in the animals, treated with a saline infusion, segment 
length shortening remained depressed. However, administration of EMD 60263 caused a dose-
dependent recovery of segment length shortening to baseline levels. 
Systolic segment length shortening in the not-stunned (LCXCA-perfused) myocardium (15 
± 2% at baseline) did not change during the induction of stunning in the adjacent myocardium. 
Infusion of saline had no effect on SLS of the not-stunned myocardium, but increased to 18 ± 
2% after the highest dose of EMD 60263 (Figure 2). This increment is very similar to that 
observed in tile animals wmch did not undergo the stunning protocol (Table 2). Compared to the 
increase in the stunned myocardium, the effect in the not-stunned segment was much less. The 
latter was Illost clearly demonstrated by SLSLADCA/SLS/.CXCA. which had decreased from 1.09 ± 
0.16 to 0.61 ± 0.16 after induction of stunning. While this ratio did not change during infusion 
of saline, there was an increase to 0.75 ± 0.15 and 0.86 ± 0.12 after 0.75 mg/kg and 1.5 mg/kg 
ofEMD 60263, respectively (both P<.05 versus stunning). 
E'(tel1lGl work 
The stunning protocol caused a decrease (P<.05) in the external work per beat of the 
LADCA-perfused myocardium to 49 ± 5% of baseline (Figures 3 and 4), and because heart rate 
LADCA LCXCA 
BL ST S, E, S, E, BL ST S, E, S, E, 
Fig 2. Bar graphs show systolic segment length shortening (SLS) at baseline (BL), during stunning (Sn, 
and after infusion of 2 vol saline (3 [8,J and 6 [8J mL) or two doses of EMD 60263 (0.75 [E,J and 1.5 [EJ 
rrgIkg). Values are mean±SEM from seven animals in each group. ~P<.OS vs baseline; +P<.OS vs stunning; 
., EMD 60263-induced changes from stunning significantly different from saline-induced changes from 
stunning. LADCA Indicates left anterior descending coronary artery; LCXCA, left circumflex coronary artery. 
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Fig 3. Representative example of left ventricular pressure (LVP}-segment length tracing after saline (A, 
n=7) or EMD 60263 (8, n=7) in pigs with stunned myocardium, Stunning was induced in the myocardium 
supplied by the left anterior descending coronary artery (LAOCA). Area supplied by the left circumflex 
coronary artery (LCXCA) served as not-stunned area. Two doses of EMD 60263 were administered over 
3 minutes at 15-minute intervals: E1=O.75 mglkg, E2=1.5 mg/kg.ln the saline-treated animals 3mL (S1) and 
6 mL SQ saline was administered. 
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did not change, there was a similar decrease (to 48 ± S% of baseline, P<.OS) in external work 
per min (data not shown). Infusion of saline had no effect on EW per beat (Figures 3 and 4) and 
EW per min of the stunned myocardium, however, after administration ofEMD 60263, EW per 
beat increased dose-dependently to 89 ± 4% of baseline after the highest dose (P<.OS vs 
stunning; Figure 4), while EW per min increased to only 63 ± 5% of baseline because of the 
lower heart rate (P<.05 vs stunning; not shown). 
The stunning protocol caused minor decreases in both EW per beat (to 92 ± 7% of baseline) 
and EW per min (to 92 ± 9% of baseline) of the not-stunned segment, because of the decrease 
in left ventricular systolic pressure (Figure 4). There were no further changes during the infusion 
of saline, but EW per beat had increased to lOS ± S% of baseline after infusion of the highest 
dose ofEMD 60263 (Figure 4), while EW per min had further decreased to 7S ± 7% of baseline 
(ie, 17 ± 6% lower than the value observed during stunning, P<.OS). 
Because of the intravenous route of administration, ENID 60263 caused increases in 
external work perfonned by both the stunned and not-stunned segments, we also calculated the 
ratio of the EW performed by the LADCA and the EW performed by the LCXCA 
(EW LADCAIEWLCXCA), in order to assess whether differences in regional performance were 
attenuated after administration of EMD 60263. After the stunning protocol this ratio was 
decreased from 1.24 ± 0.13 to 0.70 ± 0.12. Infusion of saline did not affect this ratio, but after 
the first and second dose ofEMD 60263 this ratio had increased to 0.94 ± 0.24 and 1.02 ± 0.21, 
respectively (both P<.OS vs stunning). 
Regiona/myocardial b1oodjlow and vascular resistance 
Thirty minutes after the second occlusion, transmural blood flow in the distribution area 
ofthe LADCA had decreased from 161 ± 7 mL/min/100g to 132 ± 10 mLiminl100 g (P<.OS), 
a decrease that was equally distributed over the transmural layers as the 
subendocardial/subepicardial blood flow ratio (baseline value 1.16 ± 0.06) did not change. 
Neither infusion of saline, nor that of EMD 60263 resulted in any significant changes. In the 
myocardium supplied by the LCXCA, transmural perfusion (baseline value 179 ± 9 mL/min/lOO 
g) and its distribution (baseline value subendocardial/subepicardial blood flow ratio 1.10 ± 0.04) 
were unchanged after the occlusion-reperfusion sequences. Infusion of saline or EMD 60263 
also did not affect perfusion of the not-stunned myocardium. 
Vascular resistance ofthe LADCA was increased from 0.S8 ± 0.03 mm Hg/(mL/min/I00g) 
to 0.69 ± 0.04 mm Hg/(mLiminil 00 g) (P<.OS) after the stunning protocol, but did not change 
any further during the subsequent infusion of saline or ENID 60263. The vascular resistance of 
the LCXCA was not affected by either the occlusion-reperfusion sequence or the subsequent 
infusion of saline or EMD 60263. 
Regionaimyocardiai oxygen consumption 
Oxygen saturation in the vein accompanying the LADCA (baseline 24 ± 2%) was 
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unchanged (25 ± 2%) following the two sequences of 10 min occlusion and 30 min reperfusion. 
From these data and the regional myocardial blood flow data it follows that oxygen consumption 
of the stunned myocardium had decreased from 452 ± 21 ~mol/minlIOOg to 378 ± 30 
~mol/minilOOg (P<.05), before the infusion of saline or EMD 60263 was started. There was a 
similar decrease in MV02 per beat, because heart rate was not affected. After administration of 
EMD 60263, coronary venous oxygen saturation was 29 ± 4%, which was not significantly 
different from the value before administration. MVO, was 380 ± 35 ~mol/minllOOg and 338 ± 
34 ,.unol/minIIOOg after 0.75 mg/kg and 1.5 mg/kg ofEMD 60263, respectively (both values 
P<.05 vs the MVO, before the stunning value). MVCl, per beat was not significantly affected 
despite the decrease in heart rate. Because coronary venous oxygen saturation, myocardial blood 
flow and heart rate did not change, MVO, per min and MVP per beat of the stunned 
myocardium remained unchanged during infusion of saline. 
TABLE 4. Effect of the Ca2+ Sensitizer EMD 60263 on Systemic and Regional Hemodynamics of 
Anesthetized Open-Chest Pigs After Myocardial Stunning and Adrenergic Receptor Blockade 
EMD60263 
Stunning + a- and 
Parameter Baseline r!-Adrenerglc Receptor Blockade 0.75 1.5 
HR, bpm 104.5 72.2' 58.1t 50.3t 
SAP,mmHg 107t1 86±6'" 93.5 9B±4t 
MAP,mmHg 85.2 B8±S· 72±4 69.3 
DAP,mmHg 74±2 59.4' 63±4 55±3 
CO,Umin 2.4'0.1 1.6'0.3' 1.7'0.2 1.9'0.3 
SV,mL 23.1 23M 29±4t 39±8t 
LvdP/dtmax, mm Hg/s 2260±220 1050±160' 1070±240 1150±210 
LVEDP,mmHg 9.1 15±2' 18±1 14±1 
SVR, mm Hg/(Umin) 36.1 47.9' 47±8 39.5 
SLSLAOC,6" % 19±3 9±1* 14±3t 20±2t 
SLSLCXCA' % 19.2 16±2 18±2t 23±2t 
EW/bea~OCA' mm Hg,mm 207±35 86±25' 136±32t 188±22t 
EWfbea4.cxcA' mm Hg.mm 184>19 132.27 168±26t 211±27t 
Definitions are as in Table 1; SLS, segment length shortening; LADCA, left anterior descending 
coronary artery; LCXCA, left circumflex coronary artery; and EW, external work. Pigs undewent two periods 
of 10 minutes occlusion of the LADCA each followed by 30 minutes of reperfuslon. Stunning values were 
obtained after 30 minutes of reperfusion following the second LADCA occlusion. Saline and EMD 60263 
were administered over 3 minutes at 1S-minute intervals; data were obtained 15 minutes after 
administration of each dose. Values are mean:f:SEM 
;I; P<.05 vs baseline (only for values obtained dUring stunning). 
t P<.05 vs stunning + a- and ~-adrenergic receptor blockade. 
Ca2+ sensitization and myocardial stunning 91 
Myocardial efficiency oj regional myocardium 
In view of the large decrease in the external work index EW (to 49 ± 5% of baseline) 
compared to the decrease in oxygen consumption per beat (to 86 ± 6% of baseline) it follows 
that after stunning mechanical efficiency of the LADCA-perfused myocardium (EWIMVO, per 
beat) was decreased to 58 ± 6% of baseline (P<.05). Infusion of saline had no effect on 
mechanical efficiency as both external work and myocardial oxygen consumption were unaltered 
(to 60 ± 10% and 60 ± 11% of baseline after the first and second infusion, respectively; both 
P<.05 vs baseline). Because El'vID 60263 increased external work without an adverse effect on 
MVO, per beat, the EWIMVO, per beat ratio had increased to 72 ± 11% and 88 ± 7% (NS vs 
baseline) after 0.75 mg/kg and 1.5 mg/kg ofEMD 60263, respectively. It is noteworthy that 
after the higher dose ofEMD 60263 mechanical efficiency of the stunned myocardium was not 
different from the corresponding measurement in the animals without stunning. 
In this series of experiments oxygen extraction of the not-stunned myocardium (distribution 
of the LCXCA) was not measured and oxygen consumption of that segment could therefore not 
be determined. Because in the first series of experiments (pigs without stunning) EMD 60263 
had no effect on myocardial oxygen extraction of control myocardium, we assumed that in the 
animals with stunned myocardium EMD 60263 had also no effect on oxygen extraction of the 
not-stunned myocardium. If true the ratio ofEW and transmural blood flow per beat (CBF) also 
reflects mechanical efficiency. Figure 5 clearly shows that EMD 60263 had no significant effect 
on the EW/CBF of the not-stunned myocardium. 
LADCA LCXCA 
Fig 4. Bar graphs show effect of saline (open columns, n=7) or EMD 60263 (hatched columns, n=7) 
on external work (EW) in pigs with stunned myocardium. Stunning was induced in the myocardium 
supplied by the left anterior descending coronary artery (LADCA). The area supplied by the left 
circumflex coronary artery (LCXCA) served as not-stunned area. Two doses of EMD 60263 were 
administered over 3 minutes at 15-minute intervals; E1=0.75 rug/kg, E2=1.5 mglkg.ln the saline-treated 
animals 3 mL (S,) and 6 mL (SJ saline was administered. BL indicates baseline; ST, stunning. ·P<.OS 
vs baseline; +P<.OS vs stunning; ., EMD 60263-induced changes from stunning significantly different 
from saline-induced changes from stunning. 
TABLES. Effect of the Specific Negative Chronotropic Compound Zatebradine (UL~FS 49) on Global and Regional Myocardial Performance in 
Five Anesthetized Pigs With stunned Myocardium 
Zatebradine 
Baseline Stunning 0.1 mg/kg 0.2 mg/kg 0.5 mg/kg 
HR, bpm 113±7 116±5 89±7t 68±3t 55±1t 
SAP, mm Hg 112±1 103±4' 102±4 105±5 109±5 
MAP, mm Hg 90±2 83±3' 78±4 75±2t 70±3t 
DAP, mm Hg 79±3 78±5 66±4 62±3t 53±3t 
CO,Umin 2.7±O.2 2.6±O.2 2.4±O.1 2.1±O.1t 1.8±O.1t 
SV,mL 23±2 23±2 27±2t 31±2t 33±3t 
LVdP/dt".~, mm Hg/s 2610±290 2180±190' 2360±300 2100±240 1960±160 
LVEDP, mmHg 8±1 7±1 9±2 10±1 13±1t 
SVR, mm Hg/(Umin) 33±3 33±3 33±3 37±2 41±4 
SLSLADCA'% 17±2 9±1' 10±2 11±1 11±2 
SLSLCXCA! % 15±1 14±1 15±1 15±2 16±2 
Definitions are as in Table 1; SLS, segment length shortening; LADCA, left anterior descending coronary artery; LCXCA, lett circumflex coronary artery; 
and 8JV, external work. Stunning values were obtained after two cycles of 1 a minutes of LADCA occlusion and 30 minutes of reperfusion. Zatebradine was 
administered over 3 minutes at 15-minute intervals; data were obtained 15 minutes after administration of each dose. Values are mean±SEM . 
.. P<.05 vs baseline (only for values obtained during stunning) 
t Zatebradine-induced change from stunning is significantly different (P<.05) from the saline-induced change from stunning. 
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Regional blood flows mId vascular resistances 
Blood flow and vascular resistance in a number of major organs (brain, kidneys, adrenals 
and skeletal muscle) were not significautly affected by the induction of myocardial stunning. The 
subsequent infusion of saline also did not lead to any significaut changes. After EMD 60263, 
however, blood flow to the kidneys (by 12%, P<.05) and the muscular part of the diaphragm 
decreased. This was due to the decrease in mean arterial blood pressure, because vascular 
resistance of these orgaus was not affected (not shown). 
Effect of EMD 60263 in anesthetized pigs with stunned myocardium after ct- and fl-
adrenoceptor blockade 
Systemic hemodynamics 
Blockade of the alpha- and beta-adrenoceptor, starting IS min after the second 10 min 
LADCA occlusion period, resulted in a pronounced depression of arterial blood pressure, cardiac 
output, heart rate and LVdP/dtmax and an increase in left ventricular end-diastolic pressure, 
while stroke volume was only marginally affected (Table 4). In the presence of adrenoceptor 
blockade EMD 60263, however, caused similar changes in systemic hemodynamic variables as 
in animals without adrenoceptor blockade: dose-dependent decreases in mean and diastolic 
arterial blood pressure and heart rate, a dose-dependent increase in stroke volume, while systolic 
LADCA LCXCA 
150 
" ~ 1001,-j 
BL 8T 
Fig 5. Bar graphs shoW effect of saline (open columns, n=7) or EMD 60263 (hatched columns, n=7) 
on mechanical efficiency (external work (EWJ/myocardlal oxygen consumption (MVO]) in pigs with 
stunned myocardium. Because the index EW reflects external work but does not have its dimensions, 
and in the not-stunned segment mechanical efficiency was approximated by EW/transmural blood flow 
per beat (EW/CBF perbeat), all values are presented as percentage of baseline (±SEM). Stunning was 
induced In the myocardium supplied by the left anterior descending coronary artery (LADCA). The area 
supplied by the left circumflex coronary artery (LCXCA) served as not-stunned area. Two doses of EMD 
60263 were administered over 3 minutes at 15-minute Intervals: E1=0.75 mglkg, E2=1.5 mglkg.ln the 
saline-treated animals 3 mL (S1) and 6 mL (~) saline was administered. BL Indicates baseline; ST, 
stunning. *P<.05 vs baseline. 
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arterial blood pressure, cardiac output, LVdP/dtmax and systemic vascular resistance were not 
significantly altered (Table 4). 
Regional myocardial performance 
After adrenoce~tor blockade SLS of the stmmed myocardium had decreased from 19 ± 3% 
at baseline to 9 ± 1%, while SLS of the not-stunned myocardium was not affected (baseline 19 
± 2%). In the presence of adrenoceptor blockade EMD 60263 caused dose-dependent increase 
in SLS of the stunned myocardium to 20 ± 2% after the highest dose (P<.05), an increase which 
is very similar to the ENID 60263-induced increase, when the adrenoceptors were not blocked 
(Figure 2). In the not-stunned segment SLS increased dose-dependently up to 23 ± 2% after the 
last dose ofEMD 60263. After adrenoceptor blockade external work of the stunned myocardium 
had decreased to 44 ± II % of baseline values and, because of the fan in systolic arterial blood 
pressure, external work of the not-stunned segment had decreased to 73 ± 12% of baseline 
(1'<.05, Table 4). Adrenoceptor blockade did not affect the EMD 60263-induced effects on 
external work, however, as the increases (Table 3) were very similar to the EMD 60263-induced 
increases observed in the absence of adrenoceptor blockade (Figure 3). 
Effect of the specific bmdycardic agent zatebradine (UL-FS 49) on the function of stunned 
myocardium 
In Table 5 it is shown that zatebradine in doses of 0.1 mg/kg to 0.5 mg/kg lowered heart 
rate dose-dependently from 116 ± 5 bpm to 55 ± I bpm. Similar to EMD 60263 there were dose-
dependent decreases in mean and diastolic arterial blood pressure, while systolic arterial blood 
pressure was unchanged. Systolic segment length shortening had decreased from 17 ± 2% at 
baseline to 9 ± 1% at the end of the second reperfusion period. Lowering heart rate with 
zatebradine had no significant effect on systolic segment length shortening of the stunned and 
not-stunned myocardium (Table 5). 
Discussion 
Myocardial stunning is a transient event which is characterized by a depressed function and by 
a relatively high oxygen consumption for the amount of work performed by the stunned 
myocardium. As a matter of fact several authors have shown that oxygen consumption of 
stunned myocardium is equal to or even exceeds that of normal myocardium21,22,29, although the 
latter is not a common finding.9,3o Still there is a consensus that stunned myocardium uses 
oxygen less efficiently than normal myocardium.23 The mechanisms underlying the oxygen 
wastage (ie, decreased mechanical efficiency) of stunned myocardium are unknown, but it is 
unlikely that it is caused by mitochondrial uncouplingl', an increase in basal metabolism32 or 
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changes in the Ca2+-ATPase activity of the sarcoplasmic reticuium. 1O,33 We have reported earlier 
that in the same model as used in the present study, the calcium sequestering properties of the 
sarcoplasmic reticulum were unchanged during stunning.8 It is therefore most likely that an 
inefficient utilization of ATP by the contractile apparatus is a major factor contributing to the 
oxygen wastage. A decrease in the sensitivity of the contractile regulatory proteins to calcium 
and the consequent changes in the myosin ATPase activity could explain an increase in the ratio 
of external work over oxygen consumption and the depressed contractile function of stunned 
myocardium. The aim of the present study was therefore to elucidate whether in ill vivo 
experiments the calcium-sensitizing actions of EMD 60263 could restore function as weJl as 
mechanical efficiency of shmned myocardium. Traditionally the not-stunned myocardium 
adjacent to the stunned myocardium serves as a control segment. One can not exclude, however, 
that the response of the not-stunned segment is affected by the alterations in the adjacent stunned 
myocardium. For instance, in porcine myocardium it has been shown that phosphorylation of 
phospholamban is affected when the adjacent myocardium is exposed to a prolonged period of 
ischemia?4 We therefore performed a series of experiments in which the effect of the EMD 
60263 was studied in pigs which had not undergone the stunning protocol. The results in Tables 
I and 3 show that the responses of the systemic hemodynamic variables were very similar in 
both models. The results presented in Table 2 show that in the distribution area of the LADCA, 
EMD 60263 slightly increased SLS and EW per beat, but had no effect on LADCA blood flow 
and oxygen extraction in that segment of the myocardium. Consequently, oxygen consumption 
was unchanged and mechanical efficiency, did not change (85 ± I3 % of baseline after the higher 
dose ofEMD 60263). 
Recruitment of inotropic reserve in shmned myocardium has been be accomplished by 
stimulation with adrenoceptor agonists such as dopamine and epinephrine35.37, calcium38 and by 
post-extrasystolic potentiation.39 In addition to inotropic stimulation it is also possible to enhance 
function of stunned myocardium by increasing myocardial blood flow with vasodilators such as 
dipyridamole, papaverine and nitroglycerine." In the present study, we showed that EMD 60263 
increased systolic segment length shortening of both the stunned and not-stunned porcine 
myocardium. The data presented in Figure 2 also demonstrated that the effect on the stunned 
myocardium was much more pronounced than on the not-stunned myocardium, and that 
differences in performance between the two areas were almost completely abolished. 
Comparison ofthe data presented in Table 2 and Figure 2 also teaches that the effects ofEMD 
60263 on wall function and external work in the animals with and without myocardial stunning 
were very similar to those observed in the not-stunned myocardium (distribution area of 
LCXCA). This action ofEMD 60263 was not attenuated when experiments were repeated after 
alpha- and beta-adrenoceptor blockade, thereby excluding adrenergic stimulation and 
phosphodiesterase inhibition41H2 as the cause of the positive inotropic action of EMD 60263. 
Furthennore) coronary blood flow was not increased by EMD 60263, which eliminated coronary 
vasodilation as a potential factor to the inotropic effects ofEMD 60263. A complicating factor 
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in the present study was the lowering of the heart rate by EMD 60263 as several groups of 
investigators have shown that bradycardia improves contractile function of ischemic 
myocardium.26,43 The effect of bradycardia on function of post ischemic myocardium is, however, 
not well documented. We therefore studied the effect of bradycardia on postischemic function 
by administration of the specific negative chronotropic agent zatebradine and found that we 
could not restore function, when we lowered the heart rate over an even wider range than with 
EMD 60263. Hence, we may conclude that the EMD 60263-induced bradycardia does not play 
an important role in the improvement in function. Finally, because ill vitro experiments have 
shown a negative inotropic effect of the enantiomer EMD 60264, it is most likely that EMD 
60263 exerted its effect by increasing the sensitivity of the contractile proteins to calcium. At 
first glance, our results appear to be in contrast with those reported by Heusch el al. II, who 
reported that the increases in systolic wall thickening were very similar for not-stunned and 
stunned myocardium after administration of AR-L 57. It must be kept in mind, however, that 
this drug increases myocardial contractility predominantly by phosphodiesterase inhibition." The 
fact that in the present study EMD 60263 exhibited no vasodilator properties in the systemic 
vascular bed or a number of regional vascular beds, a usual ftnding for calcium sensitizers with 
phosphodiesterase inhibitor activity is also in agreement with the ill vitro studies, which showed 
that EMD 60263 is ahuost completely devoid of any phosphodiesterase inhibitor activity. 
Parallel to the decreases after stunning and increases after EMD 60263 in systolic segment 
length shortening, we found decreases and increases in the external work index EW. This is not 
surprising, because the former is derived from the relation between the changes in segment 
length and left ventricular pressure. When we related EW to the MVO, per beat, we conftrmed 
the decrease in mechanical efficiency of stunned myocardium23 . A striking rIDding in the present 
study is, however, that this decrease in mechanical efficiency for stunned segment could be 
reversed with EMD 60263. This action of EMD 60263 appears to be speciftc for stunned 
myocardium as EMD 60263 had no effect on mechanical efficiency of the same myocardial 
segment when it was administered in the pigs without stunning (Table 2). These data provide 
strong support for the hypothesis that calcium desensitization plays a role in the relative oxygen 
wastage of stunned myocardium. Gross et al. 44 have also shown a beneftcial effect of the 
thiadiazinone derivative EMD 57033 on bioenergetics of skinned ventricular trabeculae. On the 
other hand, no beneficial effects on bioenergetics were observed in isolated heart studies using 
EMD 53998" and pimobendan.46 The last studies"·46 do not necessarily contradict the present 
results as we found only an effect of EMD 60263 on mechanical efficiency of stunned (Figure 
5) and not on that of the normal myocardium (Table 2). 
In none of the two series of experiments with E.MD 60263 the global contractility index, 
LVdP/dtmax, increased, although both SLS and stroke volume increased. A number of factors 
could explain this observation as LVdP/dtmax, in addition to myocardial contractility, also 
depends on heart rate and loading conditions of the heart. We have shown that in anesthetized 
pigs with nom1al hearts LVdP/dtmax increases markedly when heart rate is raised from 60 bpm 
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to 100 bpm". In this respect lowering heart rate should induce a decrease in L VdPfdtmax. It 
could thus be argued that the positive inotropic effects of EMD 60263 counteracted a possible 
negative effect of the bradycardia on LVdP/dtmax. Nevertheless administration ofzatebradine, 
which is devoid of inotropic actions4&, did neither improve regional function of the stunned 
myocardium (Table 5) and did not led to a decrease in LVdP/dtmax. It is quite feasible that an 
intracoronary administration using much lower doses of EMD 60263 would have provided an 
improvement in regional function without pronounced global hemodynamic effects. 
The absence of an increase in L VdP/dtmax can also be explained by intracellular changes 
in Ca2+ handling induced by the Ca2+ sensitizing properties of EMD 60263. Lee and Allen have 
shown that increasing Ca2+ sensitivity, and thereby increasing the troponin binding constant for 
Ca2+, causes a slower release of Car from troponin and hence a prolonged time course of 
tension. 49 This implies that Ca2r remains bound longer to troponin and since the sarcoplasmic 
reticulum function in our experimental model is not impaired8, a decreased Ca2+ transient might 
result." These effects can counteract each other, leading to an unchanged LVdP/dtmax. 
From the fruding that the effects of the Ca2+ sensitizer, EMD 60263, are more pronounced 
in stunned myocardium tIlan in the not-stunned myocardium, we conclude that Ca2+ desensitiza-
tion may playa role in the events leading to postischemic myocardial dysfunction and oxygen 
wastage. 
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On the Changes in Diastolic Function of Post-ischemic 
Myocardium Produced by Increases of the MyofibrillaI' Sensitivity 
to Calcium in Anesthetized Pigs 
Loe Kie Soei l lvID, Dong Sheng Fan, NID, Loes M.A. Sassen, lvID, PhD, 
Rob Krams, MD, PhD, Dirk J. Duneker, MD, PhD and Pieter D. Verdollw PhD, FESC. 
Objectives. This study was carried out to Investigate whether recovery of regional systolic function of 
stunned myocardium by increasing sensitivity of the myofibrils to Ca:24 was accompanied by impairment of 
diastolic function. 
Background. The cUnical usefulness of Ca2+ sensitizing agents has been questioned because the 
beneficial effect on systolic function might be offset by an adverse effect on diastolic function. The laHer Is 
feasible because in stunned myocardium and during other pathological conditions an increase in diastolic 
Ca2+ levels can occur, which in combination with an Increased sensitivity of the myofibrils to Ca2+ could 
impair left ventricular relaxation and left ventricular filling. 
Methods. In anesthetized pigs myocardial stunning was produced by 2 sequences of a 10 min coronary 
artery occlusion and 30 min of reperfusion. The animals were then allocated to one of four groups and 
received either 2 volumes (3 and 6 mQ of saline at 15 min intervals (control, n=7), two doses (1.5 and 3.0 
mg/kg) of the calcium sensitising agent EMD 60263 (n=8) or its enantiomer EMD 60264 (n=6) which lacks 
calcium sensitising properties, or two Infusions (1 and 3 Jlg/kg per min) of dobutamlne (n=7). Regional 
myocardial perfusion was measured with radioactive microspheres and segment length changes were 
examined with two pairs of ultrasound crystals implanted in the stunned and remote normal not stunned 
myocardium. 
Results. The stunning protocol reduced systolic segment shortening (S8) of the post ischemic 
myocardium from 17±1 % at baseline to 9±1 %, while SS ofthe normal myocardium remained unaffected 
(14±1 % at baseline). Saline or EMD 60264 did not improve the depressed systolic function of stunned 
myocardium. EMD 60263 dose-dependently Increased SS to 24±2 % In the stunned region and to 22±1 % 
In the normal region. EMD 60263 not only abolished the postsystolic segment shortening Induced by the 
stunning protocol, but also delayed the onset diastolic of segment lengthening (SL, 210 ± 40 ms for both 
regions compared to 0 ms for saline). These changes in regional wall motion were accompanied by a 
decrease In heart rate from 100±4 beats/min during stunning to 54±5 beats/min and an increase in stroke 
volume from 27±1 ml to 45±3 mt. To exclude bradycardia as a cause for these changes hearts were paced 
to restore heart rate to stunning level. Atrial pacing at stunning level (HRsluJ decreased SS in both regions 
to baseline levels. Furthermore, HRsrun decreased the delay in onset of SL in the stunned region, but did not 
effect that of the normal region. Increasing heart rate to 30 beats/min above stunning level further 
deteriorated SS and increased the delay in onset of SL. The impairment of early SL was reflected in a 
decrease in stroke volume by 39:1:7 % (P<.OS versus stunning). In contrast dobutamine at similar heart rates 
Increased SS in both regions, but did not delay the onset of SL or impair stroke volume. 
Conclusion. Increasing Ca2+ sensitivity of the myofibrils In stunned myocardium in excess of that 
needed to restore systolic segment shortening Is accompanied by similar Increases In systolic shortening 
in normal myocardium. At this high dose the onset of relaxation is delayed in both stunned and remote 
normal myocardium, while the rate of relaxation was not affected. The data suggest that, at least in this 
model, of EMD 60263 impairs diastolic function only at doses that are in excess of doses needed to restore 
systolic function. 
Key Words _ Ca2+ sensitizers _ systemic hemodynamics _ diastolic myocardial function -
myocardial oxygen consumption 
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A decreased sensitivity ofthe myofibrils to calcium has been reported to underlie the depressed 
contractile fimction of stunned myocardium. Consequently, we previously investigated the effects 
of the calcium sensitizer EMD 60263 (a thiadiazinone derivate) on contractile function in 
anesthetized pigs and observed that EMD 60263 preferentially increased systolic segment 
shortening and mechanical efficiency of stunned myocardium versus that of remote normal (not 
stunned) myocardium. l We also observed in that study that the effects of EMD 60263 were 
unmitigated in the presence non-selective u- and p-adrenoceptor blockade, indicating that the 
increased regional contractile function could not be attributed to increased Ca2+- sensitivity via 
a-adrenergic stimulation or increased cAMP production via phosphodiesterase inhibition (a 
property of the calcium sensitizer pirnobendan). 
Despite the beneficial effects of an increased Ca2+- sensitivity on systolic contractile function 
the therapeutic potential of Ca2+- sensitizing agents has been questioned, because it might 
concomitantly produce adverse effects on diastolic function. For instance, increased diastolic 
intracellular Ca"levels, which have been observed both in diseased human hearts' and stunned 
myocardium,3, .. could in combination with an increased Ca2+ sensitivity of the myofibrils impair 
left ventricular relaxation and filling resulting in a reduction in stroke volume. 
In a porcine model of myocardial stunning"S,6 we investigated whether regional diastolic 
function of stunned and remote normal myocardium is impaired by increases in responsiveness 
of the myofibrils to Ca". Although in a previous study a dose of 1.5 mg/kg ofEMD 60263 was 
able to· restore systolic contractile function in stunned myocardium, we did not observe an 
increase in end-diastolic pressure, a decrease in end-diastolic segment length or a decrease in 
stroke volume, that would indicate a disturbance in relaxation.' These findings suggest that the 
dose was either too low to impair diastolic function or that the concomitant bradycardia may 
have concealed disturbances in diastolic function. In the present study we therefore not only 
administered EMD 60263 in a dose that was in excess of that required to normalize systolic 
function of the stunned myocardium, but also restored heart rate back to pre-drug levels. Finally, 
we compared the effects of EMD 60263 on diastolic function to that of equipotent doses (with 
respect to systolic function) of the p-adrenergic receptor agonist dobutamine both at spontaneous 
and matched heart rates. 
Methods 
Animal care 
All experiments were performed in accordance with the lIGuiding Principles in the Care and 
Use of Laboratory Animals" as approved by the Council of the American Physiological Society 
and with the prior approval ofthe Animal Care Committee of the Erasmus University Rotterdam, 
Rotterdam, The Netherlands. 
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E>.perimell/a{ groups 
Four groups of animals were studied (Fig. I). After myocardial stunning was produced the 
animals received either two doses of saline (control group), two doses of EMD 60263 or its 
enantiomer EMD 60264, or two infusions of dobutamine. The effects of EMD 60264 were 
studied because it lacks the Ca" sensitising properties ofEMD 60263 but shares its inhibitory 
action on the delayed rectifier K+ current (I",), which contributes to the negative chronotropic 
effects ofEMD 60263. 1 The actions ofEMD 60263 were compared to dobutamine as this drug 
enhances contractility by elevating cyclic AMP levels. The latter not only leads to an increase 
in Ca2+ transients, but also decreases the sensitivity of myofibrlls to Ca2+ which acts to enhance 
diastolic relaxation. 
Surgical Preparation 
Overnight fasted, cross-bred Landrace x Yorkshire pigs of either sex (28-30 kg) were sedated 
with ketamine i.m.(20-30 mglkg, Apharmo, Huizen, The Netherlands) and anesthetized with 
pentobarbital Lv. (20 mglkg followed by 5-10 mglkg per hour, Sanofi, Paris, France). Then, the 
animals were intubated and connected to a respirator for intermittent positive pressure ventilation 
with a mixture of oxygen and nitrogen; arterial blood gas values were kept within the normal 
range by controlling respiratory rate and tidal volume. Fluid-filled catheters were positioned in 
the superior caval vein for administration ofhaemaccel (Behringwerke AG., Marburg, FRG) for 
replacing blood withdrawn during sampling and in the descending aorta for monitoring the aortic 
blood pressure. A micromanometer-tipped catheter (B. Braun Medical B.Y., Uden, The 
Netherlands) was inserted into a carotid artery and positioned in the left ventricle (LV) for 
recording of LV blood pressure and its first derivative (LVdP/dt). 
After administration of 4 mg pancuronium bromide (Organon Teknika, Oss, The Netherlands) 
a midsternal thoracotomy was performed and the heart was suspended in a pericardia I cradle. 
Pacing leads were attached to the right atrial appendage and connected to a pacemaker. An 
electromagnetic flow probe (Skalar, Delft, The Netherlands) was placed around the ascending 
aorta for measurement of ascending aortic blood flow. A proximal segment of the left anterior 
descending coronary artery (LADCA) was dissected out for later placement of an atraumatic 
clamp, while the vein accompanying the LADCA was cannulated for collection of coronary 
venous blood draining the LADCA perfused myocardial region. 
Regional myocardial segment shortening was measured by sonomicrometry (Triton 
Technology inc., San Diego, CA, USA) with one pair of ultrasonic crystals inserted within the 
distribution territory of the LADCA and another pair inside the distribution territory of the left 
circumflex coronary artery (LCXCA). Crystals were positioned in the midmyocardial layer 
approximately 10 nUll apart. 
Regional myocardial blood flows were determined in all groups but the EMD 60264 group 
by injecting 1-2xlO' radioactive microspheres [15 ± 1 lUll (SD) in diameterJlabeled with either 
46SC, 95Nb, 103Ru, 113 Sn or 141 Ce (NEN Company; Dreieich, FRG) into the left atrial appendage 
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using the arterial reference sampling techniques for calibration. At the end of each experiment 
tile remote nOffilal myocardium was identified by left atrial injection of patent blue violet (Sigma, 
S!. Louis, MO, USA) after ligation of the LADCA at the site of occlusion. After the animals 
were killed with an overdose of pentobarbital the heart was excised and the LV handled as 
described earlier in order to obtain regional myocardial blood flow data.' 
Erperimental Protocols 
After hemodynamic variables had been stable for at least 30 min following completion of the 
instrumentation, baseline values of systemic hemodynamics and regional myocardial function 
were recorded, arterial and coronary venous blood samples collected for determination of 
hemoglobin, oxygen saturation and blood gas values, and a batch of radioactive microspheres 
was injected into the left atrium for determination of regional myocardial blood flows. The 
myocardium in the territory of the LADCA was then stunned by two sequences of a 10 min 
proximal LADCA occlusion and 30 min of reperfusion. At the end of the second 30 min 
reperfusion period animals were allocated to the four different groups (Fig. 1). Seven animals 
served as control and received two infusions of saline (3 and 6 mlImin over 3 min) at 15 min 
intervals, while two groups of animals received two infusions (0.5 and 1.0 mg/kg over 3 min, 
total doses of 1.5 and 3.0 mg/kg, respectively) of either EMD 60263 (n=8) or enantiomer EMD 
60264 (n=6). Because of the bradycardia produced by EMD 60263 the measurements after the 
highest dose were repeated after heart rate was restored to levels recorded after stunning was 
produced (HR.~ and after increasing heart rate to 30 beatslmin above the heart rate measured at 
stunning (HR..+3o), This last set of data facilitated comparison with the data obtained in group 
four, in which animals received two consecutive dobutamine infusions at rates of 1 and 3 J..tglkg 
Baseline Stunning D, O2 Pacing 
1 
,odo"",o 0' "000'0, 1 1 lHR,] ~~~l roY Rapatfuslon, f2!l Repatfuslon.t I 
I FA I 
0 10 40 50 80 98 118 lime (min) 
r r 
Salina (n c 7) 3 6 (ml) 
EMD 60264 (n=6) t.5 3.0 (mg/kg) 
EMD 60263 (n=B) 1.5 3.0 (mg/kg) 
Dobulamlna (n=7) 3 (Ug/kg/mln) 
Fig 4. Schematic presentation of the experimental protocols. Infusion of the low dose was started after the 
measurements at stunning were obtained (t=80 min). After the effects of the low dose were measured at D1 (t=90 
min) the second dose was administered. Following measurement of the effects of the second dose at 02,(t=116 min) 
heart rate was increased by atrial pacing in the animals which received saline (control), EMD 60263 or EMD 60264 
in order to compare the results to those obtained at stunning and with dobutamine at comparable heart rate. 
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ED ES 
AoP 
LVP 
LVdP/dt 
AoF 
EDL 
ESL ====i====~~ Lmin 
Fig 4. Definition of the time intervals measured from the segment length tracings. T1 and T2, duration of ejection 
and post ejection shortening, respectively; T3, the time Interval between maximum shortening and the onset of 
segment lengthening; T(, the time Interval in which 50% of segment legnthening is achIeved. Ts. the time interval 
from 50% of relaxation. ED (end-diastole) and ES (end-systole) were defined at the opening and closure of the aortic 
valve, respectively. AoP. aortic pressure; LVP, left ventricular pressure; LVdP/dl, left ventricular dP/dl; AoF aortic 
blood flow; EDL, end-diastolic length; ESL, end-systolic length. 
per min, with each infusion lasting 15 min. The increase in heart rate by the high. dose of 
dobutamine was approximately 30 beats/min. 
Drugs 
EMD 60263 and EMD 60264 (courtesy of Prof. P. Sch.elling, E Merck Darmstadt) and 
dobutantine (Dobutrex, Eli Lilly Nederland B. V. Nieuwegein, The Netherlands) were dissolved 
in physiological saline. Fresh solutions were prepared on the day of each experiment. 
Data analysis and presentation 
Figure 2 is a presentation of systemic h.emodynamic and segment length recordings. Systolic 
Ca2+ sensitization and diastolic function 109 
segment shortening (SS) was computed as 100% x (EDL-ESL)/EDL, in which EDL and ESL 
are the segment length at the time of opening and closing of the aortic valves, respectively. The 
systolic ejection period was defIned as Til so that the velocity of segment shortening was 
computed as the mean velocity during the systolic ejection phase (EDL-ESLlT j ). Post-systolic 
segment shortening (PSS) was calculated as 100% x (ESL-L."jEDL), in which Imin is the 
minimum segment length after closure of the aortic valves. To describe in greater detail the 
segment dynamics during diastole we divided diastole into four periods and measured segment 
length changes during these four phases of diastole defIned as T,-T,. T, describes the period 
between the end of systole and the occurrence of L""", while T, was defIned as the interval 
between tlle occurrence of LmJn and onset of rapid segment lengthening. The latter is defIned as 
the instant at which the rate of segment lengthening increased sharply (Fig. 2). T, was defIned 
as the time between tlle onset of rapid segment lengthening and 50% of total diastolic segment 
lengthening, while the remainder of diastole was deflned as T s. Mean velocity of relaxation was 
computed for the period needed to achieve 50% of segment lengthening (ASL during T,+T, 
divided by the duration of T,+T,). The area inside the LV pressure-segment length was 
determined as described earlier and used as an index of external work (EW)9,1O 
Myocardial oxygen consumption (MVO,) of the perfusion territory of the LADCA was 
computed as the product of regional mean transmural myocardial blood flow and the difference 
in the oxygen contents of the arterial and coronary venous blood. ll Mechanical efficiency, 
defIned as the ratio of the regional external work and regional myocardial oxygen consumption 
(EWIMVO,), could only be determined for the distribution territory of the LADCA as oxygen 
consumption oftlle distribution area of the LCXCA was not measured. All mechanical efficiency 
data have been normalized to their respective baseline values. 
All data are presented as mean ± SEM. Intragroup comparisons were made with Duncan's 
new-multiple range-test once analysis of variance (randomized block design) had revealed that 
the samples represented different populations. Intergroup comparisons (comparing responses to 
treatment in time) were made using two way ANOVA followed by unpaired t-test. Statistical 
signifIcance was accepted for P<.05 (two-tailed). 
Results 
Systemic hemodynamics (Table 1) 
The occlusion ~ reperfusioll protocol produced a slight drop in mean arterial blood pressure 
(6 ± 3%, P<.05), secondary to a decrease in cardiac output (15 ± 4%, P<.05) and stroke volume 
(II ± 6%). This decrease in cardiac output and stroke volume was primarily caused by the 
decrease in global LV contractility, reflected by the 21 ± 5% decrease in LVdP/dt",u (P<.05), as 
heart rate, LV systolic and LV end-diastolic pressure did not change. 
Subsequent infusion of saline did not lead to further changes in any of the systemic 
Table 1. Hemod)'IllUllic Changes produced by Intravenous Infusions of Saline (Control. 0=7). EMD 60264 (n= 6). EMD 60263 (0=8) mld Dobutamine (0=7) in Anesthetized Pig~ with Stunned Myocttrdi.um. 
co 
(liters/min) 
HR 
(beats/min) 
LVSP 
(mmlIg) 
LVEDP 
(mmHgJ 
LVdP/dt,.,... 
(mmHps) 
LVdP/dt-,. 
(mml:Ig/s) 
DAP 
(mmHg) 
MAP 
(mmE;) 
sv 
(mll 
ContrOl 
EMD 60264 
EMD 60263 
Dobutrunine 
Control 
EMD 60264 
EMD 60263 
Dobutamine 
Control 
EMD 60264 
EMD 60263 
Dobutamine 
Control 
EMD 60264 
EMD 60263 
Dobutamine 
Coutrol 
EMD 60264 
EMD 60263 
Dobutamine 
Control 
EMD 60264 
EMU 60263 
Dobutamine 
Control 
EMD 60264 
EMD 60263 
Dobutamine 
Control 
EMD 60264 
EMD 60263 
Dobutamlne 
Control 
EMD 60264 
EMD 60263 
Dobutamine 
SVR Control 
(dynes.slemS) EMD 60264 
EMD 60263 
Dobutamine 
Baseline Stunning D, D~ Pacing hemg +30 
2.8 ± 0.2 
2.6 ± 0.2 
3.0 ± 0.2 
3.0 ± 0.4 
107 ± 2 
108 ± 4 
109 ± 5 
111 ± 2 
111 ± 3 
III ± 4 
113 ± 2 
109 ± 2 
, ± 1 
7 ± 1 
10 ± 1 
10 ± 2 
2110 
2030 
2130 
2610 
-2120 
-2450 
-1110 
-1920 
79 
78 
82 
81 
" '2
91 
90 
27 
24 
27 
27 
± 190 
± 240 
± 130 
± 190 
± ISO 
± 350 
± 90 
± 130 
± 3 
± 4 
± 3 
± 1 
± 3 
± 5 
± 2 
± 1 
± 2 
± 1 
± 1 
± 3 
2640 ± 240 
2960 ± 240 
2560 ± 160 
2560 ± 320 
2.4 ± 0.1' 
:U ± O.Z' 
2.7 ± 0.2 
2.5 ± 0.2 
104 ± 7 
109 ± 4 
100 ± 4 
109 ± 4 
104 ± 4 
102 ± 3 
108 ± 3 
106 ± 2 
, ± 
6 ± 
10 ± 
10 ± 
1660 
1560 
1640 
1940 
-1780 
-2060 
-1740 
-1560 
7S 
74 
7' 
80 
84 
8S 
87 
88 
23 
" 27 
23 
± 170' 
± 120" 
± 120' 
± 160' 
± 210' 
± 310' 
± SO' 
± 120' 
± 4 
± 2 
± 3 
± 1 
± 4 
± 3 
± 3 
± 1 
± 
± 2 
± 1 
± 2 
2880 ± 160 
3360 ± 160 
2720 ± 240 
2960 ± 320 
2.4 ± 0.2 
1.9 ± 0.1~ 
2.5 ± 0.2" 
2.7 ± 0.1 
105 ± 6 
91 ± 3~ 
73 ± 5"'''' 
llS ± 4 
104 ± 3 
93 ± 4 
106 ± 3 
llO ± 2 
, ± 1 
7 ± 1 
11 ± 1" 
, ± 1 
1670 
1470 
1620 
2790 
-1730 
-1240 
-1140 
-1820 
74 
63 
67 
81 
83 
75 
79 
91 
23 
21 
34 
24 
± 160 
± 140" 
± 130" 
± 130~' 
± 150 
± 140'" 
± 120'" 
± 120' 
± 2 
± 3-
± 3 ..... 
± 2 
± 2 
± 4-
± 3"''' 
± 2 
± 
± 
± 2 ..... 
± 2 
2800 ± 160 
3280 ± 240 
2720 ± 240 
2720 ± 160 
2.4 ± 0.1 
1.9 ± 0.2 
2.4 ± 0.2"'" 
3.1 ± 0.2'" 
102 ± 6 
80 ..... 5" 
54 ± 5 ..... 
133 ± 4~' 
108 ± 3 
79 ± 3'" 
109 ± 4 
III ± 2 
10 ± 1 
, ± 1 
14 ± r" 
8 ± l~t 
1700 
1210 
1720 
4180 
-1930 
-870 
-890 
-2400 
76 4' 61 
79 
86 
61 
77 
90 
24 
24 
45 
24 
± 150 
± 100" 
± 130· 
± 190'" 
± 300 
± 70'" 
± 110~ 
± 330 
± 2 
± 2+ 
..... 3H " 
± 2 
± 2 
± 4-
± 3.,"t 
± 2 
± 1 
± 1-
± 3 ..... 
± 2 
2880 ± 240 
2640 ± 240" 
'1:720 ± 240" 
2320 ± 8O~ 
2.3 ± 0.2 
1.8 ± 0.2 
2.5 ± 0.2 
106 ± 4 
108 ± 4 
100 ± 4 
109 ± 5 
74 ± 5" 
103 ± S+ 
8 ± 
7 ± 
10 ± 
1660 
1120 
1870 
-2010 
- 870 
-1220 
79 
SO 
75 
" 61 
84 
22 
17 
25 
± 140 
± 110+ 
± 120 
± 300 
± 90'" 
± 130" 
± 3 
± 3-
± 7 
± 3 
± 5" 
± 7 
± 
± 2 
± 2 
3200 ± 400 
2880 ± 240 
2880 ± 320 
2.4 ± 0.2 
2.2 ± 0.3" 
138 ± e 
130 ± 5'" 
104 ± 3 
86 ± 6 .... 
7 ± 1" 
13 ± 2 
1790 ± 160 
1670 ± 160· 
_2230 ± 260 
-1320 ± 160 
80 ± 3'" 
68 ± 5' 
87 ± 3 
73 ± 6' 
17 ± 1'" 
17 ± 2"" 
3040 ± 320 
2960 ± 320 
CO=cardiac outpUt; HR,::oheart rate; LVSP and LVEDP=left systolic and cod-diastolic pre&=. respcdivcly; LVdP/dt,... and LVdP/dt-= maximal rate ofrige and fu.Il ofleft ventricular pressure, respectively; 
DAP=dia..'¢Olic arterial. blood pressure; MAP=mean arterial blood p~ SV=stroke volume; SVR=gystemic vascular resisbnce: D~ and Dl =3 ml and 6 ml of saline for control, 1.5 mg/kg and 3.0 mg/kg for 
EM!) 60264 and EM!) 60263 and l"g/kg per min and 3 /4;/kg per min for dobut:lmine, respectively. Pacing is pacing at a heart r.lte similar to the heart rate during pacing. Pacing+30 is pacing at a heart rate of30 
beatslminabove the heart rate during tltUDIli.ng (which is equal to the heart rate after D2 in the dobutamine group). Values presented are mean value± SEM. "'P <0.05 vs baseline; + P <0.05 vs stuDIling: t changes 
vs stunning are significantly different from change..~ vs ~tunning in control anim:l1s; " changes vs stunning are tlignificantly different from change..~ vs tltUDIli.ng in the dobutamine.gtoup. t ehanges vs stunning are 
significantly different from changes vs tltUDIli.ng in the EMD 60264 group. 
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EMO 60263 
'CG 
AoP 
(mmtlg) 
L'IdP/dt (rnmHg.s") ·.::]~L~tyy~~ ______ 
AoF (L.mln") 
Sl. LADCA (mm) 
SL LCXCA (mm) 
I see 
Fig 3. This recording of a representative experiment with EMD 60263 shows that the depressed systolic segment 
shortening recovered already during infusion of the low dose of EMD 60263 and that in both the stunned (LADCA) 
and not stunned regions (LCXCA) the onset of segment lengthening was delayed after administration of the high 
dose. ECG, electrocardiogram; AoP, aortic pressure; LVP, left ventricular pressure; LVdP/dt, left ventricular dP/dt; 
AoF, aortic blood floW; SL, segment length, LADCA, left anterior descending coronary artery; LCXCA, left circumflex 
coronary artery. 
hemodynamic variables demonstrating excellent hemodynamic stability of the experimental 
preparation. Atrial pacing to increase heart rate by 30 beats/min (HR."30) caused a 2±1 mmHg 
decrease in LV end-diastolic pressure (P<.05 vs stunning) and a 27±3% decrease in stroke 
volume (P<.05 vs stunning). 
EMD 60264 caused dose-dependent decreases in heart rate, aortic blood pressure, 
L VdP/dt"., and cardiac output. Following administration of the high dose, the decrease in heart 
rate (26 ± 7%) exceeded that in cardiac output (10 ± 5%) so that stroke volume increased by 
25±8% (P<.05). The high dose also decreased systemic vascular resistance (21±7%, P<.05), but 
had no effect on LV end-diastolic pressure. Atrial pacing to restore heart rate to HR., had no 
effect all any of the global hemodynamic variables except for stroke volume which decreased to 
stunning levels. In these animals heart rate could not be increased to HR..t+30 due to 
atrioventricular block. 
EMD 60263 produced dose-dependent decreases in heart rate (up to 46 ± 3% of the value 
obtained after production of stunning), mean and diastolic arterial blood pressure (12 ± 4% and 
22 ± 3%, respectively), and cardiac output (10 ± 4%), while stroke volume increased by 69±7% 
(P<.05). LV systolic blood pressure, systemic vascular resistance and LVdP/dtm" remained 
unchanged, while the maximal rate of fall in LV pressure decreased (LVdP/dtmm) from -1740 ± 
80 mmHg S·1 to -890 ± 110 mmHg s" (P<.05) and LV end-diastolic pressure increased from 10 
± 1 mmHg to 14 ± ImmHg (1'<.05). Atrial pacing to increase heart rate to HR., resulted in a 
Table 2. Changes in Regional Post--systolic Shortening produced by Jn1l'avenollS Infusions ofSaIinc (Control), EMD 60264. EMD 60263 and Dobutamine in Anesthetized Pigs with 
Stunned Myocardium. 
Baseline Stunning D, D, Pacing 
LADCA 
EDL(mm) Control 11.0±0.7 12.0± 0.8* 11.8 ± 0.7'" 11.8±0.7 11.4±0.7'" 
E:MJ)60264 9,8±0.9 10.7±1.1* 10.8 ± 1.1 10.7± Ll 10.4±U~ 
EMD60263 12,0± 1.2 13.0 ± 1.4* 12.8 ± 1.3 12.6± 1,3+ 11.7± 1.2'" 
Dobutamine 11.2 ± 0.6 12.9 ±0.8* 11.9±0.8'" 11.2±0.6~ 
SS(%) Control 17±1 8± 1* 8±1 '±2 '.2 
E:MJ)60264 19±1 8±1 HI 6±2 4±3 
EMD60263 17±1 9± 1* 15 ± 1 .... 24 ± 2"" 17 ± I'" 
Dobutwnine 21±2 10±2 15±2"" 17 ± 2"" 
PSS(%) Control 3.1 ±0.9 7.2 ± 0.8" 6.2±0,8 5.6±1.l 5.1 ± 0.7'" 
EMD60264 1.5±0.6 9.0± L1" 9.0± 1.2 7.3 ± 1.1 7.2± 1.4 
EMD60263 1.3 ±0.4 7.0 ± 0.8" 3.2±0.4- 0.5 ± 0.2- 0.8 ± 0.3-
Dobutrunine 2.3± 1.0 8.6 ± 0:'" 4.4±0,S- 2.0 ± OS·..,. 
V,,(mm/s) Control 6.9 ± 0.5 3.3±0.7* 3.6 ±0.7 3.7± 0.8 3.6 ± 0,7 
EMD60264 7.0 ±0.9 3.2 ± 0.6* 3.0 ±0.8 2.3±0.8 1.3 ± 1.4 
EMD60263 8.2 ± 1.5 4.3± 1.1* 6,0± ut 7.8± 1.4" 7.0± vr 
Dobutamine 5.2 ± 0.2 4.4 ± 0.2* 5,2 ± 0.2+ 6.2±0.2"" 
V"",Cmm/s) Control 15,8±2.8 18.5 ±6.2 13.3 ±3.0 15.6 ± 2.8 13.5 ± 2.8 
EMD60264 9.8± 1.6 10.9 ± 1.3 7.7 ± 1.5+ 5,3 ± 1.4+ 13.3± 2.5 
EMD60263 13.4±2.0 12.6 ± 2.5 9.9±3.8 10.2±2.7 15.3±4.6 
Dobutrunine 14.6±2.9 13.3 ±2.1 13.0 ±2.4 13.2 ± 2.5 
LCXCA 
EDL(mm) Control 9.9±0.8 10.1±0.7 10.0 ± 0.7 10.1 ± 0.8 9.5 ± 0.6 
EMD60264 10.5±0.8 103 ±0.8 10.4±0.8 10.7±0.8 10.4± 0.8 
EMD60263 11.4± 1.1 11.6± 1.2 11.6±1.2 11.5 ± 1.2 10.2±0,9'" 
Dobutruninc 12.7 ± 0.7 13.2± 0.8 12.8±0.7 12.4± 0.6" 
SS(%) Control 12 ± 1 11 ±2 11 ±2 11 ± 1 11±2 
EMD60264 14±2 13± 1 13±1 13± 1 12±2 
EMD60263 14± 1 14± 1 17± 1 .... 22±1 .... 12±1 
Dobutrunine 16±2 13±2 15±2 15 ± 2"" 
PSS(%) Control 1.5 ± 0.5 2.5± 1.0 2.2±0.5 2.2±0.4 2.7 ± 0.4 
EMD60264 0.4±0.2 0.6± 0.3 0.6± 03 1.0 ±Oo4 Oo4±O.3 
EMD60263 2.1 ±0.5 1.5±0.7 0.6 ±0.4+ 0.5±0.3 0.8 ± 0.4 
Dobutamine Ll±0.2 2.4± 0.4· 1.3 ±0.4· 1.3 ± 0.2"" 
V,~(mm/ll) Control 4.4±0.3 4.1 ±0.8 3.9 ±0.6 4.l±0.7 3.8± 0.8 
EMD60264 5.9 ±0.8 5.3 ± 0.7 5.0±0.7 4.9 ± 0.7 4.7±0.7'" 
EMD60263 5.9±0.9 5.5 ± 1.0 5.8±0.7 6.2±0.9 4.0 ± 0.4 
Dobutamine 8.3± 1.3 6.6± 1.3 8.2 ± 1.4 9.6± IS 
V"",(mm/ll} Control 6.2 ± 1.0 7.3± 1,4 6.8 ± 1.1. &.0 ± 1.6 7.4± 1.2 
EMD60264 11.2 ± 2.7 7.1±1.0 83±1.9' 6.7± 1.6 6.6± 1.5 
EMD60263 10.2± 1.2 9.6± 1.2 13.4±3.2 7.3 ± 1.6 10.6±1.7 
Dobutrunine 8.3 ± 1.5 10,4 ± 1.5 9.3 ± 1.4 13.7±3.4 
Pacing +30 
10.9 ± 0.7'" 
10.8± 1.1+ 
6±2 
13 ± 1 
4,9±0.6" 
0.3 ± O.:rt" 
2.8±0.9 
5.4±0.7 
22.4 ± 4.4+ 
14.9 ± 4.5 
9.2±0.6" 
9.4± 1.0+ 
'±2 
8± 1+ 
2.5 ± 0.8 
0.6±0.2 
3.4± 0.8 
2.9 ± 0,4 
9.7±2.3 
13.9± 6.2 
LADCA"'ieft anterior descending coronary artely; LCXCA .. left e:ircwnf1ex coro~ tu'tery; EDL= end--diastolic segment length; SS"'lIystolic ~egment shortening; PSS"'Post-systolic segment shortening; V ",,""IIlean velocity of systolic 
segment shortenin~""IIlean velocity of~egment shortening between the onseto rapid segment lengthening and 50% of total diastolic se1:;entlenthening. Dl, and Dz are 3:m1 and 6 m1 saline for1he control group, 1.5 mglkg and 3 m~ foriho EMD and 1 ~ and 3 ~ for the dobutamine group. respectively. Pacing is pacing atheart rate simi1arto 'the eartrate during pacing; Pacing+ 30 is pacing at ahean rate of30 bea:tslmin above the heart 
rate uring stunning (which is equal to fue heart rate after Dz in fue dobutamine group). 
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30 
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Pacing+30 
Fig 4. Effect of saline, EMD 60264, EMD 60263 and dobutamine on systolic segment shortening (8S) of 
stunned (perfused by the left anterior descending coronary artery, LADCA) and not stunned (perfused by 
the left circumflex coronary artery. LCXCA) myocardium. EMD 60264 (n=6) and EMD 60263 (n=8) were 
administered In doses of 1.5 mglkg (D1) and 3.0 mglkg (D;Jwhile dobutamlne (n=7) was indused at rates 
of 1 Ilg/kg per min (01) and 31-19lkg per min (O;J.ln the control animals (n=7) the saline infusions were 3 
mI (01) and 6 ml (O;J. All data are mean ± SEM, * P<.05 versus baseline; .. P<.05 versus stunning. P<.05 
vS O2 
Table 3. Effects of EMD 60263 md dobut:uD.i.ne on rccional mJ::OC3Idial J2.$;rfusion md 02SJ::sen consumEtion of stunned Eorcine mJ::ocardium. 
&seliae Stunning D, D, 
Control group (n=7Y 
LADCA perjusion territory 
transmural flow (lIll/minl100g) 156 ± 6 121 ± 10* 111 ± 10 123 ± 8 
endo/epi 1.14 ± 0.05 1.18 ± 0.08 1.17 ± 0.04 1.19 ± 0.05 
CVR (mmHgI(mlInllDJI00g)) 0.58 ± 0.03 0.71 ± 0.03 0,79 ± 0.08 0.72 ± 0.04 
cvoz saturation (%) 23 ± 3 25 ± 3 23 ± 4 24 ±4 
.6.(a02 cont-cv02 cont) (;.unol/ml) 2,85 ± 0.18 2.95 ± 0.11 2.98 ± 0.12 3.04 ± 0.22 
MV02 (umollminll00g) 441 ± 26 353 ±26* 331 ± 29 362 ± 12 
LCXCAperjusion territory 
transmural flow (mlJminlI00g) 168 ± 7 160 ± 15 143 ± 15 148 ± 8 
endo/epi 1,05 ± 0.05 0.98 ± 0.06 0.94 ± 0.07 0,95 ± 0.06 
CVR (mmHgI(mlInllDJI00g)) 0.54 ± 0,03 0.54 ± 0.04 0.64 ± 0.10 0.59 ± 0.02 
EMD 60263 (n=8? 
LADCAperjusion territory 
tran.~ural flow (mlJminlI00g) 167 ± 5 122 ± 8'" 119 ± 11 118 ± 10 
endo/epi 1.07 ±0.09 1.16 ± 0.09 1.13 ± 0.09 1.17 ± 0,08 
CVR (mmHg/(m!InllDJI00g)) 0.55 ±0.02 0.73 ± 0.04* 0.70 ± 0,05 0.68 ± 0.06 
cvOz saturation (%) 2S ± 2 29 ± 4 29 ± 4 29 ± 4 
.6.(aOz com-cv0z cont) (junollml) 2.91 ± 0.18 2,74 ± 0,20 2.97 ± 0.34 2.92 ± 0,18 
MVOz (junollminll00g) 484 ± 27 328 ± 19'" 334 ± 27 334 ± 12 
LCXCAperjusion territory 
transmural flow (mlJminlI00g) 180 ± 7 164 ± 10* 138 ± 13 129 ± 10+ 
endo/epi 1.08 ± 0.06 0.99 ± 0.05* 0.99 ± 0.04 0.97 ± 0.04 
CVR (mmHg/(mlInllDJI00g)) 0.52 ± 0.03 0,54 ± 0,03 0.60 ± 0.04 0.62 ± 0.05 
Dobutamine (n=?) 
LADCi perfusion territory 
transmural flow (mlJminlI00g) 164 ± 16 130 ± 20* 172 ± 19 188 ± 12+ 
endo/epi 1.04 ± 0.06 1.06 ± 0.10 0.92 ± 0,05 0.86 ± 0.06 
CVR (mmHgI(mlInllDJI00g)) 0.58 ± 0.05 0.78 ± 0.12 0.56 ± 0.05 0.49 ± 0.03+ 
cvOz saturation (%) 34 ± 3 34 ± 3 44 ± 3+ 40 ± 3+ 
.6.(a02 cont-cvOz cont) (umollml) 2.60 ± 0.21 2.58 ± 0.18 2.37 ± 0,17 2.36 ± 0.16 
MVOz (tanollminll00g) 412 ± 27 323 ± 37 410 ± 33 440 ± 37+ 
LCXCi perjusion territory 
transmural flow (mlJminlI00g) 169 ± 19 186 ± 31 221 ± 26 237 ± 18+ 
endo/epi 0.99 ± 0.05 0.82 ± 0.14 0.80 ± 0,10 0.78 ± 0.08 
CVR (mmHgI(mlInllDJI00g)) 0.58 ± 0.07 0.56 ± 0.09 0.46 ± 0.07 0.39 ± 0.04+ 
Dz + pacing 
119 ± 7 
1.13 ± 0.11 
0,74 ± 0.05 
23 ± 3 
3.01 ± 0.25 
353 ± 17 
146 ± 9 
0.91 ± 0.04 
0,61 ± 0.05 
110 ± 17 
1.07 ± 0.07 
0.75 ± 0.12 
23 ± 3 
3.10 ± 0.22 
357 ± 35 
116 ± 17+ 
0,79 ± 0.05+ 
0.70 ± 0.09+ 
Wash-out 
130 ± 20 
1.04 ± 0.08 
0.79 ± 0.13 
31 ± 2 
2.91 ± 0.13 
380 ± 68 
170 ± 28 
0.80 ± 0.08 
0.59 ± 0.08 
LADCA=left anterior descending coronary artery; LCXCA=left circumflex coronary artery: Dl and Dz are 3 ml and 6 ml saline for the comrolgroup. 1.5 ~ and 3 nli1.ks for the EMf> 60263 and 1 ~g/kg/min 
and 3 ~gf.kg/.min for the dobutamine group. respectively. Dz + pacing is pacing at a heart rate of 30 beats/min above the heart rate during stunning (which is equal to the heart rate after Dz in the dobutamine group): 
CVR=coronary vascular :resistance; cvOz saturation=coronary venouw Oz sarurationin the great cardiac vein drai.:rung the LADCA perfusion territory: .6.(aOz cont-cvOz cont)=difference in the 0z content of arterial 
and coronary venous blood: MVOz=Oz consumption: (n)=number of observations: All d:lta are mean ± SEM; "'P<.05 vs baseline: +P< .05 vs stunning: 1) n=6 for Dz + pacing; Z) n=7 for Dz + pacing, 
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slight increase in LV systolic pressure (1'<.05 vs high dose of EMD 60263 and stunning) and 
nomlalization of both LV end-diastolic pressure and stroke volume. L VdP/dtm,u recovered to -
1120 ± 130 rnmgHg.sl but remained well below the levels observed during stunning. Increasing 
heart rate to HR.",,,,,, caused a deterioration of all global hemodynamic variables except for 
LVdP/dt.ru" which was maintained. 
Infusions of dobutamine produced dose-dependent increases in heart rate (23 ± 5%), 
LVdP/dtm" (125 ± 22%), LVdP/dtmin (60 ± 25%) and cardiac output (28 ± 10%), while arterial 
blood pressure remained unchanged. From these data it follows that a lowering of the systemic 
vascular resistance (18 ± 5%) prevented an increase in aortic blood pressure and that the increase 
in cardiac output was caused by the increase in heart rate. Stroke volume was maintained despite 
the increase in contractility which was possibly due to the decrease in left ventricular end-
diastolic pressure from 10 ± 1 mmHg to 8 ± 1 mmHg (1'<.05). 
Segment length changes 
Systolic seglllellt shortellillg (Table 2, Figs. 3 alld 4) 
During both 10 min coronary artery occlusions, there was an increase in end-diastolic length 
(EDL), complete loss of systolic segment shortening (SS) and the appearance of prominent early 
postsystolic shortening in the distribution area of the LADCA (Fig.3). During the second 
repetfusion period SS recovered to approximately 50% of baseline, while end-diastolic segment 
length increased to 10% above baseline and post-systolic segment shortening persisted. EDL and 
SS in the distribution territory of the LCXCA were not affected by the stunning protocol. 
Neither saline nor EMD 60264 had any effect on EDL or SS in the stunned and remote 
normal myocardium (Fig. 4). In the saline group increasing heart rate to 30 beats/min above 
stunning levels decreased SS of stunned myocardium (1'<.05) and tended to decrease SS in the 
nonnal myocardium, which was due to a decrease in EDL with no change in ESL. In the animals 
that received EMD 60264, atrial pacing to increase heart rate to levels observed at stunning also 
decreased EDL or SS of the stunned myocardium, though the latter failed to reach statistical 
significance 
After infusion of 1.5 mg/kg EMD 60263, SS in the distribution territory of the LADCA 
returned to baseline values, while in the remote normal segment SS increased only slightly. 
Following infusion of the high dose of EMD 60263 SS of the LADCA perfused territory 
increased to 24 ± 2%, which even exceeded the 17 ± 1% (1'<.05) at baseline, while SS of the 
normal myocardium in the LCXCA territory increased from 14± 1 % at stunning to 22± 1 %. 
Raising heart rate to baseline values was accompanied by decreases in SS to baseline values in 
both stunned and normal myocardium, while a further increase to 30 beats/min above baseline 
caused SS to fall below baseline value, especially in the normal myocardium. The EMD 60263-
induced increase in SS was accompanied by a slight decrease in end-diastolic length, which did 
not reach statistical significance. Atrial pacing further reduced end-diastolic segment length, but 
this was not different from the reduction observed in the control group. 
LADCA Control EMD 60263 
Baseline 
Stunning 
D, 
D, 
Pacing HR~, 
Pacing HR" +30 
EMD 60264 Dobutamlne 
Baseline 
Stunning 
D, 
D, 
Pacing HRt! 
Pacing HA,t +30 
.... 0 0.' 1 .... 0 0.' 1 
ES lima (8) ES tlma (8) 
LCXCA Control EMD 60263 
8aseHne 
Stunning 
D, 
D, 
Pacing HR'1 
Pacing HR., +30 
EMD 60264 Dobutamlne 
Baseline 
Stunning 
D, 
D, 
Pacing HR'I 
Pacing HRd +30 
.... 0 0.' .... 0 0.' 
ES tlma (8) ES tlma (8) 
Fig 5. Effect of EMD 60263, EMD 60264 and dobutamine on the different time phases of the segment length 
changes of stunned (LADCA) and remote normal (lCXCA) myocardium. Notice that the high dose of EMD 60263 
delayed the onset of segment lengthening ( ~), and that the effect was attenuated when heart rate was increased 
by atrial pacing. For further details see legends of figures 2 and 4. 
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Infusion of dobutamine caused dose-dependent increases in the SS of the stunned 
myocardium, although baseline values were not reached (P<'05). In the remote normal region 
SS was not affected. End-diastolic segment length decreased in both the stunned and the remote 
nonnal myocardium. 
The mean velocity of segment shortening (Vss) was decreased during stunning in all the 
experimental groups (Table 2). Infusion of saline had no effect on Vss, while infusion of EMD 
60264 tended to decrease Vss in both the stunned and normal myocardium. On the other hand, 
infusion of EMD 60263 restored Vss to pre-stunning values in the stunned region (98 ± 5% of 
baseline value), but had no effect on the Vss of the normal (LCXCA) region. Dobutamine also 
increased Vss and reached levels above baseline level in both stunned and normal myocardium 
to 121 ± 4% (P<.05) and 120 ± 12% (ns) of baseline, respectively. 
Post-systolic seglllelll shortellillg alld diastolic relaxatioll (Table 2, Fig. 5) 
Post-systoHc shortening in the stunned myocardium was not affected by either saline or 
EMD 60264, while it was completely abolished after infusion ofEMD 60263 or dobutamine. 
Atrial pacing did not affect post-systolic segment shortening in any of the experimental groups. 
In both the saline and the EMD 60264 treated animals the stunned and normal segments 
started to lengthen immediately after the segments reached their minimum length. EMD 60263 
produced a delay in onset of segment shortening, so that T, was 210 ± 30 ms (P<.05) after 
administration of the high dose. After the onset of segment lengthening the time needed to reach 
50% of diastolic segment lengthening for both myocardial segments was not different from 
baseline. However, when heart rate was raised to stunning levels the EMD 60263-induced delay 
in segment lengthening was attenuated in the stunned, but not in the normal myocardial region. 
A further increment in heart rate to 30 beats/min above stunning levels did not further decrease 
the delay in segment lengthening in either region. Infusion of dobutamine decreased the period 
of post-systolic shortening, but did not affect the time between minimum length and onset of 
segment lengthening. 
Regional myocardial perfusion and oxygen consumption (Table 3). 
Myocardial stunning decreased transmural blood flow by 23±3% (n~22), which was equally 
distributed across the left ventricular wall, while coronary vascular resistance increased by 30%. 
In the control animals there were no further changes after infusion of saline or when heart rate 
was increased to 30 beats/min above the heart rate observed during stunning. The difference in 
the arterial and coronary venous 0, contents remained also unaffected by the stunning protocol. 
Consequently, oxygen consumption of the stunned myocardium decreased in parallel with 
transmural blood flow. In the remote normal myocardium mean transmural blood flow and its 
distribution as well as coronary vascular resistance were not significantly affected. 
Administration of EMD 60263 had no effect on coronary blood flow and vascular resistance in 
the stunned myocardium. Because the difference in the arterial and coronary venous O2 contents 
Table 4. Effect ofEMD 60263 and dobutamine on e;...1emal and mechanical efficiency of stunned porcine myocardium. 
Control group 
LADCAperfusion territory 
EW boo, (mroHg.mm) 
lVrV02 lint ().1Inol/l OOg) 
ME(%) 
LCXCA peifusion territory 
EWlInt (mroHg.mm) 
EMD60263 
LADCA perfusion territory 
EW bo .. (mroHg.mm) 
MVOz bc!u ().1Inol/l00g) 
ME(%) 
LCXCA peifusion territory 
EW lint (mroHg.mm) 
Dobutaminc 
LADCAperfusion territory 
EW boo, (mmHg.mm) 
MV02 lint ().1Inol/l OOg) 
ME(%) 
LCXCAperfusion territory 
EW beat (mroHg.mm) 
Baseline 
190 ± 17 
4.1 ± 03 
100 
136 ± 10 
185±21 
4.5 ± 03 
100 
161 :I: 16 
220 ±22 
3.7± 0.2 
100 
175 ±25 
Stunning 
95 ±20'" 
3.4 ± 0.2 
79±5* 
120±14 
84:1:11* 
3.3±0.2'" 
84±3'" 
145 ± 17* 
125 ± 14'" 
2.9 ± 0.4 
65 ± 10* 
138±28 
D, 
100 ± 18 
3.2 ± 0.3 
85±6 
115 ± 12 
159 ± 13+ 
4.7 ± 0.4+ 
95 ±3+ 
161 ± 12 
194 ± 17+ 
3.6 ± 0.3 
90± 10 
160 ± 32 
D, 
108±23 
3.6 ± 0.2 
81 ± 5 
114 ± 14 
243±2r" 
6.4 ± OS 
97 ± 4" 
241 ± 15" 
206 ± 23'" 
33± 0.3 
104 ± 16+ 
137±26+ 
D2 + pacing 
63 ± 18'" 
2.6 ±OJ 
79±6 
84 ± 21"" 
89±9 
2.7± 0.3 
89±6 
58± 8+ 
LADCA=leftantenord6iCending coronary artery; LCXCA=left circumtleXcoronary artery; D1an(fD: are 3 ml and 6 ml s3.JIDe for the control group, 1.5 mglkg and 3 mglkg for the EMD 60263 arid 
1 ).1gikg1.rcin and 3 ).1g1kg/IIriD.forthe dobutamine group, respectively. Dz + pacing is pacing at a heart rate of30 beats/min above the heart rate during stunning (which is equal to the heart rate after 
D2 in the dobutanrine group); EW=e>.1emal work; MVO:=o).)'gen consumption; ME=mechanical efficiency; all data are mean ± SEM. *P<.05 vs baseline; ·P<.05 vs stunning; 1) n=6 for D: +pacing. 
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also remained unaffected, oxygen consumption in these animals paralleled the changes in 
transmural blood flow. Increasing heart rate to 30 beats/min above stunning levels had no effect 
on myocardial blood flow, its distribution or oxygen extraction. 10 the normal segment the endo-
epi blood flow ratio decreased from 0.97±0.04 to 0.79±0.05 (P<.05) when the pacing rate was 
increased to 30 beats/min above the heart rate measured following stunning. This was caused by 
a 75% increase in the vascular resistance in the endocardial layer, while resistance in the 
epicardial layer was unaffected. Dobutamine caused a dose-dependent increase in transmural 
blood flow (up to 58 ± \5%) of the stunned myocardium and therefore a decrease in the coronary 
vascular resistance. Although oxygen extraction decreased (reflected by the increase in the O2 
saturation in the great cardiac vein) myocardial oxygen consumption increased significantly with 
the highest dose of dobutamine. 
Mechanical efficiency (Table 4). 
In the distribution territory of the LADCA, mechanical efficiency was decreased to 
approximately 80% of baseline after producing stunning, a condition which was not affected by 
the saline infusions in the control group. Administration of EMD 60263 caused dose-dependent 
increases in mechanical efficiency, which returned to baseline after administration of the higher 
dose. When the pacing rate was raised by 30 beats/min above baseline there was a trend towards 
a decrease in mechanical efficiency (p=NS). During administration of dobutamine, mechanical 
efficiency also recovered dose-dependently. 
Discussion 
The present study in open-chest pigs demonstrates that high doses of the calcium sensitizer EMD 
60263 increased systolic segment shortening in the stunned myocardium more than in the remote 
nOllllal myocardium. Another major finding was that during diastole EMD 60263 abolished post-
systolic shortening in the stunned myocardium. However, the higher dose delayed the onset of 
relaxation in bOUl stunned and normal segments, although without adversely affecting global left 
ventricular function. When the hearts were paced to compensate for the EMD 60263-induced 
bradycardia relaxation normalized. These findings indicate that the delay of relaxation produced 
by the increased Ca2+ sensitivity of the myofilaments, did not exert a detrimental effect on 
regional and global left ventricular function. 
Solaro et al 12 have proposed that the calcium sensitising effects of thiadiazinone derivates 
is not due to an increased affinity of troponin C to calcium, but due to an increased activity of 
myofibrillar Mg2+ATPase, which enhances the crossbddge interaction between actin and 
myosin.12 This action of thiadiazinone derivates prolongs the duration of the attachment of 
crossbridges between actin and myosin, leading to an increase in both peak force and duration 
of the contraction and hence to an increase in the time-force integral of muscle contraction. 
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Ravens et al'recently described similar effects for EMD 60263 in isolated guinea-pig papillary 
muscle. OUf ill vivo results in tltis study are consistent with those fIndings. The increase in 
segment shortening and mean velocity of systolic segment shortening from stunning may result 
from the augmentation in peak force and the EMD 60263 induced increase of the duration of 
contraction could explain the delay in onset of segment lengthening. 
The delay in segment lengthening could be interpreted as a disturbance in diastolic 
relaxation as the high dose also produced an increase in left ventricular end-diastolic pressure. 
However, the velocity of segment lengthening and the end-diastolic segment length were not 
decreased by the calcium sensitiser, while stroke volume simultaneously increased to above 
baseline value. Induction of bradycardia to similar heart rates in an identical model of myocardial 
stunning with the specific bradycardic agent zatebradine did not induce a delay in onset of 
segment lengthening. Because at the same time zatebradine also increased left ventricular end-
diastolic pressure and stroke volume (though significantly less) without affecting end-diastolic 
segment length, it is likely that the delay in onset of segment lengthening may be caused by an 
increase in the duration of contraction.! 
A disturbance in relaxation would be expected to be most detrimental when the duration of 
diastole is shortened i.e. at higher heart rates. Thus, to study the physiological significance of the 
observed delay in segment lengthening we paced the heart to produce heart rates that equaled 
values measured following stunning and during dobutamlne infusion. Atrial pacing to restore 
heart rate to stunning levels resulted in decreased systolic shortening in both stunned and remote 
normal myocardium. The effects of atrial pacing in the presence of EMD 60263 on diastolic 
segment length changes, however, differed between these two regions. Whereas the delay in the 
onset of segment lengthening (T,) decreased in the stunned region (ns vs baseline), T, remained 
unaffected in the femote normal myocardium. The different response to pacing between the 
stunned and remote normal myocardium were unexpected, particular in view of evidence that in 
normal myocardium pacing can induce an increase in intracellular calcium, both during systole 
and diastole13·" which would tend to enhance the EMD 60263 induced diastolic relaxation 
abnormalities. On the other hand, Kusuoka et al reported that pacing increases intracellular 
inorganic phosphate levels which would reduce the myofibrillar sensitivity to calcium." This 
may explain why despite an increased diastolic intracellular calcium concentration pacing 
improved relaxation in the stunned myocardium (Le. reduced the time delay to onset of segment 
lengthening). The observation that the relaxation delay persisted in the normal area during pacing 
could be interpreted to suggest that there was still a difference in myofibrillar calcium sensitivity 
between stunned and remote normal myocardium after administration ofEMD 60263. 
When we paced the hearts at 30 beats/min above stunning value to compare the effects of 
the calcium sensitiser with the effects of dobutamine at similar heart rates, stroke volume fell 
further in the EMD 60263-treated group. The increase in left ventricular end-diastolic pressure 
and decreases in end-diastolic segment length in both stunned and remote normal myocardium 
regions (which were slightly larger than in the control group) could be due to the slowing of 
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relaxation by EMD 60263. Also left ventricular work decreased, which was not accompanied by 
a fall in myocardial oxygen consumption so that mechanical efficiency decreased. In comparison, 
dobutamine improved global LV pump function and decreased left ventricular end-diastolic 
pressure. Dobutamine also decreased end-diastolic segment length, but as it decreased end-
systolic segment length even further external work returned to baseline value. Similarly as 
myocardial oxygen consumption per beat did not alter with dobutamine mechanical efficiency 
also returned to baseline value. The beneficial effect of dobutaruille despite the increase in heart 
rates is probably due to the lusitropic effect of p-adrenergic stimulation, which stimulates not 
only the uptake of calcium by the sarcoplasmic reticulum but also desensitises troponin to 
calcimn. This is also supported by the observation that dobutamine did not produce a time delay 
in the onset of segment lengthening. 
Conclusion 
Increasing Ca" sensitivity of the myofibrils in stunned myocardium in excess of that needed to 
restore systolic segment shortening is accompanied by similar increases in systolic shortening 
in normal myocardium. At this high dose the onset of relaxation is delayed in both stunned and 
remote normal myocardium, while the rate of relaxation was not affected. The data suggest that, 
at least in this model, ofEMD 60263 impairs diastolic function Ollly at doses that are in excess 
of doses needed to restore systolic function. 
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Chapter 6 
The effect of a thiadiazinone derived Ca2+ sensitizer on the 
responsiveness of Mg2+ -ATPase to Ca2+ in myofibrils isolated 
from stunned and not-stunned porcine and human myocardium 
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The effect of the thiadiazinone derived Ca2+ sensitizer on the 
responsiveness of Mg2+ -ATPase to Ca2+ in myofibrils isolated 
from stunned and not-stunned porcine and human myocardium 
Karel Bezstarosti, Loe Kie Soei, Rob Krams, Folkert J. Ten Cate, Pieter D. Verdouw 
and Jos M.l. Lamers 
Previously we showed in an In situ porcine model that the thiadiazinone derivative [+}EMD 60263, 
a putative Ca2" sensitizer with minimal phosphodiesterase III inhibitory properties, increased contractility 
more profoundly in stunned than in not-stunned myocardium. The aim ofthe present investigation was to 
study the mechanism of action by determining the in vitro effects of {+)EMD 60263 on the Ca2+ 
responsiveness of the Mg2+-dependent ATPases of myofibrils and sarcoplasmic reticulum membrane 
vesicles isolated from normal ventricle of swine and hypertrophic septum of cardiomyopathic patients. 
Contamination oftha myofibrils with sarcoplasmic reticulum membranes was excluded by testing the effect 
of the sarcoplasmic reticulum Ca'2+ pumping ATPase Inhibitor thapsigargin. The plasma concentrations at 
which [+}EMD 60263 exerted its inotropic effect In the in situ porcine model were found to be 
submicromolar. [+]EMD 60263 stimulated concentration dependently (1-10 ~M) the submaximally activated 
Mg"-ATPase (at pCa 6.1) of pig heart myofibrils. [+]EMD 60263 (10 ~M) shifted the pCa", of porcine 
myofibrillar Ca'2+ stimulated, Mg+ dependent ATPase from 6.00 ± 0.05 to 6.67 ± 0.05, whereas the [-
]enantiomer EMD 60264 had no significant effect. AHhough the effect was much less at 1 and 3 ~M, [+]EMD 
60263 (10 !-1M) also stimulated the maximal myofibrillar Mg'2t -ATPase activity. The Hill coefficient, reflecting 
the steepness of the fitted pCaJfv1g'2+-ATPase CUlYes at half-maximal activation were not affected by [+]EMD 
60263 (10 ~M). [+]EMD 60263 (10 ~M) had no effect on sarcoplasmic reticulum Ca"-stimulated. Mg"-
dependent ATPase from swine heart. The thiadiazinone derivative [+]EMD 57033 (10 !-1M) but not its {-
]enantiomer EMD 57439 had similar, atthough less potent, effects on the pig heart myofibrillar Mg'2+-ATPase 
activity as compared to [+]EMD 60263. [+JEMD 60263 (3 ~M) produced a significantly larger le!\ward shift 
of the pCa'2+/Mg'2+-ATPase activity curve ofmyofibrils isolated from the stunned compared to the adjacent 
not-stunned myocardium (6pCaw's caused by the presence of [+]EMD 60263 amounted respectively + 
0.57 ± 0.04 and + 0.42 ± 0.05) in the in situ porcine model. The effects of [+]EMD 60263 on myofibrillar 
Mg2l--ATPase of hypertrophic human heart were Identical to those observed with porcine heart myofibrils. 
The results indicate that the positive inotropic action of [+]EMD 60263 observed in the in situ porcine model 
of stunned myocardium, may be primarily due to myofilament sensitization to Ca'2+ and that this compound 
may have a similar action on diseased human myocardium. (J Biochem Pharmacol1996 in press) 
Abbreviations Sarcoplasmic reticulum, SR; Adenoslne-5'-triphosphatase, ATPase; ethylene glycol 
bis(B-aminoethylether) N,N,N',N'-tetraacetic acid, EGTA; dithiothreitol, OTT; 4-morpholino-propane sulfonic 
acid, MOPS; inorganic phosphate, Pj; phenylmethane-sulfonylfluoride, PMSF; phosphodiesterase III, PDE 
III; left anterior desecending coronary artery, LADCA; left circumflex coronary artery (LCXCA). 
Key words • cardiac myofibrils • cardiac sarcoplasmic reticulum • human • pig • Cah 
stimulated, Mg'2+-ATPase • thladiazinone derivatives • stunning 
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Myocardial contractility can be modulated by two principal mechanisms, i) the amplitude of 
the cytosolic [Ca'+] transient, ii) the responsiveness of the myofilaments to Ca'+ [1,2] or iii) a 
combination of both mechanisms. The myofilament Caz+- sensitivity is in part related, to an 
enhancement of the Ca'+ binding to the myofilaments and this is reflected by an increased 
myofibrillar Mg'+-ATPase activity [3,4]. Most positive inotropic drugs used clinically, such as 
digitalis, u- and ll-adrenergic agonists and phosphodiesterase (PDE) inhibitors act by increasing 
cytosolic and sarcoplasmic reticulum (SR) Ca'+ loading that leads to an increase in magnitude 
oftheCa'+ transient [5]. A number ofPDE inhibitors, e.g. sulmazole, pimobendan and several 
thiadiazinone derivatives appear to produce their positive inotropic effect not only through 
increased cytosolic [Ca2+] transient as they also exert a Ca2f sensitizing action in both skinned 
and intact cardiac muscle preparations [1,6,7]. Either method of increasing myocardial 
contractile function may be damaging as the increased Ca2+- transient can potentially result into 
chronic overloading of the cell with Ca2+ [8] and the increased myofilament Ca2+- sensitization 
has the potential to prolong the time of relaxation and to impair diastolic filling of the heart [9]. 
Thiadiazinone derivatives vary widely in their potency to sensitize myofilaments to Ca2+-
and to increase cellular cyclic AMP level via their PDE III inhibitory action [10]. However, ill 
vitro studies with skinned fibers and soluble preparations of PDE III have indicated that the 
optical isomers of the racemic thiadiazinone EMD 53998 possess a remarkable separation of 
Ca'+ sensitizing and PDE III inhibitory activities [11] which can be clearly distincted. Thus, 
compared to the racemate EMD 53998, the [-]enantiomer EMD 57439 (Fig. 1) is a "pure" PDE 
III inhibitor with almost no Ca" sensitizing activity, while the [+ ]enantiomer EMD 57033 (Fig. 
I) is a potent Ca'+ sensitizer with a weak PDE III inhibitory activity. 
Recently. we reported on the ill vivo cardiovascular effect of the thiadiazinone derivative 
[+]EMD 60263 (for its chemical structure see Fig. I) in pigs with regionally stunned 
myocardium [12,13]. In these studies the effect of [+]EMD 60263 on regional myocardial 
function was assessed by measuring the systolic segment shortening, external work and 
mechanical efficiency of stunned and not-stunned myocardium [12]. It was shown that [+]EMD 
60263 increased systolic segment shortening of both the stunned and not-stunned myocardium 
but the effect on the stunned was much more pronounced than 011 the not-stunned myocardium. 
Furthermore, [+]EMD 60263 restored mechanical efficiency of stunned myocardium to baseline 
levels, while that of not-stunned myocardium was unaffected. The action of [+]EMD 60263 was 
not attenuated when experiments were repeated after u- and fi-adrenergic receptor blockade, 
thereby excluding adrenergic stimulation or PDE inhibition as the cause of the positive inotropic 
action of [+]EMD 60263 [12]. The enantiomer [-] EMD 60264 (Fig. I) has been investigated 
in the same model and found to have no effects on systolic segment shortening, external work 
and mechanical efficiency (unpublished results). In another study we demonstrated that in the 
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Fig 1 Chenical structures olthe [+lenanHorners EMD 57033 and EMD 60263 (teft) and [-1- enantiorners 
EMD 57439 and EMD 60264 (right) (see also refs. 11, 12 and 17). 
same porcine model the rate of SR Ca2+ uptake was slightly increased in stunned compared to 
not-stunned myocardium [14]. The data supported the hypothesis that a decreased sensitivity of 
the myoftlaments to Ca2+ and not a decreased SR Ca2+ pumping activity, is involved in the 
mechanism of stunning [15,16]. 
The aim of the present investigation was to complement the data on the thiadiazinone 
derivatives of our ill vivo studies [12,13] with data obtained with subcellular preparations ill 
vitro. We therefore studied the effects of [+]EMD 60263 and its [-]enantiomer EMD 60264 on 
the Ca2+ responsiveness of the Mg 2+ -ATPases measurable in SR membrane vesicles and 
myofibrils isolated from normal porcine myocardium. We studied also the effect of [+]EMD 
60263 on the Ca" responsiveness of the Mg" ATPase of myofibrils isolated from stunned and 
the adjacent not-stunned myocardium in the ill situ porcine model. Moreover, the effectiveness 
of [+ ]EMD60263 on myofibrils isolated from hypertrophic septum of patients with 
cardiomyopathy was tested. For comparison, we also measured the effects of the thiadiazinone 
derivative [+]EMD 57033, a Ca"sensitizer with weak PDE III inhibitory activity and [-] EMD 
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57439 a "pure" PDE ill inhibitor with no Ca'+ sensitizing action. The results show that [+]EMD 
60263, at concentrations (1-3 ~M) close to the plasma concentrations that were found to be 
effective in the ill situ porcine model [12], sensitizes the Mg2+-ATPase of isolated myofibrils to 
Ca2+ and had no effect on the Ca2+ stimulated Mg2+ -ATPase of isolated SR membrane vesicles. 
Consistent with the observations of our previous in vhia experiments [12] is the finding that in 
the stunned myocardium the Ca'+ sensitizing effect of [+]EMD 60263 on isolated myofibrils was 
potentiated. 
Materials and Methods 
Materials The pure enantiomers [+]EMD 60263 and [-]EMD 60264 (5-[I-(,,-ethylimino-3,4-
dimethoxybenzyl)-1,2,3,4-tetrahydro-6-quinolyl]-6-methyl-3,6-dihydro-2H-I,3,4-thiadiazin-2-
one) and [+]EMD 57033 and [-]EMD 57439 (5-[I-(3,4-dimethoxybenzyl)-1,2,3,4-tetrahydro-6-
quinolyl]-6-methyl-3,6-dihydro-2H-I,3,4-thiadiazin-2-one) were supplied by E. Merck, 
Darmstadt, Germany. Fig. I depicts the chemical structures. The only difference between the 
enantiomers is the position of the methyl group (CH,) bound to the C-atom beside the S-atom. 
Because of the asymetrical configuration of that C-atom, the [+]-enantiomer deflects the plane 
of light to the right direction, whereas the [-]-enantiomer deflects it to the left direction [17]. 
Stock solutions (0.2 liM) of [+]EMD 60263 and [-]EMD 60264 were made in destilled water 
and those (0.2mM) of [+]EMD 57033 and [-]EMD 57439 in dimethylsulfoxide and prepared 
on the day of the experiment. All solutions contained an equivalent amount of water or 
dimethylsulfoxide which had no effect on the Ca2+ responsiveness and activities of cardiac SR 
and myofibrillar Mg'+-ATPases. Control experiments also demonstrated that these thiadiazinone 
derivatives had no effect on the assay used to measure inorganic phosphate (Pi) formation. 
Leupeptin, aprotinin, pepstatin and thapsigargin were from Sigma Chemical Company (St 
Louis, USA). All other chemicals were obtained from either E. Merck (Darmstadt, Germany), 
Boehringer (Mannheim, Germany) or Sigma Chemical Company (St Louis, USA). 
Subcellular preparatiollS Sarcoplasmic reticulum (SR) vesicles and myofibrils were isolated 
from porcine ventricular muscle and hypertrophic septum of cardiomyopathlc patients 
undergoing open heart surgery. Stunned and not-stunned was obtained from 4 anesthetized open-
chest pigs in which the distribution territory of the left anterior descending coronary artery 
(LADCA) was stunned by two sequences of 10 min coronary artery occlusions and 30 min 
reperfusion. The not-stunned myocardium was obtained from the districution territory of the left 
circumflex coronary artery (LCXCA) which was not occluded. For further details of this i1l situ 
porcine model is referred to [12]. The cardiac muscle specimen (from pigs about 3 g and from 
humans not more than 1 g) were minced and mixed with 4 volumes 10 ruM NoRCO, and I mM 
dithiothreitol (DTT) and homogenized with a Polytron PTX 10 (Kinematica, GmbH, Luzern, 
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Switserland). The homogenate was centrifuged at 9000 &v for 20 min at 4'C and the supernatant 
was centrifuged again at 9000 gw for 20 min. The fmal supernatant was further subfractionated 
for isolation of enriched SR vesicles as described [18,19] (see below). The combined pellets 
were used for the isolation of the purified myofibrils according to the method described by 
Murphy and Solaro [20]. The pellets were resuspended in 4 volumes solution containing 10 mM 
EGTA, 8.2 mM MgCI" 14.4 mM KCI, 60 mM imidazole, 5.5 mM ATP, 22 ruM 
creatinephosphate, 10 D.m]"' creatine kinase, I % Triton XIOO, 5 I,g.mlo'leupeptin, 10 ~g.mlo' 
pepstatin, 10 ~g.ml·' aprotinin, 1.7 mg.mlo' phenylmethane-sulfonylfluoride (PMSF) in a glass-
Teflon homogenizer, and left on ice for 30 min and thereafter centrifuged for 15 min at II 00 g~. 
The supernatant was discarded and the myofibrillar pellet washed twice with 2 volumes 30 mM 
KCI, 30 mM imidazole and 2 mM MgCI" pH 7.0 and finally resuspended in this buffer 
containing 50 % glycerol up to a protein concentration of 10 mg.mlo,. The myofibrillar 
suspension was stored in aliquots at _800 c. 
For the isolation of SR vesicles the initial 9000 g,v supernatant was centrifuged for 30 min 
at 35000 g.y for 30 min at 4'C. The supernatant was discarded and the pellet resuspended in 3 
ml 0.6 M KCI, 20 mM 4-morpholino-propane sulfonic acid (MOPS), I mM DTT, pH 6.8, again 
centrifuged at 35000 g~. The purified SR vesicles were resuspended in 10 mm Tris, 0.3 M 
sucrose, 0.5 MKCI and I mM DTT, pH 7.0 up to a protein concentration of5-10 mg. mi·'. The 
SR vesicle suspension was stored in aliquots at -80'C. SR and myofibrillar protein (yields were 
about I and 20 mg protein/g myocardium, respectively) was determined with the method of 
Bradford [21]. 
A&,«y of the Mg'+-A1Pase The ATPase activities were determined by measuring the formation 
of Pi according to the method of Lanzetta et al [22]. Briefly, aliquots of the myofibrillar 
suspension were thawed and the glycerol-containing storage buffer was removed by 
centrifugation 15 min at 2000 g" (4'C). The myofibrillar pellet was washed twice with 60 mM 
KCI, 30 mM imidazole and 2 mM MgCI" pH 7.0 and finally resuspended in a solution 
containing 60 mM KCI, 30 mM imidazole, 2 mM MgCI" I mM DTT and 1.7 mg. mi·' PMSF. 
SR vesicles (5 ~g protein) and myofibrils (40 ~g protein) were incubated at 30'C in a total 
volume of 200 ~I solution containing 60 mMKCI, 2.5 mM MgCI" I mM DTT, 25 ruM MOPS, 
pH 7.0,2 mM ethylene glycol bis(B-aminoethylether) N,N,N',N'-tetraacetic acid (EGTA), 2 ruM 
ATP, 5 mM NaN" 0.5 ~M A23187 and various amounts of Ca'+. Different levels offree Ca'+ 
were achieved by vmying the Ca"/EGTA ratio, keeping the total EGTA concentration constant. 
Free Ca'+ in the buffer was calculated using Fabiato's SPECS computer program [23] as 
described earlier [24]. 
Determination of plasma concentrat/ons of [+ JEMD 60263 in the in situ pig lIIodel To 600 ~I 
of plasma obtained from blood samples taken at various time points during the course of the 
previous in vivo experiments with [+ ]EMD 60263 in pigs [12], 500 ~I of water saturated 
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ethylether were added and mixed well. The organic and aquous phases were separated in an 
Eppendorf table centrifuge. The organic top layer was removed and collected in an Eppendorf 
vial. This extraction procedure was repeated 5 times. The ether phases were collected separately. 
Thereafter the ether was evaporated in a speed-vac centrifuge. The residuals were resuspended 
and dissolved in 300 ~I acetonitril. The amount of [+]EMD 60263 in a given plasma sample was 
determined on a HPLC system: 30 ~I of the acetonitrH solutions were injected on a LiChrosorb 
RP 8 (5flm) RT 125-4 column (E. Merck, Darmstadt), which was equipped with a Hiber 
LiChroCart 4-4 precolmnn (E. Merck, Darmstadt). The column was equilibrated and developed 
in a buffer composed of35% acetonitril and 65% 0.1 M sodium phosphate, pH 6.0 at a flow rate 
of I ml/min. The elution was monitored at a wavelength of 320 illll. The concentration of 
[+]EMD 60263 was deduced from the area of the peaks eluting at the appropiate time from the 
column by comparison with the values determined for identically treated standard samples. The 
plasma concentration of a given blood sample was determined by adding the peak areas of the 
various ether extraction samples. 
Statistics The results are given as mean ± SEM. The pCa-Mg" ATPase data were fitted to a 
sigmoid function by nonlinear regression analysis. The data normalized to maximum activity, 
after subtracting basal ATPase activity, were fitted to the Hill equation (P ~ Po /(1 + Q/[Ca"l') 
in which Po is the maximal Ca2+ -stimulated Mg2+ -ATPase, P is the level of Ca2+ -stimulated Mg2+_ 
ATPase less than maximum, Q a constant and 11 is the Hill value as described [25,26]. For the 
Hill equation only data points were used which fulfilled the condition O.IPo < P < 0.9Po' The 
equation was solved for P, Q and 11. The pCaso (at 50 % of the maximal Ca2+-stimulated Mg2+_ 
ATPase activity), was detennined, by using 11 and the Q calculated from the Hill equation [25]. 
The pCa (i.e. -log[Ca'+]) corresponding to 50 % activation of Ca2+-stimulated Mg'+-ATPase was 
-(l/II)logQ. Data were evaluated for statistical significance by the Student t-test and significance 
was accepted at P < 0.05. The pCa" shifts caused by the presence of [+]EMD 60263 in 
myofibrils isolated from the stunned and the adjacent not-stunned myocardium was assessed by 
two-way ANOVA with repeated measuring and Bonferroni's adjustment (BMDF, Stastical 
Software Inc). 
Results 
Characterization of the Celt-stimulated MIf+ -ATPases ill the subcellular/raefiolls Before testing 
the effect of the E:MD enantiomers on the Ca2+ responsiveness of the Mi+ -ATPases of the 
isolated SR and myofibrils, we characterized a specific property of the SR Ca2+ pumping ATPase 
to exclude the possible cross-contamination of the isolated myofibrils and SR fraction. 
Contamination of the myofibrils by SR membrane vesicles was unlikely because before the last 
precipitation step during isolation the myofibrils were always treated with 1 % Triton XIOO. 
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Table 1 
Characteristics oflhe Ca2<--stimulated, MgH -dependent ATPases of porcine ventricular sarcoplasmic reticulum (SR) 
membrane vesicles and myofibrils. 
Mgl+ -ATPase (nmol Pi.min·t .rug.I) 
pCa 
Control + Thapsigargin 
SR 7 62 ± 17 55 ± 10 
5 430 ± 52 48 ± 3 
Myofibrils 7 21 ± 2 24 ± 2 
5 42 ± 4 44 ± 4 
The Mg1+-ATPase activities al pCa 7 of SR membrane yesicles and the myofibrils are always close to the basal activity 
measured in the absence ofCa1• (compare Figs. 2 and 4) and can therefore be subtracted from the activity at pCa 5 
to obtain the activities of the Calt -timulated, Mg2+ -dependent A TPascs. The thapsigargin concentration was 1 J-lM. 
Results are presented as mean ± S.E.M. for 3 experiments with different preparations of SRmcmbrane vesicles and 
myofibrils. 
Thapsigargin, which is a specific inhibitor of the SR Ca2t pump, was tested on Ca2+ stimulated 
Mg2'-dependent ATPases of both subcellular fractions (Table I). Thapsigargin (1 ~M) 
completely blocked the Ca2' stimulated part of the ATPase activity in the SR fraction whereas 
there was no effect on the Ca2t stimulated portion of the Mg2t -ATPase activity of the myofibrils. 
The same results were obtained using the myofibrils isolated from human myocardium 
(unpublished observations). The results demonstrate that SR membrane impurities associated 
with myofibrils are efficiently eliminated by the pretreatment with Triton XIOO and 
contamination of SR membrane by myofibrillar protein is also negligible. 
Plasma concentrations of [+ JElvfD 60263 at its maximal inotropic effect in the in situ porcine 
mode/Prior to the studies of the iI/vitro effects of [+JEMD 60263 on the myofibrillar and SR 
Ca2+ stimulated, Mgt dependent ATPases, we needed to know the plasma concentrations at 
which the compound was effective in our previous in vivo experin1ents [12]. When the effects 
of two consecutive doses of [+JEMD 60263 (0.75 and 1.5 mg.kg- l intravenously, n~7), 
administered at I5-minute intervals, on segment shortening, external work and mechanical 
efficiency in anaesthetized pigs were measured, plasma samples had been taken for HPLC 
analysis of the [+JEMD 60263 concentration. Each dose was infused over a 3 min period, and 
the second higher dose was infbsed 15 min later. The mean concentrations of [+JEMD 60263 
at the end of the infusion period were 4.5 ± 0.4 f,M (mean ± S.E.M, n~7; lower dose) and 8.1 
± 2.0 ~M (higher dose); they declined within 15 min to 0.14 ± 0.06 f,M and 0.45 ± 0.12 ~M, 
respectively. Thus, submicromolar plasma concentrations of [+]EMD 60263 have been measured 
at times when myocardial contractility was detennined and found to be elevated which indicates 
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that the drug may be already intracellularly effective at these low concentrations [12,13]. 
111 vitro effects o/FlvID ellalltiolllersoll myofibril"", Mg'+-AlPase isolatedji'olJlllorlJlal velltricle 
o/swille Fig. 2 shows that [+)EMD 60263 increased the submaximally activated (at pCa 6.1) 
porcine cardiac myofibrillar Mg2+-ATPase in a concentration range of 1-10 11M. The maximal 
effect was reached at drug concentrations ~ 20 ~M. The differential effects of the [+)EMD 
60263 on the Ca'+ activation of porcine cardiac myofibrillar Mg'+-ATPase are shown at three 
drug concentrations (I, 3 and 10 I,M) in Fig. 3. The enhanced response to Ca" involved two 
effects: (I) a leftward shift of the relation between pCa and myofibrillar ATPase activity. This 
is indicated by the parameters listed in the legend to Fig. 3, the pCa at half-maximal activation 
(pCa,,) was shifted to the left by [+)EMD 60263 depending on its concentration (1,3 and 10 
~M) from 6.00 ± 0.05 under control conditions to respectively 6.10 ± 0.08, 6.30 ± 0.03 and 6.67 
± 0.05 (P < 0.05 verslls control pCaso at 3 and 10 ~M [+)EMD 60263); (2) an increase of the 
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Fig.2 Effect of varying concentrations of [+]EMD 60263 on submaximally (pCa 6.1) activated Mg2+_ 
ATPase of porcine ventricular myofibrils. Stimulated ATPase activities in the presence of [+]EMD 60263 
afe expressed as % increase taking the activity in the absence of the drug as 100% See materials and 
methods for further details. Results are presented as mean ± S.E.M. for 3 experiments with different 
preparations of myofibrils. 
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Fig.3 Graphs showing the relation between pCa2+ (-log M)and the Mg2+-ATPase activity Qn nmol Pt. mg 
protein'l. mg·1) in porcine ventricle myofibrils under control conditions ( 0 , n=6), in the presence of 1 tJM 
(., n=3), 3 I'M ("', n=3) and 10 ~M [+jEMD 60263 (., n=3) and In the presence of 10 ~M [-jEMD 60264 
(+ I n=3). For further details see materials and methods. Results are presented as mean ± S.E.M. for 3 
experiments with separate preparations ofmyofibrils. Data normalized to maximum activity after subtracting 
basal Mg2+_ ATPase activity were fitted to the Hill equation giving the following parameters: under control 
conditions: pCa" = 6.00 ± 0.05 (n = 1.46 ± 0.12); in the presence of 1,3 and 10 ~M [+jEMD 60263: 6.10 
±0.08 (n= 1.32 ± 0.09), 6.30 ± 0.03 (n = 1.23 ± 0.12) and 6.67 ± 0.05 (P < 0.05 versus control pCa" at3 
and 10 ~M [+jEMD concentration) (n= 1.19 ±0.18), respectively; in the presence of 10 ~M [-jEMD 60264: 
pCa" = 6.10 ± 0.04 (n = 1.44 ± 0.25). 
maximal myofibrillar Mg2+-ATPase activity. This increasing effect on the maximal Mg 2+ -
ATPase appears to be independent of the effect on the increased Ca2+ responsiveness since it was 
measured at saturating Ca2+ concentrations, so that a change in ci+ responsiveness of the 
myoft!aments should be without an effect. This increase in the maximal Mg'+ ATPase activity, 
however, seems to level off already between 3 and 10 11M [+JEMD 60263, while the increase 
in the Ca2+ responsiveness was further increased, as can be seen from the left- and upwards 
displacement of the Mg2+ ATPase/pCa2+-cUive in comparison to the control cUlVe. The average 
Hill coefficients, reflecting the steepness oftlle fitted curves at pCaso. remained the same at each 
concentration of [+JEMD 60263 tested (legend to Fig. 3). The negative enantiomer EMD 60264 
(10 flM) had no significant effect on the Ca'+ activation pattern of the porcine cardiac 
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Flg.4 Graphs showing the relation between pCa2+ (-log M) and Mg2t-ATPase activity (in nmol PI' mg 
protein". mg") In porcine ventricle myofibrils under control conditions (0) and In the presence of 10 IJM 
EMD 57033 (.) and 10 ~M [-]EMD 57439 (+). See materials and methods for further details. Results 
are presented as mean ± S.E.M. for 3 experiments with different preparations of myofibrils. Data 
normalized to maximum aclivity after subtracting basal Mg2+ -ATPase activity were fitted to the Hill equation 
giving the following parameters: under control conditions: pCa50 = 6.04 ± 0.06, n = 1.35 ± 0.08; In the 
presence of 10 ~M [+]EMD 57033: pCa" = 6.55 ± 0.04 (P < 0.05 versus control pC,,",), n = 1.35 ± 0.09; 
in the presence of 10 ~M [-]EMD 57439: pCa", = 6.11 ± 0.03; n = 1.23 ± 0.25. 
myofibrillar Mg"-ATPase (Fig. 3). 
For comparison, Fig. 4 shows the effects of the known optical isomers, [+]EMD 57033 and 
[-]EMD 57439, on porcine heart myofibrillar Ca" stimulated Mg" dependent ATPase. Similar 
to [+]EMD 60263 (10 I'M), but to somewhat less extent, [+]EMD 57033 (10 ~M) produced a 
leftward shift (pCaso changed from 6.04 ± 0.07 nnder control conditions to 6.55 ± 0.04 (P < 0.05 
verslls control pCa"" n~3) of the Ca" activation curve of the myofibrillar Mg"-ATPase without 
changing the Hill coefficient. [+]EMD 57033 (10 ~M) also stimulated, even though less potently 
than [+ ]EMD 60263, the maximal Mg"-ATPase activity of the myofibrils. As expected, the 
negative enantiomer EMD 57439 had no effect on the Ca" activation pattern of the myofibrillar 
Mg"-ATPase (Fig 4). 
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Fig.5 Graphs showing the relation between pea2• (~Iog M) and Mg 2+-ATPase activity (in nmol Pr. mg 
proteln'l, mg"!) in porcine ventricular SR under control conditions ( 0 ) and in the presence 10 (JM [+]EMD 
60263 ( • ). See materials and methods for further details. Results are presented as mean ± S.E.M. for 
3 experiments with different preparations of SR membrane vesicles. 
II/vitro ~ffect of {+ jEMD 60263 01/ the SR Mg" -ATPase forml/ormal vel/tricle of swille Ca"-
stimulated Mg2+dependent ATPase was measured in SR vesicles isolated from porcine ventricle. 
In the assay of the ATPase Ca'+ ionophore A23l87 (0.5 JLM) was always present to uncouple 
the vesicular Ca'+ uptake process from the ATP hydrolysis to avoid possible inhibitory effects 
of the build-up electrochemical Ca" gradient on the Ca" stimulated, Mg"-dependent ATPase 
of the SR as we observed previously [18,27]. In contrast to its dramatic effects on the 
myofibrillar ATPase, [+]EMD 60263 (10 ~M) did neither affect the pCa" nor the maximum 
Ca" stimulated Mg"-ATPase of the SR (Fig. 5). 
11/ vitro ~ffect of {+jEMD 60263 01/ the pCa"IMg" -ATPase activity relatiol/ships of myofibril., 
isolaledjrom stunned cmd not-stunned myocardium Previously we showed that [+ ]E:MD 60263 
increased systolic segment shortening of both stunned and not-stunned porcine myocardium but 
the effect on the stunned was more pronounced than on the not-stunned myocardium [12]. 
Therefore, four experiments were carried out with anesthetized open-chest pigs in which the 
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Table 2 In vitro effects of 3 IJM [+JEMD 60263 on the pCa2+/Mg2• ATPase activity relationship 
measured in myofibrils isolated from stunned and not~stunned myocardium of open~chest 
anesthetized pigs. 
Maximal Caz··stimulated Mg" ATPase activity pC8so 
~nmol PI.m[l.min-1) (-log M) 
Stunned Not·stunned Stunned Not-stunned 
Pig no. +EMDMTPase +EMDMTPase +EMD .6.pCat.(l +EMD.6.pC8so 
35 56 +21 23 49 +26 5.84 6.35 +0.49 5.94 6.30 +0.36 
2 29 47 +18 37 49 +12 5.73 6.41 +0.68 5.83 6.34 +0.51 
3 41 45 +4 40 44 +4 6.10 6.67 +0.57 6.09 6.56 +0.49 
4 43 50 +7 38 47 +9 6.09 6.64 +0.55 6.18 6.51 +0.33 
mean 37 50 +13 35 47 +13 5.94 6.52 +0.51' 6.01 6.43 +0.42 
SEM 3 2 4 4 +5 0.09 0.08 0.04 0.08 0.06 +0,05 
Stunned and not-stunned myocardium was obtained from 4 anesthetized open-chest pigs In which the 
distribution territory of the LADCA was stunned by 2 sequences of 10 min coronary artery occlusion and 30 min 
reperfuslon. The not-stunned myocardium was obtained from the distribution territory of the LCXCA which was 
not occluded. The normalized pCa2>/Mg2' ATPase activity curves in the absence and presence of 3 ~M [+ JEMD 
60263, measured at the pCa2' values as these were also chosen in Figs. 3,4 and 6, were frtted to a sigmoid 
function by non-linear regression analysis. The ATPase activities normalized to maximum activity were frtted to 
the Hill equation as described in Methods, which analysis gave the calculated pCa~o values . 
• significantly different (P < 0.05) from the [+jEMD 60263-induced .b.pCa50's in the not-stunned myocardium. 
distribution territory of the LADCA was stunned by two sequences of 10 min coronary artery 
occlusion and 30 min reperfusion. The results of the individual experiments, including the mean 
data are shown in Table 2. The nonnalized pCalMg"-ATPase activity curves, obtained from the 
myofibrils isolated from the stunned and not-stunned myocardiulll, were fitted to the Hill 
equation (P ~P.,I(1 + Q/[Ca'']") and the pCa" corresponding to 50 % activation of the Ca " -
stimulated Mg"-ATPase was calculated from (-1In)log Q. No differences between not-stunned 
and stunned myocardium was seen as to the maximal activity of the Ca2+ -stimulated Mg 2+ -
ATPase (Table 2). In 3 out of the 4 pigs a rightward shill of the pCa"lMg'+-ATPase activity 
curve of stunned myocardium was observed which followed from the decrease in pCaso's (Table 
2). More experiments have to be carried out to establish whether the tendency of myofibrils from 
stunned myocardium to desensitize to Ca2+ is a reproducible finding. No differences were seen 
between the stuoned and not-stunned myocardium in the increasing effect of [+ ]EMD 60263 on 
the maximal Ca2+-stimulated Mg2+-dependent ATPase. However, the compound induced in each 
of the pigs a leftward shift of the pCa'+lMg"-ATPase activity curve (Apea50 ~ + 0.57 ± 0.04 in 
stunned versus dpCa50 = + 0.42 ± 0.05 in not-stunned myocardium. The latter finding is 
consistent with our previous observations on the effects of [+ ]EMD 60263 on systolic segment 
shortening in the ill situ porcine model. 
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Fig.6 Graphs showing the relation between peaz• (~Iog M) and Mg+ -ATPase activity On nmol PI' mg 
protein-i, mg·l ) in myofibrils isolated from human hypertrophic septum specimen measured under control 
conditions (0) and in the presence 10 IJM (+]EMD 60263 (.). See materials and methods for further 
details. Results are presented as mean ± S.E.M, for 5 experiments with different preparations of myofibrils. 
Data normalized to maximum activity after subtracting basal Mgh-ATPase activity were fitted to the HIli 
equation giving the following parameters: under control conditions: pCaw = 6,06 ± 0.09, n = 1.55 ± 0.22; 
in the presence of [+)EMD 60263: pCa50 = 6,53 ± 0.10 (P < 0,05 versus control pCa50), n = 1.61 ± 0.31. 
111 vitro effects of [+JEMD 60263 011 the myofibrillar Mg" -ATPase of humml hypertrophied 
septuIII Because no data were available on the effects of [+JEMD 60263 on human myocardium, 
we tested the drug on myofibrils isolated from the hypertrophic septum of cardiomyopathic 
patients (Fig. 6). Like its effect on porcine cardiac myofibrils, the pCa" shifted markedly to the 
left by 10 ~M [+JEMD 60263 from 6.06 ± 0.09 under control conditions to 6.53 ± 0.10 (P < 0.05 
versus control pCa,,). [+JEMD 60263 (10 ~M) also increased the maximally activated Ca" 
stimulated Mg"-ATPase of isolated human myofibrils. 
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Discussion 
The thiadiazinone [+]EMD 60263 has been described as the first Ca" sensitizhlg agent 
devoid of PDE inhibitory activity [28]. In chemically skinned ventricular fibers of pig heart, 
[+]EMD 60263 (3 ~M) shifted tlle EC" ofCa" for the contractile activation from 2.41 mM to 
0.73 mM, whereas the optical isomer [-] EMD 60264 was ineffective [28]. The concentrations 
(IC,,) of [+]EMD 60263 and [-]EMD 60264 to reach half-maximal inhibition ofPDE III activity 
of guinea pig ventricles are> 30 and 12 11M, respectively (personal communication with N. 
Beier). The results of the present experiments also provide evidence for a direct stereoselectivc 
activating effect of [+ ]EMD 60263 on the Ca" stunulated myofibrillar actomyosin Mg "-ATPase 
of pig and human myocardium. There were two effects of [+]EMD 60263: (I) the relation 
between pCa and the actomyosin Mg"-ATPase activity was shifted leftward indicative for 
increased responsiveness of the Mg" -ATPase to Ca"; (2) the maximal Cit' sthnulated Mg' 
dependent ATPase was increased pointing towards a drug action on the kinetics of the ATPase. 
Analogous results were obtained using the [+] and [-] enantiomers ofEMD 53998. The present 
observations with [+]EMD 57033 and [-]EMD 57439 on pig and human cardiac myofilaments 
are in agreement with those obtained in myofibrillar preparations from guinea pig heart [II] and 
canine ventricle [29]. In the fomler reports changes in steepness of the pCa/Mg"-ATPase curves 
were not observed at 10 ~M [+]EMD 57033, but at 30 ~M [11,29]. Likewise, in the present study 
Hill coefficients, reflecting the slopes of the fitted activation curves at pCaso were neither 
changed by 10 11M [+]EMD 57033 nor by 10 ~M [+]60263. The results provide evidence for 
two stereoselective effects ofthe thiadiazinones on the contractile apparatus of heart muscle. TIle 
fust, Ca2+ sensitization ofmyofilaments and second} increase in kinetics of the actomyosin Mg 2-1;. 
ATPase. The stereoselectivity oftlle effects of the thiadiazinones provides strong evidence that 
these agents affect a specific domain important in determining the state of activation of the 
myofilaments. Initially it was believed that the mechanism of Ca2+ activation of cardiac 
actomyosin Mg" -ATPase by the racemic EMD 53998 might involve an effect on Ca" binding 
to troponin C [10,30-32]. In subsequent studies, however, Solaro ef al demonstrated that the Ca" 
sensitization by [+] EMD 57033 appears not to involve the binding ofCa" to troponin C but 
involves a myofilament domain other than troponin C itself [29]. The studies of Solaro ef al [29] 
on desensitized myofibrils and on preparations of pure myosin and actin filaments provided 
evidence that [+]EMD 57033 acts by sthnulating the turnover of the actin-crossbridge reaction. 
111 vitro motility assays were performed by Solaro ef al [29] by adhering monomeric cardiac 
myosin to nitrocellulose-coated glass coverslips. Unregulated actin filaments were allowed to 
interact with the myosin-coated surface in the presence ofMg2+ -ATP and various concentrations 
of [+]EMD 57033. The velocity of the actin motion significantly increased with increasulg 
concentrations of [+]EMD 57033 while, [-]EMD 57439 had no effect. This proved the effect to 
be on the turnover ofthe cyclic cross-bridge. It has been questioned how the effects of [+ ]EMD 
57033 on the kinetics of the actomyosin interaction relate to the drug's Ca2+ sensitizing activity 
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[29]. The relation between the two activities is indicated by the same stereoselectivity of the two 
effects. Leijendekker and Herzig [33] estimated turnover rates of cross-bridges by biochemical 
(Mg'+-ATPase activity) and mechanical (tension development) characteristics of skinned porcine 
right ventricle. They concluded that the turnover rate of the myocardial cross-bridges was 
reduced in the presence of the racemate EMD 53998 at low Ca'+ (pCa ~ 6.25), but not at high 
Ca'+ (pCa ~ 5.85). 
The relatively long lasting myocardial contractile dysfunction after brief periods of 
ischemia has been tenned stunning. The molecular mechanism of this phenomenon is still poorly 
understood, but possible candidates are a decreased Ca'> delivery to and a decreased Ca '+ 
reponsiveness of the myofilaments [15,34-36]. Recent data from our laboratory have shown in 
a model of stunned porcine myocardium that the rate of SR calcium uptake slightly increases 
[16,36]. Therefore it is unlikely that a change in the active Ca" transport by the SR is the 
principal cause of contractile dysfunction of stunned myocardium. Other reports have 
demonstrated that the intracellular Ca2+ transient remains the same in stunned myocardium 
[34,35]. Korbmacher ef al [36] performed experiments investigating the effects of [+]EMD 
57033 on isolated stunned rabbit hearts and showed that the thiadiazinone derivative acted as a 
potent positive inotropic agent. Recently, we reported on the ill vivo cardiovascular effect of 
[+]EMD 60263 in pigs with or without stunned myocardium [12,13]. In these studies the effect 
of [+]EMD 60263 on regional myocardial function was assessed by studying the systolic 
segment shortening of stunned and not-stunned myocardial segments. It was shown that [+]EMD 
60263 increased systolic segment shortening of both the stunned and not-stunned myocardium 
and that the effect on the stunned was much more pronounced than on the not-stunned 
myocardium. No effects were observed with [-]EMD 60264 (unpublished observations). 
Consistent with the observations of our previous ill vivo experiments [12] is the present finding 
that in stunned- compared to not-stunned myocardium the Ca" sensitizing effect of [+]EMD 
60263 on isolated myofibrils was potentiated. Moreover, in 3 out of 4 pigs we found a slight 
desensitization to Ca2+ in the stunned myocardium. These slight decreases of pCaso observed 
apparently caused by stunning might be related to the more pronounced positive shifts of pCaso 
produced by [+]EMD 60263 in stunned- compared to not-stunned myocardium. A recent study 
determined the Ca2+ sensitivity of isometric tension of skinned myocytes obtained from 
endomyocardial biopsies taken from the LADCA-perfused bed (preischemic- versus stunned 
myocardium) of anesthetized open-chest pigs [37]. After more severe ischemia, a reduction of 
myofilament Ca2+ sensitivity of the isolated skinned myocytes was found which finding is in 
agreement with our ill vih'o observations comparing the Ca2+ sensitivities of the Mg2+ -ATPase 
of myofibrils from stunned and not-stunned myocardium. Moreover, it was concluded in this 
report that not only the decreased Ca'+ sensitivity of the myofilaments but also the decreased 
cycling rates of the cross-bridges likely forms the basis of stunning [37]. Similar results were 
recently obtained with ventricular trabeculae from control and stunned rat myocardium [38]. 
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At present, we report the plasma concentrations at which [+]EMD 60263 was effective in 
one of our previous ill vivo studies [12]. The effects of intravenous [+]EMD 60263 infusions 
(0.75 and 1.50 mg.kg-t, n~7) on myocardial functions (systolic segment shortening, external and 
mechanical efficiency) were determined 15 min after dmg infusion when the plasma 
concentration of [+ jEMD 60263 were 0.2 and 0.5 ~M, respectively. The stereoselective ill vitro 
effect of [+]EMD 60263 on the Ca" responsiveness of the Mg"-ATPase of myofibrils isolated 
from either nonnai, not-stunned, or stunned porcine myocardium became evident at 
concentrations (1-3 ~M) that appeared to be close to the plasma concentrations required for the 
maximum increase in systolic segment shortening of stunned and not-stunned myocardial 
segments [12]. It is also noteworthy that we observed no effects of [+]EMD 60263 on the Ca" 
responsiveness of the Mg2+ -ATPase of isolated porcine cardiac SR membrane vesicles which 
finding implies that the SRis not involved in the positive inotropic action of [+]EMD 60263 on 
swine myocardium. Moreover, by the present data additional support [12,13] is provided for the 
hypothesis that a decreased sensitivity of the myofilaments to Ca'+ and not a decreased SR Ca" 
pumping activity is involved in the mechanism of stunning [15,16,34,35]. 
[+]EMD 60263 caused not only a leftward shift in the myofibrillar pCa2+/Mg'+ ATPase 
relationship, but stimulated also the maximal Ca'+-stimulated Mg2+ -ATPase (Figs. 3 and 4 and 
Table 2). Thus even at the lowest Ca'+ concentrations the myofibrillar Mg+ -ATPase is still 
slightly increased by [+ ]EMD 60263 and this may indicate the occurrence of relaxation 
disturbances ill vivo. We have reported on the diastolic effects of [+]EMD 60263 in stunned 
porcine myocardium [39]. A bolus injection of 1.5 mg/kg returned systolic segment shortening 
to baseline value but had no effect on the diastolic segment function. When the dose was 
increased to 3.0 rug/kg systolic segment shortening in both stunned and not-stunned regions 
increased beyond baseline value. Diastolic segment lengthening, which in control animals and 
at lower doses ofEMD 60263 started to lengthen innnediately after segment shortening reached 
minimal length, was delayed at high dose. The mean velocity of segment lengthening was 
unchanged compared to baseline. However, these in vivo effects are observed at lower plasma 
concentrations of [+ ]EMD 60263 (approximately at < I f,M) than the concentrations to which 
the myofibrils were directly exposed in the ill vitro experiments. Recently, Sunderdick e/ aT [40] 
compared the effects of Ca" sensitizers [+]EMD 60263 and [+]EMD 57033 in isolated blood-
perfused rabbit heart. They used similar doses as our iu vivo studies and indeed reported that 
at the relatively high dose of 10 ~M [+]EMD 60263 had major detrimental effects on the 
relaxation and also the contractile function, but not at the lower dose of 3 ~M. 
In summary, the results show that [+]EMD 602363 at concentrations (1-3 ~M) close to the 
plasma concentrations that were found to be effective in the in situ porcine model, sensitizes 
Mg2+-ATPase of isolated porcine and diseased human cardiac myofibrils to Ca 2+ and had no 
effect on the Ca2+ stimulated Mg2+ -ATPase of isolated porcine cardiac SR membrane vesicles. 
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We conclude from these data that the positive inotropic action ofthe thiadiazinone [+)EMD 
60263 in the in situ porcine model is primarily due to myofilament sensitization to Ca2' and that 
this compound may have a similar action on the diseased human myocardium. 
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Populations consuming large amounts of fish (nv 3 fatty acids) are reported to have a lower incidence 
of ischemic heart disease, which is attributed to a reduction in atherosclerosis by n-3 fatty acids. The 
effects of n-3 fatty acids on the various biochemical variables are well documented, Yet it remains unclear 
how these effects ofn-3 fatty acids affect the in vivo process of development, progression and regression 
of lesions. Studies in animal models on n-3 fatty acids and atherosclerosis showed, in contrast to the 
results from epidemiological studies, conflicting results, which may be attributed to the diversity in animal 
species and experimental designs. In this paper we reviewed the results from our own studies and relate 
them to those found In the literature. Our studies were performed In experimental model based on the pig, 
that underwent dietary Intervention with high cholesterol and either endothelial denudation or vena-arterial 
by-pass grafting for Induction of atherosclerotic lesions. The effects of n-3 fatty acids on atherosclerosis 
was studied during the Induction period and In a subsequent period after removal of cholesterol from the 
diet. We conclude that n-3 fatty acids affect several, but not all parameters routinely used to assess the 
severity of atherosclerosis In experimental models. The duration of the induction period and therefore the 
composition of the lesions appear to be important in the few studies that reported on regression by 
Intervention with n-3 fatty acids. (In: n-3 Fatty Acids: Prevention and Treatment in Vascular Disease, 
Eds: S.D. Kristensen, E.B. Schmodt, R. De Caterine, S. Endres, Springer Verlag, London, United 
Kingdom 1995: 55-75.) 
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In the early seventies Bang and Dyerberg reported that in the Inuit population (Eskimos living 
on the West coast of Greenland) the prevalence and mortality of cardiovascular disease was 
lower compared to an equivalent population of Danes.' They also found that these Greenland 
Eskimos had a favorable plasma lipid profile, with low levels oftriglycerides, plasma cholesterol 
and very low density lipoproteins (VLDL) and high levels of high density lipoproteins (HDL). 
From this epidemiologic study it was concluded that the diet of the Inuit population, which 
contains high quantities offish and seal could contribute to these findings. Fish and seal are rich 
in long chain polyunsaturated n-3 fatty acids, which are presumed to be a major factor 
responsible for the supposedly beneficial effect of fish oil. However, one should not forget that 
other cardiovascular risk factors, such as hypertension and diabetes, are also uncommon among 
Inuit people. The report by Bang and Dyerberg' spurred many investigators to perform 
epidemiologic studies in several other countries and several of these studies confirmed that 
regular intake of fish oil was associated with a lower prevalence of cardiovascular events in 
man?'" The design of these epidemiologic studies, however, does not permit to conclude that less 
severe atherosclerosis was indeed responsible for the decreased incidence of these cardiovascular 
events. 
The mechanisms by which the n-3 fatty acids may exert their potentially beneficial effects 
are not yet fully elucidated. Epidemiologic studies have established ingestion of n-3 fatty acids 
bears a negative relation with levels of blood cholesterol, arterial blood pressure and platelet 
aggregation and thrombosis, but the possible mechanisms underlying these relationships could 
not be determined from these studies. Many investigators have therefore used to animal models 
to elucidate the mechanisms by which n-3 fatty acids may prevent or even cause regression of 
atllerosclerosis. In these models atherosclerosis is usually induced by highly controlled diets rich 
in cholesterol and endothelial injury. In this chapter we will review the rationale to study the 
effects of fish oil on the progression and regression of experimentally-induced atherosclerosis 
and compare the results of our own studies performed in pigs with those of other investigators. 
Biochemical processes modulated by n-3 fatty acids 
Oils obtained from marine life have high concentrations of long chain polyunsaturated n-3 
fatty acids. This is not surprising as the n-3 fatty acids such as eicosapentaenoic (20:n-3 or EPA), 
docosapentaenoic (22:5n-3 or DPA) and docosahexaenoic (22:6n-3 or ORA) acid, are mainly 
synthesized by algae and phytoplankton. These microorganisms then serve as food for higher 
marine life by which n-3 fatty acids will eventually reach humans. This pathway is responsible 
for the bulk of n-3 fatty acids incorporated in the human body. Synthesis can occur from 
conversion of a-linolenic acid (18:2n-3), but under normal conditions, when the 20- and 22-
chain length n-3 polyunsaturated fatty acids are sufficiently present in the diet, the contribution 
of a-linolenic acid derived 20- and 22-chain n-3 polyunsaturated fatty acids is negligible. In 
Table 1. Biochemical effects of n-3 fatty acids on cell functions and blood constituents involved in atherosclerosis 
INTIMAL HYPERPLASIA & PLATELET AGGREGATION VASCULAR SMOO1H MUSCLE TONE INFLAMMATION 
LIPID INFIL1RATION 
PLATELETS factor 4 1, TXA.z !., TXA3 i, platelet count!, TXA.zl, TXA3T 
.B~1bIombog1obulin 1, bleecling time 1 T 
PAF L, platelet survival T 
END01HELlAL PDGF I PGI3 i> PGI: preserved, EDRF effect t PGI, T, 
CELL EDRF effect t 
LIPOPROTEINS VLDL 1, triglycerides 1, LDL 1 T=, 
HOL 1 T =, change in lipoprotein size; 
apoprotein content; physical 
properties; lipoprotein metabolism; 
lipid peroxidation 
MONOCYlE IL-J; TNF I PAF I LTB41;LTBs i 
NEUTROPHIL Lm 14; Lms T, :freeradica1 synth~'is L m 4 1; L TBs T, adhesion 
1, chemotaxis 1 and chemota"cis 1 
VASCULAR blood pressure 1 t 
SMOO1H response to noradrenaline 1 
MUSCLE CELL 
COAGULATION fibrinogen =1 T, PAI~l 1 i, factor vn =T > 
FACTORS antithrombin = 1 , 
tPA t=, von Willebrand = 
For references regarding the actions of n-3 fatty acids see Sassen et als (with permission from Cardiovascular Drugs and Therapy). 
Fish oil.and experimental atherosclerosis 151 
manlmals an increased intake of n-3 fatty acids leads to a change in the function of various cell 
types and in the plasma concentrations of some blood constituents (Table 1).'·6 Part of the n-3 
fatty acid effect can be attributed to alteration of the eicosanoid production in cells by 
interference of n-3 fatty acids with the metabolism of arachidonic acid (20:4n-6). Arachidonic 
acid is produced from dietary linoleic acid (18:2n-6) by elongation and desaturation. N-3 fatty 
acids compete for the active sites of the elongation and desaturation enzymes and this explains 
the reduction of arachidonic acid formation in the presence of excessive n-3 fatty acids. 
Furthermore, the n-3 fatty acid with chain length of 20, EPA, and to a lesser extent that with 
chain length of22, DHA, are not only competing with arachidonic acid for the (re)acylation of 
membrane (lyso)phospholipids, but also for the fonnation of eicosanoids by cyclooxygenase and 
lipoxygenase. The interference with the formation of eicosanoids occurs by two mechanisms. 
Firstly, the ratc of conversion by cyclooxygenase and Jipoxygenase is lower when these enzymes 
use n-3 fatty acids substrate. Secondly, the n-3 fatty acid-derived eicosanoids are different from 
those derived from n-6 fatty acids. Moreover, the eicosanoids derived from n-3 fatty acids are 
biologically less active than their n-6 fatty acid-derived counterparts. For instance, in platelets 
the weak agonist thromboxaneA, (TXA,) is formed by cyclooxygenase from EPA at the expense 
of the strong agonist thromboxaneA, (TXA,) derived from arachidonic acid. Thus the lower ratio 
ofTXA2 over TXA3 attenuates vasoconstriction and platelet aggregation, resulting in an increase 
in bleeding time. In endothelial cells n-3 fatty acids slightly reduce the production of 
prostaglandin Ib but increase the production of the equally biologically active prostaglandin I" 
leading to a net vasodilatory effect, which depends on the TXAlPGI-ratio. It has been shown that 
endothelial ceUs of vascular rings derived from animals fed with a n-3 fatty acid enriched diet, 
release more endothelium derived relaxing factor (EDRF) after a challenge with neurohumoral 
mediators such as adenosine diphosphate (ADP), serotonin or bradykinin. Interference with the 
release mechanism afEORF was excluded as Ca2+ ionophores gave similar vasodilatory effects 
independent of n-3 fatty acid incorporation in the cell membrane.109 One possible mechanism by 
which n-3 fatty acids could increase EDRF formation is the interference of n-3 fatty acids with 
the receptor-mediated signaltransduction via phospholipase C.lO,ll This enzyme turns on the 
phosphatidylinositol cycle, an inlportant intracellular signalling process, which mediates 
extracellular stimuli, be it mechanical or neurohumoral, to the nucleus, affecting cell growth and 
transcription processes. Hence, it is also likely that expression of endothelial adhesion molecules 
and endothelial responses to mechanical stress and mitogenic responses of vascular smooth 
muscle cells, which are also biological functions that use the phosphatidylinositol cycle for 
intracellular signalling, are affected by n-3 fatty acids. Other effects of n-3 fatty acids on 
platelets and endothelial cells are the inhibition of the production and the release of growth 
factors, such as platelet-derived growth factor and fibroblast growth factor. I ' N-3 fatty acids may 
consequently, especially in the early phase of atherosclerosis, inhibit or retard smooth muscle 
cell and fibroblast proliferation. 
In monocytes n-3 fatty acids reduce the production of cytokines (interleukin-I) and tissue 
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factors such as tumor necrosis factor and platelet aggregating factor and thus alter the interaction 
between platelets and the vascular wall. In leukocytes the leukotriene production is affected via 
substrate competition for the lipoxygenase between EPA and arachidonic acid, which results in 
a reduced production of leukotriene B, (L TB,) and an increased leukotriene B, (LTB,) level. 
Compared to LTB" LTB, is a relatively weak agonist, thus dietary EPA can decrease chemotaxis 
and adhesion of monocytes and polymorphonuclear cells, modifying not only the inflammatory 
response, but also the interaction between these cells and vascular wall. EPA may retard intimal 
hyperplasia also by these actions. 
The effects of n-3 fatty acids on blood lipid and lipoprotein levels are predominantly 
characterized by a reduction in triglyceride levels. The dose of n-3 fatty acids critically 
determines the occurrence of triglyceride reduction. Furthermore, the pattern of effects on the 
plasma levels of triglycerides, very low density lipoprotein (VLDL), low density lipoprotein 
(LDL) and high density lipoprotein (HDL) is also dose-dependent. Moderate doses of n-3 fatty 
acids (1-3 g1day) also give rise to a decrease in plasma triglycerides and VLDL in both human 
normolipidemics and hyperlipidemics.13 With higher doses of n-3 fatty acids the lowering of the 
triglyceride levels becomes more clear, although it should also be stressed that the effect is more 
pronounced when the pretreatment levels of triglycerides are greater. N-3 fatty acids attenuate 
postprandial hypertriglyceridemia, and this reduction of blood lipids may therefore also add to 
the beneficial effects of fish oil. The changes in plasma lipoprotein levels, however, are not 
predictable as those in triglycerides. While most investigators report a decrease in VLDL levels, 
the reports on the levels of LDL have been inconsistent (Table I). The effect of n-3 fatty acids 
on plasma HDL cholesterol strongly depends on the dose used. Very high doses (> 10 g1day) 
have been reported to cause a decrease, while doses of 5-10 glday are found to increase HDL 
levels.13 The changes in plasma lipoprotein concentrations, however, may not necessarily reflect 
the potential anti-atherogenic effects of n-3 fatty acids on lipoproteins. N-3 fatty acids may also 
alter the physical properties and composition of lipoprotein particles. Changes in apoprotein 
content, together with n-3 fatty acid-induced modification of cellular receptor function or 
lipoprotein metabolizing enzymes and lipid transfer proteins may alter lipoprotein metabolism 
in a favorable manner regarding prevention of atherosclerosis. (See reference 5 and 6) 
There are several reports, however, that n-3 fatty acids may not exert only beneficial actions, 
but also some detrimental effects in the process of atherosclerosis. We have shown that 
incorporation of dietary n-3 fatty acids increased the susceptibility of heart membranes to free 
radicals after short periods of ischemia. H Other investigators have observed that replacement of 
dietary polyunsaturated fatty acids with monounsaturated fatty acids reduced the susceptibility 
ofLDL to oxidation, following an ill vitro incubation with copper sulfate. 1S,16 In some ill vih'o 
studies it has also been shown that after oxidative modification LDL particles are preferentially 
taken up by tissue macrophages. 17,18 It is, therefore, believed that the increased susceptibility of 
LDL to oxidative modification is implicated in the development and progression of 
atherosclerosis as accumulation of the oxidative modified LDL particles in macrophages and 
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smooth muscle cells may result in the formation of foam cells. Recently Whitman et al", 
however, showed that in vitro results of LDL oxidation may not reflect the ill vivo situation. 
Incorporation of dietary n-3 fatty acids into LDL particles was found to increase their 
vulnerability to oxidative modification in the ill vitro situation, but they did not observe an 
increase in the percent surface areas covered with atherosclerotic lesions in the various vessels. 
It is quite feasible that ill vivo circulating anti-oxidants and pro- and anti-oxidants present in the 
diet affect the effect oflocal anti-oxidant status in the vessel wall and surroundings and thereby 
modify the progress of atherosclerotic processes. 
Hypertension and diabetes are other risk factors for the development of atherosclerotic 
lesions. Most of the evidence that fatty acids may playa role in blood pressure regulation comes 
from studies in humans. Such studies are complicated, however, by difficulties in assessing 
accurately the dietary fat intake, seasonal variations in both fat intake and blood pressure and 
such confounding factors as alcohol consumption, physical activity, age, gender and total food 
intake. Beilin20 has reviewed the evidence of the potential of fatty acids to lower blood pressure 
and concluded that n-3 fatty acids have a mild antihypertensive effect, which can be most clearly 
demonstrated in patients with untreated hypertension and in the elderly. The effect of n-3 fatty 
acids may be mediated by its effect on platelet- and endothelium-derived mediators in the 
resistance vessels. Data on the effects of n-3 fatty acids in type II diabetic patients are 
unequivocal and a considerable amount of research is still needed to establish whether n-3 fatty 
acids have a beneficial effect on glucose homeostasis. A potential mechanism could be 
modulation of the function of the pancreatic islets by eicosanoids, altered membrane fluidity and 
a change in the balance between lipid and glucose oxidation.2I Modulation of arterial blood 
pressure and glucose homeostasis by n-3 fatty acids do not playa major role in most animal 
studies on the progression and regression of atherosclerosis, because neither hypertension or 
diabetes are present in the models. 
Relation between I1w3 fatty acids and atherosclerosis 
The aforementioned effects of moderate to high doses of n-3 fatty acids are the molecular 
basis for the biological effects, such as the interference with inflammatory and coagulating 
processes, blood-vascular wall interaction, cell growth factors, cell signaling, free radical 
scavenging, lipoprotein metabolism and lipid infiltration of the vessel wall, which are potentially 
beneficial. Although it is generally accepted that fish oil can interact with the processes involved 
in atherosclerosis, its contribution to the development, progression and regression of 
atherosclerotic lesions is still a point of discussion. Most of the evidence is collected from animal 
studies, but comparing the results of different studies is arduous 'work, because of the variety of 
animal models (e.g. species, interventions to accelerate atherogenic processes) and diets 
(supplementation or replacement ofn-6 fatty acids with n-3 fatty acids, duration of n-3 fatty acid 
feeding, cholesterol content, addition of bile acids) used. Also different parameters may be 
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Fig 1. Effect of n-3 ratty acids (panels C and D) on total plasma cholesterol, total cholesterol (cholesterol + 
cho[esterolester) accumulation In the aorta and luminal encroachment in the coronary artery in pigs, In which 
endothelial denudation was performed 2 weeks after the start of the diet. Panels on the left indicate the composition 
of the diets and the duration of the study. * P<.05 vs the comparitive value for the animals of group A t P<.05 vs 
the comparitive value for the animals of group 8. Data are mean±SEM. 
studied to evaluate atherosclerosis and genetic variances may be present in the studied population 
(e.g. hyper- and hyporesponders within a species with respect to cholesterol feeding).' Thus to 
appreciate the effects of n-3 fatty acids on atherosclerosis it is not only necessary to investigate 
each possible mechanism and interaction, but preferentially these investigations should be 
performed in relevant models. 
In order to ensure a valid and clinically useful outcome, a consensus should be reached on 
which animal model best resembles the human situation. Similar to man, atherosclerosis in such 
model should not only develop spontaneously with eady lesions or fatty streaks at juvenile age 
progressing to advanced lesions at elder age with complication such as fibrosis, calcification, 
ulceration and thrombosis, but should also involve the intima of the vessel wall. Primate models 
by evolution closely related to man fonn the ideal species. They do develop diet-induced lesions, 
that closely resemble human atherosclerotic lesions, both anatomically and morphologically. 
However, animal right activists and strict legislation make it hard to use monkeys in 
experiments. Dogs and especially rabbits have been extensively used in atherosclerosis studies. 
Their biggest disadvantage is that neither of them develop atherosclerosis spontaneously. In 
rabbits high cholesterol feeding is necessary to induce atherosclerosis, but at the same time this 
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also leads to excessive cholesterol (ester) accumulation in tissues. In contrast to man, where 
lesions are located in the abdominal aorta and epicardial coronary arteries, the main anatomical 
sites of lesions in rabbits are the aortic arch and the arterioles in the myocardium.22 The content 
of the lesions also differ, in that they consist mainly of fat and complicated lesions are rarely 
encountered. Atherosclerotic lesions are not easily obtained in dogs. Apart from feeding a high 
cholesterol diet, damage to the endothelial surface or even the thyroid gland is required to obtain 
atherosclerosis and despite a similar arterial distribution of lesions the injury primarily involves 
the media. In swine spontaneous development of atherosclerosis can be found and, besides being 
similar to those in man, it also starts at an early age (6 months),23 However, as atherosclerosis 
in the swine is also a very slow process, it takes several years before mature atherosclerotic 
lesions can be observed. So in most studies induction of atherosclerosis is accelerated using diets 
with a high fat and/or cholesterol content and added bile acids, which in combination with 
endothelial injury can produce severe lesions. Also the high costs of strictly controlled diets and 
housing of large animals under experimental conditions have been major reasons that the 
duration of most large animal studies was short and the size of the experimental groups was 
relatively small. That the latter may easily lead to erroneous (both positive and negative) 
conclusions has been amply demonstrated by Rich et ai. 24 
Apart from the above mentioned problems, concerning the chosen model, experimental 
design, etc., there appears to he no real consistency in the effect of 0-3 fatty acids on 
atherosclerosis. In a recent review we scrutinized the outcome of studies investigating the effect 
ofn-3 fatty acids on atherogenesis in hypercholesterolemic animals' Although 10 out of the 21 
studies showed a beneficial outcome and only 4 showed an unfavorable effect, the authors were 
critical about this outcome and argued that perhaps several studies yielding negative results are 
not submitted for publication, thereby possibly creating a bias to positive results. 
Effects of 0-3 fatty acids in OUI' own studies. 
Our fIrst studies were not primarily aimed to investigate the effects of n-3 fatty acids on the 
progression and regression of atherosclerosis, but on the modification of plasma and cell 
membrane lipids and systemic hemodynamics, cardiac function, arrhythmias and ischemia-
reperfusion injury by these fatty acids?O,26 These parameters were monitored in piglets from the 
Landrace x Yorkshire race, which shortly after they were weaned were fed a basal diet to which 
9% w/w of either lard fat or fIsh oil was added. The fIsh oil treated group showed a marked 
increase in the amount of n-3 fatty acids incorporated in the cell membranes of platelets and 
cardiac cell membranes, plasma triglycerides and both total and high density lipoprotein (HDL) 
cholesterol levels were reduced. These changes did not lead to changes in systemic 
hemodynamics, arrhythmias and cardiac response to ischemia. However, after short periods of 
ischemia the hyperemia in the fish oil fed animals was increased probably due to a larger 
vasodilatory response of the coronary vascular bed, which coincided with a decrease in 
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Fig 2. Effect of n-3 fatty acids (panel C) on total plasma cholesterol, total cholesterol (cholesterol + 
cholesterolester) accumulation in the aorta and luminal encroachment in the coronary artery in pigs, in which 
endothelial denudation was performed and bile acids (0.5% w/w) was added to the diet at respectively 1 and 3 
months after the start of the diet. Panels on the left indicate the composition of the diets and the duration of the 
study. * P<.05 vs the comparitive value for the animals of group A Data are mean±SEM. 
thromboxane A,/prostaglandin I, ratio (TXA,/PGI,). In the same model the postprandial 
responses of plasma lipids and glucose were significantly altered compared to the lard fat treated 
group." Consistent with other reports postprandial plasma triglycerides and free fatty acids were 
found to be decreased by fish oil feeding. This is largely due to a decrease in very low density 
lipoprotein (VLDL) production rather than an increased lipolysis by lipoprotein lipase and 
hepatic lipase.27,28 In a parallel series of experiments we have used a different supplement to the 
basal diet. Instead of9% (w/w) fish oil, a mixture of 4.5% offish oil and 4.5 % of lard fat was 
added, which is a more realistic dose of fish oil for man.29,30 The duration for the study was 
increased to 16 weeks, but the responses of plasma triglycerides, total cholesterol and HDL-
cholesterol at 8 and 16 weeks were identical with the lower dose ofn-3 fatty acids. the same was 
true for the post-prandial responses at 16 weeks. The findings suggest that in the dose range 
between 4.5% w/w and 9% w/w there is no dose-dependent effect of fish oil on lipid levels in 
the nonnolipidemic swine model. Although not designed to investigate atherosclerosis the results 
of these studies do indicate that n-3 fatty acids may exert an effect on the process of 
atherosclerosis. It is, however, interesting to notice that not all changes point in the same 
direction. The decreased TXAiPGI2 ratio points toward vasodilation and a reduction in 
thrombogenesis and thereby reducing cardiovascular riskfactors. It has been proposed that 
lowering of post-prandial lipid levels by n-3 fatty acids reduces the exposure time of the vessels 
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Fig 3. Effect of n~3 fatty acids (panel D) on total plasma cholesterol and the regression of atherosclerosis as 
assessed by total cholesterol accumulation (cholesterol + cholesterolester) in the aorta and luminal encroachment 
in the coronary artery in pigs, in which endothelial denudation was performed and bile acids (0.5% w/w) was added 
to the diet at respectively 1 and 3 months after the start of the diet. The 2% cholesterol was removed from the diet 
after 8 months of induction. Notice that n~3 fatty acids have no significant effect on lotal cholesterol accumulation 
in the aorta and luminal encroachment in the coronary artery. Panels on the left indicate the composition of the diets 
and the duration of the study_ Data are mean±SEM. 
and thereby the risk of atherosclerosis." The same reasoning is also valid for the lower total 
cholesterol and triglyceride plasma levels. In contrast, HDL cholesterol and the ratio HDLltotal 
cholesterol, which are believed to be inversely related to atherosclerosis, were reduced 
suggesting an increased risk of atherosclerosis. 
In subsequent studies, we investigated the effect of n-3 fatty acids on atherosclerosis variables 
in both normolipidemic and hypercholesterolemic Landrace x Yorkshire swine. In 
nonnolipidemic animals development of atherosclerotic lesions was enhanced by implanting a 
Teflon constrictor with a fixed diameter of 2 rum around the left anterior descending coronary 
artery (LADCA)." Prior to surgery the animals were fed diets to which either 9% (w/w) of lard 
fat or 4.5% (w/w) lard fat and 4.5% (w/w) fish oil was added for a period of2 months. The diet 
regime extended for another 2 months before luminal encroachment was assessed as a measure 
for atherosclerosis. This study showed a favorable effect as luminal encroachment at the site of 
the constrictor was reduced from 62±7% in tile lard fat fed group to 11±4% in the group fed with 
fish oi1.32 Furthermore an improvement was observed in the endocardial/epicardial blood flow 
ratio in the LADCA-perfused myocardial region of the fish oil fed group and hence regional 
myocardial contractile function was found to be better preserved than in the lard fat group. This 
Table 2. Effects of n-3 fatty acids on experimental atherogenesis in pigs 
AurnOR 
Hill et 3144 
Hill ct 314 !i 
Weiner et 3137 
Kimetal~ 
Hartog et aln 
Sa.<:sen et 314l 
Induction of 
atherosclerosis 
hyperchol~i:erolemia 
+ bile acids 
hyperchol~"tcrolemia 
+ bile acids 
hypercholesterolemia 
+ bile acids + abrasion 
hypercholesterolemia 
+ bile acids 
normocholesterolemia 
+ teflon coru.1rictor 
hypercholesterolemia 
+ bile acids + abra:,.'ion 
TIME 
(months) 
24 
12 
8 
4 
4 
8 
DOSE OF EPA and/or DHA 
6% total n-3 (weighf>1o in diet) 
3% total n-3 (weighf>1o in diet) 
3% total n-3 (weighf>1o in diet) 
30 m1 cod liver oil per day per animal 
(330 EPA +330 DHA)' 
- (100 EPA+IOO DHA)' (mglkglday) 
0.36%EPA+O.23%DHA 
(weight% in diet) 
(1040 EPA+743 DHA)' 
- (242 EPA+I75 DHA)' (mg/kglday) 
liS BLOOD VESSEL 
I' Aorta 
Coronary artery 
I' Aorta 
Coronary artery 
Aorta 
Coronary artery 
S Coronary artery 
S Aorta 
Coronary artery 
Coronary artery 
Aorta 
Coronary artery 
ASSESSMENT OF 
A 1HEROSCLEROSIS 
LE' 
%lesionsb 
aortic lipids 
LE' 
LE' 
%lcsionsb 
aortic lipids 
LE' 
LE' 
%lesionsb 
aortic lipids 
LE' 
LE 
LE 
LE 
LE 
%lesions 
aortic lipids 
LE 
EFFECT OF FISH OIL 
FC=;CE= 
! 
FC=;CE= 
FC=;CE= 
! 
! 
EPA. eicosapentaenoic acid (20:5n..:3); DHA, docosahexaenoic acid (20:6n..:3); "tallow used as control diet; ~ semiquantitative histologic grading; 0 coconut-oil used as control diet; d dose at the beginning 
of the dietary period; ~ dose at the end of the dietary period; lIS, isocaloric or supplementary administration of fish oil; %Iesions stands for the percentage of the surface of the vessel that is covered 
with intimal lesions; LE, luminal encroachment; Fe, free cholesterol; CE, esterified cholesterol; Te, total cholesterol; Effect offish oil: =, unchanged; 1, decrease; r, increase. Adapted from Sassen 
et alo (with permission from Cardiovascular Drugs and Therapy). 
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may indicate a better vasodilatory reserve of the endocardial layer due to n-3 fatty acids, which 
agrees with our earlier finding of a decreased TXA,lPGI, ratio after multiple sequences of 
occlusion and reperfusion. Both phenomena confoml with the reduced ADP-induced aggregation 
of platelets found in this study. 
Regression of atherosclerosis in animal models have' been shown in several species. 22,33-36 In 
a recent review on regression of atherosclerosis Schwartz et al proposed four possible targets for 
intervention; plaque initiation, plaque progression, plaque stabilization and reduction in plaque 
size and removal of constituents. Plaque initiation (formation of new lesions) and also plaque 
stabilization, which involves thromboresistance and thromboregulation of the atherosclerotic 
plaque, have already been shown to be affected by n-3 fatty acids (Table I). However, little is 
known about the effects of n-3 fatty acids on plaque progression and plaque size reduction. In 
Qur subsequent studies we therefore not only focussed on the effects of n-3 fatty acids on 
progression, but also on regression (reduction in atherosclerotic lesions) of atherosclerosis. To 
this end, similar to the models used by other investigators .... " a high cholesterol diet and abrasion 
of the endothelial surface was used to accelerate tile development oflesions (Table 2). In tile first 
series of experiments atherosclerosis was induced with a diet containing 2% cholesterol and 7% 
lard fat for 4 months together with endothelial denudation of the LADCA and abdominal aorta 
in the second week. 38 At the end of the induction period plasma cholesterol level had doubled 
(2 mM at baseline), while cholesterol + cholesterolester content of the abraded aorta was 45% 
higher than in the non-abraded aorta. Similarly there was a nearly IO-fold increase in luminal 
encroachment in the abraded coronary artery (1.3±O.3 in the non-abraded coronary artery, Figure 
I). After the induction period a low cholesterol diet supplemented with 4.5% (w/w) or 9% (w/w) 
offish oil or lard fat was administered for 3 months to induce regression of atherosclerosis. In 
both fish oil groups, plasma cholesterol levels returned to baseline values and was significantly 
reduced compared to the group fed with only lard fat, without an effect on lipid accumulation 
in either the abraded or non-abraded aorta. In the abraded coronary artery, however, fish oil 
dose-dependently reduced the luminal encroachment and prevented progression of luminal 
encroachment in the non-abraded artery, compared to the fIndings in the lard fat group. The 
latter finding corresponds with the observation by Clarkson et al.," who found that elevated 
levels of plasma cholesterol correlated with progression of the lesions. Plasma cholesterol levels 
and luminal encroachment after induction were considerably lower in our study than those 
reported in the literature31•40 ) however. For instance, Weiner et al reported a luminal 
encroachment of 44% compared to only 11% in our study at the end of the induction period.37 
This suggests a less severe atherosclerotic lesion in our study, which consequently could have 
contributed to our positive results obtained in the regression period. The very high plasma 
cholesterol levels obtained in their study (approximately 14 ruM against 4 mM in our study) may 
underly these differences. Therefore we performed a second series of experiments in which the 
development and regression of atherosclerosis was investigated, in animals, which were now fed 
a basal diet for 8 months (instead of 4 months), to which either 10% (w/w) of lard fat, 2% 
cholesterol plus 8% lard fat or 2% cholesterol plus 4% lard fat and 4% fish oil were added, to 
induce atherosclerosis.'1 After I month the LADCA and abdominal aorta were denuded and in 
accordance with the study of Weiner et al37 bile acids were added to the high cholesterol groups 
to further enhance plasma cholesterol levels. Higher plasma cholesterol levels were indeed 
obtained with this protocol and averaged 9 mM. In the non-abraded aorta fish oil prevented the 
accumulation of free cholesterol in the aortic wall compared to the cholesterol-lard fat group, 
but had no effect on lipid content in the abraded segment of the aorta (Figure 2). Staining the 
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Fig 4. Comparison of the effects of 2% cholesterol feeding on plasma levels of cholesterol and triglycerides in 
domestic crossbred Landrace x Yorkshire pigs and G6ttingen mini-pigs. Notice that In contrast to the domestic pigs 
the Gottingen mini-pigs respond with a marked Increase in total plasma cholesterol. • P<.OS vs Baseline. Data are 
mean±SEM. 
intimal surface of the aorta with Sudan IV, however, revealed no differences between lard fat 
and fish oil groups. Luminal encroachment of both the abraded and non-abraded coronary 
arteries were not affected by fish oil during the induction of atherosclerosis, in contrast to the 
severe of luminal encroachment reported by Weiner et al37 (Figure 2). The higher content of bile 
acids and saturated fat in the diets used by Weiner et al and hence the hlgher plasma cholesterol 
level may account for the differences. Moreover, despite the longer duration of the induction 
period and addition of bile acids to the diet, there seems to be no difference in the diet-induced 
atherosclerosis as assessed by total cholesterol (cholesterol + cholesteroles\er) accumulation in 
the aorta and luminal encroachment of the coronary artery between our own two studies (Figures 
I and 3). Regression of atherosclerosis in our model was sutdied by removing the 2% cholesterol 
from the diet and substituting the 8% with 10% of lard fat and the 4% of lard fat and fish oil 
with 5% of each fat. After an induction period with cholesterol and lard fat the animals were fed 
with one of these diets for a period of 4 months (Figure 3). The results of this study revealed 
that, in comparison to the lard fat group, fish oil attenuated the progression of atherosclerosis 
leading to less lipid accumulation in the damaged aortic wall and less luminal encroachment in 
the coronary arteries. However, in contrast to our previous study, there was no a reduction in 
coronary luminal encroachment. These results are in agreement with those reported by Fincham 
et al (Table 3).42 These investigators observed that after an induction period of more than one 
year fish oil was unable to induce regression of atherosclerosis in coronary arteries and the aorta 
of hypercholesterolemic non-human primates. In addition to the study of Sassen et al regression 
of atherosclerotic lesions has been observed by Zhu et a1.38,43 This last group of investigators 
reported a decrease in percent of aortic and pulmonary artery surface areas covered with 
atherosclerotic lesion after an induction period, which lasted only 10 weeks. The number of 
studies on the effect of fish oil on regression of atherosclerosis is small, but the results presented 
in Table 3 suggest that the duration of the induction period may be important as only the studies 
with induction periods lasting less than 4 months showed positive results. The longer induction 
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Fig 5. Comparison of the effect of 0-3 fatty acids (panel C) and 0-6 fatty adds (panel D) on total plasma 
cholesterol and total cholesterol (cholesterol + cholesterolester) accumulation in the aorta In Gottingen mini-pigs, 
which were fed a high cholesterol diet for 8 weeks. * P<.05 vs the comparitive value for the animals of group A. t 
P<.05 vs the comparitive value for the animals of group B. Data are mean±SEM. 
period possibly lead to a different structure and composition of the atherosclerotic lesions, which 
are more resilient to regression by fish oil. 
Accelerating the process of atherosclerosis with high cholesterol forage, bile acids and 
endothelial denudation render the foregoing studies to criticism as the induction process might 
affect the form and composition of the atheroscleroticlesions formed. The Landrace x Yorkshire 
pig race probably represents a hyporesponder to cholesterol feeding and needs very long 
protocols to develop atherosclerosis spontaneously. In contrast the swine breed G6ttingen mini-
pigs reacts more readily to a challenge with high cholesterol (Figure 4). Together with their 
smaller stature and a lower rate of growth, which facilitates their handling, they are more 
suitable for studies on atherosclerosis. Because of these advantages we have chosen for the 
GOttingen mini-pigs ill our latest atherosclerosis study. In this study a forage with 2% cholesterol 
and 9% of lard fat and 4.5% of lard fat, plus either 4.5% of lard fat, sunflower oil or fish oil 
increased total plasma cholesterol level from about 3 ruM to about 14 ruM in 2 weeks time again 
without addition of bile acids. Furthermore after 8 weeks white-yellowish elevations on the inner 
surface of the abdominal aorta (fatty streak-like lesions) were observed. Compared to 
macroscopically normal tissue, the lesions contained more unesterified and esterified cholesterol. 
This model was used to study whether the protection afforded by fish oil is a direct effect of n-3 
fatty acids or secondary to a fish oil induced-increase in the ratio of polyunsaturated/saturated 
Table3. Effect of 0-3 fatty acids on the regression of atherosclerosis in animal models 
AUTIlolt ANIMAL TIME (months) DOSE OF liS - PLASMA LIPIDS BLOOD VESSEL ASSESSMENT OF EFFECT OF FISH OIL 
(Induction of EPA and/or DHA A1HEROSCLEROSIS 
atherosclerosis) Induction Regression (mg&g/day) 
Sassen et a138 swine 4 3 188"·210' EPA TC I. Tg I Aorta Lipids PL=; TC=; TG= 
(hyperchole:-.1erolemia 12S"M!4Qb DHA Coronary artery LE ~ (dose dependent) 
+ abrm.i.on) 380"M39()b EPA 
209"M220b DHA 
Zhuetal43 rabbit 2.5 10 82"·73b EPA S TC=. Tg= Aorta %lesions 
(hyperchole:-."1erolemia) 5S"-49b DHA Pulmonary artery % lesions 
Fmcham et a142 Vervet monkeys 24.5 20 30.1 EPA TC=.Tg= Aorta LE 
(non-human primates) 9.7DHA %le..~ons 
(hypercholesterolemia) Cerebral artery LE 
Coronary artery LE 
Sa.">Sen et a141 swine 8 4 309a·193b EPA Aorta %lesion 
(hyperchole:-.molemia 220"-137b DHA - ascending (non-abraded) Lipids PL=; CEI; FC=; TG= 
+ abrasion + bile acids) • abdonrinal (abrndod) Lipids PL=; CE=; FC=; TG= 
Coronary artery LE 
EPA, eicosapentaenoicacid (20:511~-fDHA. d6cosahex8elnoic aCid-(20:6n-3);--" dose afthe begfnrung ofthedietar)i-perlod; b--dose at theend ofthedietiiry period; lIS, isocaloric or supplementary 
administration offish oil; %Iesions stands for the percentage of the surface of the vessel that is covered with intimal lesions; LE, luminal enchroachment; PL, phospholipids; FC, free cholesterol; CE, 
esterified cholesterol; TC, total cholesterol; T9, triglycerides. Adapted from Sassen et al6 (with permission from Cardiovascular Drugs and Therapy). 
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Fig 6. P.roposed scheme for definite and possible mechanisms of n-3 fatty acids on atherogenesis. 
fatty acid (PIS ratio). The dietary vitamin E regime was chosen such that the levels of vitamin 
E in the various lipoproteins did not depend on the type of fatty acid or the PIS ratio in the diet. 
This experimental strategy is different from what we and others have used before and is to 
exclude the possibility that the effects of dietary n-3 fatty acids could, at least in part, be ascribed 
to a changed oxidant status of the animal. Vegetable oils rich in n-6 fatty acids are also reported 
to protect against ischemic heart disease probably due to a beneficial effect on plasma levels of 
lipoproteins and cholesterol. Replacing a part of the lard fat with the sunflower oil increased the 
PIS ratio from 0.49 to 1.50, but with fish oil as substitute for lard fat to only 0.S3. Nevertheless, 
only the group fed with fish oil showed a favorable effect on the fatty lesions in the aorta (total 
plasma cholesterol was not affected by the diets, Figure 5). Compared to both sunflower oil and 
lard, fat fish oil did not only reduce the number of animals in which lesions were observed, but 
also reduced the total cholesterol content in these lesions. It is therefore Illost likely that the 
prevention of cholesterol accumulation by fish oil is caused by a direct effect of n-3 fatty acids 
rather than by a higher PIS ratio. The direct effect of n-3 fatty acids on total cholesterol 
accumulation in the vessel wall may be attributed to the reduction in the VLDL-cholesterol level 
and cholesteryl ester-rich VLDL by n-3 fatty acids. Our other objective was to study the 
influence of the three diets 011 the progression of intimal thickening in saphenous vena-arterial 
grafts. In these grafts atherosclerosis develops in an accelerated fashion similar to that in abraded 
164 
vessels Of vessels with a constrictor. It is thus quite feasible that fish oil also protects these vein-
grafts against atherosclerosis. OUf preliminary results showed lower occlusion rates in the fish 
oil treated group during the first 6 weeks after placement of the saphenous grafts in the carotid 
arteries. However, lipid accumulation in the graft was not affected in contrast to the spontaneous 
lipid accumulation in the abdominal aorta. This finding suggests that an intact endothelial layer 
andlor function may affect the effects of fish oil on the progression of atherosclerosis. 
Summary and conclusions 
We conclude from our studies that the presence of an intact endothelial layer, 
hypercholesterolemia and the history of the lesions deteruline the ultimate effect of n-3 fatty acid 
supplementation to the diet on the development and regression of atherosclerosis. However one 
should realize, that in these studies other potentially atherogenic influences such as hypertension, 
diabetes, aging and smoking were not taken into account. Because these parameters affect 
endothelial and platelet function it is feasible that they can also modify the effect of n-3 fatty 
acids. Therefore, while in animal models with experimentally-induced atherosclerosis n-3 fatty 
acids are effective in preventing the formation of new lesions and in slowing the progression of 
established lesions, this does not necessarily imply that the same effects will be obtained in man, 
in which all other riskfactors may be present. 
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The Effects of Dietary Fish Oil on Progression of Atherosclerosis 
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The Effects of Dietary Fish Oil on Progression of Atherosclerosis 
in Vein Grafts and Aorta in Hypercholesterolemic Swine: 
A Comparison with Sunflower Oil and Lard Fat 
L.K. Soei, J.R van Meegen, H.M.M. van Beusekom, D.R.W. Dekkers, L.M. Scheek, 
lMJ. Lamers, A. van Tol, P.D. Verdouw 
Background. The accelerated form of atherosclerosis Is responsible for late failures in vein graft 
patency and represents a major problem in coronary bypass surgery. In earlier studies with 
hypercholesterolemIc dogs dietary fish oil has been shown to effectively reduce intimal thickness in vein 
grafts. In the present study Is Investigated whether the effect of dietary fish oil is based on a direct effect 
ofn-3 fatty acids or an increase in polyunsaturated/saturated fatty acid ratio. Therefore, a comparison was 
made between the effects of fish oil, sunflower oil or lard fat on atherosclerosis In vein grafts. The effects 
afthe different fatty acids on atherosclerosis in a control vein, left circumflex coronary artery (LCXCA) and 
abdominal aorta were also investigated. 
Methods and Results. Thirty-two pigs were fed a 2% cholesterol diet, which also contained by 
weight either 4.5% fish oil and 4.5% lard fat (FO, n=8), 4.5% sunflower oil and 4.5% lard fat (SO, n=9) or 
9% lard fat (LF, n=11), for 8 weeks. After 2 weeks the animals received saphenous vein bypass grafts of 
both carotid arteries. A separate group of 4 animals were fed a normocholesterolemic diet to evaluate 
development of atherosclerosis in the abdominal aorta and changes in blood lipids. No beneficial effect of 
FO Versus the SO and LF groups was observed in de grafts as assessed by luminal encroachment, intimal 
thickness and measurement ofNpid accumulation. Similarly, no differences in the control vein and LCXCA 
were observed between the 3 hypercholesterolemic diets using the same parameters. In the abdominal 
aorta of the nonnocholesterolemic animals raised lesions developed spontaneously, which contained more 
cholesterolester than a macroscopically normal portion of abdominal aorta. Hypercholesterolemia 
increased the cholesterolester content of these lesions, but the cholesterolester content in the Fa group 
was significantly less than in the SO and LF groups. The aortic lesions in SO and LF also contained more 
unesterified cholesterol than in the nonnocholesteroiemic group. Mean plasma cholesterol Increased from 
2.8±O.1 mM to 14.5±0.1 mM (for ail diet groups), prior to and at the end of the experimental protocol. 
Increased cholesterol concentrations were found in all lipoprotein density fractions. Fa reduced VLDL, IDL 
and HDL cholesterol compared with SO. Compared to LF only VLDL cholesterol was reduced by FO. 
Plasma LDL cholesterol were identical for the 3 hypercholesterolemic groups. Furthermore, the chemical 
composition of the VLDL particles in the Fa were altered. These particles contained relatively less 
cholesterolester and more triglycerides than SO and LF groups. Regression analysis indicated that VLDL 
cholesterol was related to the total cholesterol and cholesterolester contents ofthe aortic lesions (r=0.77, 
p<O.001). 
Conclusion. These data suggest that dietary fish oil can inhibit the effects of hypercholesterolemia 
on progression of atherosclerosis and that VLDL cholesterolester may play an key role in this process. 
Furthermore, the anti-atherosclerotic effect offish oil can be attributed to a direct effect of n-3 fatty acids 
and not to an increase In polyunsaturated/saturated fatty acid ratio. 
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Despite the development of interventional cardiology and new phannacological agents, coronary 
artery bypass grafting (CAB G) still takes a prominent place in the treatment of ischemic heart 
disease. The advantage of CABG is that in bypassing the original stenosis one achieves complete 
revascularisation independent of the severity of the primary, However, attrition rate of the grafts 
and thus recurrence of clinical symptoms are rather high. With the saphenous vein a conduit 12% 
of the grafts occlude during the first month and this has increased to 22% at the end of the first 
year. In the following years occlusion rates rise to 35% and to more than 50% at 5 and 10 years 
post operatively.l The internal mammary artery as bypass conduit suffers less from late failures, 
but the two internal manlmary arteries provide insufficient material for multiple bypass grafting. 
Thus despite inferior longterm patency rates the saphenous vein is still the most often used 
conduit for CABG. 1,'3 
During the first month of the postoperative period acute thrombosis occurs in 10% of the 
grafts,2 which is likely secondary to endothelial damage of the vein graft during surgery. The 
medial layer is also damaged during surgery and the associated inflammatory response may 
trigger the fibrointimal hyperplasia, the principal cause for late luminal narrowing, Beyond the 
first year fibrointimal hyperplasia remains the predominant pathology in the grafts, but these 
abnonnalities may develop into mature lipid-laden atherosclerotic plaques in the years thereafter. 
However, total occlusion leading to death is usually not caused by either fibrointimal hyperplasia 
or atherosclerosis, but by a superimposed thrombotic event. Thus the rational treatment of vein 
graft occlusion should focus on attenuation of progression of atherosclerosis and thrombosis. 
Consumption of fish has in epidemiological studies been associated with a reduction in 
cardiovascular disease.4,5 The exact mechanisms are still unknown, but the favorable effect of 
fish oil on the atherosclerotic process could result from alterations in plasma lipoproteins, 
platelet and endothelial function and inflammatory response. 4,5 These alterations may reduce 
thrombosis and, because thrombosis is not only related to early, but also to late vein graft failure, 
makes fish oil an attractive candidate for reducing vein graft occlusion. The anti-inflammatory 
effect of dietary fish oil may reduce neutrophil and monocyte adhesion and chemotaxis to the 
graft and lead to a reduction in lipid accumulation and the release of growth factors, Earlier 
studies have shown that fish oil can inhibit vein graft intimal thickening in hypercholesterolemic 
dogs,~' To elucidate whether this effect is due to the n-3 fatty acids present in fish oil or to an 
increase of the polyunsaturated/saturated fatty acid ratio, in the present study we investigated the 
effects of dietary fish oil in a hypercholesterolemic swine model of arterialized saphenous vein 
grafts and compared them to those obtained with dietary sunflower oil and lard fat. We also 
studied the effects of the different fatty acids on atherosclerotic lesions in the abdominal aorta. 
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Table 1. Composition of the atherosclerotic base diet before addition of 4.5% 9 (w/w) of either 
fish oil, sunflower oil or lard fat. 
Content (g%) 
FO SO LF 
Ingredients 
Corn (extruded) 32 32 32 
Wheat (extruded) 18 18 18 
Soybean meal 14 14 14 
Wheat middlings 9 9 9 
Dehydrated skimmed milk powder 14 14 14 
CaHP04.2H2O 1.3 1.3 1.3 
CaCOO, 1.1 l.l I.l 
NaCI, iodinized 0.3 0.3 0.3 
MgO 0.05 0.05 0.05 
MgSO, 0.05 0.05 0.05 
KH2P04 0.36 0.36 0.36 
Choline chlonde 50% (wlw) 0.18 0.18 0.18 
Vitamin and trace element mlxesa 0.7 0.7 0.7 
Lard fat 4.5 4.5 9 
Fish oil 4.5 
Sunflower all 4.5 
Cholesterol 2.0 2.0 2.0 
FO fish oil diet; SO sunflower oil diet; LF lard fat diet. 'Vitamin and trace element mixes supply the following per 100 
g diet: retinol 1400 IU; cholecalcifero1140 IU; cc-tocophero18 mg; menadione 0.2 mg; thiamine hydrochloride 1.8 mg; 
riboflavin 1.8 mg; pyridoxine RellA mg; niacin 3,6 mg; vitamin C coated 20 mg; calcium D-pantothenate 3.6 mg; 
folic acid 0.4 mg; cyanocobalamin 0.004 mg; biotin 0.1 mg; inositol 4.5 mg; iron subcarbonate (57% Fe) 9.1 mg; 
FeS04.H20(30% Fe) I4mg; Cu2(OHhCOJ (55% Cu) 2.3 mg; ZnO (78% Zn) II mg; MnO (62% Mn) 9.1 mg; 
Na2ScJ5Hp (45% Se) 0.08 mg; Ca(IOJ)l (65% J) 0.2 mg; CoCOl (47% Co) 0.09 mg. "Cholesterol content was not 
detennined in the nonnocholesterolcmic diet. The composition is on an as fed basis. 
LF ! 2% cholesterol + 9% lard Fal 
FO 12% cholesterol + 4.5% Lard Fat + 4.5% Fish 011_ 
Protocol: 
I 
1 
atert 
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I 
o 
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Fig 1. Schematic presentation of the three 
dietary groups achieved by replacing 4.5% 
(w/w) of lard fat with either 4.5% (w/w) of 
sunflower oil or 4.5% (w/w) of fish oil. 
Hypercholesterolemic diets were 
administered for 8 weeks, while saphenous 
veno-arterial bypass graftfng took place 2 
weeks after the onset of the experimental 
protocol. LF, lard fat group; SO, sunflower 
oil group; FO, fish oil group. 
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Materials and Methods 
Animal care 
All experiments were performed in accordance witjI the guiding principles in the care and 
use of animals as approved by the Council of the American Physiological Society and under the 
regulations of the Animal Care Committee of the Erasmus University Rotterdam, Rotterdam, 
the Netherlands. 
Experimelltal groups alld protocol 
Gottingen mini-pigs (n~29, both female and castrated male), entered the study weighing 
between 18-20 kg and were allocated randomly to 3 groups (Fig. I); a fish oil group (Fa, n~8), 
a sunflower oil group (SO, n~9) and a lard fat group (LF, n~ II). To obtain the 3 diet groups the 
animals were fed a low fat «2%, w/w) base diet (Hope Farms BV, Woerden, The Netherlands), 
which contained 2% (w/w) cholesterol and either 4.5% (w/w) fish oil and 4.5% (w/w) lard fat 
(Fa) or 4.5% (w/w) sunflower oil and 4.5% (w/w) lard fat (SO) or 9% (w/w) lard fat (LF; Table 
I, Figure I). The fatty acid profile (Table 2) of the dietary fish oil, sunflower oil and lard fat 
Table 2. Fatty acid compositions of the fish oil, sunflower oil and lard fat added to the 
atherogenic diet, containing 2% (w/w) cholesterol and 4.5% (w/w) lard fat. 
Fish Oil 
(mol %) 
Fatty Acid 
16:0 19.7 
16:1",7 8.5 
18:0 3.7 
18:1",9 10.2 
18:1",7 4.5 
18:2",6 1.7 
18:3",3 1.1 
20:5",3 19.9 
22:6",3 10.6 
others 2.1 
PUFNSFA ratio 1.42 
PUFA=polyunsaturated fatty acids; SFA=saturated fatty acids. 
Sunflower 011 
(mol %) 
6.7 
0.1 
3.9 
20.2 
0.8 
66.6 
1.7 
6.28 
Lard Fat 
(mol %) 
27.1 
2.2 
15.0 
36.8 
2.9 
10.8 
1.0 
4.2 
0.29 
resulted ultimately in a polysaturated/saturated fatty acid ratio of 0.49 for the lard fat diet, 1.50 
for the sunflower oil diet and 0.83 for the fish oil diet. To compensate for the increased 
polyunsaturated/saturated fatty acid ratio in the diets different amounts of vitamin E (u-
tocopherol) were added to the different diets. The u-, (p+y)- and 3-tocopherol content of the 
fat/oils listed in Table 2 was detemlined by HPLC analysis and subsequent correction for relative 
biological activities of the different tocopherol components, yielded 0, 706 and 352 mg/kg 
u-tocopherol equivalents for lard fat, sunflower oil and fish oil, respectively. On basis of the 
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relative content of the polyunsaturated fatty acids with varying number of double bonds the 
minimally required .. -tocopherol content was calculated to be 113, S9S and 860 mg/kg fat/oil. 
Because in the sunflower oil there was a 20% excess a-tocopherol, in the final calculation for 
matching the .. -tocopherol contents a 20% excess was also provided for the lard fat and fish oil. 
This meant that we added 18.4,9.2 and 4S.9 mg .. -tocopherol/kg in to the complete LF, SO and 
FO diets, respectively. It should also be noted that 80 mg/kg .. -tocopherol was already present 
in the base diet (Table I). 
The experimental protocol lasted for 8 weeks, during which the animals received SOO g of 
forage per day. Before the animals were placed on their diet blood was drawn from the jugular 
vein for determination of total plasma cholesterol. After 2 weeks of diet, the animals received 
an autologous venous bypass graft in both carotid arteries and again blood samples were drawn 
to monitor plasma cholesterol levels. At the end of the 8-week protocol the animals were 
anestlletized with ketamine (700 mg) and sodium pentobarbital (IO-IS mg/kglhour), intubated 
and connected to a respirator. After blood samples were collected the grafts were dissected free 
and patency was evaluated by pulsation of the distal carotid artery or by blood flow through the 
graft. The left graft was penusion fixed ill situ with a pressure of 100 em H20 with 10% 
phosphate buffered formaline and stored until histological processing. The remaining saphenous 
vein from the right hindleg was taken as a negative control for the amount of intimal thickening. 
Mter the anhnals were killed with an overdose of sodium pentobarbital the left circumflex 
coronary artery and the aorta were harvested and used to assess the effect of the diets on 
development of atherosclerosis in normal vessels. 
An additional group of 4 animals received a normocholesterolemic diet (N: Barley, JSg%; 
Rape seed extracted, Sg%; Tapioca, 30g%; Wheat, 12.6g%; Soybean toasted, 2.0g%; Soybean 
meal, 20.Sg%; Meat meal, 3.9g%; Anhnal fat, 1.9g%; Molasses, 2.7g%; Wheat middlings, 
4.2g%; CaHPO,.2H,o, 0.42g%;CaC03, 0.2Sg%; NaCI,iodinized, 0.3Sg%; Vitamin and trace 
element mixes, 1.00g% [see table I]) for 8 weeks to evaluate the spontaneous development of 
atherosclerosis in the aorta (Table I). Blood samples were taken from these animals, but they 
did not receive an autologous saphenous vein transplant. 
lnte/position of the saphenolls vein into the carotid arteries 
After overnight fasting the pigs were anesthetized with SOO mg of ketamine, intubated and 
connected to a respirator for ventilation with a mixture oxygen and nitrous oxide (1 :2) and 2% 
of ethrane. The saphenous vein was extracted from the left hindleg over a length of 
approximately 8 cm (in situ) and carefully flushed with a saline solution containing 2% 
papaverine, split in half and preserved in the flush solution before implantation. Care was taken 
not to distend the vein graft to minhnize endothelial danlage. At the same time both carotid 
arteries were dissected free from their surroundings. After injection of 5,000 IV of heparin one 
carotid artery was clamped and a piece of the artery (approximately 3cm) removed. One half of 
the saphenous vein was interposed using end-to-end anastomoses. After this procedure was also 
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performed on the other artery, the animals were allowed to recover from surgery. 
Plasma lipids 
At the onset of the study and after 2 weeks blood samples were drawn from the subclavian 
vein for measuring total plasma cholesterol. After 8 weeks the blood samples were drawn from 
the superior caval vein and total cholesterol, free cholesterol and trigiycerides, which were 
assayed enzymatically using kits (GHOD-PAP and GPO-PAP) from Boehringer GmbH, 
Mannheim, Germany. Phospholipids were assayed using the kit (PAP 150) from BioMerieux, 
Charbonnieres, Les Bains, France. 
For the male population (Fa, SO and LF, n~6; N, n~4) plasma lipoproteillB were separated 
by dellBity-gradientultracentrifhgation into 4 fractions (VLDL, IDL, LDL and HDL)(9) The lipid 
composition was detennined in each fraction using the same kits. Protein content of the different 
fractions was measured according to the method of Lowry et al. 10 The fatty acid composition 
(in mol%) of the phospholipids and cholesterolesters, extracted from the total plasma lipids, was 
detennined by transmethylation with BF, in methanol and gaschromatography (CP-Sil 88 coated 
fised silicon capillary column from Chrompack, Middelburg, The Netherlands) as previously 
described. H,12 
Intimal thickening oflhe venous bypass grafts, saphenous vein and corollmy ar/elY 
The graft, the saphenous vein and the left circumflex coronary artery were imbedded in 
paraffrne and transverse sections were made every 1 mm. The sections were routinely stained 
with haematoxylin-eosine (HE) and elastic von Gieson (EvG). The elastic stained slides were 
used to determine intimal thickening with a computer-assisted morphometric analysis system 
(Sigmascan/Image, Jandel Scientific GmbH, Erkrath, Germany). The area between the 
endothelial lining of the lumen and the internal elastic lamina (IEL) was taken as the intima area. 
The encroachment was defined as the ratio (x 100%) of the intima area and the corrected area 
within the IEL. The corrected area within the IEL was calculated from the perimeter of the IEL 
assuming that the IEL was a perfect circle. Mean intimal thickness was defined as the difference 
between the radius of the lumen and the radius of the IEL. Both radii were calculated from their 
respective perimeters. The lumen area was also calculated from the perimeter of the lumen. The 
media area was taken as the difference between the areas circumscribed by the internal and 
external elastic laminae. 
Lipid infiltration a/venous bypass graft. saphenous vein and aortic wall 
Chemical analysis of the vessel wall 
The graft in the right carotid artery and a part of the right saphenous vein were dissected 
free and frozen in liquid nitrogen before storage at -80°C. For determining the effect of the 
lipid-enriched diets on lipid accumulation in spontaneous atherosclerosis the aorta was dissected 
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free and a longitudinal incision was made on the ventral side of the aorta. Inspection of the aorta 
showed the presence of macroscopic elevations (fatty streaks) in the abdominal aorta distal to 
the renal arteries (labelled lesions). In the absence of macroscopic elevations a representative 
biopsy was taken randomly from the infrarenal abdominal aorta. Samples from the suprarenal 
abdominal aorta served as control (non-lesions, Fig. 2). Samples of aortic lesions and non-lesions 
were dissected free of adventitia and directly frozen in liquid nitrogen and stored at - 80'C until 
analysis using the method of Bligh and Dyer for lipid extraction." Briefly, tissue samples were 
homogenized in a Braun microdismembrator and the obtained powder was extracted with 
chloroform/methanollsaline (4:10:5, v/v/v). After centrifugation at 1500 g_ for 5 min and 
washing the pellet by rehomogenization in 1.9 mI of the same solvent, the two supernatants were 
combined and mixed with 1.5 ml chloroform and 1.5 ml saline. After vigorous vortexing and 
subsequent phase separation, the upper phase and the intermediate solid material were discarded. 
Subsequently the mixture was dried under nitrogen at 37"C and the residue dissolved in 0.2 ml 
2-propranoL Cholesterol and cholesterolester, triglyceride and phospholipid contents were 
measured with enzymatic kits (see before). In the delipidized extracts protein and DNA contents 
were measured.14 
Statistical allalysis 
All data are presented as mean ± standard error of the mean (SEM). The data were analyzed 
statistically using a one-way analysis of variance followed when appropriate by either the 
Student-Newman-Keuls procedure for multiple comparisons of mean values or by the Kruskall-
Wallis test on ranks. Statistical significance was accepted at P<.05. Correlations were 
Coronary_,'Vy:::, 
Alien'es 
Diaphragm~ 
Renal Meries_ 
Aortic Arch 
\'Clesc,enciing Aorta 
Lesion Area 
Fig 2. A schematic presentation of the 
location aftha elevated patches on the luminal 
surface of the abdominal aorta ([eslon area) 
and the macroscopically normal abdominal 
aorta (non-lesion area). 
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determined with the Spearman rank order correlation analysis. 
Results 
Patency of the grafts 
Graft patency showed a marked difference between the groups. In the lard fat group 32% 
of the grafts were occluded, whereas in the sunflower and in the fish oil groups the percentages 
were 0% and 6%, respectively (both P<.05 vs lard fat group). Histological analysis showed not 
only that all occlusions were caused by early thrombosis of the graft, but also that, in some 
patent grafts, remnants of mural thrombi were present (results not shown). In 6 of the II grafts 
belonging to the lard fat group thrombosis was found, 4 of these grafts were not patent. 
Thrombosis was also found in 2 grafts in each of the other 2 diet groups, but these were all 
patent. 
Fibrointimal hypeJplasia 
Fibrointimal hyperplasia in the vein grafts was assessed by determining luminal 
encroachment and intimal thickness (Table 3). No statistical difference was observed between 
the 3 diet groups even after exclusion of the thrombosed grafts. There were also no differences 
between the intima area or intimal thickness of the grafts of the different diet groups. Therefore, 
the tendency of a lower luminal encroachment in the fish oil treated group was more probably 
a refection of the larger lumen area and diameter in this group than of inhibition of fibrointimal 
hyperplasia. 
Intimal hyperplasia was non-existent in the control vein (Table 4). To assess the effect of 
Table 3. The effects of fish oil, sunflower oil and lard fat on luminal encroachment and size of 
the saphenous vein graft. 
Luminal Intimal Area 
encroachment Thickness LUmen Intima Media 
(%) (mm) (mm2J (mm2J (mm2J 
Fish oil· (n=8) 41 .11 11.2'3.2 3.5. 0.6 2.7' 0.6 
Sunflower oil* (n=9) 44.7 7.8 ± 2.5 4.7.1.3 2.8 ± 0.2 
Lard fat' (n=11) 56±9 4.4±1.5 2.5 ± 0.5 1.4 ± 0.2 
Without thrombosis: 
Fish ont (n=6) 26±7 0.24 ± 0.06 14.6 ± 3.1 3.4.0.7 3.2 ± 0.6 
Sunflower oW (n=7) 39 ±6 0.35 ±0.04 8.7 ± 3.1 3.2. 0.2 2.9 ± 0.3 
Lard fatt (n=5) 29.5 0.26 ± 0.06 8.7. 2.0 2.7 ± 0.7 2.0.0.3 
• Data are for all the grafts including the grafts occluded by thrombosis. t Data are for a subset of the grafts 
in which histological analysis revealed no signs of thrombosis. Values are mean±SEM. 
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the hypercholesterolemic diet and the different fatty acids on spontaneous atherosclerosis in the 
arterial vascular bed morphometry was also performed on the left circumflex coronary artery. 
In this last vessel slight inthnal hyperplasia could be observed, but average luminal 
encroachment did not exceed 3.3±1.2% in any of the diet groups (Table 4). 
Table 4. The effects of fish oil, sunflower oil and lard fat on luminal encroachment and size of 
the control vein and left circumflex coronary artery. 
Area 
Lumlnal encroachment Lumen Intima Media 
(%) (mm"') (mm2) (mm'l) 
Vein 
Fish oil (n=8) 0 0.62.0.07 0 0.86' 0.07 
Sunflower oil (n=9) 0 0.44. 0.09 0 0.89' 0.06 
Lard fat (n=11) 0 0.51 .0.08 0 1.00' 0.09 
Left circumflex coronary artery: 
Fish oil (n=8) 2.4'1.6 0.96. 0.10 0.02' 0.01 0.81 • 0.07 
Sunflower oil (n=9) 3.3' 1.2 0.87. 0.14 0.03. 0.01 0.71 • 0.04 
Lard fat (n=11) 3.2' 1.6 0.69. 0.15 0.04.0.02 0.52.0.10 
Values are mean±SEM. 
Lipid accumulation in the vein graft and the control vein 
The effect of hypercholesterolemia and the different dietary fatty acids on the content of 
cholesterol, cholesterylesters, phospholipids and triglycerides in the graft and control vein are 
shown in Table 5. Grafting the saphenous vein into the arterial system produced an increase in 
cholesterolester content in all groups, but there was no difference between the groups in either 
the control vein or the graft. The triglyceride and phospholipid contents of the graft was 
unaffected by arterialisation in the sunflower oil and lard fat treated groups, but phospholipids 
in the fish oil treated group had increased (P<.05). The vein was unaffected by the 3 
hypercholesterolemic diets. These results did not change when the lipid contents were expressed 
per g protein or per g DNA instead of per g wet weight. 
Lipid acculJIulation in the aorta 
Lipid accumulation was macroscopically observed as elevated patches on the luminal aspect 
of the abdominal aorta. All lesions were found between the renal arteries and the aortic 
bifurcation, but they were not detected in all anhnals. In the lard fat group they occurred in 8 of 
the 11 animals and in the sunflower oil group in 7 of the 9 animals, while in the fish oil group 
only 3 out of the 8 animals had these lesions (P>.05). In the normocholesterolemic group 3 out 
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Table 5. The effects of dietary fish oil, sunflower oil and lard fat on lipid accumulation 
(fJmoUgwetwdghl) in the control vein and the vein graft. 
Cholesterol Cho!esterolester Cholesterol + Phospholipids Triglycerides 
Cholesterolester 
Vein: 
Fish 011 (n=8) 4.69 ± 0.44 1.62 ± 0.45 6.31 ± 0.73 3.96 ± 0.37 3.41 ± 0.63 
Sunflower oil (n=9) 5.01 ± 0.26 1.86 ± 0.24 6.88 ± 0.41 4.40 ± 0.22 3.62 ± 0.57 
Lard fat (n=11) 5.22 ± 0.38 2.25 ± 0.34 7.47 ± 0.62 4.60 ± 0.26 8.23 ± 1.78 
Vein graft: 
Fish oil (n=8) 6.35 ± 0.51 3.26 ± 0.86' 9.61 ± 1.21 5.58 ± 0.24' 5.72 ± 1.93 
Sunflower oil (n=9) 6.55 ± 0.55 4.83 ± 0.98' 11.38 ± 1.45 5.05 ± 0.38 3.45 ± 0.88 
Lard fat (n=11) 5.72 ± 0.28 3.40 ± 0.58' 9.13 ± 0.78 4.73 ± 0.22 4.56±1.71 
Values are mean±SEM, *P<.05 vein graft versus control vein in the same diet group. 
of the 4 animals presented themselves with these lesions. The occurrence of these lesions thus 
appeared to be independent of the cholesterol or the fatty acid content of the diets. 
In the non-lesion areas no difference was obselVed in total cholesterol, phospholipid and 
triglycerides content of the aortic wall between the 4 groups (Fig. 3). Cholesterol and 
cholesterolester levels of the lesion areas had increased compared to the non-lesion areas in all 
4 groups. However, whereas the fish oil group showed no significant differences compared to 
the diet with nomlal cholesterol, the cholesterol and cholesterolester contents of the lesions were 
significantly higher in both the sunflower oil and lard fat groups than in the 
normocholesterolemic and the fish oil diet. The phospholipid and triglyceride contents were 
unaffected by the diets (Fig. 3). These results did not change when the lipid contents were 
expressed per g protein or per g DNA instead of per g wet weight. 
Fatty acid composition 
Fatty acid composition of the cholesterolester and phospholipids in plasma qualitatively 
reflected the differences in fatty acid composition of the fish oil, sunflower oil or lard fat added 
to the base diet (Table 2). Addition of sunflower oil to the hypercholesterolemic diet caused the 
relative content of the totaln-6 fatty acid pool of serum cholesterolester and phospholipids to 
increase at the expense of saturated and monounsaturated fatty acids. Addition of fish oil caused 
a relative increase in tlle total n-3 fatty acids, which only in tlle phospholipids was at the expense 
ofn-6 fatty acids. In the grafts cholesterolester and phospolipids contained relatively more n-3 
and n-6 polyunsaturated fatty acids (pUPA) in the fish oil and the sunflower oil groups, 
respectively. Generally, the incorporation of n-3 PUPA was at the expense of n-6 PUPA. 
Surprisingly, dietary sunflower oil had no effect on the relative n-6 PUP A of the phospholipid 
fraction of the aortic lesion, but clearly increased the relative n-6 PUP A content of the 
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Choiesterolesler 
PhospholipIds Tr[glycerldes 
Fig 3. Bar graph showing the free cholesterol, esterified cholesterol, phospholipids and triglycerides content of 
the lesion and non~!esion areas of the abdominal aorta. O=Normocholesterolemlc group, n=4; sunflower group, 
n=9; lard fat group, n=11; fish oil, n=8. Values are mean±SEM. "P<.05 vs the normotipidemlc group. A P<.05 
vs the fish oil group .• P<.05 lesion area Vs non-lesion area within a dietary group. 
phospholipids in the graft. 
Plasma lipids 
During high cholesterol feeding total plasma cholesterol increased more than 4-fold from 
2.8±0.1 mmolfL at baseline to 14.S±O.1 mmolfL (P<.OS, all animals combined). At the end of 
the dietary period there was no difference in total plasma cholesterol level in the 3 
hypercholesterolemic groups, but the rate of increase in total plasm.a cholesterol was attenuated 
by fish oil as at 2 weeks the total plasma cholesterol level in the fish oil group was significantly 
lower than in the sunflower oil and lard fat group (Fig. 4). 
With the nomlocholesterolemic diet, total plasma cholesterol was about equally distributed 
in the HDL and LDL lipoprotein fractions and little cholesterol was present in VLDL and IDL 
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Table 6. The effects of dietary fish oil, sunflower oil and lard fat on the polyunsaturated fatly acid 
composition (mol%) of the total lipid fraction of serum, vein grafts and aortic lesions. 
Fish Oil Sunflower Oil Lard Fat 
CE PL CE PL CE PL 
Serum: 
SFA+ MUFA 57 ± 1 60 ± 1 52±2 57 ± 1 66 ± 1 64 ± 1 
n·6 PUFA 33 ± 1 19 ± 1 48 ±2 40 ± 1 34 ± 1 31 ± 1 
n·3 PUFA 11 ± 1 21 ± 1 0±1 3±1 0±1 5±1 
Vein graft: 
SFA+ MUFA 71 ± 1 67 ± 1 64 ± 1 63 ± 1 78 ± 1 72±2 
n·6 PUFA 19 ± 1 22 ± 1 34 ± 1 35 ± 1 20 ± 1 25±2 
n·3 PUFA 10 ± 1 11 ± 1 2±1 2±1 2±1 3±1 
Aortic lesions: 
SFA+MUFA NO' NO' 72±2 67 ± 1 82 ± 3 68±2 
n·6 PUFA NO NO 26±2 31 ± 1 17 ± 3 30 ± 2 
n·3 PUFA NO NO 1 ± 1 2±1 1 ± 1 3±1 
Fish oil, n=3; sunflower oil, n=3; lard fat, n=4; CE=cholesterolesters; PL=Phospholipids; 
SFA=saturated fatty acids; MUFA=monounsaturated fatty acids; PUFA=polyunsaturated fatty acids. 
ND=not detemined. * No accurate determination of fatty acids could be made of the cholesterolester In 
aortic lesions due to the low quantity. Values are mean ± SEM. 
(Fig. 5). Feeding a 2% cholesterol diet markedly increased LDL cholesterol in all diet groups. 
In the fish oil group only LDL cholesterol increased significantly while in the sunflower and lard 
fat groups, in addition to LDL cholesterol, also VLDL and IDL cholesterol levels increased 
(P<.05 vs the normolipidemic animals). Only in the sunflower oil group there was an increase 
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Fig 4. Plasma content of total cholesterol at the start of the experimental protocol (week 0), at the time of 
saphenous vena-arterial bypass grafting (week 2) and at the end of the experimental protocol (week 8) for the 
3 high cholesterol diets groups and the normolipidemlc diet group. Lard fat, n=11; sunflower oil, n=9; fish oil, 
n=8; normolipidemic, n=4. Values are mean±SEM. * P<.05 vs normolipidemic group .• P<.05 vs lard fat .• 
P<.05 vs sunflower oil group .• P<.05 vs fish oil group. 
182 
Lard fat Sunflower oil 
* • • I j 
~ ~ 
~ ~ 
• • E E 
E E 
Fish oil Normolipldemlc 
* 
I I i 
g E + ~ 
• • + • • • E • • • + + 
• • 
Fig 5, Bar graphs showing the distribution of plasma cholesterol between the different lipoprotein fractions of 
the male population (Fish oil, sunflower oil and lard fat groups, 0=6; normocholesterolemic group, n=4). VLDL, 
very low density lipoproteins; JOL, intermediate density lipoproteins; LOL, low density lipoproteins; HOL, high 
density lipoproteins. Values are mean±SEM. ~ P<.05 vs normolipldemlc group .• P<.05 vs lard fat. • P<.05 vs 
sunflower oil group .• P<.05 vs fish oil group. 
in HDL cholesterol. VLDL cholesterol was higher in the lard fat group than in the fish oil group. 
All lipoprotein fractions had, except for LDL, an increased cholesterol level in the sunflower 
group compared to the fish oil group (Fig. 5). 
The chemical composition of the LDL and HDL particles was not altered by the high 
cholesterol diet or the different fatty acids in the hypercholesterolemic diet. The chemical 
composition of the IDL fraction in the 3 hypercholesterolemic diets did not differ. However, the 
VLDL fraction in the sunflower and lard fat groups showed a marked reduction in triglyceride 
content in favor of the cholesterol and cholesterol ester contents. This reduction in VLDL 
triglyceride content was much less in the fish oil group and did not reach statistical significance 
when compared with the normocholesterolemic animals (Fig. 6). 
Table 7. Correlations between the total cholesterol content of the different lipoprotein fractions 
and the total cholesterol, free cholesterol and cholesterolester content of the aortic lesions. 
AoTC AoFC AoCE 
Total cholesterol p p P 
VLDL 0.77 <0.001 0.77 <0.001 0.72 <0.001 
IDL 0.62 0.002 0.64 0.001 0.62 0.002 
LDL 0.21 0.342 0.24 0.278 0.28 0.210 
HDL 0.65 <0.001 0.66 <0.001 0.68 <0.001 
AoTC total cholesterol content of the aortic lesion area; AoFC free cholesterol content of the aortic lesion 
area; AoCE=cholesterolester content of the lesion area; VLDL=very low density lipoprotein; tDL=fntermediate 
density lipoprotein; LDL=low density lipoprotein; HDL=high density lipoprotein. 
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Fig 6. Pies showing the effects of 
dietary fish oil, lard fat and sunflower 
oil on the triglycerides, phopholipJds, 
cholesterol and protein content of the 
VlDL fraction of the male population 
(Fish oil, sunflower oil and lard fat 
groups, n=6; normocho!esterolemlc 
group, n=4). The VLOL fraction of the 
normolipidemic group contained more 
triglycerides and less cholesterol than 
the VLOL fracllon of the sunflower oil 
and lard fat groups (P<.05), while no 
difference was observed with the 
VLDL fraction of the fish oil group. 
However, there were also no 
difference In the phosphoJipd and 
protein composition of the VLOL 
fraction between the 3 
hypercholesterolemIc diet groups. 
VLDL, very low density lipoproteins. 
Correlations hetween plasma lipids cOld lipid accumulation 
Plasma VLDL cholesterol concentration correlated with the cholesterol content of the lesion 
area in the abdominal aorta (all animals combined, .=0.77, p<O.OOI, Table 7). HDL cholesterol 
levels was also correlated to the cholesterol content of the lesion area (.=0.65, p<O.OOI), but 
stepwise regression analysis showed that HDL did not decrease the variability, indicating that 
VLDL and HDL were dependent variables. LDL cholesterol concentration did not correlate with 
the cholesterol content of the aortic wall. Furthennore, the cholesterol content of the aortic lesion 
area showed a positive correlation with the cholesterolester content ofVLDL (.=0.75, p<O.OOI). 
Because VLDL cholesterol ester content showed a strong negative correlation with VLDL 
triglyceride content (.=-0.98, p<O.OOI), a significant negative correlation was found between 
VLDL triglyceride content and cholesterol content of the aortic lesion area (.=-0.72, p<O.OOI). 
No correlations were found between the cholesterol content of the control vein or vein graft and 
the cholesterol concentration in the different lipoprotein fractions. 
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Discussion 
In the present study we observed that, while dietary fish oil (FO) and sunflower oil (SO) 
produced less thrombotic occlusions thau lard fat (LF), there was no favorable effect of dietary 
fish oil on vein graft atherosclerosis as assessed with luminal encroachment, intimal thickness 
and the accumulation of total cholesterol, compared with sunflower oil aud lard fat. However, 
the accumulation of total cholesterol in aortic lesions was markedly decreased by n-3 fatty acid 
intake. Furthermore, the aortic total cholesterol content was strongly correlated with VLDL 
cholesterol concentration. 
Our findings in the grafts are in contrast to earlier reports on the effects of FO. In 
hypercholesterolemic dogs FO has consistently been found to reduce intimal thickening.'"' 
Because we feel that intimal thickness and luminal encroachment do not correctly reflect the 
morfometric changes in vessels, in the present study we also reported on luminal, intimal and 
media areas. The increase in intima area was similar for the 3 hypercholesterolemic diet groups, 
but luminal area in the FO group was consistently higher thau with SO or LF, although statistical 
significance was not reached. Consequently, the average luminal encroachment and intimal 
thickness was lowest for the FO group compared to the SO and LF groups (see Table 3). 
However, this can not explain the discrepancy with earlier reports, as Sarris et at reported that 
the decrease in intimal thickening was accompanied by a decrease in intimal area. 6 The effect 
offish oil on intimal thickening could be species related. Whereas pigs were used in the present 
study, all other studies were performed in dogs.'"' Dogs hardly developed arterial atherosclerosis 
even after high cholesterol feeding aud the lesions usually involved the media. '.".16 Perhaps these 
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Fig 7. Graph showing the 
correlation between VLDL 
cholesterol concentration and 
cholesterol content of the aortic 
lesion in the male population (Fish 
oil, sunflower oil and lard fal groups, 
n=6; normocho!esterolemic group, 
n=4) 
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characteristics also applied to vein graft atherosclerosis. Landymore et ai, who also studied the 
vein grafts 6 weeks after implantation, reported an intimal thickness less than 40 ~m, 7 while we 
observed a mean intimal thickness in the vein grafts between 220-300 ~m. Even an induction 
period of3 months and a 5% cholesterol diet, as employed by Sarris et ai, resulted in an intimal 
thickness of only 149 ± 19 ~m.6 
Anotller key factor could be that in our experimental model plasma cholesterol levels were 
higher than reported for tlle hypercholesterolemic canine model.~' High plasma cholesterol had 
been shown to positively correlate to progression of atherosclerotic lesions,7 and could be a 
reason why we did not observe a favorable effect of FO in the graft. Furthermore, the type of 
vein used as an arterial conduit could also have played a role. We had chosen to employ the 
saphenous vein in accordance to clinical practice, while diaphanous veins such as femoral and 
jugular veins were used in the canine models. Diaphanous veins are more delicate and 
unaccustomed to hydrostatic pressure compared to extremity veins. The latter, therefore, have 
greater wall thickness and strength, and could respond differently to arterialization." 
The accumulation of total cholesterol in the graft was also not favorably affected by FO. 
Dietary intervention with FO, however. showed a significant effect in the abdominal aorta. In 
the normolipidemic group raised patches or lesions were macroscopically visible on the luminal 
aspect of the abdominal aorta, similar as those reported by Kobari et al" Compared to a 
macroscopically normal piece of aorta (non-lesion area) these lesions contained more 
cholesterolester. Feeding with diets containing 2% cholesterol further increased cholesterol 
content in the lesions, but the hypercholesterolemia-induced cholesterol accumulation in the 
lesion area was markedly inhibited by FO. This was likely due to a direct effect of n-3 fatty acids 
rather than an increase in polyunsaturated/saturated fatty acid ratio of the diet, because neither 
the SO nor the LF diet could emulate the favorable effect ofFO. Furthermore, the cholesterol 
content of the aortic lesion area was positively correlated to plasma VLDL cholesterol 
concentration (Table 7), suggesting that VLDL cholesterol was a predicting factor for cholesterol 
accumulation in the aorta. This is further supported by our current finding that VLDL cholesterol 
was lowest in the FO group compared to LF and SO groups and that the positive correlation 
between VLDL cholesterol and aortic lesion cholesterol content remained even without the 
normocholesterolemic animals. In view of the age of the animals, which was between 10 to 12 
months, these aortic lesions could be considered early atherosclerotic lesions and therefore this 
finding supports the report of Berenson et ai, that low VLDL cholesterol levels were related to 
fatty streaks in the coronary arteries of persons, aged 6-30 years." Our data also support the 
notion that the levels of cholesteryl ester rich VLDL particles relate to the severity of 
atherosclerotic lesions. 21 A positive correlation was also observed between plasma HDL 
cholesterol levels and cholesterol content of the aortic lesion area and this finding contested to 
some extend the protective nature of high plasma IIDL cholesterol concentration. The increase 
in cholesterol content of the lesion area was similar to our reports on cholesterol accumulation 
in the abraded abdominal aorta of hypercholesterolemic swine. Sassen et al found that in 
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hypercholesterolemic swine endothelial denudation signillcantiy increased the cholesterol 
content in the aortic wall after 8 months. II However, FO was unable to prevent the cholesterol 
accumulation in the abraded aorta. Although a different strain of pigs (Yorkshire x Landrace 
versus GOttingen miniature swine) and a longer induction period (8 months versus 2 months), 
the present favorable effect of FO in the lesion area of the aorta therefore suggests that intact 
endothelium is required for the effectiveness of FO in the inhibition of atherosclerosis. 
The inhibition of aortic atherosclerosis in this experimental model raised the question why 
FO was ineffective in inhibiting lipid accumulation in the graft. During the surgical preparation 
the grafts were invariably traumatised, }·3 and in response to this trauma an inflammatory reaction 
and wound healing would ensue with neutrophil and monocyte infiltration of the graft wall. The 
increased presence of macrophages together with the hypercholesterolemia may explain the 
increased cholesterol content of the graft. Another possibility could be the injured endothelial 
layer of the graft. 1-3,V,21 The PDAY (pathobiological Determinants of Atherosclerosis in Youth) 
study reported that alterations of the endothelial function are implicated in the increased 
permeability of the endothelial barrier for lower-density lipoproteins and the development of 
early atherosclerotic lesions."'2S Ross et al posed the hypothesis that endothelial injury due to 
a hypercholesterolemic envirournent could enhance atherosclerosis." In the graft endothelial 
injury would increase platelet aggregation. Several investigators have implicated platelet 
aggregation Witil fibrointimal hyperplasia, because anti-platelet therapy decreased fibrointimal 
thickening in the graft."-" With the loss of the endothelial layer fish oil would loose a major 
point of action, such as reduction of platelet derived growth factor and increase in endothelium 
derived relaxing factor and prostaglandins, by which it could reduce fibrointimal hyperplasia, 
in the vein graft. That an intact endothelial layer could reduce intimal hyperplasia was 
demonstrated by Shiokawa et ai, who observed an inverse correlation between the rate of re-
endothelialization and intimal thickness in vein grafts.31 In our hypercholesterolemic swine 
model the 6 weeks post surgery could prove to be too short for the endothelial layer, as well as 
endothelial function, to fully recover in the vein graft and hence for fish oil to show a marked 
difference in intimal hyperplasia. A longer post-operative period in the experimental protocol 
could therefore alter the outcome of the present study. A similar mechanism would also explain 
the recent finding that fish oil was effective in improving vein graft patency in patients after I 
year. 17 
We conclude that fish oil may act as a potent antiatherosclerotic agent, which action is 
likely to be mediated by a reduction in plasma VLDL cholesterol concentration and a change in 
the chemical composition of VLDL. Furthermore. the more pronounced antiatherosclerotic 
effect of fish oil in the aorta than in the vein graft suggests that an intact endothelium is a 
prerequisite for fish oil to be effective. The inhibition of atherosclerosis in the aorta is probably 
caused by a direct effect of n-3 fatty acids and not by an increase in tile 
polyunsaturated/saturated fatty acid ratio in the diet. 
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Effect of Dietary Fish Oil on Regression of Vein Graft and Aortic 
Atherosclerosis: A CompaIison with Sunflower Oil, Lard Fat and 
an Isocaloric Quantity of Carbohydrates 
L.K. Soei, H.M.M. van Beusekom, lR. van Meegen, L.M. Scheek, D.H.W. Dekkers, 
lMJ. Lamers, A. van Tal, PD. Verdouw 
Background and aims of the study. Several studies have reported that In a hypercholesterolemic 
canine model fish all inhibits vein graft atherosclerosis. Although in a previous study using 
hypercholesterolemic swine we could not show a favorable effect of fish oil on atherosclerosis in vein 
grafts, dietary fish oil Was shown to enhance regression of atherosclerotic lesions induced by a low 
cholesterol diet. The effect of dietary fish oil on regression ofvein graft atherosclerosis is unknown and is 
therefore the focus of attention in the present study. Furthermore, the effects of n~3 fatty acid-rich diet were 
compared with those obtained with n-6 fatty acid-rich diet, lard fat or an isocaloric quantity of 
carbohydrates. The effects of these diets on regression of atherosclerosis were also assessed in a control 
vein, the left circumflex coronary artery (LCXCA) and the abdominal aorta. 
Methods and Results. Venoarterial grafts were implanted In both carotid arteries of pigs (n=47), 
which 2 weeks before surgery were started on a diet containing 2% cholesterol and 9% lard fat. Six weeks 
later the animals were randomly assigned to receive a low-cholesterol diet containing by weight either 4.5% 
fish all and 4.5% lard tat (FO, n=9), 4.5% sunflower oil and 4.5% lard tat (SO, n=9), 9% lard tat (LF, n=9) 
or 4.5% lard fat and an isocaloric quantity of carbohydrates (CH, n=9) for an additional 8 weeks. A control 
group (C, n=11) were sacrificed before assignment to a low cholesterol diet. Although total cholesterol 
accumulation in the graft and a control vein decreased with all low cholesterol diets, luminal encroachment 
and intimal thickness remained unchanged. There were no differences in these parameters between the 
4 low cholesterol diets either. Also the hypercholesterolemia-Induced aortic lesions showed no reduction 
in total cholesterol content. low cholesterol feeding decreased plasma choleslerollevels from 10.7±0.6 
mM at the end of the induction period to 2.5±0.1 mM. Plasma VLDL-, IDL- and LDL-cholesterol 
concentrations decreased with all 4 diets, but only FO and CH had also lower HDL-cholesterol 
concentration. Furthermore, FO had a higher VLDl-cholesterol concentration than CH and a lower HDl-
-cholesterol concentration than LF. Compared to SO FO had lower LDL- as well as HDL-cholesterol 
concentrations. The chemical composition of the lipoproteins showed a higher free cholesterol content of 
the VLDL particle with FO and CH diets than with SO diet. Regression analysis indicated that 
VLDL-triglycerides and VLDL-total cholesterol concentration were positively correlated to cholesterol 
accumulation in the aorta (r=0.77, p<0.001, r=0.62, p<O.01, respectively), but did not correlate with vein 
graft total cholesterol. 
Conclusions. The decrease in total cholesterol accumulation in the graft Indicates that regression 
of vein graft atherosclerosis occurs with a cholesterol lowering diet, but independent of dietary fatty acids 
in our swine. In the present study regression has not been sUbstantiated by a decrease in luminal 
encroachment or intimal thickness and thus precludes any definite conclusion about regression. The 
discrepancy between the efflux of total cholesterol from the aorta, vein graft and control vein may indicate 
that different mechanisms underly atherosclerosis In veins and arteries. Similar 10 our previous study high 
plasma VLDL concentrations can predict total cholesterol accumulation in the aortic wall, suggesting that 
in this animal model VLDL playa role in the development of arteriosclerosis. 
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The longterm patency of vein grafts is threatened by atherosclerosis in the transplanted vessels. 
Implicated in the development of atherosclerosis are several reactive processes. Early after 
coronary bypass surgery thrombosis is often found in the grafts and may trigger the 
atherosclerosis process, as the aggregation of platelets release amongst others growth factors. 
Subsequent fibrointimal hyperplasia and lipid deposition there within may eventually lead to 
atherosclerotic lesions, which are indistinguishable from atherosclerotic lesions in the nearby 
coronary arteries,l,2 Next to prevention of graft atherosclerosis, inducing regression of graft 
atherosclerosis may also have a beneficial effect on longterm patency. Anti-platelet therapy has 
been shown to improve short term (up to 1 month) patency rates, but patency at 1 year does not 
benefit as much, probably because anti-platelet therapy does not nffect proliferative processes.3 
Therefore, it is not likely that anti-platelet therapy will induce regression of gr~ft atherosclerosis. 
Another option may be modification of plasma lipoproteins. Lowering of plasma total 
cholesterol has been implicated in inducing regression of atherosclerotic lesions. Blankenhorn 
et al showed that lowering of plasma cholesterol with colestipol-niacin therapy induces 
regression in coronary atherosclerosis, but only reduces progression of atherosclerosis in 
coronary venous bypass grafts' Dietary fish oil may be more effective than cholesterol lowering 
agents alone, because it may target additional cellular and molecular mechanisms and thereby 
not only facilitate the removal of lipids from the vessel wall, but also inhibit ongoing 
proliferative processes. Several investigators have shown that fish oil exert an additional effect 
to lowering plasma cholesterol on regreession of atherosclerosis. For instance Zhu et at reported 
that aortic sudanophilic lesions induced by a high cholesterol diet were reduced in rabbits, when 
the animals were placed on a normal diet supplemented with fish oil or verapamil. S In swine 
Sassen et al showed that coronary atherosclerosis, which were induced by endothelial denudation 
and high cholesterol feeding, regressed on a low cholesterol diet containing fish oil.' 
In the present study we investigated whether regression of atherosclerosis in saphenous vein 
grafts and in the aortic wall could be favorably influenced by dietary fish oil. Furthermore, we 
also studied whether altering the fatty acid prome of lipids in plasma lipoproteins and in the 
atherosclerotic lesions particularly as to the n-3 and n-6 fatty acids by either dietary fish oil, 
sunflower oil or lard fat could facilitate lipid removal from the saphenous vein graft and the 
aortic wall. An additional diet group, in which a portion of the dietary fat was replaced by an 
isocaloric amount of carbohydrates, was added to investigate whether a low fat, carbohydrate-
enriched diet was also effective in regressing atherosclerosis in the studied vessels. 
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Matel'ials and Methods 
Animal care 
All experiments were performed in accordance with the guiding principles in the care and 
use of animals as approved by the Council of the American Physiological Society and under the 
regulations of the Animal Care Committee of the Erasmus University Rotterdam, Rotterdam, 
the Netherlands. 
Experimental groups cmd protocol 
Gottingen mini-pigs (n~29, both female and castrated male), weighing 18-20 kg, were put 
OIl a diet, containing 2% (w/w) cholesterol and 9% (w/w) lard fat (Hope Farms BV, Woerden, 
The Netherlands). After 2 weeks the animals received an autologous venous bypass graft in both 
carotid arteries. For induction of atherosclerotic lesions in the graft the animals continued the 
same diet for another 6 weeks. Thereafter, these animals were randomized into 4 groups (Fig. 
I); a fish oil group (FO, n~9), a sunflower oil group (SO, n~9), a lard fat group (LF, n~9) and 
Table 1. Composition of the post-induction diets. 
Content (g%) 
FO SO LF CH 
Ingredients 
Corn (extruded) 32 32 32 30 
Wheat (extruded) 18 18 18 17 
Soybean meal 14 14 14 13 
Wheat middling 9 9 9 8 
Dehydrated 14 14 14 13 
skimmed milk 1.3 1.3 1.3 1.2 
powder 1.1 1.I 1.I 1.0 
CaHP04.H2O 0.3 0.3 0.3 0.3 
CaCOO3 0.05 0.05 0.05 0.04 
NaCI,lodlnized 0.05 0.05 0.05 0.04 
MgO 0.36 0.36 0.36 0.34 
MgSO, 0.18 0.18 0.18 0.17 
KH2P04·2H2O 0.7 0.7 0.7 0.6 
Choline chloride 4.5 4.5 9 4.5 
50% (w/w) 4.5 
Vitamin and trace 4.5 
element mixesa II 
Lard tat 
Fish oil 
Sunflower oil 
Extra carbohydrates 
FO=ftsh oil diet; SO=sunflower oil diet; LF lard fat diet CH=carbohydrate diet. 'Vitamin and 
truce element mixes supply the foIIowing per 100 g diet: retinol 1400 IU; cholccalcifcrol140 
IU; «-tocopherol 8 mg; menadione 02 mg; thiamine hydrochloride 1.8 mg; riboflavin 1.8 mg; 
pyridoxineHCll.4 mg; niacin 3.6 mg; vitamin C coated 20 mg; calcium D-pantothenate 3.6 
mg; folic acid 0.4 mg; cyanocobalamin 0.004 mg; biotin 0.1 mg; inositol 4.5 rug; iron 
subcrubonate (57% Fe) 9.1 mg; FeS04.HlO (30% Fe) 14 mg; CulOHhCOl (55% Cu) 2.3 mg; 
ZnO(78% Zu) 11 mg; :MnO (62%Mn) 9.1 mg; NazSel 5H10 (45% Se) 0.08mg; Ca(I03h (65% 
J) 0.2 mg; CoCO) (47% Co) 0.09 mg. The composition is on an as fed basis. 
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a carbohydrates group (CIl, n~9). For the subsequent 8 weeks the 2% cholesterol was removed 
from the diet and the animals were fed a diet, containing either 4.5% (w/w) fish oil and 4.5% 
(w/w) lard fat (FO) or 4.5% (w/w) sunflower oil and 4.5% (w/w) lard fat (SO) or 9% (w/w) lard 
fat (LF). In the carbohydrates group the 4.5% lard fat was replaced by an isocaloric amount of 
carbohydrates. The fatty acid profile (Table 2) of the dietary lard fat, sunflower oil and fish oil 
resulted ultimately in a polysaturated/saturated fatty acid ratio of 0.49 for the lard fat diet, 1.50 
for the sunflower oil diet and 0.83 for the fish oil diet. To compensate for the increased 
polyunsaturated/saturated fatty acid ratio in the diets different amounts of vitamin E (u-
tocopherol) were added to the different diets.The U-, (P+y)- and 3-tocopherol content of the 
fatloils listed in Table 2 was determined by HPLC analysis and subsequent correction for relative 
biological activities of the different tocopherol components, yielded 0, 706 and 352 mg/kg 
IX-tocopherol equivalents for lard fat, sunflower oil and fish oil, respectively. Based upon the 
relative content of the polyunsaturated fatty acids with varying number of double bonds the 
minimally required IX-tocopherol content was calculated to be 113, 595 and 860 mg/kg fatloil. 
Because in the sunflower oil there was a 20% excess a-tocopherol, in the final calculation for 
I 2% Chole~larol and 9% lard fat 
FO LI __ +-_____ ----"I~~(tK~~s:gU~ 
SO I~____i----- :;'j:iKjiii;:i!iij:;:ii:,,:iCi::iiiiiiiii;;ii';,:i 
LF LI _--+-____ ----"I~~};;~J;!~ 
CH LI ___ .-: ________ ---'1.4.5% lard fat + carbohydrates" 
i i 
start surgery 
diet 
o 
i 
Change 
of diet 
8 
weeks 
i 
harvesting 
of grafts 
16 
Fig 1. Schematic presentation oftha experimental protocol and the diets of the different groups. A diet containing 
2% cholesterol and 9% lard fat was administered for 8 weeks. Two weeks after the onset of the experimental 
protocol the animals received a saphenous veno·arterial bypass graft In both carotid arteries. In the post·lnduction 
period cholesterol was removed from the diet and the animals were randomly assigned to the 4 diet groups, fish 
oil group (FO), sunflower oil group (SO), lard fat group (LF) and a group in which 4.5% lard fat was replaced by an 
isocaloric quantity of carbohydrates (CH). 
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Table 2. Fatty acid compositions of the fish oil, sunflower oil and lard fat added to the 
atherogenic diet, containing 2% (w/w) cholesterol and 4.5% (w/w) lard fat. 
Fish Oil Sunflower Oil Lard Fat 
(mol%) (mol %) (mol%) 
Fatty Acid 
16:0 19.7 6.7 27.1 
16:1",7 8.5 0.1 2.2 
18:0 3.7 3.9 15.0 
18:1",9 10.2 20.2 36.8 
18:1",7 4.5 0.8 2.9 
18:2",6 1.7 66.6 10.8 
18:3",3 1.1 1.0 
20:5",3 19.9 
22:6",3 10.6 
others 2.1 1.7 4.2 
PUFAISFA raUo 1.42 6.28 0.29 
PUFA=polyunsaturated fatty acids; SFA-saturated fatty acids. 
matching the u-tocopherol contents a 20% excess was also provided for the lard fat and fish oil. 
This meant that we added 18.4, 9.2 and 45.9 rug u-tocopheroVkg to the complete LF, SO and 
Fa diets, respectively. For the CH diet similar amounts of u-tocopherol as in the SO diet was 
added. It should be noted that 80 mglkg u-tocopherol was already present in the base diet (Table 
1 ). 
At the end of the protocol the animals were anesthetized with ketamine (700 rug) and 
sodium pentobarbital (10-15 mg/kg/hour), intubated and connected to a respiratory ventilator. 
The venous bypass grafts were dissected free and patency was evaluated by pulsation of the 
distal carotid artery or by blood flow through the graft. The left graft was perfusion fixed in situ 
with a pressure of 100 em of H20 with a 10% phosphate-buffered formaline and stored until 
histological processing. The remaining saphenous vein from the right hindleg was taken as a 
negative control for the amount of intimal thickening. After an overdose of sodium pe"ntobarbital 
the left circumflex coronary artery (LCXCA) and the aorta were harvested. These vessels were 
used to determine regression of atherosclerosis in this model, which resulted from the 
hypercholesterolemia during the first 8 weeks of the experimental protocol. Blood samples were 
drawn from the jugular vein at the beginning of the protocol, just before surgery, at 8 weeks and 
before the animals were sacrificied to monitor plasma cholesterol and triglyceddes levels. 
A control group consisting of 11 animals was sacrificed after the induction period to 
determine the level of atherosclerosis in the vein grafts, control vein, left circumflex coronary 
artery and aorta, and was considered to be the baseline level to which the regresssion was rated 
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(induction group). These animals were also enrolled in a previous study investigating the effect 
of fish oil on the development of atherosclerosis in saphenous vein grafts (unpublished data). 
llltelposition of the saphenous vein info the carotid m,/eries 
After overnight fasting the pigs were anesthetized with 500 mg of ketamine, intubated and 
connected to a respirator for ventilation with a mixture of oxygen and nitrous oxide (1 :2) and 
2% of ethrane. The saphenous vein was extracted from the left hindleg over a length of 
approximately 8 cm (in situ) and carefully flushed with a saline solution containing 2% 
papaverine, split in half and preselVed in the flush solution before implantation. Care was taken 
not to distend the vein graft to minimize endothelial damage. At the same time both carotid 
arteries were dissected free from their surroundings. After injection of 5,000 IU of heparin one 
carotid artery was clamped and a piece of the artery (approximately 3cm) removed. One half of 
the saphenous vein was interposed using end-ta-end anastomoses. After this procedure was also 
performed on the other artery, the animals were allowed to recover from surgery. 
Plasma lipids 
At the onset of the study and after 2 weeks blood samples were drawn from the subclavian 
vein for measuring total plasma cholesterol. After 8 weeks the blood samples were drawn from 
the superior caval vein and total cholesterol, free cholesterol and triglycerides, which were 
assayed enzymatically using kits (GHOD-PAP and GPO-PAP) from Boehringer GmbH, 
Mannheim, Germany. Phospholipids were assayed using the kit (PAP 150) from BioMerieux, 
Charbonnit~res, Les Bains, France. 
In the male population (FO, SO, LF and CH, n~5) plasma lipoproteins were separated by 
density-gradient ultracentrifugation into 4 fractions (VLDL, IDL, LDL and HDL).'The lipid 
composition was detennined in each fraction using the same kits. Protein content of the different 
fractions was measured according to the method of Lowry et al. (8) The fatty acid composition 
of the phospholipids and cholesterol esters, extracted from the total plasma lipids, was 
determined by transmethylation with BF, in methanol and gaschromatography (CP-Sil 
88-coated fused silicon capillary column from Chrompack, Midde1burg, The Netherlands) as 
previously described.9,lo 
Intimal thickening of the venous bypass grafts, saphenolls vein and coronaty artelY 
The graft, the saphenous vein and the LCXCA were imbedded in paraffme and transverse 
sections were made every 1 nun. The sections were routinely stained with haematoxylin-eosine 
(HE) and elastic von Gieson (EvG). The elastic stained slides were used to determine intimal 
thickening with a computer-assisted morphometric analysis system (SigmascanlImage, Jandei 
Scientific GmbH, Erkratll, Gennany). The area between the endothelial lining of the lumen and 
the internal elastic lamina (!EL) was taken as the intima area. The encroachment was defined 
as the ratio (x 100%) of the intima area and the corrected area within the!EL. The corrected area 
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within the IEL was calculated from the perimeter of the IEL assuming that the IEL was a perfect 
circle. Mean intimal thickness was deftned as the difference between the radius of the lumen and 
the radius of the IEL. Both radii were calculated from their respective perimeters. The lumen 
area was also calculated from the perimeter of the lumen. The media area was taken as the 
difference between the areas circumscribed by the internal and external elastic laminae. 
Lipid infiltration of venous bypass graft, saphenous vein and aortic wall 
The graft in the right carotid artery and a part of the right saphenous vein were dissected 
free and frozen in liquid nitrogen before storage at -80 'C. For determining the effect of the 
lipid-enriched diets on lipid accumulation in spontaneous atherosclerosis the aorta was dissected 
free and a longitudinal incision was made on the ventral side of the aorta. Inspection of the aorta 
showed the presence of macroscopic elevations (fatty streaks) in the abdominal aorta distal to 
the renal arteries (labelled lesions). In the absence of macroscopic elevations a representative 
biopsy was taken randomly from the infrarenal abdominal aorta. Samples from the suprarenal 
abdominal aorta served as control (non-lesions, Fig. 2). Samples of aortic lesions and non-lesions 
were dissected free of adventitia and directly frozen in liquid nitrogen and stored at - 80'C until 
analysis using the method of Bligh and Dyer for lipid extraction. II Briefly, tissue samples were 
homogenized in a Braun microdismembrator and the obtained powder was extracted with 
chloroform/methanol/saline (4:10:5, v/v/v). After centrifugation at 1500 g=, for 5 min and 
washing the pellet by rehomogenization in 1.91111 of the same solvent, the two supernatants were 
combined and mixed with 1.5 ml chloroform and 1.5 rul saline. After vigorous vortexing and 
Coronary 
Arteries -
Olaphragm,~ 
Aortic Arch 
OescElnd,inaAorta 
Non-lesion Area 
Fig 2. A schematic presentation of 
the location of the elevated patches 
on the luminal surface of the 
abdominal aorta (lesion area) and 
the macroscopically normal 
abdominal aorta (non-lesion area). 
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subsequent phase separation, the upper phase and the intemlediate solid material were discarded. 
Subsequently the mixture was dried under nitrogen at 37"C and the residue dissolved in 0.2 ml 
2-propranol. Cholesterol and cholesterolester, triglyceride and phospholipid contents were 
measured with enzymatic kits (see before). In the delipidized extracts protein and DNA contents 
were measured.9 
Statistical allalysis 
All data are presented as mean ± standard error of the mean (SEM). The data were analyzed 
statistically using a one-way analysis of variance followed when appropriate by either the 
Student-Newman-Keuls procedure for multiple comparisons of mean values or by the Kruskall-
Wallis test on ranks. Statistical signillcance was accepted at P<.05. Correlations were 
determined with the Spearman rank order correlation analysis. 
Results 
Patellcy oj the grafts 
In the induction group sacrificied 6 weeks post-surgery occlusion rate of the vein grafts was 
32%. The removal of the 2% cholesterol from the diet with or without a partial replacement of 
dietary lard fat resulted in occlusion rates of25%, 19%, 6% and 25% for the fish oil, sunflower 
oil, lard fat and carbohydates groups, respectively (P>.05). 
Table 3, The effects offish oil, sunflower oil, lard fat and carbohydrates on regression of luminal 
encroachment and size of the saphenous vein graft after withdrawal of cholesterol from the diet. 
Luminal Intimal Area 
encroachment Thickness Lumen Intima Media 
(%) (mm) (mm2J (mm2) (mm:t) 
Induction: 
2% cholesterol (n=11) 56± 9 0.26 ± 0.06 4.4±1.5 2.5 ± 0.5 1.4±0.2 
+ 9% lard fat 
Regression: 
Fish oil (n=9) 35 ± 11 0.31 ± 0.05 6.8 ±2.7 2.9 ±0.5 1.9 ± 0.2 
Sunflower oil (n=9) 41 ± 10 0.21 ± 0.04 4.4 ± 1.8 1.8 ± 0.4' 1.7±0.3 
Lard fat (n=9) 38 ± 8 0.36 ±0.03 6.4 ± 2.2 3.8 ± 0.4 1.7±0.1 
Carbohydrates (n=9) 41 ± 10 0.23 ± 0.04 4.9 ± 1.2 2.0 ± 0.3' 1.7 ± 0.2 
Values are mean±SEM. *P<.05 vs. The lard fat group. 
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FibroilllilJla/ hypeJP/asia 
The effect of the different diets in the post-induction period on fibrointimal hyperplasia was 
assessed with luminal encroachment, intimal thickness and intima area. None of the diets showed 
a significant decrease versus the induction group in any of these parameters. Although no 
difference was observed in luminal encroachment and mean intimal thickness between the 
regression groups themselves, intima area in the LF group was significantly larger than that in 
the SO and CH groups (Table 3). 
In Table 4 is shown that the control vein was not affected by the 4 regression diets 
compared to the induction group. Despite feeding of the low cholesterol diets luminal 
encroachment tended to increase in the LCXCA, but statistical significance was not reached. 
Surprisingly, lumen and media area of the LCXCA in the regression groups were significantly 
higher than those in the induction group (Table 4). 
Table 4. The effects of fish oil. sunflower oil and lard fat on luminal encroachment and size of the 
control vein and left circumflex coronary artery. 
Area 
Luminal encroachment LUmen Intima Media 
(%) (mm2) (mm2J ~mm2J 
Vein 
Induction (n=11) 0 0.51 ± 0.08 0 1.00 ±0.09 
Fish oil (n=9) 0 0.65 ± 0.13 0 0.88 ± 0.07 
Sunflower oil (n=8) 0 0.55 ±0.10 0 0.93 ± 0.08 
Lard fat (n=8) 0 0.34 ± 0.05 0 0.80 ± 0.08 
Carbohydrates (n=8) 0 0.29 ± 0.04 0 0.76 ± 0.05 
Left circumflex coronary artery: 
Induction (n=11) 3.2 ± 1.6 0.69±0.15 0.04 ± 0.02 0.52 ± 0.10 
Fish oil (n=8) 4.4±1.7 1.53 ± 0.12' 0.08 ± 0.04 1.00 ± 0.08* 
Sunflower oil (n=9) 4.6±1.1 1.23 ±0.14' 0.06 ± 0.02 0.88 ± 0.06' 
Lard fat (n=9) 10.5 ±2.7 1.28 ± 0.09' 0.16 ± 0.05 1.03 ± 0.07' 
Carbohydrates (n=9) 6.0 ± 1.4 1.29 ± 0.09' 0.08 ± 0.02 0.91 ± 0.06' 
Values are meantSEM. ·P<.05 vs. Induction group. 
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Table 5. The effects of dietary fish Dill sunflower oil, lard fat and carbohydrates on lipid 
accumulation in the control vein and the vein graft after induction of lipid accumulation with a 
diet containing 2% cholesterol and 9% lard fat. 
Cholesterol Cholesterolester Cholesterol + Phospholipids Triglycerides 
Cholesterolester 
()!ffiOVg) (jJmollg) tumoUg) (I-lmollg) Wmollg) 
Vein: 
Induction (n=ll) 5.22 ± 0.38 2.25 ± 0.34 7.47 ± 0.62 4.60 ± 0.26 8.23 ± 1.78 
Fish 011 (n=9) 4.52 ± 0.70 0.00 ± 0.13" 4.50 ± 0.59" 4.39 ± 0.77 2.27 ± 0.39" 
Sunflower all (n=9) 5.19 ± 0.74 0.00 ± 0.05" 5.17 ± 0.76" 5.43 ± 0.77 1.43 ± 0.25" 
Lard fat (n=9) 3.94 ± 0.29 0.02 ± 0.06" 3.96 ± 0.31" 4.30 ± 0.22 2.93 ± 1.12" 
Carbohydrates (n=9) 4.06 ± 0.22 0.16 ± 0.03" 4.22 ± 0.21" 3.58 ± 0.43 2.93 ± 0.54" 
Vein graft: 
Induction (n=ll) 5.72 ± 0.28 3.40 ± 0.58 9.13 ± 0.78 4.73±0.22 4.S6±1.71 
Fish oil (n=9) 3.68 ± 0.31" 0.59 ± 0.30" 4.27 ± 0.55" 3.50 ± 0.33 3.87 ± 1.78 
Sunflower oil (n=9) 4.45 ± 0.43" 0.23 ± 0.45" 4.68 ± 0.37" 4.20 ± 0.47 9.02 ± 3.57 
Lard fat (n=9) 4.24 ± 0.24" 1.28 ± 0.30" 5.53 ± 0.29" 3.65 ± 0.36 4.86 ± 2.91 
Carbohydrates (n=9) 3.73 ± 0.18" 0.55 ±O.lS" 4.28 ± 0.25" 3.99 ± 0.39 6.31 ± 2.38 
Values are mean±SEM. ·P<.05 versus Induction group. 
Lipidaccllmulatioll ill/he vein graft and the cOlltrol saphenous vein 
The induction diet of 2% cholesterol and 9% of lard fat led to a total cholesterol content 
of7.47 ± 0.62 ~moVg and 9.]3 ± 0.78 ~moVg for the saphenous vein and vein graft, respectively 
(Table 5, Fig 3). Eight weeks after changing the diets total cholesterol of the saphenous vein 
decreased significantly in all regression groups, which was mainly due to a decrease in 
cholesterol ester content. The triglycerides content of the saphenous vein also decreased 
compared to the induction group (P<.05). In the vein grafts total cholesterol content also 
decreased during the regression period of the experimental protocol. In contrast to the control 
vein this was due to a decrease in both free and esterified cholesterol. The cholesterolester 
content ofthe vein graft, however, remained significantly increased versus the control vein. The 
decreases induced by the different regression diets were not significantly different in both the 
saphenous vein and the vein graft. 
LipidacclIlJIu/ation ill the aorta 
In Table 6 the effects of the induction diet and the regression diets on lipid accumulation 
in the abdominal aorta are shown. Dietary FO, SO and LF had no effects on Iipidaccumulation 
in the non-lesion and lesion area compared to the induction group. Only the carbohydrates group 
had a lower cholesterolester content of the non-lesion area than the induction group. In all 
regression groups the lesion area still contained more cholesterolester than in the non-lesion area. 
ratty acid composition o/the lipids in the vein grafts and aorta 
The fatty acid composition ofthe cholesterolester and phopholipids in the vein grafts were 
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Fig 3. Bar graph showing the free cholesterol, esterified cholesterol, phospholipids and trlgtycerides content of the 
vein and the vein graft. I=induction group (n=11); FO=fish oil group (0=9); SO=sunflower oil group (n=9); LF=lard 
fat group (n=9); CH=carbohydrate group (n=9)Values are mean±SEM. ·P<.05 vs the induction group; • P<.05 vein 
graft vs vein within a dietary group. 
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Table 6. The effects of dietary fish all, sunflower oil, lard fat and carbohydrates on lipid 
accumulation in the lesion and the non-lesion areas of the abdominal aorta after induction of 
lipidaccumulation with a diet containing 2% cholesterol and 9% lard fat. 
Cholesterol Cholesterolester Cholesterol + Phospholipids Trigtycerides 
Cholesterolester 
(~moVg) (~moVg) (~moVg) (~moVg) (~moVg) 
Non-lesion area: 
Induction (n=ll) 3.92 ± 0.19 1.24 ± 0.35 5.16±0.53 3.42 ± 0.12 3.32 ± 0.98 
Fish oil (n=9) 3.71 ± 0.27 0.33 ± 0.24 4.04 ± 0.49 3.43 ± 0.16 4.93 ±2.32 
Sunflower oil (n=9) 4.11 ±0.27 0.76 ± 0.18 4.86 ± 0.41 3.70±0.19 2.83 ±0.66 
Lard fat (n=9) 3.96 ± 0.17 0.50±0.19 4.45 ± 0.29 3.79 ± 0.22 4.85 ± 1.23 
Carbohydrates (n=9) 3.62 ± 0.15 0.24 ± 0.07' 3.85 ± 0.18 3.54 ± 0.18 3.14 ± 0.96 
Lesion area: 
Induction (n=ll) 5.46 ± 0.49 4.03 ± 0.74 9.50 ± 1.18 3.99 ± 0.35 3.50 ± 1.32 
Fish oil (n=9) 6.52 ± 0.96' 2.64 ± 1.01' 9.16 ± 1.91' 4.41 ± 0.37 2.58 ± 0.43 
Sunflower oil (n=9) 7.26 ±0.79· 4.10 ± 0.56' 11.36 ± 1.32' 4.99 ± 0.43' 3.10±1.08 
Lard fat (n=9) 5.68 ± 0.59' 2.40 ± 0.71' 8.08 ± 1.28' 4.23 ±0.26 1.92 ± 0.60 
Carbohydrates (n=9) 4.89 ± 0.41' 1.86 ±0.42· 6.75 ± 0.79' 4.02 ±0.23 3.00 ± 0.86 
Values are mean±SEM. *P<,05 versus Induction group .• P<.05 lesion area vs non-lesion area within a diet 
group. 
similar for the SO and LF groups (Table 7). Replacement of a half of the dietary lard fat with 
fish oil caused a relative increase in total n-3 fatty acids and a relative decrease in total n-6 fatty 
acids incorporated in the cholesterolester and phospholipids of the vein graft. No determinations 
in the aortic lesions of the fish oil group had been carried out. In the aortic lesions there was no 
difference in the n-6 fatty acid pool of the phospholipids between SO and LF. However, the fatty 
acid composition of the cholesterolesters showed a marked increase in n-6 polyunsaturated fatty 
acid incorporation at the expense of saturated and monounsaturated fatty acids. 
Table 7. Polyunsaturated fatty acid content (mol%) of the lipids in vein grafts and aortic lesions. 
Fish oil (n=3) Sunflower oil (n=3) Lard Fat (n=3) 
CE PL CE PL CE PL 
Vein grafts: 
SFA+MUFA 67±2 71±1 58 ± 3 67 ± 1 61 ±3 67 ±2 
n-6 PUFA 29±2 21 ± 1 39 ± 3 30 ± 1 37 ±3 30 ±2 
n-3 PUFA 4 ± 1 8 ± 1 2±1 3 ± 1 2±1 3±1 
Aortic lesions: 
SFA+MUFA -' -' 64 ±4 66 ± 1 82 ± 3 69 ± 1 
n-6 PUFA 35 ± 4 32 ± 1 16 ± 3 29 ± 1 
n-3 PUFA 1 ± 1 2 ± 1 1 ± 1 2 ± 1 
CE=cholesterol ester; PL phospholipids; SFA-saturated fatty acids; MUFA monounsaturated fatty acids; 
PUFA=polyunsaturated fatty acids. - = not determined. * No determination of fatty acids was made of the 
cholesterolester in aortic lesions aftha fish oil group. Values are mean ± SEM. 
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Fig 4. Bars representing the plasma 
cholesterol concentration before 
administration of the induction diet (week 
0), at the time of surgery (week 2), at the 
end aftha induction period (week 8) and at 
the end aftha experimental protocol (week 
16). The values at week 0, 2 and 8 weeks 
are the average for all the animals, 
because randomization happens at 8 
weeks. In the lard fat group plasma 
cholesterol concentration did not 
completely returned to levels measured at 
week 0, but analysis with a paired t-test 
between the plasma cholesterol 
concentratton at week 0 and week 16, but 
statistical significance was not reached 
(P<.05). Values are mean±SEM. 
During the induction period total plasma cholesterol increased from 2.4±0.1 mM to 
10.7±O.6 mM at baseline and at week 8, respectively. Low cholesterol feeding reduced an 
average total plasma cholesterol to 2.S±O.1 mM for all diets combined (Fig. 4, P<.OS vs plasma 
cholesterol at the end of the induction period). No difference was observed between the different 
regression diets. 
Plasma VLDL-, IDL- and LDL-cholesterol concentrations decreased with all 4 regression 
diets compared to the induction group, but only the FO and CH groups had lower HDL 
cholesterol concentrations (Table 8). Furthermore, FO feeding resulted in higher VLDL 
cholesterol concentration than CH feeding and in lower HDL cholesterol concentration than LF 
feeding. Compared to the SO group, FO lowered LDL- and HDL-cholesterol concentrations. 
The HDL fraction in the CH group also contained less cholesterol than in the SO group. Between 
the SO and LF groups no differences were observed. 
Table 8. The effects of dietary fish oil, sunflower oil, lard fat and carbohydrates on the distribution 
of cholesterol over the different lipoprotein fraction. 
lipoprotein fractions 
VLDL IDL LDL HDL 
Induction (n=6) 1.11 ±0.48 3.41 ± 1.49 6.54± 2.14 1.56 ± 0.28 
Fish oil (n=5) 0.08 ± 0.05' 0.02 ± 0.01' 0.88 ± 0.15' 0.80 ± 0.24' 
Sunflower oil (n=5) 0.05 ± 0.02' 0.01 ± 0.01' 1.24 ± 0.28' 1.41 ± 0.25" 
Lard Fat (n=5) 0.03 ± 0.01' 0.04 ± 0.04' 1.58 ± 0.56" 1.23 ± 0.08' 
Carbohydrates (n=5) 0.03 ± 0.01" 0.01±0.01' 1.12 ± 0.20' 1.05 ± 0.18' 
Induction the animals, that were fed a diet containing 2% cholesterol and 9% lard fat. VLDL=very low 
density lipoproteins; IOL=intermedfate density lipoproteins; LOL=low density lipoproteins; HDL=high density 
lipoproteins. *P<.05 vs induction; 'P<.05 vs fish oil; 'P<.05 vs carbohydates 
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The different fatty acids in the regression diet induced marked changes in the chemical 
cemposition of the VLDL fraction. In the Fa and CH groups free cholesterol and phospholipid 
centent increased compared to the SO group. Furthermore the VLDL fraction of the CH group 
also contained less triglycerides than that of the SO group (Fig 5). The chemical composition 
of the IDL, LDL and HDL fraction did not differ between the Fa, SO and LF groups. The CH 
group centained more free cholesterol in the IDL and LDL fractions. In the HDL fraction free 
cholesterol of the CH group was only higher when compared to the LF group. 
Correlatiolls between plasma lipids and lipid content of the various vessel 
The cholesterol accumulation in the aortic lesions and the control vein correlated with the 
triglyceride and cholesterol concentrations in the VLDL fraction (for all regression groups 
r~O.77, p<O.OI and FO.62, p<O.OI, respectively). VLDL concentration, however, did not 
correlate with the cholesterol content of the vein graft. Instead cholesterol content of the graft 
showed a better cerrelation with the LDL cholesterolester concentration (F0.48, P<.05). HDL 
Induction 
Regression: 
Fish oil 
Sunflower all 
lard fat 
Carbohydrates 
" 
" 
Fig 5. Pies showing the effects 
of the induction diet and the 
subsequent dietary Intervention 
with dietary fish all, sunflower 
oil, lard fat and an isocaloric 
quantity of carbohydrates on the 
triglyceride, phophoJipid, free 
cholesterol, cholesterolester and 
protein content of the VlDL 
fracUon of the male population 
(For all groups, n=5). *P<.05 vs 
sunflower oil. 
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cholesterolester concentration showed a positive correlation with the cholesterol content of the 
aorta, graft and control vein (Table 9). 
Discussion 
The most important finding in this study was that in a direct comparison with sunflower oil 
(SO), lard fat (LF) and an isocaloric quantity of carbohydrates (CH) fish oil (FO) did not 
enhance the effects of a cholesterol lowering diet on promoting ·regression of atherosclerosis, 
However, the effects of cholesterol lowering diet on of atherosclerosis in the vein graft were not 
consistent. While there was a marked decrease in cholesterol content of the vein graft, luminal 
encroachment and intimal thickness of the vessel remained unaffected and therefore did not 
substantiate "regression" of graft atherosclerosis. Similar observations were also made in the 
control vein. On the other hand in the left circumflex coronary artery (LCXCA) lumen and 
media area increased significantly, but luminal encroachment showed a tendency to increase 
during the post-induction period compared to the induction group. Total cholesterol 
Table 9. Correlations between the total cholesterol content of the different lipoprotein fractions 
and the total cholesterol of the aortic lesions, vein grafts and control veins. 
Total cholesterol content 
Aortic lesion Vein graft Control vein 
p p P 
T otaf cholesterol 
VLDL 0.62 <0.01 -0.06 0.81 0.57 <0.01 
IDL 0.14 0.54 0.37 0.11 -0.05 0.84 
LDL 0.00 0.99 0.38 0.10 -0.02 0.95 
HDL 0.41 0.07 0.40 0.08 0.46 0.04 
Cholesterolester 
VLDL 0.63 <0.01 0.10 0.67 0.56 0.01 
IDL 0.25 0.28 0.40 0.08 0.01 0.98 
LDL 0.10 0.66 0.48 0.03 0.06 0.80 
HDL 0.46 0.04 0.45 0.05 0.47 0.04 
T riglycerides 
VLDL 0.77 <0.001 -0.05 0.85 0.58 <0.01 
IDL 0.06 0.81 0.28 0.23 0.05 0.84 
LDL -0.26 0.26 -0.37 0.11 -0.11 0.64 
HDL 0.01 0.96 -0.15 0.52 0.03 0.90 
VLDL=very low density lipoprotein; IDL -intermediate density lipoprotein; lDL-fow density lipoprotein; 
HDL=high density lipoprotein. 
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accumulation in the lesion and non-lesion areas of the aorta remained unaffected during the 
post- induction period. The cholesterol content of the aortic lesion and the vein were both 
positively correlated to plasma VLDL-cholesterol concentration, while the cholesterol content 
of the graft was related to plasma LDL-cholesterolester concentration. 
The reduction in total cholesterol content in the vein grafts has not led to a decrease in 
luminal encroachment or mean intimal thickness of the graft (Table 3). Because the 
atherosclerosis process in the grafts was characterized by total cholesterol accumulation and 
fibrointimal hyperplasia, the time course for regression may be different for the various 
parameters by which atherosclerosis is assessed. Donald et al reported that reduction in total 
cholesterol accumulation, especially the cholesterol ester part, was present in the early phase of 
regression. 12 Regression of advanced atherosclerotic lesions, which contain a higher fibrotic 
component, takes much longer. In the aorta Kobari et al has found regression of fatty streaks, 
but not of the fibrous plaque lesions after a 9 month regression period.13 Regression of advanced 
lesions has been presented by Daoud et ai, but their observation followed a regression period of 
14 months Oil a diet, low in fat and cholesterol." The present ftnding of a lower total cholesterol 
content, but similar luminal narrowing may represent an early form of regression of 
atherosclerosis in vein grafts, provided that regression follows the same time course in grafts and 
in arteries. The present experimental post-induction period of2 months may have been too short 
to investigate the effect of fish oil on the cellular components of vein graft atherosclerosis in 
pigs. 
As described above luminal encroachment in the LCXCA did not show any regression of 
atherosclerosis in the post-induction period. In the LF group luminal encroachment even tended 
to increase, but statistical significance was not reached. The latter is a consistent finding in our 
laboratory as Sassen et al have reported the same phenomenon twice.6,9 In those studies we 
observed that in the post-induction period luminal encroachment of non-abraded coronary 
arteries increased when by weight 9% or 10% lard fat remained present in the diet.6,9 The higher 
plasma cholesterol in lard fat fed group was proposed to underly this phenomenon, because 
Clarkson et al reported that progression of atherosclerosis would occur when plasma cholesterol 
concentration did not completely return to baseline values. IS In the present study plasma 
cholesterol concentration in the LF also did not completely return to mean baseline level 
(2.4±0.6 mM and 3.O±O.7 mM, at the onset and at the end of the experimental protocol, 
respectively, P<.05 as tested with a paired t-test), but similar to the increase in luminal 
encroachment statistical significance was not reached. The tendency of coronary luminal 
encroachment to increase was, however, accompanied by a significant increase in both lumen 
and media area, which was consistent in all post-induction diet groups. This finding coincides 
with reports that hypercholesterolemia interferes with endothelial nitric oxide production (for 
review see ref. 16), and may explain the narrowed lumen in the induction group. The increased 
media area in the post- induction period may be a response to the increased stress in the vessel 
wall as lumen diameter increases, suggesting some kind of remodeling of the coronary artery. 
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In contrast to the graft and the control vein, removal of the 2%cholesterol from the diet did 
not result in a lower total cholesterol content in the lesion and non-lesion area of the abdominal 
aorta. This finding suggests) that accumulated cholesterolester more easily leaves from the walls 
of veins and grafts than that of the aorta. A possible explanation for these differences may be the 
integrity of the endothelium of the various vessels studied. During surgery the preparation of the 
saphenous vein invariably causes a loss of endothelium. 1,2,11 The subsequent exposure of the vein 
graft to arterial blood pressures may not only hinder re-endothelialization, but also diminish the 
function of the remaining and regenerated endothelial cells. This is evidenced by a report of 
Finck et aI, who found that after 6 months endothelial pemleability in arterialized vein grafts was 
still increased, while a confluent endothelium was already present after 1 month. IS Furthermore, 
vein grafts retains many of the specific characteristics of veins.2 One of the characteristics is that 
veins have a more permeable endothelium than arteries. 19 The latter coincides with our rIDding 
that in the control veins total cholesterol content decreases due to a lowering in plasma 
cholesterol.Thus, not only the absence of a functional endothelial layer, but also the presence of 
venous endothelium may result in a higher susceptibility of the vein grafts for changes in plasma 
cholesterol level. 
For the post-induction groups the cholesterol content in the aortic lesions showed a positive 
correlation with VLDL-triglyceride as well as VLDL-cholesterol concentrations. This finding 
is in apparent contrast with our previous ftnding in hypercholesterolemic swine that VLDL 
triglycerides are negatively correlated to the cholesterol content of the aortic lesions 
(unpublished data). This may be related to the change in chemical composition of the VLDL 
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Fig 6. Graphs showing the individual pOints used for determInation of the relation between the cholesterol content 
of the aortic lesion area and plasma VLDL triglyceride and cholesterol concentration. VLDL=very low density 
lipoprotein. 
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fraction. Relative to VLDL of animals in the hypercholesterolemic induction group, in the post-
induction period VLDL contained more triglycerides and less cholesterol ester in all dietary 
groups (Fig. 5). A cholesterol-rich VLDL particle undoubtedly is more atherogenic than a 
triglyceride-rich VLDL particle. It is therefore likely that cholesterol content in the aortic 
lesions correlates with the major lipid constilnent of VLDL. This also means that in swine 
VLDL is a predicting factor for aortic total cholesterol infiltration. 
We conclude that a low cholesterol diet can effectively reduce the cholesterol content of 
vein grafts irrespective of the presence of fish oil, sunflower oil, lard fat or an isocaloric quantity 
of carbohydrates in the diet. However, the duration of the present slndy precludes any 
conclusions on the beneficial effect of fish oil on regression of fibrointimal hyperplasia in vein 
grafts. The higher susceptibility of the vein grafts to changes in plasma cholesterol levels than 
tlle aorta suggests a different endothelial function in the vein graft compared to that in the aorta. 
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Chapter 10 
General discussion 
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In this thesis 2 facets of cardiovascular disease and their therapeutic modulation are discussed. 
The fIrst concerns myocardial stunning and its pharmaceutical treatment. The second concerns 
the problems following revascularisation of the ischemic myocardium by venous coronary artery 
bypass grafting. 
Since Heyndrickx et al fIrst described the phenomenon of prolonged post-ischemic 
contractile dysfunction of the myocardium, several investigators had searched for ways to recruit 
contraclile function.! Smith et al were the fIrst to report that contractile function can be recruited 
with p-adrenergic receptor agonists.' Many investigators had since confIrmed these report 
(chapter 2). However, they all used either systolic segment shortening or wall thickening to 
assess recovery of systolic function. The problem with these variables of contratile function is 
that they are highly dependent on the loading conditions of the left ventricle and in chapter 2 
several drugs are described which improve contractile function of stunned myocardium by 
reducing afterload of the left ventricle. In chapter 3 we have used the end-systolic left ventricular 
pressure-segment length relationship, which provides a load-independent index of regional 
myocardial contractility,3 to assess recruitment of contractile function with dobutamine in left 
ventricular stunned myocardium. Because this method is independent of loading conditions, it 
may also serve to compare stunning in left and right ventricles and their response to chronotropic 
and inotropic stimulation with dobutamine. Brief occlusion of the left anterior descending 
coronary artery decreased both load-dependent and load-independent variables of contractility. 
Subsequent chronotropic stimulation did not affect contractility, but infusion of dobutamine 
improved both load-dependent and load-independent variables of contractility in stunned 
myocardium of both ventricles (chapter 3). 
The main concern of inotropic stimulation with p-adrenergic receptor agonists is that the 
increase in contractility is accompanied by an increase in myocardial oxygen demand and thus 
coronary blood flow. In the presence of stenosis of the coronary artery this may induce an 
oxygen deficit of the myocardium and worsen contractility in stunned myocardium. Furthermore 
it is doubtful whether p-adrenergic receptor agonists targets the underlying mechnnism of 
stunned myocardium. Kusuoka and Marban have proposed that the likely mechanism underlying 
the prolonged contractile dysfunction of stunned myocardium is a decrease in the calcium 
sensitivity ofthemyofIbrils.'" Recently the group of Marban provides further evidence that the 
myofibrillar sensitivity to calcium has been decreased in stunned myocardium and they also 
report that stunned myocardium copes poorly with an increased calcium load warrants against 
excessive inotropic stimulation such as p-adrenoceptor agonists or phosphodiesterase 
inhibitors.6,7 The rational approach to treat myocardial stunning will be to restore the calcium 
sensitivity of the myofIbrils. 
Until now most alleged calcium sensitizers used to improve contractile function also 
possesses phosphodiesterase inhibitory properties. EMD 60263 is a newly developed 
thiadiazinone derivative which sensitizes the myofilaments to calcium, but possesses only 
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minimal phosphodiesterase inhibitory properties.8 Thiadiazinone derivatives increases calcium 
sensitivity by increasing the myofibrillar Mg2+ ATPase activity.' In chapter 6 is shown that ill 
vitro the effects ofEMD 60263 are specific for myofibrillar Mg2+ ATPase activity and that EMD 
60263 has no effect on sarcoplasmic reticular Mg'+ ATPase activity. In chapter 4 we have 
investigated the effects ofEMD 60263 on contractile function in an in vivo model of stunned 
myocardium. In this model we have previously demonstrated that the maximal calcium pump 
activity of the sarcoplasmic reticulum had not decreased during stunning.1O Administration of 
EMD 60263 dose-dependently increases systolic segment shortening and total recovery of 
systolic segment shortening is achieved at a dose of 1.5 mg/kg. However, the improvement is 
accompanied by a decrease in heart rate, which can be attributed to blockade of the delayed 
rectifying current. Bradycardia may also improve systolic segment shortening, but this 
mechanism has been excluded, because neither the specific bradycardic agent zatebradine nor the 
isomeric enantiomer EMD 60264, which is identical to EMD 60263 except for the calcium 
sensitizing properties, could emulate the improvement in systolic segment shortening induced 
by EMD 60263. Other mechanisms have also been excluded, because the effects ofEMD 60263 
on systolic segment shortening are unaffected by C<- and p-adrenergic receptor blockade. These 
results also support the hypothesis that a decrease in myofibrillar sensitivity to calcium is the 
underlying mechanism of stunned myocardium. 
Some investigators, however, fear that increasing the calcium sensitivity of the myofibrils 
may have detrimental effects on diastolic function, because under pathologic conditions such as 
myocardial stunning and heart failure increased intracellular calcium have been observed. lI 
Impairment of diastolic relaxation and thus left ventricular filling may subsequently hamper 
systolic function. At a dose of 1.5mg/kg ofEMD 60263, which already fully recovers systolic 
segment shortening, we observe no detrimental effect of increasing myofibrillar calcium 
sensitivity on diastolic function as assessed with diastolic segment length changes. At higher 
doses ofEMD 60263 (3.0 rug/kg) increases both systolic segment length and stroke volume to 
above baseline level (chapter 5). However, concurrently the onset of diastolic segment length 
lengthening has been delayed, perhaps indicating diastolic dysfunction. Subsequent atrial pacing 
at heart rate levels before stunning to exclude the effects ofEMD 60263-induced bradycardia 
returns systemic hemodynamics and regional contractile function to baseline values. Furthermore 
atrial pacing does mitigate the delay in the onset of segment lengtilening in stunned myocardium, 
but not in the not stunued myocardium. The different response to atrial pacing suggests that 
despite a restoration in systolic segment shortening there is still a difference in the calcium 
sensitivity of the myofibrils of stunned and not stunned myocardium. To compare the effects of 
EMD 60263 Witll those of dobutamine the hearts have been paced at 30 beats per minute above 
stunning level. At this heart rate level systemic hemodynamics are impaired, because of diastolic 
relaxation problems as end-diastolic segment length decreased and end-diastolic left ventricular 
pressure increased. That diastolic function may be inlpaired at higher doses ofEMD 60263 can 
also be deducted from our fIndings in the ill vitro study (chapter 6). Myofibrillar Mg2+ ATPase 
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activity at low calcium levels and high doses of EMD 60263 (> 10 ~M) are shown to be higher 
than those at high calcium levels without EMD 60263. Recently Sunderdick et al have also 
shown that in isolated rabbit hearts high doses ofEMD 60263 (3 and 10 f,M) deteriorates systolic 
function, due to relaxation abnormalities. 12 In the same model EMD 57033, which has more 
phosphodiesterase inhibitory properties than EMD 60263, have also been tested, but in contrast 
to EMD 60263 improves not only systolic, but also diastolic function," 
Calcium sensitizers are promising inotropic agents, but warrant further investigations. The 
possible diastolic relaxation problems with high doses ofEMD 60263 perhaps serve as a caution 
against the use and development of pure calcium sensitizers. Development of calcium sensitizing 
agents tllat also possess some phosphodiesterase inhibitory activity such as EMD 57033 may be 
a better alternative. Unpublished data from our laboratory obtained in conscious pigs with normal 
myocardium have shown that EMD 57033 increases systolic contractile fUllction by increasing 
the myofibrillar calcium sensitivity, but in contrast to EMD 60263 does not impair diastolic 
relaxation. Investigating the effects of EMD 57033 ,in a similar animal model of stunned 
myocardium may reveal whether this is the correct future direction of treating myocardial 
stunning. 
Instead of treating the consequences of myocardial ischemia such as stunned myocardium. 
treatment can be implemented at an earlier stage. Progression of atherosclerosis in the epicardial 
coronary arteries may necessitate revascularisation to prevent further cardiovascular events. One 
of the techniques is coronary artery bypass grafting. The shorttenn results of CABG is favorable 
as both mortality and clinical symptoms are reduced.13 However, these grafts are more 
susceptible to atherosclerosis, which therefore progresses in an accelerated fashion compared to 
native coronary atherosclerosis. The exact mechanism is unknown, but damage to the endothelial 
layer ofthe graft and the ensueing thrombosis and wound healing are likely to be involved in the 
genesis of graft atherosclerosis. 
Various treatments have been proposed to reduce atherosclerosis in the grafts. Fuster and 
Chesebro have shown that anti-platelet therapy effectively reduces early graft failures, but the 
beneficial effect on late graft failures is less striking. H They believe that anti-platelet therapy 
may prevent a complicating thrombus superimposed on intimal hyperplasia in the graft, but that 
anti-platelet therapy is ineffective in preventing the primary occlusive proliferative disease. 
Angelini and Newby proposed lowering of plasma cholesterol because the predominant 
underlying mechanism of late graft failures is accumulation of lipids within the fibrointimal 
hyperplasia and graft wall,l' The latter have since been confirmed by Blankenhorn et ai, who 
have found that colestipol-niacin therapy inhibited progression of atherosclerosis in coronary 
bypass grafts. 16 A favorable effect offish oil on experimental arteriosclerosis have been reported 
by several investigators (chapter 7). Because the process behind late graft failure resembles 
atherosclerosis in nearby coronary arteries, fish oil may also excert a favorable effect on vein 
graft atherosclerosis. III hypercholesterolemic dogs fish oil have been shown to effectively inhibit 
intimal thickening in veno-arterial bypass graftsY·19 However according to Sarris et ai, 
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differences in lipoprotein metabolism and fibrinolytic system between dogs and humans may 
alter the pathogenesis of vein graft atherosclerosis." Thus, whereas in dogs modulation of growth 
factors" and platelet functionl~i9, but not modulation of plasma lipoproteins", by fish oil are the 
predominant factors determining graft atheroscierosi,s, in humans modulation of plasma 
lipoproteins may playa more important role. 
Therefore, we investigated in a hypercholesterolemic swine model ofveno-arterial bypass 
grafting the effects of fish oil on progression and regression of graft atherosclerosis. In contrast 
to the studies in hypercholesterolemic dogs, we did not observe a favorable effect of fish oil on 
atherosclerosis in the grafts as assessed with cholesterol accumulation and morfometry (luminal 
encroachment and intimal thickness). The control vessels, the right saphenous vein and the left 
circumflex coronary artery, did also not differ between the fish oil, sunflower oil and lard fat 
groups. Fish oil, however, did excert a favorable effect in the hypercholesterolemia-induced fatty 
streaks of the abdominal aorta, which had a lower cholesterolester content than those in the 
sunflower oil or lard fat group. The differences could not be explained with total plasma 
cholesterol, which was similar in the three hypercholesterolemic groups. The distribution of 
cholesterol between the different lipoprotein fractions was significantly altered by fish oil. 
VLDL-cholesterol was lower with fish oil than in the other 2 groups, while HDL-cholesterol in 
the fish oil group was lower than in the sunflower oil group. Furthermore, the chemical 
composition ofthe VLDL particles was altered by fish oil, containing more triglycerides and less 
cholesterolester dIan in the odler 2 groups. Between sunflower oil and lard fat groups there were 
no differences. Stepwise regression analysis for all animals revealed that VLDL-cholesterol 
correlated to the cholesterol content of the fatty streaks in the abdominal aorta (J=O.77, p<O.OOI). 
These results suggested that VLDL-cholesterol was a predicting factor for the 
hypercholesterolemia-induced lipid accumulation in normal aortic tissue. The difference in 
response to fish oil between the abdominal aorta and the graft suggested that the presence of an 
intact endothelial layer is a prerequisite for fish oil to excert a favorable effect on progression of 
atherosclerosis. 
In chapter 9 the effects of fish oil on regression of graft atherosclerosis are discussed. 
Several investigators have shown that fish oil can potentiate the effect of lowering plasma 
cholesterol on regression of arteriosclerosis, but the question remains whether this also apply to 
venous bypass grafts. The results in chapter show that lowering plasma cholesterol can decrease 
cholesterolester content of the graft, but that this effect is independent of the fatty acid present 
in the diet. Because the marfometric parameters have not changed it seems that regression 
depends on the method used to assess atherosclerosis. The difference in response to lowering 
plasma cholesterol between veins and vein grafts and aorta suggests that different mechanisms 
underly the atherosclerosis process in veins and arteries. Similar to our findings in chapter 8 a 
positive correlation between VLDL concentration and total cholesterol content in the aortic fatty 
streaks. It is possible that VLDL concentration playa major role in modulating total cholesterol 
accumulation in the aortic wall. 
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The studies regarding fish oil in this thesis show no beneficial effect of fish oil on 
atherosclerosis in venous bypass grafts. The effects offish oil in the abdominal aorta as observed 
in chapter 8 are the most promising, but the question remains whether fish oil should be 
administered to the whole population to prevent atherosclerosis. In our hypercholesterolemic 
swine model in which the development of atherosclerosis has been accellerated fish oil is able 
to mitigate the development and progression of atherosclerosis. This finding coincides with the 
report of Bang et al in the Inuit population." The lower incidence of cardiovascular disease in 
the Inuit population compared to a comparable age-group of Danes may also imply that fish oil 
inhibits rather than totally prevent the development of atherosclerosis. Furthermore the results 
in chapter 8 suggest that the endotlleliallayer may play an important role in mediating the effects 
of fish oil 011 atherosclerosis, but because we have not investigated this aspect in tWs thesis no 
definite conclusions can be made. In chapter 9 we have observed that lowering of plasma 
cholesterol decreases total cholesterol content of the vein grafts. This may ultimately result in 
a reduction of fibrointimal thickening and thus reduce late graft failures. While we have not 
found any evidence in our present experiments that this might happen, other investigators have 
shown that regression of fibrous lesions can be obtained using longer post-induction periods. 
However, longer experimental protocols may also alter the present findings in both chapter 8 and 
9. A consistent finding in both chapter 8 and 9 is the correlation between cholesterol content of 
the aortic wall and VLDL concentration. Also in the PDA Y study a correlation has been found 
between VLDL-cholesterol concentration and the severity of the atherosclerotic lesions in the 
aorta and coronary artery." VLDL concentration may therefore be used in the clinical setting as 
a predicting factor of development of atherosclerosis. Furthermore, lowering of plasma VLDL 
concentration may result in a reduction of atherosclerosis and thus represent a future direction 
of treating coronary atherosclerosis and ischemic heart disease. 
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Dit proefschrifl heefl betrekking op ontstaan en behandeling van ischemie van het 
hartspienveefsel, het myocard. Echter, voordat ingegaan wordt op de verschillende 
therapeutische mogelijkheden van myocard ischemie, is het belangrijk om eeest uader in te gaan 
op de term myocard ischemie en de achtergronden daarvan. 
Myocard ischemie haudt in dat er een onbalans bestaat tussen energie vraag en energie 
aanbod in het hart weefse!. Het hart is van nature een aeroob orgaan, wat inhoudt dat het hart 
weefsel continu zuurstof nodig heeft om voldoende energie te genereren om in leven te bJijven 
en om de pompfunktie van het hart te kunnen garanderen. Onder normale omstandigheden haalt 
het hart vrijwel al het zuurstof uit het aangeboden bloed. Dit betekent dat wanneer er een 
toename anstaat in de energie en daarmee dus van de zuurstof vraag van het hart, deze alleen 
voldaan kan worden door een toename in bloeddoorstroming van het myocarrl. Een belallgrijke 
rol hierbij spelen de kransslagaderen (coronair vaten) van het hart. Gezonde coronair vaten 
ktmnen zelfs tijdens hevige inspanning zander moeite voldoen aan de toename in energie vraag. 
De disbalans in energie vraag en aanbod ontstaat wanneer er onvoldoende bloed kan worden 
aangevoerd via de coronair vaten bijvoorbeeld als gevolg van een vernauwing van het bloedvat, 
de aanwezigheid van een bloedstolsel of eeo combinatie van beide. 
Onder invloed van ischemie verandert in het myocard de stofwisseling en daarmee de 
pompfunktie van het hart. Door het tekort aan zuurstof gaat de aerobe stofwisseling over in 
anaerobe stofwisseling, die gekenmerkt wordt door melkzuur produktie en een Iagere energie 
opbrengst. Hierdoor kan het hart weefsel oiet voldoende energie generereo om contractie of 
homeostase van de hartcel te kunnen waarborgen, waardoor de pompfunktie van het hart en 
uiteindelijk oak de levensvatbaarheid van de hartcellen in geding kom!. Het uiteindelijke 
resultaat van myocard ischemie is echter afhankelijk van de duur en de ernst van ischemie. 
Wanneer men praat over een volledige afsluiting van een coronair vat en een gezond myocard 
dan heeft een ischemie duur van minder dan 2 minuten geen blijvende nadelige gevolgen voor 
het myocard. Opheffing van de afsluiting leidt dan oak tot een direkt en volledig herstel van 
contractiele funktie van het myocard. Duurt de afsluiting langer dan 20 minuten dan beginnen 
hartcellen af te sterven en herstel van de bloeddoorstroming zal leiden tot een vertraagd en 
onvolledig hers tel van de contractiele funktie. Is de duur van de ischemie tussen de 2 en 20 
minuten dan blijven de hartcellen in leven, maar na normalisatie van de bloedvoorziening kan 
het uren tot dagen duren voordat er een volledig herstel van de contractiele funktie heeft plaats 
gevonden. Dit fenomeen, ook weI "myocardial stunning" genoemd, is voor het eerst beschreven 
door Heyndrickx et a!. Zij hebben in een diermodel gevonden dat na een korte periode van 
ischemie met een duur van minder dan 20 minuten regionale myocard funktie sterk verminderd 
bleef, ondanks normale bloeddoorstroming en afwezigheid van celdood. 
Myocardial stunning van een deel van de linker hartkamer (linker ventrikel) heefl op zich 
geen behandeling nodig, omdat funktie herstel spontaan zal plaats vinden. Ditgeldt echter aileen 
maar, indien de rest van de linker ventrikel nonnaal funktioneert en de pompfunktie van het hart 
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gewaarborgd blijfi. Komt de pompfunktie wei in het gedrang dan is behandeling noodzakelijk. 
Farmacologische behandeling van myocardial stunning is gericht op het voorkomen ervan, of 
op verbeteren van de contractiele functie van het gestunde myocard. In hoofdstuk 2 van dit 
proefschrift zijn de diverse behandelingsmogelijkheden beschreven, maar in het kader van de 
samenvatting zal aileen worden ingegaan op de behandeling, die gericht is op het verhagen van 
de contractiele funktie. 
Van p-adrenerge receptor agonisten zoals adrenaline en noradrenaline is bekend dat ze de 
contractiliteit (inotropie) van het myocard verhogen. Deze en verwante stoffen zijn dan ook als 
eerste geprobeerd om de contractiele funktie in het gestunde myocard te verhogen. Smith et al 
hebben als eerste laten zien, dat isoprenaline in staat was de contractiele funktie van het gestunde 
myocard volledig temg te brengen. Sindsdien hebben meerdere onderzoekers dit bevestigd, maar 
de effekten van deze stoffen zijn tot nu toe aileen onderzocht voar de linker ventrikel. Over 
stunning van de reehter ventrikel en de behandeling daarvan is weinig bekend. Pompfunktie van 
de rechter ventrikel is belangrijk voor de vulling van de linker ventrikel en een falen van de 
rechler ventrikel zou de pompfunktie van de linker ventrikel nadelig kunnen beInvloeden. 
Hiermee verband houdend is het oak van belang om te weten of stunning van de feehter 
ventrikel op dezelfde manier zal reageren op contractiliteit verhogende farmaca als de linker 
ventrikeL In hoofdstuk 3 hebben we deze aspecten onderzocht en vonden dat de contractiele 
funktie na stunning procentueel hetzelfde afnam in de rechter en linker ventrikeL Verder reageert 
de gestunde rechter ventrikel op dezelfde manier als de gestunde linker ventrikel op zowel hart 
frequentie verhoging als op inotrope stimulatie met dobutarnine. 
Hoewel p-adrenerge receptor agonisten en oak fosfodiesterase rernmers de contractiele 
funktie van het gestunde myocard kunnen verhogen, blijfi de vraag of dit wei de meest 
aangewezen therapie is. Een rationele therapie zou zijn om de onderliggende mechanismen van 
de afname in contractiele funktie direkt aan te pakken. Vele mechanismen zijn voorgesteld als 
de onderliggende oorzaak, maar in een recent overzicht van de literatuur laat Bolli zien dat vrije 
zuurstof radicalen en/of een verstoring van de calcium homeostase binnen de cel de meest 
waarschijnlijke oorzaken zijn, De huidige mening is, dat tijdens de occlusie en in het begin van 
de daarop volgende herstel van de bloeddaorstroming vrije zuurstaf radicalen worden gevormd, 
die op hun beurt de calcium gevoeligheid van de contractiele elementen van de hartspiercel 
(myofibrillen) verlagen. De p-adrenerge receptor agonisten, fosfodiesterase remmers en 
verhoging van extracellulair calcium verbeteren de contractiele funktie van het gestunde 
myocard door de calcium transient te verhogen, met andere woorden de amplitude van de 
intracellulaire calcium con centra tie in de cel neemt toe, In aile drie de gevallen wordt de 
verminderde calcium gevoeligheid van de myofibrillen eigenlijk behandeld met een overmaat 
aan calcium en een betere therapie zou kunnen zijn het verhagen van de calcium gevoeligheid 
met zogenaamde calcium sensitizers. 
Tot voor kort was er geen bewijs dat calcium sensitizers de contractiele funktie van het 
gestunde myocard illl'ivD kunnen herstellen, omdat de gebruikte calcium sensitizers vaak ook 
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nog phosphodiesterase inhibiterende eigenschappen bezitten. [n de drie volgende hoofdstukken 
van dit proefschrift zijn de effecten onderzocht van cen nieuw ontwikkelde calcium sensitizer 
EMD 60263, die nauwelijks meer fosfodiesterase remmende eigenschappen bezit. Hoofdstuk 4 
behandelt de effecten van EMD 60263 op de contractiele funktie van normaal en gestund 
myocard. In cen varkensmodel verlaar het myocard na stunning ongeveer 50% van zijn 
oorspronkelijke contractiele functie, bepaald met regionale segment [engle verkorting. 
Toediening van EMD 60263 herstelde dosis-afbankelijk de segment lengte verkorting in het 
gestunde gebied en met cen dosis van 1,5 mglkg was er zeffs een volledig herstel van de segment 
[engle verkorting. Opvallend was het feit dat het effect in het gestunde gebied beduidend hoger 
was dan in het aanliggende gebied. Ook de mechanische efficientie of wei de hoeveelheid arbeid 
per eenheid verbruikte zuufstof, die was afgenomen tijdens stunning, werd weer volledig 
hersteld. In het niet-gestunde gebied was er geen toename van de mechanische efficientie. Deze 
effecten gingen echter gepaard met een afname van de hart frequentie. Toediening van een 
specifiek hartfrequentie verlagende stof, zatebradine, leidde niet tot een verbetering van segment 
lengte verkorting. Andere mechanismen, die zouden kunncn lei den tot verbetering van de 
contractiele funktie werden uitgesloten, omdat toediening van (t- and p-adrenerge receptor 
blokkers de effecten van EMD 60263 op het gestunde myocard niet blokkeerden. 
Volgens sommige onderzoekers kan verhoging van de calcium gevoeligheid, naast 
verbetering van de contractiele funkle, oak leiden tot een verslechtering van de relaxatie van het 
myocard. Een vertraagde relaxatie zou de vulling van de ventrikels nadelig kunnen belnvloeden, 
hetgeen de pompfllnktie van het hart doet afnemen. [n hoofdstllk 5 hebben we aan de hand van 
hetzelfde varkensmodel als we in hoofdstuk 4 gebmiken de effecten van EMD 60263 onderzocht 
op regionale segment lengte verlenging, als maat voor relaxatie. Bij een dosering van 1,5 mglkg 
vanden we wederom een volledig herstel van segment lengte verkorting, hetgeen echter niet 
gepaard ging met een afwijkende segment lengle verlenging. Verhoging van de dosering tot 3,0 
mglkg vertraagde het begin van segment lengte verkorting in zowel het gestunde als het niet-
gestunde myocard. Dit hield in dat de contractie duur van het myocard verlengd was vergeleken 
met de situatie onder normale condities of na toediening van 1,5 mg/kg EMD 60263. Om 
onderscheid te kunnen maken tussen de effecten van EMD 60263-geinduceerde hartfrequentie 
verlaging en van calcium gevoeligheid verhoging op de segment lengte verlenging, werd de 
hartfrequentie verhoogd tot het niveau van vlak voor de toediening van EtvID 60263. 
Hartfrequentie verhoging door middel van elektrische prikkeling van de rechter atrium (atrial 
pacing) leidde tot een nomlalisatie van segment lengte verlenging in het gestunde gebied, maar 
niet in het aanliggende normale gebied. Aangezien atrium stimulatie niet aileen de calcium 
transient doet stijgen, maar o;)k de calcium gevoeligheid verlaagt, suggereert dit verschil van 
reactie in segment lengte verlengillg, dat na toediening van EMD 60263 er nog steeds een 
verschil bestaat in de calcium gevoeligheid tussell het gestunde en het niet-gestunde myocard. 
[n hoofdstuk 6 hebben we onderzocht of EMD 60263 inderdaad de calcium gevoeligheid 
verhoogd van de myofibrillen en niet van andere intraceUulaire strukturen in een in vitro 
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opstellingen de bevindingen bevestigen de resultaten van de hoofdstukken 4 en 5. 
Voor de toekomst is het onzeker of de ontwikkeling van pure calcium sensitizers zoals 
EMD 60263 weI gelndiceerd is, vanwege de mogelijke relaxatie stoornissen. Misschien vormen 
de calcium sensitizers, die oak nog enige fosfodiesterase,remmende eigenschappen bezitten, een 
beter altematief, omdat fosfodiesterase remming de relaxatie van het myocard kan bevorderen. 
EMD 57033 is een calcium sensitizer, die meer fosfodiesterase remmende eigenschappen bezit 
dan EMD 60263. Recente resultaten (nog niet gepubliceerd) uit ons laboratorium laten zien dat 
EMD 57033 de contractiele funktie verhoogt door een toename in de calcium gevoeligheid van 
de niet-gestunde myofibrillen. Echter, in tegenstelling tot EMD 60263 zijn er met EMD 57033 
geen relaxatie stoomissen waameembaar. EMD 57033 zal binnenkort getest worden in hetzelfde 
dierexperimentele model voar myocardiale stunning, zoals beschreven in hoofdstuk 6. 
In de behandelde hoofdstukken heeft de nadruk voornamelijk gelegen op behandeling van 
de gevolgen van ischemie en in het bijzonder van myocardiale stunning. Eehter, behandeling kan 
ook meer stroomopwaarts plaats vinden. De oorzaak van ischemie, een vernauwing van het 
eoronair vat, kan worden opgeheven door revascularisatie van het myocard. Ondanks nieuwe 
ontwikkelingen in de interventie cardiologie, zoals ballon dilatatie en het plaatsen van 
endovasculaire prothesen neemt coronaire omleiding (bypass) chirurgie nog steeds een 
belangrijke plaa!s in bij het herstellen van de bloeddoorstroming naar het myocard. Bij een 
dergelijke operatie wordt een vene of een arterie van elders uit het Bchaam gebruikt om een 
omlegging om de coronaire vemauwing te maken. Het resultaat van eell bypass operatie is vaak 
gunstig, zoals gemeten aan overleving en vermindering van klinische symptol11en. Echter, 
vemauwing en zelfs volledige occlusie van dergelijke bypass transplantaten komen veelvuldig 
voor. Hiermee keren de klinische symptomen van myocard ischemie terug, die weer leiden tot 
een nieuwe ingreep. De precieze mechanismen die tot occlusie van de graft lei den zijn onbekend, 
maar schade aan de endotheellaag van het transplantaat en de daarmee gepaarde thrombose en 
wondheling kunnen een versnelde vorm van atherosclerose (aderverkalking) op gang brengen. 
In het begin van de jaren zeventig beschreven Bang et al dat in de Inuit populatie (een 
eskimo stam aan de westkust van Groenland) de mortaliteit ten gevolge van hart- en vaatziekten 
lager was dan bij een vergelijkbare populatie Denen. Zij brachten deze bevinding in relatie met 
een verhoogde visconsumptie. Sindsdien hebben vele onderzoekers de effecten van visolie 
bestudeerd op atherosclerose. Hieruit bleek dat het gunstige effect van visconsumptie wordt 
veroarzaakt door de visolie. In hoofdstuk 7 word! ingegaan ap welke wijze visolie atherosclerose 
gunstig kan beInvloeden. Verder worden ook de effecten van visolie op experimenteie 
atherosclerose in dierrnodellen besproken. Het gunstige effect van visolie op het ontstaan en de 
progressie van atherosclerose gebeurt op velerlei manieren, waaronder modificatie van plasma 
IipoproteInen, hloedplaatjes en endotheel functie, ontstekingsreacties en groeifactoren. 
Dat visolie atherosclerose, gemeten aan intima verdikking, kan verminderen in veneuze 
bypass transplantaten is reeds aangetoond in hypercholesterolemische handen. In hoofdstuk 8 
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wordt ingegaan op de vraag ofhet effect van visolie op de transplantaten tot stand komt door een 
direkt effect van de n-3 vetzuren in visolie of door een taename in de meervoudig 
onverzadigd/verzadigd vetzuur ratio. Daarom zijn de effecten van visolie vergeleken met de 
effecten van zonnebloemolie en reuzel vet op de transpiantaten. Oak is onderzocht of de 
samenstelling van de lipoproteinen hierin een rol speell. In hoofdstuk 9 worden de effecten van 
visolie op regressie van atherosclerose in de transplantaten besproken. In dierexperimenteel 
onderzoek is aangetoond dat visolie het gUllstige effect van plasma cholesterol verlaging op 
regressie van atherosclerose kan potentieren, maar o~bekend is of dit oak geldt voor veneuze 
bypass transplantaten. 
Deze probleemstellingen werden onderzocht in een hypercholesterolemisch varkensmodel 
voce veneuze bypass transplantaten. In tegenstelling tot de studies in honden, zagen we in de 
transplantaten geen voordeel van dieet visolie ten opzichte van dieet zonnebloemolie en 
reuzelvet, beoordeeld aan de hand van lipideinfiltratie en morfometrie (vaat vernauwing en 
intima dikte). Morfometrisch onderzoek liet ook geen verschil zien in de controle vene en de 
linker circumflex coronair arterie tussen de drie groepen. Een verschil tussen de drie 
hypercholesterolemische groepen werd gezien in de infrarenale abdominale aorta. De 
atheroselerotische aorta of een representatief stuk aorta uit hetzelfde gebied bevatte in de visolie 
groep significant minder totaal cholesterol, met name cholesterolester, dan in de zonnebloemolie 
en reuzelvet groepen. Verdere analyse liet zien, dat de veranderingen in cholesterol accumulatie 
in de aorta gerelateerd zijn aan de veranderingen in plasma VLDL-cholesterol. De waargenomen 
verschillen in de effecten van visolie op lipide accumulatie in de transplantaten en de aorta 
suggereren, dat de aanwezigheid van een optimaal functionerende endotheellaag 
(binnenbekleding van een vat en een belangrijk verschil tussen de recent geplaatste veneuze 
bypass graft en de "intacte" aorta) een vereiste is om een positief effect van visolie op 
atherosclerose te zien. 
De resultaten in hoofdstuk 9 tonen aan, dat verlaging van het plasma cholesterol en niet 
de aanwezigheid van visolie, zonnebloemolie, reuzel vet of koolhydraten in het dieet een groot 
effect heeft op lipide aecumulatie in de transplantaten. Aangezien de morfometrische grootheden 
niet verbeteren ten opzichte van de inductie groep, lijlct regressie van atherosclerose in de 
transplantaten afhankelijk te zijn van de gebruikte meetmethode. In de aorta was er geen afname 
in cholesterolaccumulatie te zien, maar deze bleek ook in de regressie studie gerelateerd te zijn 
aan de VLDL concentratie. De afnames in cholesterol accumulatie in de transplantaten en de 
controle vene, maar niet in de aorta, suggereren dat verschillende mechanismen ten grondslag 
liggen aan het verloop van het atherosclerose praces in venen en arterien. Het is mogelijk dat 
ook bier de VLDL concentratie een rol speett. 
De onderzoeken inzake visolie beschreven in dit proefschrift tonen aan dat visolie geen 
effect heeft op atherosclerose in een veneuze bypass transplantaat. Hoewel de effecten van 
vi solie in de aorta hoopgevend zijn, is het de vraag of visolie wei de aangewezen therapie is 
tegen atheroselerose in de gemiddelde populatie. In het door ons gebruikte 
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hypercholesterolemisch varkensmodel waarin het atherosclerose process wordt versneld heeft 
visolie een vertragend effect op het ontstaan en progressie van atherosclerose. Deze observatie 
is in Qvereenstemming met de bevindingen van Bang et al in de Inuit popuiatie. De verminderde 
incidentie van hart- en vaatziekten in deze populatie ten opzichte van een ook qua leeftijd 
vergelijkbare groep Denen zau oak kunnen wijzen op een preventieve werking van visolie. De 
resultaten in hoofdstuk 8 suggereren dat het endotheel hierin een belangrijke rol speelt, maar 
uitsluitsel kunnen we op dit moment niet geveu, omdat we dit aspect niet hebben onderzocht. 
In hoofdstuk 9 is de belangrijkste bevinding dat verlagiug van de plasma cholesterol concentratie 
een gunstige invloed heeft op cholesterol ophoping in de bypass grafts. Het is mogelijk dat deze 
invloed op de lange duur vruchten zal afwerpen en de occlusie van de transplantaten gunstig 
beInvloedt. We hebben dit niet knnnen staven met ons huidige experimentele proto collen. Een 
langere duur van het experimentele protocol ZQll de resultaten zoals beschreven in de 
hoofdstukken 8 en 9 kunnen veranderen. Een waarneming die een direkte toepassing in de 
kliniek zou knnnen vinden is de relatie tussen cholesterolophoping in de aortawand en de plasma 
VLDL concentratie. Een verlaging van de plasma VLDL concentratie hetzij middels dieet, hetzij 
middels geneesmiddelen lijkt een bruikbare manier om progressie van atherosclerose te 
verminderen. 
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